,bcr_patient_barcode,tx_on_clinical_trial,regimen_number,bcr_drug_barcode,bcr_drug_uuid,total_dose,total_dose_units,prescribed_dose,prescribed_dose_units,number_cycles,days_to_drug_therapy_start,days_to_drug_therapy_end,therapy_types,drug_name,drug_type,drug_type_2,clinical_trail_drug_classification,regimen_indication,regimen_indication_notes,route_of_administrations,therapy_ongoing,measure_of_response,day_of_form_completion,month_of_form_completion,year_of_form_completion,project
4271,TCGA-05-4384,NO,,TCGA-05-4384-D36331,281E8624-371D-4473-BA5E-E41E0C21D551,,,,,NA,61,153,Chemotherapy,Cisplatin|Vinorelbine,Alkylating agent|Antimitotic,Alkylating agent|Antimitotic,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4274,TCGA-05-4384,NO,,TCGA-05-4384-D36334,5B01A1B0-5946-4ECC-A816-E6DC557CF563,,,,,NA,245,426,Ancillary,Zoledronic acid,Antiresorptive,Other,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4273,TCGA-05-4384,NO,,TCGA-05-4384-D36333,8009725B-0627-43CB-B0EB-37B12CCB3848,,,,,NA,395,426,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4275,TCGA-05-4390,NO,,TCGA-05-4390-D36457,1C563458-F78C-43FA-9FD0-9F31F386B0D7,,,,,NA,61,92,Chemotherapy,Cisplatin|Vinorelbine,Alkylating agent|Antimitotic,Alkylating agent|Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4277,TCGA-05-4398,NO,,TCGA-05-4398-D36463,9DC1C815-EC00-4CDE-BB84-3F8EB3DD9B4F,,,,,NA,0,92,Chemotherapy,Carboplatin|Etoposide,Alkylating agent|Topoisomerase inhibitor,Alkylating agent|Topoisomerase inhibitor,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4279,TCGA-05-4402,NO,,TCGA-05-4402-D36467,C22C6B31-7A7B-4961-B95D-137666A2C3FF,,,,,NA,30,91,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4280,TCGA-05-4402,NO,,TCGA-05-4402-D36468,BA9F9930-88F2-4DA0-982D-BEDBEA793B76,,,,,NA,30,91,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4281,TCGA-05-4402,NO,,TCGA-05-4402-D36469,8CEA61DA-614E-4CE9-8202-877E85ECC83F,,,,,NA,122,122,Immunotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4285,TCGA-05-4427,NO,,TCGA-05-4427-D36565,8809622A-D398-4D9D-95B7-92480AD0CA12,,,,,NA,61,122,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4286,TCGA-05-4427,NO,,TCGA-05-4427-D36566,2978B988-DC8D-449A-83CC-6C4831AA0FE2,,,,,NA,61,122,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4287,TCGA-05-4432,NO,,TCGA-05-4432-D36425,50774761-63F6-4356-AFF1-6CB33BC143F8,,,,,NA,31,61,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4288,TCGA-05-4432,NO,,TCGA-05-4432-D36426,7CDBF312-289A-49AD-989C-52221C8B04E8,,,,,NA,31,61,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
4291,TCGA-05-5425,NO,,TCGA-05-5425-D36418,188127D6-E1B8-4C4D-907E-3CEEF9D3C816,,,,,NA,608,669,Immunotherapy,Gefitinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4290,TCGA-05-5425,NO,,TCGA-05-5425-D36417,5BEC112E-BA69-4195-810A-A41A10693781,,,,,NA,700,761,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4289,TCGA-05-5425,NO,,TCGA-05-5425-D36415,B19108E0-0562-45A5-A84F-1EB6D1A472B0,,,,,NA,700,761,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUAD
4293,TCGA-05-5428,NO,,TCGA-05-5428-D36413,871796B4-AAF5-4244-9638-B330F655C4AF,,,,,NA,62,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,10,2012,TCGA-LUAD
4294,TCGA-05-5428,NO,,TCGA-05-5428-D36412,6CA3C122-D3BF-44D7-A79B-A496388F0C6E,,,,,NA,62,153,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUAD
5977,TCGA-13-A5FT,NO,NA,TCGA-13-A5FT-D43570,36283F3D-1E06-4D7C-A64E-DF9B07460DD9,,,,,NA,49,111,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,26,5,2013,TCGA-OV
5978,TCGA-13-A5FT,NO,NA,TCGA-13-A5FT-D43571,F6311109-F942-40EE-BBC7-BC3334388892,,,,,NA,48,117,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,26,5,2013,TCGA-OV
5979,TCGA-13-A5FU,NO,NA,TCGA-13-A5FU-D43573,84B42869-00D9-41FA-BB29-C17DB74E66C9,,,,,NA,35,182,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,26,5,2013,TCGA-OV
5980,TCGA-13-A5FU,NO,NA,TCGA-13-A5FU-D43574,A3157A7F-920B-484C-A9B4-BF6C78BC2CFE,,,,,NA,35,182,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Partial Response,26,5,2013,TCGA-OV
4733,TCGA-18-3412,NO,NA,TCGA-18-3412-D69103,2CDD95C7-2C43-4511-A840-2BD14EDFDF3B,NA,,,,NA,55,117,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,29,12,2014,TCGA-LUSC
4732,TCGA-18-3412,NO,NA,TCGA-18-3412-D69102,C4E06ED4-54B7-4025-A17F-CFF5937F2B8E,NA,,,,NA,55,117,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,29,12,2014,TCGA-LUSC
4734,TCGA-18-3412,NO,NA,TCGA-18-3412-D69104,88067AFE-D1FA-4DD8-8925-16C65BAD165F,NA,,,,NA,287,301,,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,29,12,2014,TCGA-LUSC
4736,TCGA-18-3415,NO,NA,TCGA-18-3415-D67630,13821C6D-01CF-41E5-93E7-6F7B848F4391,NA,,,,NA,95,95,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,11,2014,TCGA-LUSC
4737,TCGA-18-3415,NO,NA,TCGA-18-3415-D67631,17749743-6117-43AE-8421-06703FADDCF0,NA,,,,NA,130,172,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,11,2014,TCGA-LUSC
4735,TCGA-18-3415,NO,NA,TCGA-18-3415-D67629,F1AC6A9E-D576-417C-983B-E8D1AED078B8,NA,,,,NA,95,179,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,11,2014,TCGA-LUSC
7207,TCGA-29-A5NZ,YES,NA,TCGA-29-A5NZ-D59532,B8A9B895-3774-4B7A-8E4E-601BAEEB0C3B,,,,,NA,25,151,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,14,5,2014,TCGA-OV
7203,TCGA-29-A5NZ,YES,NA,TCGA-29-A5NZ-D59533,061ED9E3-C6F0-4348-9A32-9FAAD64DC411,,,,,NA,25,151,,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,14,5,2014,TCGA-OV
7204,TCGA-29-A5NZ,NO,NA,TCGA-29-A5NZ-D59534,2ABD0BB8-6960-48F8-B08D-28AB17CF9FE6,,,,,NA,396,543,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,14,5,2014,TCGA-OV
7205,TCGA-29-A5NZ,NO,NA,TCGA-29-A5NZ-D59535,55F4F735-7B13-4FA5-8105-4B4D8480A870,,,,,NA,396,543,,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Partial Response,14,5,2014,TCGA-OV
7208,TCGA-29-A5NZ,NO,NA,TCGA-29-A5NZ-D59536,F16C6D42-2092-4457-B4B5-D5F1169B78FD,,,,,NA,686,817,,Gemcitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-OV
8029,TCGA-2A-A8VT,NO,NA,TCGA-2A-A8VT-D64628,9804256C-57A6-4DD3-9AAA-5E51F57DAA41,NA,NA,NA,,NA,85,1086,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Stable Disease,4,12,2014,TCGA-PRAD
9569,TCGA-2E-A9G8,NO,NA,TCGA-2E-A9G8-D59815,A4823502-4CBD-4B1E-AEC1-8F2354DAAA6F,NA,,,,NA,488,580,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,5,2014,TCGA-UCEC
9570,TCGA-2E-A9G8,NO,NA,TCGA-2E-A9G8-D59816,B2A9F3C5-EC2F-4E11-A5C9-B9CD9C7BE1FA,NA,,,,NA,488,610,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,5,2014,TCGA-UCEC
9326,TCGA-2G-AAF1,NO,NA,TCGA-2G-AAF1-D58179,1F8DCCB8-BF92-4C0E-8169-CB1EEEF8648C,NA,NA,NA,NA,NA,32,32,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,8,4,2014,TCGA-TGCT
9329,TCGA-2G-AAF6,NO,NA,TCGA-2G-AAF6-D62553,05083A31-871C-437E-ACCF-84C87C420FA3,NA,NA,NA,NA,NA,816,879,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9327,TCGA-2G-AAF6,NO,NA,TCGA-2G-AAF6-D59673,C8A9436C-9541-4925-BF5C-CF0E19E59A4A,NA,NA,NA,NA,NA,816,879,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,20,5,2014,TCGA-TGCT
9328,TCGA-2G-AAF6,NO,NA,TCGA-2G-AAF6-D62552,6B3513CC-EC64-463C-A3D1-189198E7FB3A,NA,NA,NA,NA,NA,816,879,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9331,TCGA-2G-AAF8,NO,NA,TCGA-2G-AAF8-D62554,93E53906-0111-4EC9-AAE2-BBBFD2CEB8C2,NA,NA,NA,NA,NA,3349,3420,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9330,TCGA-2G-AAF8,NO,NA,TCGA-2G-AAF8-D59675,D2F47543-5C2D-49B3-AF5D-F7CF57BB6972,NA,NA,NA,NA,NA,3349,3420,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,20,5,2014,TCGA-TGCT
9334,TCGA-2G-AAFE,NO,NA,TCGA-2G-AAFE-D62556,4967772A-57B7-41FB-AF9B-C81FA3F29F1F,NA,NA,NA,NA,NA,644,686,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9333,TCGA-2G-AAFE,NO,NA,TCGA-2G-AAFE-D62555,AA619083-3413-4C9A-AAB1-B2CF1E2F7391,NA,NA,NA,NA,NA,644,686,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9332,TCGA-2G-AAFE,NO,NA,TCGA-2G-AAFE-D59677,799117DC-91CF-4F28-8613-8065874A9989,NA,NA,NA,NA,NA,644,686,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,20,5,2014,TCGA-TGCT
9337,TCGA-2G-AAFG,NO,NA,TCGA-2G-AAFG-D62558,7F6C3C91-267F-44D8-9FA3-C762C1005617,NA,NA,NA,NA,NA,2506,2565,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9335,TCGA-2G-AAFG,NO,NA,TCGA-2G-AAFG-D62367,06E4DC08-EFBE-40BB-9AAC-CCA60D748F67,NA,NA,NA,NA,NA,2506,2565,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,16,7,2014,TCGA-TGCT
9336,TCGA-2G-AAFG,NO,NA,TCGA-2G-AAFG-D62557,1EA1816E-1062-415B-8994-F77E5C448920,NA,NA,NA,NA,NA,2506,2565,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9340,TCGA-2G-AAFH,NO,NA,TCGA-2G-AAFH-D62560,D871DB1F-9058-4502-B9BF-631333F6F8B8,NA,NA,NA,NA,NA,22,79,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9338,TCGA-2G-AAFH,NO,NA,TCGA-2G-AAFH-D58307,6895ECEF-69CD-4C66-A52F-77277291AB77,NA,NA,NA,NA,NA,22,79,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,8,4,2014,TCGA-TGCT
9339,TCGA-2G-AAFH,NO,NA,TCGA-2G-AAFH-D62559,7075DFE6-7755-482C-A7D3-6DBA0C8D611A,NA,NA,NA,NA,NA,22,79,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9346,TCGA-2G-AAFL,NO,NA,TCGA-2G-AAFL-D62564,6DEB0CF1-5EA7-423B-B6E3-62C5459A112D,NA,NA,NA,NA,NA,135,180,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9344,TCGA-2G-AAFL,NO,NA,TCGA-2G-AAFL-D59684,A57E2607-A4D1-4BDB-ABA5-57A56F39627D,NA,NA,NA,NA,NA,135,180,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9345,TCGA-2G-AAFL,NO,NA,TCGA-2G-AAFL-D62563,EC965EDF-91A2-4A73-956E-9DD5AF921F1D,NA,NA,NA,NA,NA,135,180,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9349,TCGA-2G-AAFM,NO,NA,TCGA-2G-AAFM-D62566,AC2A0BC2-713A-4956-81B5-91DF1F0B3BD5,NA,NA,NA,NA,NA,18,74,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9347,TCGA-2G-AAFM,NO,NA,TCGA-2G-AAFM-D59291,48E2A041-3009-480C-B50A-CCF9754A10BD,NA,NA,NA,NA,NA,18,74,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9348,TCGA-2G-AAFM,NO,NA,TCGA-2G-AAFM-D62565,9890C983-BDB5-44AB-B9E8-70524274F962,NA,NA,NA,NA,NA,18,74,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9351,TCGA-2G-AAFN,NO,NA,TCGA-2G-AAFN-D62567,F26DDB00-F773-4C5C-8804-8201E8B5B318,NA,NA,NA,NA,NA,18,91,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9350,TCGA-2G-AAFN,NO,NA,TCGA-2G-AAFN-D59293,8FB6BEE1-A19F-469A-B5D4-C8F74185AAF5,NA,NA,NA,NA,NA,18,91,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9354,TCGA-2G-AAFO,NO,NA,TCGA-2G-AAFO-D62569,8004AF50-9497-4914-BEAB-2A348EBAFB7A,NA,NA,NA,NA,NA,25,71,Hormone Therapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9352,TCGA-2G-AAFO,NO,NA,TCGA-2G-AAFO-D59295,15FAB13C-6AB6-4D73-B33E-8793BEB1947C,NA,NA,NA,NA,NA,25,71,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9353,TCGA-2G-AAFO,NO,NA,TCGA-2G-AAFO-D62568,EA104544-DF76-4B1A-A0E4-1C632AC806AE,NA,NA,NA,NA,NA,25,71,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9357,TCGA-2G-AAFY,NO,NA,TCGA-2G-AAFY-D62574,3395F6FE-BE7C-40B2-B2EC-0FD735F8B99C,NA,NA,NA,NA,NA,11,71,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9355,TCGA-2G-AAFY,NO,NA,TCGA-2G-AAFY-D59302,513E69E0-26EF-40C3-8451-D3B434E76871,NA,NA,NA,NA,NA,11,71,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9356,TCGA-2G-AAFY,NO,NA,TCGA-2G-AAFY-D62573,E66340CD-D2D1-4CE2-96DD-19E95ABDBB7D,NA,NA,NA,NA,NA,11,71,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9359,TCGA-2G-AAFZ,NO,NA,TCGA-2G-AAFZ-D62575,3D4F9D6E-AD7D-4750-AA4F-1767EEC029C5,NA,NA,NA,NA,NA,11,13,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,21,7,2014,TCGA-TGCT
9360,TCGA-2G-AAFZ,NO,NA,TCGA-2G-AAFZ-D62576,83BB795B-B2A0-43E3-8A4F-361D756A866C,NA,NA,NA,NA,NA,11,79,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,21,7,2014,TCGA-TGCT
9358,TCGA-2G-AAFZ,NO,NA,TCGA-2G-AAFZ-D59304,A6A1D159-01B4-426A-AE86-4C72A4515066,NA,NA,NA,NA,NA,11,79,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,3,6,2014,TCGA-TGCT
9363,TCGA-2G-AAG0,NO,NA,TCGA-2G-AAG0-D62578,997CC56B-2D5B-475B-8F88-3726FB7F4620,NA,NA,NA,NA,NA,92,135,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9361,TCGA-2G-AAG0,NO,NA,TCGA-2G-AAG0-D59687,33B93107-705D-48AF-BA99-CBB4401AD87E,NA,NA,NA,NA,NA,92,135,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9362,TCGA-2G-AAG0,NO,NA,TCGA-2G-AAG0-D62577,9CA5FC3B-E21F-48FC-9977-4BA15F573B3E,NA,NA,NA,NA,NA,92,135,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,21,7,2014,TCGA-TGCT
9366,TCGA-2G-AAG5,NO,NA,TCGA-2G-AAG5-D62855,52A687BF-079D-480F-A95E-9681ECDE5CEF,NA,NA,NA,NA,NA,480,515,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9364,TCGA-2G-AAG5,NO,NA,TCGA-2G-AAG5-D59691,3E205E48-EF71-4340-9C35-4F274EBB28E7,NA,NA,NA,NA,NA,480,515,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9365,TCGA-2G-AAG5,NO,NA,TCGA-2G-AAG5-D62854,760A00CC-9CC9-41B4-AEC0-2573A4A61A36,NA,NA,NA,NA,NA,480,515,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9369,TCGA-2G-AAG8,NO,NA,TCGA-2G-AAG8-D62857,48CE32AB-FCE9-41D9-8F64-AECCE648D21A,NA,NA,NA,NA,NA,29,73,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9367,TCGA-2G-AAG8,NO,NA,TCGA-2G-AAG8-D59437,308F5B35-7FD1-46E4-8D78-415EC16A4E71,NA,NA,NA,NA,NA,29,73,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9368,TCGA-2G-AAG8,NO,NA,TCGA-2G-AAG8-D62856,7B123EB1-853F-401F-8CA9-154D35EE3716,NA,NA,NA,NA,NA,29,73,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9372,TCGA-2G-AAG9,NO,NA,TCGA-2G-AAG9-D62859,FC5AE19C-B59D-468A-A312-6E2D60CDABD8,NA,NA,NA,NA,NA,5,63,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9370,TCGA-2G-AAG9,NO,NA,TCGA-2G-AAG9-D59439,70263870-E07A-4A42-8ACD-ACBFA988915B,NA,NA,NA,NA,NA,5,63,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,3,6,2014,TCGA-TGCT
9371,TCGA-2G-AAG9,NO,NA,TCGA-2G-AAG9-D62858,0B1A2365-860E-4159-BA51-45D54AAFB2BF,NA,NA,NA,NA,NA,5,63,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9373,TCGA-2G-AAGA,NO,NA,TCGA-2G-AAGA-D59441,09624419-27BA-4DBF-A4F5-38FD71990102,NA,NA,NA,NA,NA,124,128,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9375,TCGA-2G-AAGA,NO,NA,TCGA-2G-AAGA-D62861,A75A832E-02CD-4C8B-AF3F-9297578BB955,NA,NA,NA,NA,NA,124,195,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9374,TCGA-2G-AAGA,NO,NA,TCGA-2G-AAGA-D62860,6AE7B021-A825-4030-BD7A-0CED9287A332,NA,NA,NA,NA,NA,124,195,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9378,TCGA-2G-AAGC,NO,NA,TCGA-2G-AAGC-D62865,87D911F9-F7C6-45A0-A322-0060667567CF,NA,NA,NA,NA,NA,371,402,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9376,TCGA-2G-AAGC,NO,NA,TCGA-2G-AAGC-D59692,9DF43BB8-BA99-4B18-8580-A9C1F0B72400,NA,NA,NA,NA,NA,371,402,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9377,TCGA-2G-AAGC,NO,NA,TCGA-2G-AAGC-D62864,063DCED2-8164-4ED4-AD4C-F1A2885AAD56,NA,NA,NA,NA,NA,371,402,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9381,TCGA-2G-AAGE,NO,NA,TCGA-2G-AAGE-D62867,9B5DB620-F561-4109-987E-916ABB126E24,NA,NA,NA,NA,NA,127,171,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9379,TCGA-2G-AAGE,NO,NA,TCGA-2G-AAGE-D59693,7D71382C-A0EF-4A0E-A792-7759D13466C0,NA,NA,NA,NA,NA,127,171,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9380,TCGA-2G-AAGE,NO,NA,TCGA-2G-AAGE-D62866,637E1D06-009B-4834-A3AB-63857B6FE82B,NA,NA,NA,NA,NA,127,171,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9384,TCGA-2G-AAGF,NO,NA,TCGA-2G-AAGF-D62869,ED187D87-EB87-4149-97C0-90565A90D4BF,NA,NA,NA,NA,NA,144,202,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9382,TCGA-2G-AAGF,NO,NA,TCGA-2G-AAGF-D59694,77157B04-5037-49BA-8CCC-8BCED15EFB38,NA,NA,NA,NA,NA,144,202,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,3,6,2014,TCGA-TGCT
9383,TCGA-2G-AAGF,NO,NA,TCGA-2G-AAGF-D62868,43DC0CE8-1488-4A94-9B27-84A12D4594D9,NA,NA,NA,NA,NA,144,202,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9387,TCGA-2G-AAGG,NO,NA,TCGA-2G-AAGG-D62871,8C3F758B-9FD8-49E8-A41D-FD3D85811E3C,NA,NA,NA,NA,NA,11,56,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9385,TCGA-2G-AAGG,NO,NA,TCGA-2G-AAGG-D59500,77843205-55F8-4B9A-B81D-CB4E6C6795C0,NA,NA,NA,NA,NA,11,56,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9386,TCGA-2G-AAGG,NO,NA,TCGA-2G-AAGG-D62870,A8E42395-0C84-4909-9F6F-3FA950AB29C0,NA,NA,NA,NA,NA,11,56,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9390,TCGA-2G-AAGJ,NO,NA,TCGA-2G-AAGJ-D62873,E6C7F310-9545-4C4E-B9CC-1D5268E8FFD3,NA,NA,NA,NA,NA,173,229,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9388,TCGA-2G-AAGJ,NO,NA,TCGA-2G-AAGJ-D59696,A0B9B1A9-494B-4A42-82F6-D787D32C6277,NA,NA,NA,NA,NA,173,229,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9389,TCGA-2G-AAGJ,NO,NA,TCGA-2G-AAGJ-D62872,AD31BD45-FF94-43BB-824F-9D87106D89C5,NA,NA,NA,NA,NA,173,229,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9393,TCGA-2G-AAGK,NO,NA,TCGA-2G-AAGK-D62875,4D3DC4F3-0A3C-438E-ACCD-6AC14127A347,NA,NA,NA,NA,NA,718,774,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9391,TCGA-2G-AAGK,NO,NA,TCGA-2G-AAGK-D59697,0ED4EEDB-2A67-47A0-8EAB-0AADCD90CCFD,NA,NA,NA,NA,NA,718,774,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9392,TCGA-2G-AAGK,NO,NA,TCGA-2G-AAGK-D62874,D8821E8F-6B32-4441-A1A7-F22404382DD3,NA,NA,NA,NA,NA,718,774,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9394,TCGA-2G-AAGN,NO,NA,TCGA-2G-AAGN-D59551,16C1C4BE-4005-40E8-B0D8-ABD185EFC1DA,NA,NA,NA,NA,NA,11,71,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9396,TCGA-2G-AAGN,NO,NA,TCGA-2G-AAGN-D62879,F16B4FFB-D9DD-4C2A-81AA-3B8D73E50393,NA,NA,NA,NA,NA,11,80,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9395,TCGA-2G-AAGN,NO,NA,TCGA-2G-AAGN-D62878,A0E3C05E-1516-4A9B-A965-E527CCDA9EEC,NA,NA,NA,NA,NA,11,80,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9399,TCGA-2G-AAGO,NO,NA,TCGA-2G-AAGO-D63442,71F0C700-7829-4547-A187-7FD423BDD160,NA,NA,NA,NA,NA,28,84,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,11,8,2014,TCGA-TGCT
9397,TCGA-2G-AAGO,NO,NA,TCGA-2G-AAGO-D60243,0BD1342F-C56A-4340-BD87-972022CDBB98,NA,NA,NA,NA,NA,28,84,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9398,TCGA-2G-AAGO,NO,NA,TCGA-2G-AAGO-D63441,A543B184-2D2B-40F5-A5A2-54187E838AFD,NA,NA,NA,NA,NA,28,84,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,11,8,2014,TCGA-TGCT
9402,TCGA-2G-AAGP,NO,NA,TCGA-2G-AAGP-D62881,41BB6F92-32C4-4ECC-B654-4C27B8D2E777,NA,NA,NA,NA,NA,8,53,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9400,TCGA-2G-AAGP,NO,NA,TCGA-2G-AAGP-D59554,3FBB3CFB-CDA1-42B2-B31B-62C2191AA3E2,NA,NA,NA,NA,NA,8,53,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9401,TCGA-2G-AAGP,NO,NA,TCGA-2G-AAGP-D62880,94514FF9-7E5D-4C4A-8CEF-C5012C00865B,NA,NA,NA,NA,NA,8,53,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9405,TCGA-2G-AAGS,NO,NA,TCGA-2G-AAGS-D62887,CF3BF15F-B0DF-409F-B3DB-B06B744C86D1,NA,NA,NA,NA,NA,17,49,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9403,TCGA-2G-AAGS,NO,NA,TCGA-2G-AAGS-D61132,F3000EF3-9660-45BA-9587-754026A59013,NA,NA,NA,NA,NA,17,49,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9404,TCGA-2G-AAGS,NO,NA,TCGA-2G-AAGS-D62886,5432E030-D713-4D0A-88F8-7B49330DF489,NA,NA,NA,NA,NA,17,49,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9408,TCGA-2G-AAGT,NO,NA,TCGA-2G-AAGT-D62889,F935AFAC-23B7-45F5-882E-E0F5CACB1327,NA,NA,NA,NA,NA,11,71,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9406,TCGA-2G-AAGT,NO,NA,TCGA-2G-AAGT-D59698,645393CC-A8E7-4AB6-8386-26C51964F8E8,NA,NA,NA,NA,NA,11,71,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9407,TCGA-2G-AAGT,NO,NA,TCGA-2G-AAGT-D62888,EF80BAF8-CC5E-41A2-B31A-653F68674B27,NA,NA,NA,NA,NA,11,71,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,28,7,2014,TCGA-TGCT
9411,TCGA-2G-AAGV,NO,NA,TCGA-2G-AAGV-D62893,6FB5ED3A-90F6-4403-B58B-AF0C13E52BA0,NA,NA,NA,NA,NA,3,62,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9409,TCGA-2G-AAGV,NO,NA,TCGA-2G-AAGV-D59565,167452B1-68C9-481F-9062-1EDA81DB6B24,NA,NA,NA,NA,NA,3,62,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9410,TCGA-2G-AAGV,NO,NA,TCGA-2G-AAGV-D62892,F026EDDD-FDA9-4027-8EA6-879E6B52371B,NA,NA,NA,NA,NA,3,62,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-TGCT
9414,TCGA-2G-AAGZ,NO,NA,TCGA-2G-AAGZ-D62915,61B7930A-5579-49FA-9CDD-1B4F1AE3B521,NA,NA,NA,NA,NA,-1,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9412,TCGA-2G-AAGZ,NO,NA,TCGA-2G-AAGZ-D59608,6A4164F6-36B1-48B6-81DB-4574A8A5CB18,NA,NA,NA,NA,NA,-1,83,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9413,TCGA-2G-AAGZ,NO,NA,TCGA-2G-AAGZ-D62914,9D1EDBE0-80A3-4DA4-B041-D74AF7336A50,NA,NA,NA,NA,NA,-1,83,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9417,TCGA-2G-AAH0,NO,NA,TCGA-2G-AAH0-D62917,E3EC80D3-CA08-421A-9A8C-E4027DF5ED57,NA,NA,NA,NA,NA,122,179,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9415,TCGA-2G-AAH0,NO,NA,TCGA-2G-AAH0-D59699,28632706-582B-432B-81B7-CB763684A525,NA,NA,NA,NA,NA,122,179,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9416,TCGA-2G-AAH0,NO,NA,TCGA-2G-AAH0-D62916,C5184C78-ED90-444C-ABDA-1363FC52485D,NA,NA,NA,NA,NA,122,179,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9420,TCGA-2G-AAH4,NO,NA,TCGA-2G-AAH4-D62919,41C9FDE7-6571-4C83-A40C-B31C4A77D940,NA,NA,NA,NA,NA,9,95,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9418,TCGA-2G-AAH4,NO,NA,TCGA-2G-AAH4-D59615,7A5B6EFB-5235-4D5F-885A-2E4A845E6803,NA,NA,NA,NA,NA,9,95,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9419,TCGA-2G-AAH4,NO,NA,TCGA-2G-AAH4-D62918,AE0E5B6A-19BB-470B-A17C-A8EB59716F5B,NA,NA,NA,NA,NA,9,95,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9423,TCGA-2G-AAH8,NO,NA,TCGA-2G-AAH8-D62923,A05A3552-359A-4ADC-963B-72E9A2397D57,NA,NA,NA,NA,NA,2,68,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9421,TCGA-2G-AAH8,NO,NA,TCGA-2G-AAH8-D59703,302E90CA-5913-44F9-87D5-4B94C083A0B8,NA,NA,NA,NA,NA,2,68,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9422,TCGA-2G-AAH8,NO,NA,TCGA-2G-AAH8-D62922,1B183519-BB90-4D9F-B087-A03A9117F881,NA,NA,NA,NA,NA,2,68,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9426,TCGA-2G-AAHA,NO,NA,TCGA-2G-AAHA-D62926,CA131447-2142-436A-B262-BE5F68382AAB,NA,NA,NA,NA,NA,4,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9424,TCGA-2G-AAHA,NO,NA,TCGA-2G-AAHA-D59707,A4178174-9425-4CDF-9897-C7D2DDE63DD5,NA,NA,NA,NA,NA,4,83,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,4,6,2014,TCGA-TGCT
9425,TCGA-2G-AAHA,NO,NA,TCGA-2G-AAHA-D62925,8C8C9646-5697-45D6-AED1-86AB5F197138,NA,NA,NA,NA,NA,4,83,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9429,TCGA-2G-AAHC,NO,NA,TCGA-2G-AAHC-D62928,FC34170A-F0FD-43B7-9E04-D33D6C43819E,NA,NA,NA,NA,NA,3,50,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9427,TCGA-2G-AAHC,NO,NA,TCGA-2G-AAHC-D59711,378993C6-B8A1-4193-8202-718061C319BB,NA,NA,NA,NA,NA,3,50,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,6,2014,TCGA-TGCT
9428,TCGA-2G-AAHC,NO,NA,TCGA-2G-AAHC-D62927,5908FFE6-A3CE-4D8E-B0CF-F0E88A3619EB,NA,NA,NA,NA,NA,3,50,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9432,TCGA-2G-AAKD,NO,NA,TCGA-2G-AAKD-D62946,029B034E-863E-42CC-A360-273369B5B04F,NA,NA,NA,NA,NA,-4,45,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9430,TCGA-2G-AAKD,NO,NA,TCGA-2G-AAKD-D60247,B2B07B95-7F6E-48CD-8ADF-9BA871610E48,NA,NA,NA,NA,NA,-4,45,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,20,6,2014,TCGA-TGCT
9431,TCGA-2G-AAKD,NO,NA,TCGA-2G-AAKD-D62944,F0F0DAD5-FF40-46A6-90AB-64B02818A6AD,NA,NA,NA,NA,NA,-4,45,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9435,TCGA-2G-AAKG,NO,NA,TCGA-2G-AAKG-D62950,21440746-AF3A-40E2-ACA2-344D1CE95C4B,NA,NA,NA,NA,NA,134,182,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9433,TCGA-2G-AAKG,NO,NA,TCGA-2G-AAKG-D60322,4968C24A-19BC-4BF0-9123-AF9E3F4C157B,NA,NA,NA,NA,NA,134,182,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,20,6,2014,TCGA-TGCT
9434,TCGA-2G-AAKG,NO,NA,TCGA-2G-AAKG-D62948,9EA591BD-34CA-4E55-AC90-3E97B437ECE3,NA,NA,NA,NA,NA,134,182,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9438,TCGA-2G-AAKH,NO,NA,TCGA-2G-AAKH-D62953,1EAC7600-A1B9-4958-9FA2-6D22B6C20572,NA,NA,NA,NA,NA,24,65,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9436,TCGA-2G-AAKH,NO,NA,TCGA-2G-AAKH-D60325,A9955F9A-6421-4253-A108-E67F5BED4E68,NA,NA,NA,NA,NA,24,65,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,20,6,2014,TCGA-TGCT
9437,TCGA-2G-AAKH,NO,NA,TCGA-2G-AAKH-D62952,6A80B03A-F51C-437F-9F5D-E047D5CB65B2,NA,NA,NA,NA,NA,24,65,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9441,TCGA-2G-AAKL,NO,NA,TCGA-2G-AAKL-D62957,10808A07-B59B-4AFD-B9DC-852D4EF79473,NA,NA,NA,NA,NA,6,78,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9439,TCGA-2G-AAKL,NO,NA,TCGA-2G-AAKL-D60330,BC1B0E9A-7BF5-489B-A237-9FBBFEE5CBB2,NA,NA,NA,NA,NA,6,78,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,20,6,2014,TCGA-TGCT
9440,TCGA-2G-AAKL,NO,NA,TCGA-2G-AAKL-D62956,E788CD02-43CF-467E-97F3-C9DC882D2E4D,NA,NA,NA,NA,NA,6,78,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9444,TCGA-2G-AAKM,NO,NA,TCGA-2G-AAKM-D62959,ED71C67D-7B20-4AA1-9EC3-3A281905EEF6,NA,NA,NA,NA,NA,4,50,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9442,TCGA-2G-AAKM,NO,NA,TCGA-2G-AAKM-D60332,15DF0420-94C7-4279-906F-511661C8ECDF,NA,NA,NA,NA,NA,4,50,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,20,6,2014,TCGA-TGCT
9443,TCGA-2G-AAKM,NO,NA,TCGA-2G-AAKM-D62958,4788B8BA-6100-4BF6-91DA-FC7F2BCD8525,NA,NA,NA,NA,NA,4,50,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,29,7,2014,TCGA-TGCT
9447,TCGA-2G-AAL7,NO,NA,TCGA-2G-AAL7-D62963,51B74AF8-7F1C-4FAF-9295-02FF011241BE,NA,NA,NA,NA,NA,15,71,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
9445,TCGA-2G-AAL7,NO,NA,TCGA-2G-AAL7-D60346,602C5878-8ADB-4F24-888E-8F1A458C4500,NA,NA,NA,NA,NA,15,71,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,20,6,2014,TCGA-TGCT
9446,TCGA-2G-AAL7,NO,NA,TCGA-2G-AAL7-D62962,8CE74702-EDAE-4DDA-895F-F7B4C485F96F,NA,NA,NA,NA,NA,15,71,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,29,7,2014,TCGA-TGCT
7782,TCGA-2L-AAQA,NO,NA,TCGA-2L-AAQA-D62943,5D3AD779-FBE7-47E6-B637-7117FD435A60,NA,NA,NA,NA,NA,82,126,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,7,2014,TCGA-PAAD
7783,TCGA-2L-AAQE,NO,NA,TCGA-2L-AAQE-D67050,84A1AD20-F28D-467D-853A-BAB1608F7EB1,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,10,2014,TCGA-PAAD
7784,TCGA-2L-AAQI,NO,NA,TCGA-2L-AAQI-D62945,BAEB6BC0-C599-4813-86AC-B5EDEA4D74C8,NA,NA,NA,NA,NA,42,72,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,7,2014,TCGA-PAAD
7785,TCGA-2L-AAQJ,NO,NA,TCGA-2L-AAQJ-D67342,8D5D9FBE-2C5E-4AB8-A1CF-47C82B31A3DC,NA,NA,NA,NA,NA,50,171,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,4,11,2014,TCGA-PAAD
2728,TCGA-2W-A8YY,NO,NA,TCGA-2W-A8YY-D58309,14ACEFE0-DDC0-4A31-B354-D0A304A6C773,NA,,NA,,NA,57,99,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2014,TCGA-CESC
9448,TCGA-2X-A9D5,,NA,TCGA-2X-A9D5-D59250,B83B6E04-91DA-4711-AC5E-D891F5D141B8,NA,NA,NA,NA,NA,18,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,6,5,2014,TCGA-TGCT
9449,TCGA-2X-A9D5,,NA,TCGA-2X-A9D5-D59251,E0AEF07D-204B-48A8-8B57-D038CF19A65A,NA,NA,NA,NA,NA,18,83,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,6,5,2014,TCGA-TGCT
4205,TCGA-2Y-A9GV,NO,NA,TCGA-2Y-A9GV-D66920,2ED70472-0453-4F85-9A75-C8A9A6BDD3A9,NA,,NA,,NA,2233,2304,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,3,11,2014,TCGA-LIHC
4208,TCGA-2Y-A9H8,YES,NA,TCGA-2Y-A9H8-D67251,D29ED18B-0AEF-4D85-B579-589538D17FC5,NA,,NA,,NA,498,608,Chemotherapy,Everolimus,MTOR inhibitor,Other,,,,,NO,Stable Disease,3,11,2014,TCGA-LIHC
4158,TCGA-2Z-A9J3,YES,NA,TCGA-2Z-A9J3-D65744,686D5742-2924-4E7C-B54D-744767ECBC56,,,,,NA,83,295,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,24,10,2014,TCGA-KIRP
4784,TCGA-33-AASI,NO,NA,TCGA-33-AASI-D64999,8857466A-8AD5-472C-8399-A5CD3401FA1B,NA,,,,NA,134,134,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,17,9,2014,TCGA-LUSC
4783,TCGA-33-AASI,NO,NA,TCGA-33-AASI-D64998,C630A1CC-8E2B-4990-BA84-F83DC8A38A24,NA,,,,NA,134,134,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,17,9,2014,TCGA-LUSC
4793,TCGA-34-5240,NO,NA,TCGA-34-5240-D32184,438C956F-7388-49AC-8481-B4539EAD5862,NA,,,,NA,153,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,5,2012,TCGA-LUSC
4794,TCGA-34-5240,NO,NA,TCGA-34-5240-D32185,556A6EAD-B090-40C5-B986-2E678C7DF5C0,NA,,,,NA,153,153,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,5,2012,TCGA-LUSC
4798,TCGA-34-8454,NO,NA,TCGA-34-8454-D69228,C9C9AE41-AAAD-4E3B-BF53-0F5911C456CB,NA,,,,NA,68,166,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,30,12,2014,TCGA-LUSC
4799,TCGA-37-A5EL,NO,NA,TCGA-37-A5EL-D72519,7B1CC5D3-BB08-46A8-9158-57B6E7682D2C,NA,,,,NA,222,228,Chemotherapy,Temozolomide,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,9,7,2015,TCGA-LUSC
7787,TCGA-3A-A9I5,YES,NA,TCGA-3A-A9I5-D64508,E180BA5B-E2C2-45B6-93A4-885CD36D165C,NA,NA,NA,NA,NA,110,147,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,24,9,2014,TCGA-PAAD
7786,TCGA-3A-A9I5,YES,NA,TCGA-3A-A9I5-D64507,3CEA9A6E-C1FB-4402-8B02-46E1337DA20E,NA,NA,NA,NA,NA,78,211,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,24,9,2014,TCGA-PAAD
7795,TCGA-3A-A9I9,NO,NA,TCGA-3A-A9I9-D64535,E44D1857-36A4-4259-94BA-45C07E6373E2,NA,NA,NA,NA,NA,73,265,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7794,TCGA-3A-A9I9,NO,NA,TCGA-3A-A9I9-D64534,897A53DE-6974-49EC-9C07-9A7F2F0AA8D3,NA,NA,NA,NA,NA,97,336,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7793,TCGA-3A-A9I9,NO,NA,TCGA-3A-A9I9-D64533,C68A0307-9A5A-48CB-A3A9-09CCA1231F9E,NA,NA,NA,NA,NA,294,336,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7797,TCGA-3A-A9I9,NO,NA,TCGA-3A-A9I9-D64537,D6E7D11E-25A5-4C42-B27D-4E35BDCDC9B9,NA,NA,NA,NA,NA,518,620,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,24,9,2014,TCGA-PAAD
7796,TCGA-3A-A9I9,NO,NA,TCGA-3A-A9I9-D64536,9D2D7777-3330-49DC-871E-E0EBA9310FB0,NA,NA,NA,NA,NA,518,620,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,24,9,2014,TCGA-PAAD
7800,TCGA-3A-A9IC,NO,NA,TCGA-3A-A9IC-D64558,4A9CFA3E-9372-4D34-B5DB-579E094EDDF5,NA,NA,NA,NA,NA,98,105,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7799,TCGA-3A-A9IC,NO,NA,TCGA-3A-A9IC-D64557,A63CD170-5C14-4878-8A6A-1A0B15722D93,NA,NA,NA,NA,NA,125,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7798,TCGA-3A-A9IC,NO,NA,TCGA-3A-A9IC-D64556,442D6AAE-BB31-4FFF-B678-346DEEF7600F,NA,NA,NA,NA,NA,168,245,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7801,TCGA-3A-A9IC,NO,NA,TCGA-3A-A9IC-D64559,CE667EC1-F176-480E-81CA-293C5E960AA7,NA,NA,NA,NA,NA,512,722,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,24,9,2014,TCGA-PAAD
7802,TCGA-3A-A9IH,NO,NA,TCGA-3A-A9IH-D64566,4EF5B0EB-E7CF-43AC-91FC-CAB554C73C0F,NA,NA,NA,NA,NA,71,237,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,24,9,2014,TCGA-PAAD
7803,TCGA-3A-A9IH,NO,NA,TCGA-3A-A9IH-D68659,BD64BBAF-218B-49CD-B25E-B5F276D28185,NA,NA,NA,NA,NA,379,538,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,5,12,2014,TCGA-PAAD
7809,TCGA-3A-A9IX,NO,NA,TCGA-3A-A9IX-D65536,1D246263-1DDB-45E2-A7AF-6890ACED07FF,NA,NA,NA,NA,NA,97,128,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,24,9,2014,TCGA-PAAD
7810,TCGA-3A-A9IX,NO,NA,TCGA-3A-A9IX-D65537,697255B1-B7C4-4DAF-B325-F6B0C25C4AA4,NA,NA,NA,NA,NA,155,239,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,24,9,2014,TCGA-PAAD
7811,TCGA-3A-A9IZ,NO,NA,TCGA-3A-A9IZ-D65542,CD66EAEB-39A4-4F5B-8BA8-E7D1D74C88AC,NA,NA,NA,NA,NA,111,224,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,24,9,2014,TCGA-PAAD
7812,TCGA-3A-A9J0,NO,NA,TCGA-3A-A9J0-D65545,CC98A6AA-71CE-453D-B072-1B9854B0F2AD,NA,NA,NA,NA,NA,153,335,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,24,9,2014,TCGA-PAAD
8391,TCGA-3B-A9HI,NO,NA,TCGA-3B-A9HI-D68653,18428FA9-5534-402D-A19C-0C4644083590,NA,,NA,,NA,850,959,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,5,12,2014,TCGA-SARC
8390,TCGA-3B-A9HI,NO,NA,TCGA-3B-A9HI-D67109,5EA39D1D-AA33-43F9-B8CF-2D2A7C2BDB12,NA,,NA,,NA,850,959,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,5,12,2014,TCGA-SARC
8392,TCGA-3B-A9HI,NO,NA,TCGA-3B-A9HI-D67110,A972D93A-7742-4B10-B940-07B48E681B53,NA,,NA,,NA,983,1262,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,30,12,2014,TCGA-SARC
8393,TCGA-3B-A9HI,NO,NA,TCGA-3B-A9HI-D67111,F6E1D28B-02E9-4B1C-9AE3-7B79F34DD15F,NA,,NA,,NA,983,1262,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,30,12,2014,TCGA-SARC
8397,TCGA-3B-A9HL,NO,NA,TCGA-3B-A9HL-D67363,7F868C4E-9F4C-4837-9827-528244347D9A,NA,,NA,,NA,229,432,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,4,11,2014,TCGA-SARC
8398,TCGA-3B-A9HL,NO,NA,TCGA-3B-A9HL-D67364,A08F4459-C37C-4652-A555-0E4BEA0B8E80,NA,,NA,,NA,229,432,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,4,11,2014,TCGA-SARC
8400,TCGA-3B-A9HP,NO,NA,TCGA-3B-A9HP-D68524,B2360E51-9CED-4D6B-998F-C330E0B7C699,NA,,NA,,NA,595,616,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,24,11,2014,TCGA-SARC
8401,TCGA-3B-A9HP,NO,NA,TCGA-3B-A9HP-D68525,7DC62343-856B-48C6-8D43-E4DA4463F70F,NA,,NA,,NA,595,616,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,24,11,2014,TCGA-SARC
8404,TCGA-3B-A9HR,NO,NA,TCGA-3B-A9HR-D68590,F77080D1-6AC0-42D0-9F01-678FA9F0306E,NA,,NA,,NA,1425,1621,Chemotherapy,Trabectedin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,1,12,2014,TCGA-SARC
8405,TCGA-3B-A9HR,YES,NA,TCGA-3B-A9HR-D68591,613FA37B-F4F9-4FEA-867F-9E89B0AC3553,NA,,NA,,NA,1758,2096,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,1,12,2014,TCGA-SARC
8406,TCGA-3B-A9HR,NO,NA,TCGA-3B-A9HR-D68592,6085945A-E678-4E14-B9D7-39D04A88BD8E,NA,,NA,,NA,2117,2396,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,1,12,2014,TCGA-SARC
8407,TCGA-3B-A9HR,NO,NA,TCGA-3B-A9HR-D68593,5846808D-0289-44B8-B04B-C17210DC11E5,NA,,NA,,NA,2117,2396,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,1,12,2014,TCGA-SARC
8408,TCGA-3B-A9HR,NO,NA,TCGA-3B-A9HR-D68594,95942730-D152-44C2-B097-CEE4DF9E2EF1,NA,,NA,,NA,2396,2683,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,,,NA,,NO,Clinical Progressive Disease,1,12,2014,TCGA-SARC
8411,TCGA-3B-A9HS,NO,NA,TCGA-3B-A9HS-D68601,782C96B0-5406-4AFB-A630-D57ED5CF3032,NA,,NA,,NA,1034,1132,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,2,12,2014,TCGA-SARC
8412,TCGA-3B-A9HS,NO,NA,TCGA-3B-A9HS-D68602,E008F582-9826-430B-95AE-AD2D5F0F8AD0,NA,,NA,,NA,1034,1132,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,2,12,2014,TCGA-SARC
8414,TCGA-3B-A9HT,NO,NA,TCGA-3B-A9HT-D68608,A5DBA199-0F5F-4C30-978D-F25015901727,NA,,NA,,NA,51,103,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,2,12,2014,TCGA-SARC
8416,TCGA-3B-A9HV,NO,NA,TCGA-3B-A9HV-D68630,A9FE99C8-F16A-41F6-8546-B8CB542E76C0,NA,,NA,,NA,105,270,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8415,TCGA-3B-A9HV,NO,NA,TCGA-3B-A9HV-D68629,CDA1CE4D-C39A-4F5D-8553-1E87ED9488D6,NA,,NA,,NA,112,271,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8418,TCGA-3B-A9HV,NO,NA,TCGA-3B-A9HV-D68632,2419604F-4A3D-423A-A831-742368A39117,NA,,NA,,NA,339,369,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8417,TCGA-3B-A9HV,NO,NA,TCGA-3B-A9HV-D68631,46337714-684D-436F-B191-3899FE559154,NA,,NA,,NA,339,369,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8420,TCGA-3B-A9HZ,NO,NA,TCGA-3B-A9HZ-D68639,A14D3AC9-B008-4365-93D7-A302C3672220,NA,,NA,,NA,482,602,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8419,TCGA-3B-A9HZ,NO,NA,TCGA-3B-A9HZ-D68638,A79EDB17-F4A9-436A-B3B4-C554647096D6,NA,,NA,,NA,482,602,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8421,TCGA-3B-A9HZ,NO,NA,TCGA-3B-A9HZ-D68640,15EF1060-13E4-4D68-8319-D6682C4E38EE,NA,,NA,,NA,834,889,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8423,TCGA-3B-A9HZ,NO,NA,TCGA-3B-A9HZ-D68642,CC5F4D5A-1F73-44E1-9755-A50EEE407775,NA,,NA,,NA,906,1164,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8422,TCGA-3B-A9HZ,NO,NA,TCGA-3B-A9HZ-D68641,92FF8EB2-7B91-433F-8258-95EC5D453D72,NA,,NA,,NA,906,1164,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8424,TCGA-3B-A9I0,YES,NA,TCGA-3B-A9I0-D68644,ECDD97E7-DEEB-4047-B6E7-FD9361AD4F27,NA,,NA,,NA,580,706,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,Chemotherapy,,NA,,NO,Stable Disease,5,12,2014,TCGA-SARC
8426,TCGA-3B-A9I0,NO,NA,TCGA-3B-A9I0-D68646,0087FFBB-A1B6-4358-B3A3-C2A478E6B4E3,NA,,NA,,NA,941,1054,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8425,TCGA-3B-A9I0,NO,NA,TCGA-3B-A9I0-D68645,9A810B8C-48D6-4181-AE50-23A947D5AEB9,NA,,NA,,NA,948,1054,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8427,TCGA-3B-A9I1,NO,NA,TCGA-3B-A9I1-D68648,65534F66-EAAA-41FE-A647-968C23245532,NA,,NA,,NA,71,176,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8429,TCGA-3B-A9I1,NO,NA,TCGA-3B-A9I1-D68650,BEDE14A8-2C61-454C-8B93-237A0FD97CB7,NA,,NA,,NA,332,388,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
8430,TCGA-3B-A9I1,NO,NA,TCGA-3B-A9I1-D68651,9B7ADE90-93B3-4A9F-B507-7D655D8B410B,NA,,NA,,NA,437,500,Immunotherapy,Letrozole,Aromatase inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,5,12,2014,TCGA-SARC
7820,TCGA-3E-AAAZ,NO,NA,TCGA-3E-AAAZ-D65338,17D297D1-B33F-433E-A8FB-624A3894B275,NA,NA,NA,NA,NA,1332,1789,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,24,9,2014,TCGA-PAAD
7818,TCGA-3E-AAAZ,NO,NA,TCGA-3E-AAAZ-D60367,033897A0-BA24-419D-967D-1FBF872B3E34,NA,NA,NA,NA,NA,1332,1789,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,6,6,2014,TCGA-PAAD
5089,TCGA-3H-AB3K,YES,NA,TCGA-3H-AB3K-D63509,B00CC242-1AE5-4622-9840-3E1DF8DE9129,NA,NA,NA,NA,NA,52,71,Targeted Molecular therapy,dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Partial Response,11,8,2014,TCGA-MESO
5091,TCGA-3H-AB3L,YES,NA,TCGA-3H-AB3L-D63585,3A166A84-D66D-495F-8072-540C9414542F,NA,NA,NA,NA,NA,69,96,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,13,8,2014,TCGA-MESO
5092,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60586,429E616F-6A0C-45DC-B85A-EE65490F6D49,NA,NA,NA,NA,NA,38,66,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,11,6,2014,TCGA-MESO
5093,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60588,A7171629-F49E-44F9-8E1A-3BF45896C7C5,NA,NA,NA,NA,NA,120,386,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,11,6,2014,TCGA-MESO
5094,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60589,2CF9BB9E-5A95-446A-8E83-B6436942DE6A,NA,NA,NA,NA,NA,120,386,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,11,6,2014,TCGA-MESO
5096,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60592,271365E2-1DA4-4B0E-8C8D-9E06EE0D87E3,NA,NA,NA,NA,NA,120,386,Targeted Molecular therapy,Everolimus,MTOR inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,11,6,2014,TCGA-MESO
5099,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60596,3DB085C4-DC87-4E33-86D3-1618DC6ADF39,NA,NA,NA,NA,NA,471,604,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,,NA,NA,NA,NO,Stable Disease,11,6,2014,TCGA-MESO
5100,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60597,C621D9B9-8CCC-4B79-9194-7959179B3814,NA,NA,NA,NA,NA,471,604,Targeted Molecular therapy,Temsirolimus,MTOR inhibitor,Other,,NA,NA,NA,NO,Stable Disease,11,6,2014,TCGA-MESO
5098,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60595,8017F9C5-2F43-47AE-BC78-5D2B7A4DEDE3,NA,NA,NA,NA,NA,471,604,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Stable Disease,11,6,2014,TCGA-MESO
5097,TCGA-3H-AB3M,YES,NA,TCGA-3H-AB3M-D60593,2031FB30-84AA-472D-AD8B-F8B00FA789C7,NA,NA,NA,NA,NA,736,800,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,11,6,2014,TCGA-MESO
5101,TCGA-3H-AB3O,YES,NA,TCGA-3H-AB3O-D60479,A95EA018-0F72-45ED-817F-8CE707EF7B6E,NA,NA,NA,NA,NA,54,93,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5103,TCGA-3H-AB3O,NO,NA,TCGA-3H-AB3O-D60484,5D09C250-5B55-4524-8743-CD0BEE1D9C9A,NA,NA,NA,NA,NA,197,286,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5104,TCGA-3H-AB3O,NO,NA,TCGA-3H-AB3O-D60485,B96B4FF5-8914-4BFF-9F03-F79814CBA107,NA,NA,NA,NA,NA,197,286,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5102,TCGA-3H-AB3O,YES,NA,TCGA-3H-AB3O-D60482,622DB14D-E758-4815-93CE-3AB5E9CAB10A,NA,NA,NA,NA,NA,194,908,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5106,TCGA-3H-AB3O,YES,NA,TCGA-3H-AB3O-D60489,56020589-2BBE-4362-B806-2F93399C47A2,NA,NA,NA,NA,NA,1084,1265,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5105,TCGA-3H-AB3O,YES,NA,TCGA-3H-AB3O-D60486,323C388C-AC8E-4F48-BD0C-FEB1B39330A1,NA,NA,NA,NA,NA,1084,1265,Targeted Molecular therapy,Cediranib,Angiogenesis inhibitor,Other,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5107,TCGA-3H-AB3O,YES,NA,TCGA-3H-AB3O-D60490,D5BABB86-CC75-4990-BF03-8BFD62F5FF35,NA,NA,NA,NA,NA,1084,1265,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,10,6,2014,TCGA-MESO
5108,TCGA-3H-AB3S,YES,NA,TCGA-3H-AB3S-D60435,B4870ADF-ACE0-4862-924E-213632306526,NA,NA,NA,NA,NA,47,79,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,9,6,2014,TCGA-MESO
5110,TCGA-3H-AB3S,YES,NA,TCGA-3H-AB3S-D60437,D9802431-50AE-4651-B8E4-EC1FD4E7CCC9,NA,NA,NA,NA,NA,221,264,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,9,6,2014,TCGA-MESO
5109,TCGA-3H-AB3S,YES,NA,TCGA-3H-AB3S-D60436,A84D9FDF-CD5D-4DB2-8B2C-16132EE4AE03,NA,NA,NA,NA,NA,221,275,Targeted Molecular therapy,Erlotinib,HER1 inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,9,6,2014,TCGA-MESO
5112,TCGA-3H-AB3T,YES,NA,TCGA-3H-AB3T-D60425,D6A1EE2F-FE07-4F9F-8A8B-11E8FB7F4479,NA,NA,NA,NA,NA,35,61,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,9,6,2014,TCGA-MESO
5115,TCGA-3H-AB3U,YES,NA,TCGA-3H-AB3U-D60167,0DE236CE-D843-4221-9175-868AA3285E27,NA,NA,NA,NA,NA,90,110,Targeted Molecular therapy,Dasatinib,Hematopoiesis inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,30,5,2014,TCGA-MESO
5117,TCGA-3H-AB3X,NO,NA,TCGA-3H-AB3X-D60158,ACF47B23-2970-496C-AEDD-04663A2B6624,NA,NA,NA,NA,NA,435,461,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,30,5,2014,TCGA-MESO
5118,TCGA-3H-AB3X,NO,NA,TCGA-3H-AB3X-D60159,5A09D695-625B-40A9-A3CF-C5A192ABF453,NA,NA,NA,NA,NA,435,461,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,30,5,2014,TCGA-MESO
4211,TCGA-3K-AAZ8,NO,NA,TCGA-3K-AAZ8-D64051,53F09997-1A79-41DE-A307-66747EA290B2,NA,,NA,,NA,212,304,,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,25,8,2014,TCGA-LIHC
8863,TCGA-3M-AB46,NO,,TCGA-3M-AB46-D62340,A8A6E33A-7DF9-466B-ABD0-F8EB912CAA9E,,,,,NA,92,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,15,7,2014,TCGA-STAD
8864,TCGA-3M-AB46,NO,,TCGA-3M-AB46-D62341,68A96028-7241-4576-BEF3-522FB06F918D,,,,,NA,92,212,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,15,7,2014,TCGA-STAD
8868,TCGA-3M-AB47,YES,,TCGA-3M-AB47-D63807,BD0300F3-3F28-4175-B3A5-66933FBA9BA7,,,,,NA,122,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,19,8,2014,TCGA-STAD
8866,TCGA-3M-AB47,YES,,TCGA-3M-AB47-D62415,0E179CDF-639A-4865-8C10-D026B21350A7,,,,,NA,122,153,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,16,7,2014,TCGA-STAD
8865,TCGA-3M-AB47,YES,,TCGA-3M-AB47-D62414,7085FF17-B2F6-4379-A52C-02E0AE0D3FF8,,,,,NA,122,242,,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,16,7,2014,TCGA-STAD
8869,TCGA-3M-AB47,YES,,TCGA-3M-AB47-D63808,B51C6EE9-22F5-4866-B30E-63C380B27504,,,,,NA,181,242,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,19,8,2014,TCGA-STAD
8867,TCGA-3M-AB47,YES,,TCGA-3M-AB47-D63806,232467AA-D9FE-4745-9752-0D4468BA22B3,,,,,NA,181,242,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,19,8,2014,TCGA-STAD
7432,TCGA-3P-A9WA,NO,NA,TCGA-3P-A9WA-D60124,ADC8FFC1-7FE3-4DBB-A041-FC4CD4F35B60,,,,,NA,92,212,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,29,5,2014,TCGA-OV
7431,TCGA-3P-A9WA,NO,NA,TCGA-3P-A9WA-D60123,CBB9DB6A-C8A4-465E-8180-0CE8BB362721,,,,,NA,92,212,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,29,5,2014,TCGA-OV
5122,TCGA-3U-A98E,YES,NA,TCGA-3U-A98E-D65107,2DC00697-BB27-4F0D-A2B9-F1D982556D5F,NA,NA,NA,NA,NA,802,1060,Targeted Molecular therapy,Apitosilib,MTOR inhibitor,Other,,NA,NA,NA,NO,Partial Response,22,1,2015,TCGA-MESO
5126,TCGA-3U-A98F,NO,NA,TCGA-3U-A98F-D65125,3D7A506C-5E1C-43AE-B76D-BB72E3C3C40B,NA,NA,NA,NA,NA,162,302,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,22,1,2015,TCGA-MESO
5127,TCGA-3U-A98F,NO,NA,TCGA-3U-A98F-D65128,A59F5A5C-1865-42A9-A911-55C504AD38D2,NA,NA,NA,NA,NA,162,302,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,22,1,2015,TCGA-MESO
5133,TCGA-3U-A98J,NO,NA,TCGA-3U-A98J-D65238,0BBED9A2-5DB6-4710-A789-9A8C1FE591FF,NA,NA,NA,NA,NA,137,228,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,22,1,2015,TCGA-MESO
5134,TCGA-3U-A98J,NO,NA,TCGA-3U-A98J-D65240,B0F05433-AA96-4191-B6D4-461FF55E9879,NA,NA,NA,NA,NA,137,228,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,22,1,2015,TCGA-MESO
2928,TCGA-3X-AAV9,NO,NA,TCGA-3X-AAV9-D59950,51CC30E9-BA70-49F4-8F12-C5419751557F,NA,NA,NA,NA,NA,253,326,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,26,5,2014,TCGA-CHOL
2927,TCGA-3X-AAV9,NO,NA,TCGA-3X-AAV9-D59949,24CDD866-74A2-4B6F-813B-CB7C616A642A,NA,NA,NA,NA,NA,253,326,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,26,5,2014,TCGA-CHOL
7439,TCGA-42-2582,NO,NA,TCGA-42-2582-D31446,44CFCC79-0825-468C-84A0-5E1288307CF4,,,,,NA,800,955,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Stable Disease,2,5,2012,TCGA-OV
4840,TCGA-43-5668,NO,NA,TCGA-43-5668-D31292,E44C56C7-883C-4560-BFBD-D8C992F20603,NA,,,,NA,481,551,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,27,4,2012,TCGA-LUSC
4845,TCGA-43-6647,NO,NA,TCGA-43-6647-D39008,2082F424-9D4C-44E3-96D9-BAD10FDCDC08,NA,,,,NA,90,153,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,1,2013,TCGA-LUSC
4844,TCGA-43-6647,NO,NA,TCGA-43-6647-D39007,DDB4549A-5D4F-4E62-90EC-22EEB9E1F68F,NA,,,,NA,90,153,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,8,1,2013,TCGA-LUSC
4851,TCGA-43-A474,NO,NA,TCGA-43-A474-D37080,845EAC18-C727-4CFE-BA04-6A068BB970AF,NA,,,,NA,101,172,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,11,2012,TCGA-LUSC
4852,TCGA-43-A474,NO,NA,TCGA-43-A474-D37081,F29D1667-A937-43BA-BE77-E4C62F4A0216,NA,,,,NA,101,172,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,23,11,2012,TCGA-LUSC
4853,TCGA-43-A475,NO,NA,TCGA-43-A475-D37108,B4808E6D-57FF-4965-991C-FD0813625EBC,NA,,,,NA,109,172,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,11,2012,TCGA-LUSC
4854,TCGA-43-A475,NO,NA,TCGA-43-A475-D37109,9AC6843E-FE86-40ED-B200-5B3A41AE6931,NA,,,,NA,109,172,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,11,2012,TCGA-LUSC
4855,TCGA-43-A56V,NO,NA,TCGA-43-A56V-D41938,22E0EB20-6263-4BA5-973E-CCF6DCAF5A15,NA,,,,NA,47,111,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,4,2013,TCGA-LUSC
4856,TCGA-43-A56V,NO,NA,TCGA-43-A56V-D41939,898B239C-847F-4C11-8A53-5FA888C4B6ED,NA,,,,NA,47,111,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,4,2013,TCGA-LUSC
4341,TCGA-44-8117,NO,,TCGA-44-8117-D32727,EEB0D889-2452-4652-AD4C-81CCD822D2CE,,,,,NA,113,133,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,13,6,2012,TCGA-LUAD
4340,TCGA-44-8117,NO,,TCGA-44-8117-D32726,19D36EEB-480F-4671-BCA8-86F6494EA205,,,,,NA,113,176,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,6,2012,TCGA-LUAD
4343,TCGA-44-A47F,NO,,TCGA-44-A47F-D36954,2F7AD0AB-78F2-4B48-8180-C42A2ECE1D3A,,,,,NA,122,185,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,11,2012,TCGA-LUAD
4342,TCGA-44-A47F,NO,,TCGA-44-A47F-D36953,73D0B0CD-088C-4220-9ED5-280121CCD432,,,,,NA,122,185,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,20,11,2012,TCGA-LUAD
4359,TCGA-49-AAR2,NO,,TCGA-49-AAR2-D72096,5FF030BD-A154-4ACD-B9B3-057B31650269,,,,,NA,85,123,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,10,4,2015,TCGA-LUAD
4361,TCGA-49-AAR4,NO,,TCGA-49-AAR4-D65010,AB97458F-B092-494A-BCEE-2FD308ED618A,,,,,NA,57,61,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,17,9,2014,TCGA-LUAD
4360,TCGA-49-AAR4,NO,,TCGA-49-AAR4-D65009,4477C3EF-3A88-4C2F-955E-149887AC8C8F,,,,,NA,57,61,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,17,9,2014,TCGA-LUAD
2929,TCGA-4G-AAZO,NO,NA,TCGA-4G-AAZO-D62167,DA3CDAE0-3E09-4885-85DD-D56EDBA4AAC1,NA,NA,NA,NA,NA,427,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,YES,Stable Disease,26,7,2014,TCGA-CHOL
333,TCGA-4H-AAAK,NO,,TCGA-4H-AAAK-D68065,08F129B2-D118-4CA1-B51F-A648445EC84E,,,,,,27,98,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,11,2014,TCGA-BRCA
335,TCGA-4H-AAAK,NO,,TCGA-4H-AAAK-D68072,A6A3B982-CF4E-4E87-9F53-A31FE7AD6C2E,,,,,,27,98,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,13,11,2014,TCGA-BRCA
334,TCGA-4H-AAAK,NO,,TCGA-4H-AAAK-D68067,D675535D-A6A0-4634-8E6C-A5B7C8E61289,,,,,,27,98,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,13,11,2014,TCGA-BRCA
9450,TCGA-4K-AA1G,NO,NA,TCGA-4K-AA1G-D67884,414B164A-E30F-48B4-A793-97A609FF0289,NA,NA,NA,NA,NA,28,107,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9452,TCGA-4K-AA1G,NO,NA,TCGA-4K-AA1G-D67885,B0051356-C673-4F85-9943-F8180CF08064,NA,NA,NA,NA,NA,28,107,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9451,TCGA-4K-AA1G,NO,NA,TCGA-4K-AA1G-D67881,48C42494-C5BC-4FEC-9A95-0D799A855F56,NA,NA,NA,NA,NA,28,107,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9454,TCGA-4K-AAAL,NO,NA,TCGA-4K-AAAL-D67905,3C0702D5-328F-4C10-8DC1-8049EE9F1457,NA,NA,NA,NA,NA,5,111,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9455,TCGA-4K-AAAL,NO,NA,TCGA-4K-AAAL-D67907,D0F1A599-824D-4326-B472-1E7D8A89463B,NA,NA,NA,NA,NA,5,111,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9453,TCGA-4K-AAAL,NO,NA,TCGA-4K-AAAL-D67899,7CC85BA0-E422-4D20-8F8B-14BDFFF0C9CD,NA,NA,NA,NA,NA,5,111,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,12,11,2014,TCGA-TGCT
9554,TCGA-4V-A9QQ,NO,NA,TCGA-4V-A9QQ-D63295,22088491-5D4C-4DB1-96B6-6DAA2E40F4C9,NA,NA,NA,NA,NA,261,369,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,5,8,2014,TCGA-THYM
9553,TCGA-4V-A9QQ,NO,NA,TCGA-4V-A9QQ-D63294,BD9A4A5E-14B7-4F93-8605-A6C2C2FB06BD,NA,NA,NA,NA,NA,261,369,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,5,8,2014,TCGA-THYM
4362,TCGA-50-5051,NO,,TCGA-50-5051-D32021,487b2e04-b00a-4221-b759-d6496965c6d9,,,,,NA,62,123,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,15,5,2012,TCGA-LUAD
4363,TCGA-50-5051,NO,,TCGA-50-5051-D32022,f3f3dcc2-08bc-4d5d-9293-f608b65f06e9,,,,,NA,62,123,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,15,5,2012,TCGA-LUAD
4365,TCGA-50-5055,NO,,TCGA-50-5055-D41755,7404E87B-2128-4132-AB47-14402C1130F0,,,,,NA,1135,1284,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,27,3,2013,TCGA-LUAD
4366,TCGA-50-5055,NO,,TCGA-50-5055-D41761,9AAF3C36-BC75-459E-9B70-00E485E07138,,,,,NA,1135,1284,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,27,3,2013,TCGA-LUAD
4367,TCGA-50-5055,NO,,TCGA-50-5055-D41762,53DEAEDA-8DF5-4023-9F27-12DD16A6A2C1,,,,,NA,1284,1522,,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,27,3,2013,TCGA-LUAD
4368,TCGA-50-5055,NO,,TCGA-50-5055-D41763,C6E4C339-ED92-49E9-BE3C-37BFC3B9D570,,,,,NA,1522,1649,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,27,3,2013,TCGA-LUAD
4369,TCGA-50-5055,NO,,TCGA-50-5055-D41764,3B8F2796-A1BC-4B2A-AC33-8108523F87C6,,,,,NA,1649,NA,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,27,3,2013,TCGA-LUAD
4370,TCGA-50-5066,NO,,TCGA-50-5066-D32029,5be0e05b-35a4-4283-90e3-38874324ed7a,,,,,NA,508,567,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,15,5,2012,TCGA-LUAD
4372,TCGA-50-5066,NO,,TCGA-50-5066-D32031,1ac70461-ad8a-48f2-b045-ce88d310315b,,,,,NA,508,567,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Stable Disease,15,5,2012,TCGA-LUAD
4371,TCGA-50-5066,NO,,TCGA-50-5066-D32030,ad7d0412-3694-4490-8268-f0191cbe615c,,,,,NA,508,567,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,15,5,2012,TCGA-LUAD
4373,TCGA-50-5068,NO,,TCGA-50-5068-D32058,416e251e-06ba-4e59-b9b0-22db5fac92e1,,,,,NA,99,140,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,16,5,2012,TCGA-LUAD
4376,TCGA-50-5072,NO,,TCGA-50-5072-D32061,84dcbd76-6ce7-47f8-beba-5421a69c3189,,,,,NA,121,182,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,16,5,2012,TCGA-LUAD
4377,TCGA-50-5072,NO,,TCGA-50-5072-D32062,26e785c9-d595-4ed7-a15b-7a0d73b47e07,,,,,NA,121,182,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,16,5,2012,TCGA-LUAD
4378,TCGA-50-5930,NO,,TCGA-50-5930-D32066,1a5b7d4d-a7ea-4064-b672-a951d639b77e,,,,,NA,85,146,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,16,5,2012,TCGA-LUAD
4379,TCGA-50-5933,NO,,TCGA-50-5933-D32106,668c16ce-1cba-4ca4-bccf-1a6e757231c0,,,,,NA,189,210,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,5,2012,TCGA-LUAD
4380,TCGA-50-5933,NO,,TCGA-50-5933-D32107,69084794-9ae1-4394-bad1-f449c2205282,,,,,NA,189,210,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,5,2012,TCGA-LUAD
4381,TCGA-50-5936,NO,,TCGA-50-5936-D41910,26C486FA-3DCE-4BA5-A30E-544DBBDDEE25,,,,,NA,188,257,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,3,4,2013,TCGA-LUAD
4382,TCGA-50-5941,NO,,TCGA-50-5941-D32131,c30f3b22-ea7d-4ef7-8735-85a743e37de2,,,,,NA,NA,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,5,2012,TCGA-LUAD
4383,TCGA-50-5941,NO,,TCGA-50-5941-D32132,1d4ba45d-7254-42be-a255-644f5af80b46,,,,,NA,NA,NA,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,5,2012,TCGA-LUAD
4385,TCGA-50-6590,NO,,TCGA-50-6590-D43831,A3CB9C93-4673-49EE-AB53-9823D496F039,,,,,NA,92,189,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,6,2013,TCGA-LUAD
4384,TCGA-50-6590,NO,,TCGA-50-6590-D43830,A075B030-D2CD-4488-9FD9-D0BFD2A087A7,,,,,NA,92,189,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,6,2013,TCGA-LUAD
4386,TCGA-50-6595,NO,,TCGA-50-6595-D44132,5CE76459-2545-4AE1-BFB7-D99A28C8576B,,,,,NA,123,162,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,13,6,2013,TCGA-LUAD
4388,TCGA-50-8459,YES,,TCGA-50-8459-D42680,4E2BDC04-BC96-442A-A92E-F5E7E00A1E90,,,,,NA,76,147,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,4,2013,TCGA-LUAD
4389,TCGA-50-8459,YES,,TCGA-50-8459-D42681,C21CFFFF-014E-482A-B414-AFF5106E530C,,,,,NA,76,147,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Complete Response,26,4,2013,TCGA-LUAD
4387,TCGA-50-8459,YES,,TCGA-50-8459-D42678,F90C20E9-5A78-4BD2-8814-AEFA21BA329D,,,,,NA,76,147,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,26,4,2013,TCGA-LUAD
4867,TCGA-52-7812,NO,NA,TCGA-52-7812-D39714,07815A8B-AAFF-4B14-94EC-3B8A077996A0,NA,,,,NA,529,638,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUSC
4868,TCGA-52-7812,NO,NA,TCGA-52-7812-D39719,9773E151-B94D-4C6B-8487-0E597A862DE6,NA,,,,NA,656,797,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUSC
4395,TCGA-53-7624,NO,,TCGA-53-7624-D39735,9628B2FD-EDBE-415B-A139-7EC10C28CF7E,,,,,NA,66,186,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4396,TCGA-53-7624,NO,,TCGA-53-7624-D39736,5CDA082A-CFF9-4E2A-9C47-299425450EF8,,,,,NA,66,186,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4397,TCGA-53-7624,NO,,TCGA-53-7624-D39737,87E2D964-3168-438C-9CB9-1F81D70122AE,,,,,NA,339,490,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4398,TCGA-53-7624,NO,,TCGA-53-7624-D39738,0F25327C-C54D-4542-A956-47AFFD9D63B5,,,,,NA,339,490,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4399,TCGA-53-7624,NO,,TCGA-53-7624-D39739,EAC0A9FD-301B-48F7-AFD2-499DFE2F0418,,,,,NA,339,490,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4394,TCGA-53-7624,NO,,TCGA-53-7624-D39732,588CEFB2-2FCB-4A28-893B-35DDF6E44FB9,,,,,NA,726,782,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4393,TCGA-53-7624,NO,,TCGA-53-7624-D39731,F6AB7F08-1341-440F-90F1-54F3E9CF0C7F,,,,,NA,803,861,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4391,TCGA-53-7624,NO,,TCGA-53-7624-D39729,28681B5B-2CCC-41DB-B342-A1BB56EE7432,,,,,NA,880,922,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4390,TCGA-53-7624,NO,,TCGA-53-7624-D39727,CABE6493-EEA3-4417-991E-E2D8BAA5D0F4,,,,,NA,924,966,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4392,TCGA-53-7624,NO,,TCGA-53-7624-D39730,03D35A9D-2F9E-4DD6-BEF9-4EAE9D35C1DB,,,,,NA,980,980,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,1,2013,TCGA-LUAD
4400,TCGA-53-7626,NO,,TCGA-53-7626-D39213,0BEFAE89-775A-44A5-8352-ECB58FBCA0B3,,,,,NA,NA,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,15,1,2013,TCGA-LUAD
4401,TCGA-53-7626,NO,,TCGA-53-7626-D39214,61FB2C2D-04A9-420C-881B-821008C23CCA,,,,,NA,NA,NA,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,15,1,2013,TCGA-LUAD
4404,TCGA-53-7813,NO,,TCGA-53-7813-D41069,81C8185C-C45B-44F1-A49B-4F668D595E8F,,,,,NA,62,146,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,11,3,2013,TCGA-LUAD
4405,TCGA-53-7813,NO,,TCGA-53-7813-D41072,B98BBB32-9B61-4BA9-8A39-D94A205614DC,,,,,NA,62,146,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,11,3,2013,TCGA-LUAD
4406,TCGA-53-A4EZ,NO,,TCGA-53-A4EZ-D40957,EAB7D354-078B-4978-AD4F-A6B8C3C68D35,,,,,NA,132,226,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,3,2013,TCGA-LUAD
4407,TCGA-53-A4EZ,NO,,TCGA-53-A4EZ-D40958,58DBAB3C-5977-4D7B-8AF2-07D3D6AC5F27,,,,,NA,132,226,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,3,2013,TCGA-LUAD
4408,TCGA-55-1596,NO,,TCGA-55-1596-D40545,D3AC7328-D4A7-4F72-86F7-07379246F800,,,,,NA,34,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,2,2013,TCGA-LUAD
4409,TCGA-55-1596,NO,,TCGA-55-1596-D40546,5871BBDC-FC66-413D-8DE6-E44CB7DACA4D,,,,,NA,34,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,2,2013,TCGA-LUAD
4410,TCGA-55-5899,NO,,TCGA-55-5899-D43195,C4183530-28BE-42D7-AD22-5C1C476E2388,,,,,NA,146,208,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2013,TCGA-LUAD
4411,TCGA-55-5899,NO,,TCGA-55-5899-D43196,314FCD94-F0EA-4781-95F8-659D257724EB,,,,,NA,146,208,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-LUAD
4412,TCGA-55-6712,NO,,TCGA-55-6712-D46640,54BFE572-6DCC-4E84-884A-ED9F30AA3A5E,,,,,NA,55,164,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,13,8,2013,TCGA-LUAD
4413,TCGA-55-6712,NO,,TCGA-55-6712-D46641,E61C6649-A6C8-4399-BC96-CE8A7ADA6686,,,,,NA,55,164,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,13,8,2013,TCGA-LUAD
4415,TCGA-55-6970,NO,,TCGA-55-6970-D57906,E7D92A5F-612A-448A-B26A-B4E6D018D887,,,,,NA,89,117,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,28,3,2014,TCGA-LUAD
4416,TCGA-55-6970,NO,,TCGA-55-6970-D57907,E03F99C9-6200-45D2-AFA8-A1289F63B270,,,,,NA,89,117,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,28,3,2014,TCGA-LUAD
4417,TCGA-55-6970,NO,,TCGA-55-6970-D57908,E5FF3DC9-209A-481E-BF51-DB84716FF0C4,,,,,NA,162,183,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,28,3,2014,TCGA-LUAD
4418,TCGA-55-6979,NO,,TCGA-55-6979-D40547,F521F7CC-4443-4315-B2C2-B486B17D0DC5,,,,,NA,57,149,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,22,2,2013,TCGA-LUAD
4419,TCGA-55-6979,NO,,TCGA-55-6979-D40548,7F10EFEE-013A-4927-8BAD-1683AED5FA99,,,,,NA,57,149,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,22,2,2013,TCGA-LUAD
4423,TCGA-55-6982,NO,,TCGA-55-6982-D46637,8D09A550-760E-4CF9-8FC7-95C7C2613527,,,,,NA,698,939,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,13,8,2013,TCGA-LUAD
4421,TCGA-55-6982,NO,,TCGA-55-6982-D46628,51A05329-99B3-4DE3-BEEC-F7B7584AEE8C,,,,,NA,397,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,13,8,2013,TCGA-LUAD
4422,TCGA-55-6982,NO,,TCGA-55-6982-D46629,F2442589-3EA6-4F5B-AA58-D61A68517EBF,,,,,NA,397,NA,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,13,8,2013,TCGA-LUAD
4427,TCGA-55-7227,NO,,TCGA-55-7227-D65705,5BC0FDF2-9109-4D86-A20D-1322832BE50E,,,,,NA,289,409,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,26,9,2014,TCGA-LUAD
4428,TCGA-55-7227,NO,,TCGA-55-7227-D65706,2D4D2D9E-CEB1-4321-A97C-750CB79A547B,,,,,NA,289,409,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,26,9,2014,TCGA-LUAD
4429,TCGA-55-7227,NO,,TCGA-55-7227-D65707,DEF1B875-0578-458E-9F26-D60CAAD1BB9B,,,,,NA,442,876,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,26,9,2014,TCGA-LUAD
4430,TCGA-55-7281,NO,,TCGA-55-7281-D47811,F65BFFAD-A23B-4066-829C-5D92F15865DE,,,,,NA,424,474,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,28,8,2013,TCGA-LUAD
4431,TCGA-55-7281,NO,,TCGA-55-7281-D47814,B212E1D8-57BE-4365-BFBA-1EA76A701912,,,,,NA,508,579,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,28,8,2013,TCGA-LUAD
4432,TCGA-55-7281,NO,,TCGA-55-7281-D47815,DC5037B4-AFDE-459F-8830-340492F0AA06,,,,,NA,508,579,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,28,8,2013,TCGA-LUAD
4433,TCGA-55-7281,NO,,TCGA-55-7281-D47816,638427FC-0F5A-4F6A-8E41-E90771270BA7,,,,,NA,712,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,28,8,2013,TCGA-LUAD
4435,TCGA-55-7281,NO,,TCGA-55-7281-D47818,F582DDC9-3FBE-4AC6-870A-530C86640E54,,,,,NA,712,NA,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Partial Response,28,8,2013,TCGA-LUAD
4434,TCGA-55-7281,NO,,TCGA-55-7281-D47817,5046F93F-1D01-4A67-9B87-ED115A6C742A,,,,,NA,712,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,28,8,2013,TCGA-LUAD
4436,TCGA-55-7283,NO,,TCGA-55-7283-D46989,E0804552-E06E-4FA2-A637-AFD1546794D4,,,,,NA,83,386,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,21,8,2013,TCGA-LUAD
4437,TCGA-55-7283,NO,,TCGA-55-7283-D46990,1B14B0D0-2927-4B35-9310-FE9EC2E5726C,,,,,NA,83,386,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Partial Response,21,8,2013,TCGA-LUAD
4441,TCGA-55-7574,NO,,TCGA-55-7574-D64282,855D0B62-EF5B-4164-B03B-74957166BF47,,,,,NA,478,631,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Partial Response,28,8,2014,TCGA-LUAD
4440,TCGA-55-7574,NO,,TCGA-55-7574-D64281,4FE5B8E6-4EEE-41ED-986D-BD7841309AFC,,,,,NA,478,631,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,28,8,2014,TCGA-LUAD
4443,TCGA-55-7576,NO,,TCGA-55-7576-D45605,12803CED-7A32-4FB2-B0BB-7351A5C61BA7,,,,,NA,104,168,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,7,2013,TCGA-LUAD
4442,TCGA-55-7576,NO,,TCGA-55-7576-D45604,081CF755-293A-4A75-8F90-BC270CBB0C58,,,,,NA,104,168,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,17,7,2013,TCGA-LUAD
4446,TCGA-55-7910,NO,,TCGA-55-7910-D66141,76D8449C-257D-474B-A830-EDE15DAE2DDD,,,,,NA,253,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,10,2014,TCGA-LUAD
4447,TCGA-55-7914,NO,,TCGA-55-7914-D59093,6C2F2B61-58BA-4970-BC91-DF0902E87C39,,,,,NA,27,132,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUAD
4449,TCGA-55-7914,NO,,TCGA-55-7914-D59095,6A7819DA-BFA9-4BCF-BA27-3DC196B9EF70,,,,,NA,27,132,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUAD
4448,TCGA-55-7914,NO,,TCGA-55-7914-D59094,5EEF9195-2694-425E-9C08-5C82278C9C16,,,,,NA,27,132,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUAD
4450,TCGA-55-7994,NO,,TCGA-55-7994-D47824,711DE5E8-64BE-4AE2-9B48-BE206A7960AC,,,,,NA,56,121,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,8,2013,TCGA-LUAD
4451,TCGA-55-7994,NO,,TCGA-55-7994-D47825,C4E8D500-182E-4A75-9E3A-5EC4E60DD487,,,,,NA,56,121,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,28,8,2013,TCGA-LUAD
4452,TCGA-55-7995,NO,,TCGA-55-7995-D65702,39A1C7F0-0574-41C9-98D5-D0D7AF66D866,,,,,NA,483,525,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,9,2014,TCGA-LUAD
4453,TCGA-55-7995,NO,,TCGA-55-7995-D65703,386B9E74-6618-451B-8F90-9F3BFDE51CD1,,,,,NA,483,525,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,9,2014,TCGA-LUAD
4454,TCGA-55-8205,NO,,TCGA-55-8205-D59042,0EC2801F-BAED-4EC4-973E-BE336BDA8894,,,,,NA,93,154,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,4,2014,TCGA-LUAD
4455,TCGA-55-8205,NO,,TCGA-55-8205-D59043,E6B41481-C1F8-465D-8757-E2F2F2B0A4DB,,,,,NA,93,154,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,4,2014,TCGA-LUAD
4457,TCGA-55-8301,NO,,TCGA-55-8301-D56263,81EAC4EA-9876-4E67-B2D2-230762F91928,,,,,NA,261,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,30,1,2014,TCGA-LUAD
4458,TCGA-55-8301,NO,,TCGA-55-8301-D56264,D6B06699-89FF-4995-95D5-D7B9B1095651,,,,,NA,261,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,30,1,2014,TCGA-LUAD
4459,TCGA-55-8505,NO,,TCGA-55-8505-D47799,E1832AA8-C7E7-4BF8-BF54-E7BC3EEF3619,,,,,NA,96,159,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,8,2013,TCGA-LUAD
4460,TCGA-55-8505,NO,,TCGA-55-8505-D47801,57354507-5DEF-495C-8B74-0E7773AC1C4B,,,,,NA,96,159,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,28,8,2013,TCGA-LUAD
4461,TCGA-55-8508,NO,,TCGA-55-8508-D66138,09E9C95E-CD77-45FB-AF89-25C96E794AB8,,,,,NA,57,120,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,10,2014,TCGA-LUAD
4462,TCGA-55-8508,NO,,TCGA-55-8508-D66139,E05A3BB7-4A18-439D-BDD9-4DBBA8128428,,,,,NA,57,120,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,3,10,2014,TCGA-LUAD
4463,TCGA-55-8513,NO,,TCGA-55-8513-D64284,2FEFA276-5D66-46D2-B73C-6138E1E304B9,,,,,NA,352,460,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,28,8,2014,TCGA-LUAD
4467,TCGA-55-8615,NO,,TCGA-55-8615-D56258,E08B7831-B7A9-4EC0-9D20-39B36957E6C1,,,,,NA,234,324,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,1,2014,TCGA-LUAD
4468,TCGA-55-8615,NO,,TCGA-55-8615-D56259,2B2ABC4D-DB6C-4DBC-9DD8-519DEE12F63C,,,,,NA,234,416,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,30,1,2014,TCGA-LUAD
4465,TCGA-55-8615,NO,,TCGA-55-8615-D56256,C3E3F94E-7959-47E7-941B-5092013166FF,,,,,NA,89,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,1,2014,TCGA-LUAD
4466,TCGA-55-8615,NO,,TCGA-55-8615-D56257,BCB6362E-FD58-49FE-82E2-ACD98A53F2D7,,,,,NA,89,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,30,1,2014,TCGA-LUAD
4470,TCGA-55-A48X,NO,,TCGA-55-A48X-D61503,119EF573-924B-4764-935E-8156AEC3B7B8,,,,,NA,66,150,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,6,2014,TCGA-LUAD
4469,TCGA-55-A48X,NO,,TCGA-55-A48X-D61502,D62B9942-18BB-46BB-9CD2-27E149A14B9D,,,,,NA,66,160,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,6,2014,TCGA-LUAD
4471,TCGA-55-A48Y,NO,,TCGA-55-A48Y-D59059,47E0007B-5A41-4E22-8E2B-2483E168CA99,,,,,NA,91,163,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,4,2014,TCGA-LUAD
4472,TCGA-55-A48Y,NO,,TCGA-55-A48Y-D59060,A497B509-E9BB-4278-851A-F25CB653F363,,,,,NA,91,163,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,4,2014,TCGA-LUAD
4473,TCGA-55-A48Z,NO,,TCGA-55-A48Z-D59069,AFA50190-D879-4A5D-A4A9-F1A7F1E161AA,,,,,NA,58,202,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,30,4,2014,TCGA-LUAD
4474,TCGA-55-A48Z,NO,,TCGA-55-A48Z-D59070,1B807520-A86F-4B84-8830-F8DDCC3231BE,,,,,NA,58,202,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,30,4,2014,TCGA-LUAD
4869,TCGA-56-7222,NO,NA,TCGA-56-7222-D47056,5E6D7891-A371-4CF7-B374-1644EA8BD452,NA,,,,NA,62,133,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-LUSC
4870,TCGA-56-7222,NO,NA,TCGA-56-7222-D47057,879A4789-EBD8-44E1-90C6-014A08210189,NA,,,,NA,62,133,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,21,8,2013,TCGA-LUSC
4871,TCGA-56-7222,NO,NA,TCGA-56-7222-D47058,ABC452D4-7CF4-4D57-B4AF-E18F0BBB60EE,NA,,,,NA,427,519,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,21,8,2013,TCGA-LUSC
4872,TCGA-56-7222,NO,NA,TCGA-56-7222-D47059,958724DB-EBDE-4829-AD3E-3ECD9B7A8DAD,NA,,,,NA,427,519,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,21,8,2013,TCGA-LUSC
4875,TCGA-56-7579,NO,NA,TCGA-56-7579-D60117,341B3213-33D7-4DA0-936E-896158E8A414,NA,,,,NA,88,136,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4874,TCGA-56-7579,NO,NA,TCGA-56-7579-D60116,4B621263-6743-4952-9983-7D721D814A32,NA,,,,NA,88,215,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4876,TCGA-56-7579,NO,NA,TCGA-56-7579-D60118,EC6585FB-918C-4C04-9DB7-4B65DBAADDFC,NA,,,,NA,165,215,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4878,TCGA-56-7579,NO,NA,TCGA-56-7579-D60120,DA92DB59-C64B-4E4F-A102-C837B696D71D,NA,,,,NA,349,471,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4877,TCGA-56-7579,NO,NA,TCGA-56-7579-D60119,9669EC70-C336-4CDF-8218-A31BE9DDD7AE,NA,,,,NA,349,471,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4881,TCGA-56-7579,YES,NA,TCGA-56-7579-D72569,1CB0D459-7478-4201-812E-9FAA07052A89,NA,,,,NA,585,710,,Selumetinib,MEK inhibitor,Other,,,,,NO,Clinical Progressive Disease,21,7,2015,TCGA-LUSC
4880,TCGA-56-7579,NO,NA,TCGA-56-7579-D60122,CC762C73-CA48-4BA9-8A51-79D88F599013,NA,,,,NA,724,NA,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,29,5,2014,TCGA-LUSC
4883,TCGA-56-7822,NO,NA,TCGA-56-7822-D66154,219F859D-BF30-4DB7-990D-8268E23132FA,NA,,,,NA,311,332,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,3,10,2014,TCGA-LUSC
4884,TCGA-56-7823,NO,NA,TCGA-56-7823-D60129,471CEC7A-35BF-42D0-88D9-DAD0D2D0A96F,NA,,,,NA,129,197,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,5,2014,TCGA-LUSC
4885,TCGA-56-7823,NO,NA,TCGA-56-7823-D60130,43855D49-2DDE-4276-B1FF-CC4B8ACF3A9D,NA,,,,NA,129,197,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,29,5,2014,TCGA-LUSC
4887,TCGA-56-8308,NO,NA,TCGA-56-8308-D35779,17F4BE6B-23FF-4233-9C41-C03B09E46E91,NA,,,,NA,57,203,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,8,10,2012,TCGA-LUSC
4886,TCGA-56-8308,NO,NA,TCGA-56-8308-D35778,43B921F2-205B-40CF-96E6-65AE81272CA0,NA,,,,NA,57,203,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,8,10,2012,TCGA-LUSC
4888,TCGA-56-8624,NO,NA,TCGA-56-8624-D47794,02973D5E-80D8-452B-8FD1-BB2B8C75475A,NA,,,,NA,69,69,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,8,2013,TCGA-LUSC
4889,TCGA-56-8624,NO,NA,TCGA-56-8624-D47795,72D69F4E-7D93-4B93-B1CE-DD53F4B28BD0,NA,,,,NA,69,69,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,28,8,2013,TCGA-LUSC
4890,TCGA-56-8625,NO,NA,TCGA-56-8625-D59029,CBF87725-77BE-423C-AA06-838C1162D36E,NA,,,,NA,120,140,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUSC
4892,TCGA-56-8625,NO,NA,TCGA-56-8625-D59032,97548FA9-060F-41A5-A8DF-A48F5BD14325,NA,,,,NA,140,217,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUSC
4891,TCGA-56-8625,NO,NA,TCGA-56-8625-D59030,1B80B618-DAC1-41A0-8A07-AD9F437EC8DE,NA,,,,NA,162,217,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUSC
4893,TCGA-56-8629,NO,NA,TCGA-56-8629-D57033,5CC85BE8-348D-4C9C-801D-404F4D4E356C,NA,,,,NA,66,148,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,2,2014,TCGA-LUSC
4894,TCGA-56-8629,NO,NA,TCGA-56-8629-D57034,3B5E5BDF-0A84-45F1-BFA3-29AF8826B831,NA,,,,NA,66,148,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,28,2,2014,TCGA-LUSC
4895,TCGA-56-A4BW,NO,NA,TCGA-56-A4BW-D66150,3F4BD48C-57B8-48E2-980B-1A6E59A4A5E1,NA,,,,NA,30,109,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,10,2014,TCGA-LUSC
4896,TCGA-56-A4BW,NO,NA,TCGA-56-A4BW-D66151,17CD76AD-14BA-4A0D-96B8-9A17DF1A2DD0,NA,,,,NA,30,109,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,10,2014,TCGA-LUSC
4898,TCGA-56-A62T,NO,NA,TCGA-56-A62T-D66647,50B6136D-E914-4F39-A21B-B8E86FD9B857,NA,,,,NA,45,80,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2014,TCGA-LUSC
4899,TCGA-56-A62T,NO,NA,TCGA-56-A62T-D66649,82A53D0A-6350-4C14-B725-327C2712E631,NA,,,,NA,45,80,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,10,2014,TCGA-LUSC
4900,TCGA-58-8387,NO,NA,TCGA-58-8387-D33510,C67727C3-E4F0-42B1-A5A2-3474F4067DF3,NA,,,,NA,22,129,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,7,2012,TCGA-LUSC
4901,TCGA-58-8387,NO,NA,TCGA-58-8387-D43185,BEE41A26-4D5D-4424-A41B-74F3E322A6BE,NA,,,,NA,22,129,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-LUSC
4902,TCGA-58-8391,NO,NA,TCGA-58-8391-D33508,D396FA38-F109-437C-A734-0DC2B8CA8671,NA,,,,NA,42,159,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,7,2012,TCGA-LUSC
4903,TCGA-58-8391,NO,NA,TCGA-58-8391-D43186,D7B49C5C-2F64-405A-A2DF-2BE0A9B8E4AF,NA,,,,NA,42,159,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,15,5,2013,TCGA-LUSC
4904,TCGA-58-A46J,NO,NA,TCGA-58-A46J-D36301,6C2CAE90-6334-40CE-8611-C9AE3E9E13CE,NA,,,,NA,56,134,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,10,2012,TCGA-LUSC
4905,TCGA-58-A46J,NO,NA,TCGA-58-A46J-D43187,197C1200-584D-49C7-A0F8-8C9FAFBD8C30,NA,,,,NA,56,134,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-LUSC
4906,TCGA-58-A46K,NO,NA,TCGA-58-A46K-D36299,ED901B75-674E-4DBB-9B5C-A18B119786FB,NA,,,,NA,85,171,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,10,2012,TCGA-LUSC
4907,TCGA-58-A46K,NO,NA,TCGA-58-A46K-D43188,8727FFB4-B037-4F3F-9F88-07E3BCF88F89,NA,,,,NA,85,171,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-LUSC
4908,TCGA-58-A46L,NO,NA,TCGA-58-A46L-D36302,7B4811EB-B63E-4DBB-9685-EEED68622451,NA,,,,NA,67,265,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,10,2012,TCGA-LUSC
4909,TCGA-58-A46L,NO,NA,TCGA-58-A46L-D43189,DE8F4EF3-7870-48C0-B0EC-5C9ED9715C21,NA,,,,NA,67,265,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-LUSC
9573,TCGA-5S-A9Q8,NO,NA,TCGA-5S-A9Q8-D64498,51AE8C2B-147A-4785-B895-44D3C74EAF2A,NA,,,,NA,33,138,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,9,2014,TCGA-UCEC
9574,TCGA-5S-A9Q8,NO,NA,TCGA-5S-A9Q8-D64499,C3D2C1D7-A802-4380-AE62-B29E2614F2BB,NA,,,,NA,33,138,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,9,2014,TCGA-UCEC
338,TCGA-5T-A9QA,NO,,TCGA-5T-A9QA-D66890,41E877E4-A74A-4E15-A061-03DAFF7922A1,,,,,,23,94,,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,25,10,2014,TCGA-BRCA
341,TCGA-5T-A9QA,NO,,TCGA-5T-A9QA-D66893,DCD07D88-6185-4E6B-B95A-FCBE7B9ECDDB,,,,,,NA,94,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,10,2014,TCGA-BRCA
9557,TCGA-5U-AB0D,NO,NA,TCGA-5U-AB0D-D61828,F2BABE8A-3752-4F5D-8BDA-5FABC22F1A00,NA,NA,NA,NA,NA,15,201,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,31,7,2014,TCGA-THYM
9558,TCGA-5U-AB0D,NO,NA,TCGA-5U-AB0D-D65402,CB954220-3357-4720-B7F7-2453891E78B0,NA,NA,NA,NA,NA,15,201,,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,23,9,2014,TCGA-THYM
7504,TCGA-5X-AA5U,NO,NA,TCGA-5X-AA5U-D69110,75E7835F-DABB-414B-939A-450620B2352C,,,,,NA,63,178,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,29,12,2014,TCGA-OV
7503,TCGA-5X-AA5U,NO,NA,TCGA-5X-AA5U-D69109,22AB155E-AD49-40BF-BE96-92E5512C3A5C,,,,,NA,63,178,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,29,12,2014,TCGA-OV
7502,TCGA-5X-AA5U,NO,NA,TCGA-5X-AA5U-D68523,BCE4C9F7-2318-4C8B-8545-9F0283051595,,,,,NA,66,178,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,24,11,2014,TCGA-OV
4479,TCGA-62-8398,NO,,TCGA-62-8398-D33507,316E364F-9824-4D22-AB44-6C9181EF3AAA,,,,,NA,41,113,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,7,2012,TCGA-LUAD
4480,TCGA-62-8398,NO,,TCGA-62-8398-D40458,BB70829B-5995-4D0D-ABEF-22D1AD108527,,,,,NA,41,113,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,2,2013,TCGA-LUAD
4483,TCGA-62-A46U,NO,,TCGA-62-A46U-D36362,7D7C9C05-6714-45E1-BFA5-C1EC33D20EBF,,,,,NA,71,161,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,10,2012,TCGA-LUAD
4484,TCGA-62-A46U,NO,,TCGA-62-A46U-D40575,A6950970-9BFA-42C0-99E7-E2B841A95279,,,,,NA,71,161,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2013,TCGA-LUAD
4485,TCGA-62-A46Y,NO,,TCGA-62-A46Y-D36365,55FA6477-77DE-4CB4-9BDF-8AC7045569AA,,,,,NA,74,256,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,10,2012,TCGA-LUAD
4486,TCGA-62-A46Y,NO,,TCGA-62-A46Y-D40578,06D3010F-39E9-4C9D-96D8-EAE50C4C705B,,,,,NA,74,256,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2013,TCGA-LUAD
4487,TCGA-62-A471,NO,,TCGA-62-A471-D36369,0B09C8A2-1EDD-4523-9B04-7C6DCA69D4CE,,,,,NA,41,115,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,10,2012,TCGA-LUAD
4489,TCGA-62-A471,NO,,TCGA-62-A471-D40577,8E2B3458-E311-41FF-BA45-78E93803E232,,,,,NA,41,115,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,25,2,2013,TCGA-LUAD
4488,TCGA-62-A471,NO,,TCGA-62-A471-D40576,AB370E23-6CB3-4C2D-AAEE-F18B9832C078,,,,,NA,41,115,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2013,TCGA-LUAD
4501,TCGA-64-5778,NO,,TCGA-64-5778-D31472,fc448027-ade7-47c9-8323-907f35fc2702,,,,,NA,1174,NA,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,YES,Clinical Progressive Disease,3,5,2012,TCGA-LUAD
4504,TCGA-64-5779,YES,,TCGA-64-5779-D31475,d2824bc2-e94d-4926-9b6b-0600e519bb80,,,,,NA,94,157,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4505,TCGA-64-5779,YES,,TCGA-64-5779-D31476,b55016e7-e7a7-430d-93e0-377e6fb2fb50,,,,,NA,94,157,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4511,TCGA-64-5781,NO,,TCGA-64-5781-D31493,acadc104-cf2b-4ac0-8598-f4e35edbb3d1,,,,,NA,159,187,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4509,TCGA-64-5781,NO,,TCGA-64-5781-D31491,04bd06de-39e1-47d6-bdb4-de3aeccf9f63,,,,,NA,131,215,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4510,TCGA-64-5781,NO,,TCGA-64-5781-D31492,86ff15d3-47d0-47e5-ad61-cded2ed6345d,,,,,NA,131,215,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4517,TCGA-64-5815,NO,,TCGA-64-5815-D31482,f1173777-7ce0-422c-8f6f-e4216233f93e,,,,,NA,83,132,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4516,TCGA-64-5815,NO,,TCGA-64-5815-D31481,65568c73-1054-4a71-bb8c-ecdd22eaf03e,,,,,NA,83,132,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4518,TCGA-64-5815,NO,,TCGA-64-5815-D31483,20c7f73f-0afe-4e4a-b887-93338bfd9df6,,,,,NA,146,195,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4519,TCGA-64-5815,NO,,TCGA-64-5815-D31484,4878b403-b86b-448f-a98c-f33fb9f7ea01,,,,,NA,146,195,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,3,5,2012,TCGA-LUAD
4975,TCGA-66-2757,NO,NA,TCGA-66-2757-D36958,06901047-8E23-4FD5-94F9-FA9BC6E65805,NA,,,,NA,943,943,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUSC
4974,TCGA-66-2757,NO,NA,TCGA-66-2757-D36957,8150705F-2447-445D-8D04-327BFDE4D292,NA,,,,NA,943,1035,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUSC
4976,TCGA-66-2757,NO,NA,TCGA-66-2757-D36961,632C27CA-AEE1-4CA5-BFA0-60EF8D1C5C84,NA,,,,NA,1277,1277,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,5,12,2012,TCGA-LUSC
4977,TCGA-66-2758,NO,NA,TCGA-66-2758-D36609,FB434B10-9AF4-477A-87BE-3F2E6190DCC9,NA,,,,NA,89,181,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4978,TCGA-66-2758,NO,NA,TCGA-66-2758-D36610,AD2ED244-0961-46E7-90A6-ADEECFC10CC5,NA,,,,NA,89,181,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4979,TCGA-66-2759,NO,NA,TCGA-66-2759-D36688,D1D0716E-9968-45D0-B496-A18C951556B1,NA,,,,NA,92,214,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4980,TCGA-66-2759,NO,NA,TCGA-66-2759-D36689,3E28237C-3389-48E1-B3B6-4F4B3540FCA9,NA,,,,NA,92,214,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4981,TCGA-66-2771,NO,NA,TCGA-66-2771-D36694,6E11FED7-4213-41C7-985E-3ACBE3485ADC,NA,,,,NA,61,153,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4982,TCGA-66-2771,NO,NA,TCGA-66-2771-D37690,1EC683CB-84BA-442A-A4A4-9B42100E6D70,NA,,,,NA,61,153,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4983,TCGA-66-2778,NO,NA,TCGA-66-2778-D36697,4A91E26E-05E4-40EA-BD97-015BC02EF14E,NA,,,,NA,184,244,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4984,TCGA-66-2778,NO,NA,TCGA-66-2778-D37691,25859CDE-2F5C-465E-BFC5-E24B4E89071A,NA,,,,NA,184,244,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4986,TCGA-66-2783,NO,NA,TCGA-66-2783-D37020,F88F25B1-5D5F-4DF4-981A-BAD29D73B159,NA,,,,NA,90,151,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4987,TCGA-66-2783,NO,NA,TCGA-66-2783-D37021,04ED6633-DA37-4D3A-AEAD-F3C4749A1F95,NA,,,,NA,90,151,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4989,TCGA-66-2792,NO,NA,TCGA-66-2792-D37043,8B4C2FB0-E0D3-46D2-972B-F1F822FAB353,NA,,,,NA,91,214,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4990,TCGA-66-2792,NO,NA,TCGA-66-2792-D37045,49524870-5409-439A-A9FA-84F2D3A6B8EE,NA,,,,NA,91,214,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,12,2012,TCGA-LUSC
4995,TCGA-68-A59I,NO,NA,TCGA-68-A59I-D40352,52984027-6AAD-4999-96CD-AE6DF723295E,NA,,,,NA,50,50,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,18,2,2013,TCGA-LUSC
4996,TCGA-68-A59I,NO,NA,TCGA-68-A59I-D40351,E9B37E36-0BDA-4513-8128-98E9B366BA08,NA,,,,NA,58,121,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,18,2,2013,TCGA-LUSC
4997,TCGA-68-A59I,NO,NA,TCGA-68-A59I-D56683,638F5B86-FB1A-4D5E-B4FD-BB53AFCDD685,NA,,,,NA,58,121,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,18,2,2014,TCGA-LUSC
4998,TCGA-68-A59I,YES,NA,TCGA-68-A59I-D56685,C0921151-EF45-418A-A7B4-842E0384A1D2,NA,,,,NA,216,272,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,18,2,2014,TCGA-LUSC
4531,TCGA-69-7973,NO,,TCGA-69-7973-D30344,D947DBDE-9875-4B03-AE2A-F2B3AE12CCD8,,,,,NA,91,132,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,4,2012,TCGA-LUAD
4532,TCGA-69-7973,NO,,TCGA-69-7973-D30346,8C538EDD-BE6D-4A7E-8936-5487EB1589D3,,,,,NA,91,132,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,4,2012,TCGA-LUAD
4534,TCGA-69-7974,NO,,TCGA-69-7974-D30368,E368B4BF-E5C5-4E85-BDA5-8A7A50246BA7,,,,,NA,33,96,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,9,4,2012,TCGA-LUAD
4535,TCGA-69-7974,NO,,TCGA-69-7974-D30370,D76675FA-0F02-4B08-91C1-D014BBC62EF2,,,,,NA,75,96,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,4,2012,TCGA-LUAD
4542,TCGA-69-A59K,NO,,TCGA-69-A59K-D40359,095F50E9-408C-4353-B7D6-339A2BBC1895,,,,,NA,72,135,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,18,2,2013,TCGA-LUAD
4543,TCGA-69-A59K,NO,,TCGA-69-A59K-D40360,EE6D5CA4-FDD0-45B6-A767-D5B34DE311ED,,,,,NA,72,135,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,18,2,2013,TCGA-LUAD
4544,TCGA-71-6725,NO,,TCGA-71-6725-D70932,C96AEDBF-65F7-4278-9841-02DE35F2FBD4,,,,,NA,107,127,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,3,2015,TCGA-LUAD
4545,TCGA-71-6725,NO,,TCGA-71-6725-D70933,58FFFDD4-06DF-4156-903D-ECAA85C8D3B5,,,,,NA,107,127,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,10,3,2015,TCGA-LUAD
4566,TCGA-73-4675,NO,,TCGA-73-4675-D71058,25DC92F4-A154-4196-9D5F-4BE559E42ABA,,,,,NA,27,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,3,2015,TCGA-LUAD
4565,TCGA-73-4675,NO,,TCGA-73-4675-D71057,3C9951FA-7567-4A17-8ED5-031F790060D7,,,,,NA,27,117,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,17,3,2015,TCGA-LUAD
4564,TCGA-73-4675,NO,,TCGA-73-4675-D71056,13B8CCE4-8461-4A03-A567-E5922A9A11A4,,,,,NA,110,482,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,3,2015,TCGA-LUAD
4567,TCGA-73-4675,NO,,TCGA-73-4675-D71059,1C265224-D738-4F25-8103-9B037F9C9447,,,,,NA,459,483,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,17,3,2015,TCGA-LUAD
4569,TCGA-73-4675,NO,,TCGA-73-4675-D71061,08130C1E-5BB6-4080-939E-11D5E4215EEF,,,,,NA,459,483,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Stable Disease,17,3,2015,TCGA-LUAD
4568,TCGA-73-4675,NO,,TCGA-73-4675-D71060,DC1FC3CB-3680-4D2A-86C2-B9DBC184D6BC,,,,,NA,459,483,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,17,3,2015,TCGA-LUAD
4570,TCGA-73-4675,NO,,TCGA-73-4675-D71062,3BF6C8DC-1CB9-4686-987C-7DA51220B8A3,,,,,NA,592,676,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,17,3,2015,TCGA-LUAD
4575,TCGA-73-7498,NO,,TCGA-73-7498-D32539,0809DF70-4919-4CE8-926D-7348AC6DC9B7,,,,,NA,47,110,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,31,5,2012,TCGA-LUAD
4577,TCGA-73-7498,NO,,TCGA-73-7498-D32543,554C1877-3CCE-449E-9CA4-5FF8E51826CE,,,,,NA,68,110,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,5,2012,TCGA-LUAD
4579,TCGA-73-7498,NO,,TCGA-73-7498-D48757,C2185383-54C4-42AD-B2BF-402648CCF841,,,,,NA,47,131,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,9,2013,TCGA-LUAD
4578,TCGA-73-7498,NO,,TCGA-73-7498-D48756,5FD1CDCF-3998-4DC4-A725-FE3A445BE552,,,,,NA,47,131,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,20,9,2013,TCGA-LUAD
4580,TCGA-73-A9RS,NO,,TCGA-73-A9RS-D60824,F9D3AD0B-B57B-4BC4-BE99-581990D65A30,,,,,NA,130,186,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,6,2014,TCGA-LUAD
4582,TCGA-73-A9RS,YES,,TCGA-73-A9RS-D60827,F252506A-D42C-4B51-8A33-83867E2282B5,,,,,NA,130,186,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,17,6,2014,TCGA-LUAD
4581,TCGA-73-A9RS,NO,,TCGA-73-A9RS-D60826,0462262C-D185-4D68-B111-FE7D35239FFC,,,,,NA,130,186,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,17,6,2014,TCGA-LUAD
4583,TCGA-73-A9RS,NO,,TCGA-73-A9RS-D60828,91902CAB-804C-475D-855B-44440709C0BE,,,,,NA,200,242,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,17,6,2014,TCGA-LUAD
4584,TCGA-73-A9RS,NO,,TCGA-73-A9RS-D60829,F29AAA5F-2DEF-42E3-AAB4-39BC2259681E,,,,,NA,242,284,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,17,6,2014,TCGA-LUAD
5006,TCGA-85-6798,NO,NA,TCGA-85-6798-D65762,9847173A-B627-4B19-9509-7E9018945AE2,NA,,,,NA,20,111,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,30,9,2014,TCGA-LUSC
5005,TCGA-85-6798,NO,NA,TCGA-85-6798-D65761,54CFBC9C-1CE5-48CB-AF2C-BA40C865A955,NA,,,,NA,20,111,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,30,9,2014,TCGA-LUSC
5007,TCGA-85-7697,NO,NA,TCGA-85-7697-D65977,2C853E6E-B369-4F47-9B35-DDBFD7D3F88C,NA,,,,NA,18,134,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5008,TCGA-85-7697,NO,NA,TCGA-85-7697-D65981,304D5C10-FA28-4FE0-8018-3087DE3778F6,NA,,,,NA,18,134,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5010,TCGA-85-7698,NO,NA,TCGA-85-7698-D65986,AC75D5D0-13D6-43A8-AD8E-0F86909A12AE,NA,,,,NA,654,738,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5009,TCGA-85-7698,NO,NA,TCGA-85-7698-D65985,9B2D4976-4124-4BAF-99DC-D9E346A88C23,NA,,,,NA,654,738,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5011,TCGA-85-7699,NO,NA,TCGA-85-7699-D65988,C5B86771-0225-43B8-A38B-07F4476CF8BA,NA,,,,NA,19,112,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5012,TCGA-85-7699,NO,NA,TCGA-85-7699-D65989,31E60E49-2696-45D2-9142-27F0F6B12C1B,NA,,,,NA,19,112,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2014,TCGA-LUSC
5013,TCGA-85-7699,NO,NA,TCGA-85-7699-D65990,C7DDE231-C2CD-4D83-8011-14051DCB9200,NA,,,,NA,761,892,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,15,10,2014,TCGA-LUSC
5014,TCGA-85-7699,NO,NA,TCGA-85-7699-D65991,2AA02746-0F03-4F74-85F9-848B1BAE59D8,NA,,,,NA,761,892,Chemotherapy,Zoledronic acid,Antiresorptive,Other,,,,,NO,Clinical Progressive Disease,15,10,2014,TCGA-LUSC
5015,TCGA-85-8276,NO,NA,TCGA-85-8276-D66444,5212C6B2-22B2-4F80-9828-CC425F0D39F0,NA,,,,NA,17,144,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,10,2014,TCGA-LUSC
5016,TCGA-85-8276,NO,NA,TCGA-85-8276-D66445,BD77EDB6-F9A9-4DAC-8BFC-002ECD9B6E61,NA,,,,NA,17,144,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,10,2014,TCGA-LUSC
5018,TCGA-85-8351,NO,NA,TCGA-85-8351-D66074,9907C02C-313D-40A2-BF00-FE19C6F89C65,NA,,,,NA,22,139,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,10,2014,TCGA-LUSC
5019,TCGA-85-8351,NO,NA,TCGA-85-8351-D66075,C79704EA-5288-4805-BC86-29704A8BF377,NA,,,,NA,22,139,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,10,2014,TCGA-LUSC
5020,TCGA-85-8664,NO,NA,TCGA-85-8664-D59090,DE153EA5-3BF1-41BE-8F4D-3673A03D7411,NA,,,,NA,446,495,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,4,2014,TCGA-LUSC
5025,TCGA-85-A50Z,NO,NA,TCGA-85-A50Z-D55529,56D87C17-698F-416E-AFB9-6F64AA9795B2,NA,,,,NA,35,42,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,1,2014,TCGA-LUSC
5024,TCGA-85-A50Z,NO,NA,TCGA-85-A50Z-D55528,1D7D4633-F5BD-45B6-B214-EF0A27C07893,NA,,,,NA,35,42,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,8,1,2014,TCGA-LUSC
5027,TCGA-85-A512,NO,NA,TCGA-85-A512-D55532,461EC91C-2A55-47FB-9F18-971AA8146FCA,NA,,,,NA,42,78,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,1,2014,TCGA-LUSC
5026,TCGA-85-A512,NO,NA,TCGA-85-A512-D55531,EB661580-F6E3-4C8E-955A-7ECDAA5B640D,NA,,,,NA,42,78,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,8,1,2014,TCGA-LUSC
4618,TCGA-86-7701,NO,,TCGA-86-7701-D36484,24A17B71-0E0B-4803-A21C-02BCB336024D,,,,,NA,27,207,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2012,TCGA-LUAD
4617,TCGA-86-7701,NO,,TCGA-86-7701-D36483,EC1417C7-2349-4F98-939F-E7E643F30F87,,,,,NA,27,207,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,31,10,2012,TCGA-LUAD
4620,TCGA-86-7701,NO,,TCGA-86-7701-D58403,7741F434-FD67-473C-B872-5A2B21734ED8,,,,,NA,454,601,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,9,4,2014,TCGA-LUAD
4621,TCGA-86-7701,NO,,TCGA-86-7701-D58404,444CAEFF-EDEE-460D-9C88-C49C232A90DB,,,,,NA,454,601,Ancillary,Zoledronic acid,Antiresorptive,Other,,,,,NO,Stable Disease,9,4,2014,TCGA-LUAD
4625,TCGA-86-7711,NO,,TCGA-86-7711-D36470,5969CF61-8D1A-4E11-8018-EA0CC6004B7B,,,,,NA,37,181,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2012,TCGA-LUAD
4626,TCGA-86-7711,NO,,TCGA-86-7711-D36471,88D02F6F-8FB9-47F9-8722-B3078EA28D7B,,,,,NA,37,181,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,31,10,2012,TCGA-LUAD
4628,TCGA-86-7713,NO,,TCGA-86-7713-D35430,20185B1B-9AFC-48FB-A72A-4E830C7CB786,,,,,NA,29,182,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,9,2012,TCGA-LUAD
4627,TCGA-86-7713,NO,,TCGA-86-7713-D35429,505DA070-940F-431E-B3D0-0DEC1E27D175,,,,,NA,29,182,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,27,9,2012,TCGA-LUAD
4629,TCGA-86-7954,NO,,TCGA-86-7954-D57949,D1519FCC-3805-4E15-B46C-49EA3BCEEC7D,,,,,NA,55,81,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,3,2014,TCGA-LUAD
4630,TCGA-86-7954,NO,,TCGA-86-7954-D57950,3D5B9CB0-F3CF-411C-8AFB-E3271BA29B8C,,,,,NA,55,81,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,28,3,2014,TCGA-LUAD
4632,TCGA-86-7955,NO,,TCGA-86-7955-D41099,6E123B02-3E4D-4660-9400-A5BDA061292D,,,,,NA,27,274,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,3,2013,TCGA-LUAD
4631,TCGA-86-7955,NO,,TCGA-86-7955-D41098,7C0A1FDD-293F-4DF9-AC3D-67AB0630FF20,,,,,NA,27,274,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,12,3,2013,TCGA-LUAD
4634,TCGA-86-7955,NO,,TCGA-86-7955-D63519,4F1FAE32-57AF-472B-8BCD-8E1EAB496CDC,,,,,NA,823,922,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,8,2014,TCGA-LUAD
4633,TCGA-86-7955,NO,,TCGA-86-7955-D63518,B33DF174-A60F-4916-97D6-315FF1B3CBF3,,,,,NA,823,922,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,12,8,2014,TCGA-LUAD
4636,TCGA-86-8054,NO,,TCGA-86-8054-D41094,7BBDF359-8AE5-4BBC-9539-38B87210A586,,,,,NA,65,136,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,3,2013,TCGA-LUAD
4635,TCGA-86-8054,NO,,TCGA-86-8054-D41093,AB80A551-9E5E-4095-8852-00599B1C8859,,,,,NA,65,136,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,3,2013,TCGA-LUAD
4638,TCGA-86-8075,NO,,TCGA-86-8075-D41681,7E6A245F-8FC9-4F05-BA87-C6FC12A202EB,,,,,NA,201,364,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4637,TCGA-86-8075,NO,,TCGA-86-8075-D41680,3C971D88-EA87-4F2F-893C-B7BB558C402E,,,,,NA,201,364,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4641,TCGA-86-8076,NO,,TCGA-86-8076-D41685,6DF79C11-EF79-4AF7-90DA-26FB54BB5161,,,,,NA,40,193,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4640,TCGA-86-8076,NO,,TCGA-86-8076-D41684,50F44FAB-0ED8-4107-BFA7-F1D90752FECF,,,,,NA,40,193,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4643,TCGA-86-8278,NO,,TCGA-86-8278-D41671,9ACDE909-44BF-475C-AAFC-8C721F24CFD9,,,,,NA,29,156,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,25,3,2013,TCGA-LUAD
4642,TCGA-86-8278,NO,,TCGA-86-8278-D41670,964E5BFB-3A3B-47C8-A346-6F5BDACA4D99,,,,,NA,29,156,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,25,3,2013,TCGA-LUAD
4646,TCGA-86-8279,NO,,TCGA-86-8279-D41677,233E4E3A-65B3-467B-B214-C52773DD2094,,,,,NA,28,119,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4645,TCGA-86-8279,NO,,TCGA-86-8279-D41676,9F2065E1-C62F-4D2A-92CB-B1DB2F7963E2,,,,,NA,28,119,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,25,3,2013,TCGA-LUAD
4647,TCGA-86-8280,NO,,TCGA-86-8280-D66080,7B11F24A-04FA-472B-A420-D8E1764C3600,,,,,NA,16,129,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4648,TCGA-86-8280,NO,,TCGA-86-8280-D66081,2895FB6B-3FC1-4DFD-B743-1CB915268336,,,,,NA,16,129,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4649,TCGA-86-8669,NO,,TCGA-86-8669-D66086,E18E7469-7056-41A2-8BB1-43EE190292AC,,,,,NA,854,938,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4650,TCGA-86-8669,NO,,TCGA-86-8669-D66087,336C3649-8213-4895-8F57-85A6FEE79492,,,,,NA,854,938,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4651,TCGA-86-8671,NO,,TCGA-86-8671-D66090,151A219B-0DB6-4158-A30B-35B97CC9A1A9,,,,,NA,18,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4652,TCGA-86-8671,NO,,TCGA-86-8671-D66091,36EB3446-D9DC-4620-830A-8CE6A214F2DB,,,,,NA,18,104,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,10,2014,TCGA-LUAD
4654,TCGA-86-8674,NO,,TCGA-86-8674-D42029,34F415AA-90DB-4E2C-9F08-160D35EAA160,,,,,NA,57,81,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,4,2013,TCGA-LUAD
4653,TCGA-86-8674,NO,,TCGA-86-8674-D42028,55CE92CA-ED7F-460F-BCDD-25F915DE1A54,,,,,NA,57,81,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,9,4,2013,TCGA-LUAD
4656,TCGA-86-A4D0,NO,,TCGA-86-A4D0-D52968,781B2224-221B-4BDA-9872-513C7BF06A99,,,,,NA,76,80,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,12,2013,TCGA-LUAD
4655,TCGA-86-A4D0,NO,,TCGA-86-A4D0-D52966,6BF8E543-7F35-4B18-83AE-963B50ADA0CD,,,,,NA,76,80,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,12,2013,TCGA-LUAD
4659,TCGA-86-A4P8,NO,,TCGA-86-A4P8-D48293,C22B8623-E5C2-4F22-8CCD-7859A4802584,,,,,NA,43,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,9,2013,TCGA-LUAD
4660,TCGA-86-A4P8,NO,,TCGA-86-A4P8-D48295,054E5CD2-940A-4364-A458-39387314D2AE,,,,,NA,43,106,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,11,9,2013,TCGA-LUAD
5029,TCGA-90-6837,,NA,TCGA-90-6837-D46082,D2BA7B68-12F9-4F3E-AA6C-DD6D56AE9402,NA,,,,NA,148,176,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,31,7,2013,TCGA-LUSC
5030,TCGA-90-6837,,NA,TCGA-90-6837-D46083,7E55BA65-342E-4311-9543-AF88CA4EA762,NA,,,,NA,176,197,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,7,2013,TCGA-LUSC
5031,TCGA-90-6837,,NA,TCGA-90-6837-D46084,BE6C700F-B51D-419A-9C20-040952F35D5B,NA,,,,NA,176,197,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,31,7,2013,TCGA-LUSC
5032,TCGA-90-A4EE,,NA,TCGA-90-A4EE-D41930,AB8EA8EE-28BB-4A3A-A100-9C936CB5D0D9,NA,,,,NA,121,184,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,4,2013,TCGA-LUSC
5033,TCGA-90-A4EE,,NA,TCGA-90-A4EE-D41931,11E1680A-9F35-4AED-BBB5-908AA04E6A54,NA,,,,NA,121,184,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,4,2013,TCGA-LUSC
5034,TCGA-90-A59Q,,NA,TCGA-90-A59Q-D45222,57B77654-0CE9-4AFB-9429-10916B74305E,NA,,,,NA,75,117,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,7,2013,TCGA-LUSC
4661,TCGA-91-6848,,,TCGA-91-6848-D32644,84DFEC23-536C-4115-8F5A-A423FC91FAE2,,,,,NA,91,154,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,6,2012,TCGA-LUAD
4662,TCGA-91-6848,,,TCGA-91-6848-D33330,C0CD8924-B559-41B3-B3A3-53EFB06231E5,,,,,NA,91,154,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,28,6,2012,TCGA-LUAD
4663,TCGA-91-7771,,,TCGA-91-7771-D37917,494CE129-C26D-4374-B915-382105753D85,,,,,NA,77,156,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-LUAD
4664,TCGA-91-7771,,,TCGA-91-7771-D37919,7D947262-1775-4C0C-981A-AAF1E6E7D92E,,,,,NA,77,156,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-LUAD
5038,TCGA-92-8063,NO,NA,TCGA-92-8063-D32173,577a2a3a-0bdd-4888-96f3-4ad52554dfee,NA,,,,NA,52,94,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,5,2012,TCGA-LUSC
4666,TCGA-93-A4JN,NO,,TCGA-93-A4JN-D64293,7A4ADFCB-3BF9-433A-8A71-9BF156B3E93A,,,,,NA,410,697,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,28,8,2014,TCGA-LUAD
4667,TCGA-93-A4JP,NO,,TCGA-93-A4JP-D65104,6D848A43-59A3-46FE-9574-9F37B0059EC8,,,,,NA,17,101,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,18,9,2014,TCGA-LUAD
4672,TCGA-95-A4VK,NO,,TCGA-95-A4VK-D40500,676EB575-B085-4F0A-AAD2-CD3F2A17544E,,,,,NA,76,121,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,21,2,2013,TCGA-LUAD
4673,TCGA-95-A4VK,NO,,TCGA-95-A4VK-D40512,F28DCD0F-6819-45FB-9F86-5FACA3E69090,,,,,NA,76,121,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,21,2,2013,TCGA-LUAD
4674,TCGA-95-A4VP,NO,,TCGA-95-A4VP-D40540,EEC4E284-83E6-48D8-9E22-87A68963B598,,,,,NA,63,126,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,22,2,2013,TCGA-LUAD
4675,TCGA-95-A4VP,NO,,TCGA-95-A4VP-D40543,B3A1D470-D0D9-4ABF-A3AF-1447CD0096B4,,,,,NA,63,126,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,22,2,2013,TCGA-LUAD
5048,TCGA-96-A4JK,NO,NA,TCGA-96-A4JK-D40919,FCE82BE2-BAB7-416D-8A5F-CC483933D3F5,NA,,,,NA,47,139,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,3,2013,TCGA-LUSC
5047,TCGA-96-A4JK,NO,NA,TCGA-96-A4JK-D40918,D2ABC2A9-8DF3-43A8-9CF0-CE090BB383E0,NA,,,,NA,47,139,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,7,3,2013,TCGA-LUSC
5050,TCGA-96-A4JL,NO,NA,TCGA-96-A4JL-D40916,30A91173-72F9-42D3-B0D2-64120ACD1E94,NA,,,,NA,52,136,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,3,2013,TCGA-LUSC
5049,TCGA-96-A4JL,NO,NA,TCGA-96-A4JL-D40915,5C1CCACD-D745-4D1A-859C-14F1AB3F09CE,NA,,,,NA,52,136,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,7,3,2013,TCGA-LUSC
4689,TCGA-97-8176,NO,,TCGA-97-8176-D35660,3CDB750D-9A1C-4C74-B647-D988440014AE,,,,,NA,77,161,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,5,10,2012,TCGA-LUAD
4690,TCGA-97-8176,NO,,TCGA-97-8176-D35661,C2AF0586-F52E-443A-9120-934B54628579,,,,,NA,77,417,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Partial Response,5,10,2012,TCGA-LUAD
4691,TCGA-97-8176,NO,,TCGA-97-8176-D35662,49597D40-3617-493C-8061-8DCCB9871B6B,,,,,NA,77,417,Ancillary,B12,Rescue agent,Other,,,,,NO,Partial Response,5,10,2012,TCGA-LUAD
4698,TCGA-97-8547,NO,,TCGA-97-8547-D35446,8EDFE56A-3EB6-47A8-A4BA-2255FF3A3418,,,,,NA,47,111,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,9,2012,TCGA-LUAD
4697,TCGA-97-8547,NO,,TCGA-97-8547-D35445,46926057-7C1B-4651-913D-B4C08C699594,,,,,NA,47,111,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,27,9,2012,TCGA-LUAD
406,TCGA-A2-A0CK,NO,,TCGA-A2-A0CK-D42397,F5986AFE-856D-4225-B5CE-EA9C5922B674,,,,,,1451,1518,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,4,2013,TCGA-BRCA
404,TCGA-A2-A0CK,NO,,TCGA-A2-A0CK-D32655,66EDDC61-9F6C-4BBA-A99E-BCD484A1A162,,,,,,NA,NA,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,6,2012,TCGA-BRCA
405,TCGA-A2-A0CK,NO,,TCGA-A2-A0CK-D32656,9C6B9B44-4C5B-42CD-8AA6-38038395E117,,,,,,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,6,2012,TCGA-BRCA
403,TCGA-A2-A0CK,NO,,TCGA-A2-A0CK-D32654,9B39167B-12F1-4113-A4B9-6D87C0D579F0,,,,,,NA,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,6,2012,TCGA-BRCA
415,TCGA-A2-A0CL,YES,,TCGA-A2-A0CL-D39784,3CD728D5-9818-47B3-AED9-099463BAC77E,,,,,,126,168,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,Antimetabolite,,,,NO,Complete Response,1,2,2013,TCGA-BRCA
422,TCGA-A2-A0CO,NO,,TCGA-A2-A0CO-D33663,80B1C97B-8D60-43C3-BDCE-AC0B58A11419,,,,,,84,512,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,12,7,2012,TCGA-BRCA
432,TCGA-A2-A0CR,NO,,TCGA-A2-A0CR-D32691,A7033B5A-843E-4899-98F4-FAA742F71CB5,,,,,,105,147,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,6,2012,TCGA-BRCA
431,TCGA-A2-A0CR,NO,,TCGA-A2-A0CR-D32690,D0B85F79-B3D8-4E9F-A1AA-E2C032E70AB5,,,,,,105,147,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,7,6,2012,TCGA-BRCA
433,TCGA-A2-A0CR,NO,,TCGA-A2-A0CR-D32692,B04147AD-6DB7-426E-AA27-E42D79761AE0,,,,,,140,203,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,6,2012,TCGA-BRCA
434,TCGA-A2-A0CR,NO,,TCGA-A2-A0CR-D32693,15734CC3-5FE8-44C0-8E0B-651B026DFC80,,,,,,224,300,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,7,6,2012,TCGA-BRCA
490,TCGA-A2-A0EP,NO,,TCGA-A2-A0EP-D34476,2B8CBF67-155E-4E57-A98D-DE14635EFF9B,,,,,,92,141,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,8,2012,TCGA-BRCA
491,TCGA-A2-A0EP,NO,,TCGA-A2-A0EP-D34477,173BF0C9-24F6-4410-AFF4-7061C0A143DB,,,,,,92,141,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,16,8,2012,TCGA-BRCA
492,TCGA-A2-A0EP,NO,,TCGA-A2-A0EP-D34479,C6483A02-70E1-4780-BC05-4AE04CAF32CB,,,,,,169,195,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,16,8,2012,TCGA-BRCA
493,TCGA-A2-A0EP,NO,,TCGA-A2-A0EP-D34480,FFB9FA64-1267-4A11-8416-9F07A311CF55,,,,,,222,1781,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,16,8,2012,TCGA-BRCA
494,TCGA-A2-A0EP,NO,,TCGA-A2-A0EP-D34482,0E2A204E-622E-437C-ADF2-E2DEA2F32B38,,,,,,1959,2461,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,16,8,2012,TCGA-BRCA
517,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59516,435F5BFB-5046-4569-B0B6-57857326B73A,,,,,,813,903,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,14,5,2014,TCGA-BRCA
518,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59517,9978CD5C-428A-4871-B65B-A055D9325955,,,,,,904,1001,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,14,5,2014,TCGA-BRCA
519,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59518,086CE23B-765A-4665-BD7E-9CD16396B4B9,,,,,,1002,1365,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
520,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59519,69429F28-2A38-4B0B-9306-59A9133230D7,,,,,,1158,1422,Ancillary,Zoledronic acid,Antiresorptive,Other,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
521,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59520,1071A37F-0128-473D-8BA3-2DBF3AD5953E,,,,,,1366,1562,Hormone Therapy,Fulvestrant,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
522,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59521,01259757-DD3D-4DF9-9686-9CB07AE8A150,,,,,,1425,1718,Ancillary,Denosumab,Antiresorptive,Other,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
523,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59522,C89E1F88-A478-4697-9540-2AC63A295747,,,,,,1618,1722,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
524,TCGA-A2-A0EW,NO,,TCGA-A2-A0EW-D59523,9FAAE45E-9014-4CD8-BBBA-F327C60E65D7,,,,,,1696,1787,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,14,5,2014,TCGA-BRCA
666,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34447,B3410728-5DD2-4C46-8F60-384AE7FD0DE0,,,,,,112,154,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
667,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34449,57BE30DA-D982-441F-9385-4A8F49FD6C7F,,,,,,112,154,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
668,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34450,C4D6719C-2751-4CCD-A188-EC01BB23E1B0,,,,,,167,210,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
669,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34451,8FC4D02E-D7CA-465A-A5DF-A4C2323A2ACC,,,,,,281,682,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,15,8,2012,TCGA-BRCA
670,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34452,0E43D65F-FF3E-49BB-9DEA-8C8B0BF3AD17,,,,,,695,806,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,15,8,2012,TCGA-BRCA
671,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34453,F4FCCE3E-BB62-4A80-909D-A1DC2198705D,,,,,,895,958,Ancillary,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,15,8,2012,TCGA-BRCA
672,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34454,055A4779-B7FE-4F15-894F-81785BED5BE4,,,,,,874,980,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,15,8,2012,TCGA-BRCA
673,TCGA-A2-A3XS,NO,,TCGA-A2-A3XS-D34455,0221663A-3CAA-42B8-B315-073962FBD6FF,,,,,,986,1022,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,15,8,2012,TCGA-BRCA
674,TCGA-A2-A3XT,NO,,TCGA-A2-A3XT-D34495,C93B9D6C-DE38-4B66-AA69-C788731E6DA2,,,,,,35,83,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,17,8,2012,TCGA-BRCA
675,TCGA-A2-A3XT,NO,,TCGA-A2-A3XT-D34496,314F8E23-81C1-41B5-BB1D-78A78525EE50,,,,,,35,83,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,17,8,2012,TCGA-BRCA
676,TCGA-A2-A3XT,NO,,TCGA-A2-A3XT-D34497,3E9B81CF-BFAD-4C78-AC24-32461C485692,,,,,,97,161,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,17,8,2012,TCGA-BRCA
680,TCGA-A2-A3XU,NO,,TCGA-A2-A3XU-D34709,D7667385-C63A-4D90-AE37-D95D1BC45AD5,,,,,,596,718,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,28,8,2012,TCGA-BRCA
681,TCGA-A2-A3XU,NO,,TCGA-A2-A3XU-D34710,45C67643-FF02-4C5B-874F-3D7D85A8FE9D,,,,,,657,902,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,28,8,2012,TCGA-BRCA
682,TCGA-A2-A3XV,NO,,TCGA-A2-A3XV-D34630,71D050BF-7E93-4BA7-B969-F1887FC94B89,,,,,,62,175,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
683,TCGA-A2-A3XV,NO,,TCGA-A2-A3XV-D34631,7CF49A37-54D6-47C1-B0FA-F3732990E8A2,,,,,,62,175,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
684,TCGA-A2-A3XV,NO,,TCGA-A2-A3XV-D34632,212FE1BA-E2B8-435A-91E6-5BC6F1B03C9B,,,,,,62,428,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
687,TCGA-A2-A3XW,YES,,TCGA-A2-A3XW-D34432,FBBE5DDA-17FD-4605-B38C-1F391379A514,,,,,,69,139,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
686,TCGA-A2-A3XW,YES,,TCGA-A2-A3XW-D34431,5DE33005-8993-4B5B-8D3A-F74A18EAE600,,,,,,69,139,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
688,TCGA-A2-A3XW,YES,,TCGA-A2-A3XW-D34433,17ED55A4-16C3-4F43-8986-3714A71F0F78,,,,,,153,223,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
690,TCGA-A2-A3XX,NO,,TCGA-A2-A3XX-D34438,9F081506-F377-47BB-8EE6-EDE38541E7B9,,,,,,80,129,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
691,TCGA-A2-A3XX,NO,,TCGA-A2-A3XX-D34439,588DB182-2F95-48D2-A365-0BDF34B3C1FB,,,,,,80,129,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
692,TCGA-A2-A3XX,NO,,TCGA-A2-A3XX-D34441,B6FD1396-6FE8-44FF-A6AC-72B380261AD5,,,,,,143,185,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,8,2012,TCGA-BRCA
694,TCGA-A2-A3XY,YES,,TCGA-A2-A3XY-D34407,E7F46F97-06FB-49A1-B9B2-DC0F211325DC,,,,,,86,149,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,8,2012,TCGA-BRCA
693,TCGA-A2-A3XY,YES,,TCGA-A2-A3XY-D34406,CBE5F428-42AB-4719-A28B-3D8E9903B596,,,,,,86,149,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,8,2012,TCGA-BRCA
696,TCGA-A2-A3XY,YES,,TCGA-A2-A3XY-D34409,385416B0-05A4-45C0-A807-DDFFE65C59EE,,,,,,170,170,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,8,2012,TCGA-BRCA
695,TCGA-A2-A3XY,YES,,TCGA-A2-A3XY-D34408,2BB3150F-2130-4FA5-9E80-A2F76E236D3C,,,,,,170,170,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,8,2012,TCGA-BRCA
697,TCGA-A2-A3XY,YES,,TCGA-A2-A3XY-D34411,6B22D335-A270-451A-93F4-A11F8A4875A6,,,,,,184,254,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,8,2012,TCGA-BRCA
698,TCGA-A2-A3XY,NO,,TCGA-A2-A3XY-D43312,4620C49F-B2FE-4FBD-8CD3-C2CAFBD9EEA4,,,,,,816,913,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,16,5,2013,TCGA-BRCA
699,TCGA-A2-A3XY,NO,,TCGA-A2-A3XY-D43313,89205666-328A-4D84-8355-E8627C761EC5,,,,,,816,1019,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,16,5,2013,TCGA-BRCA
701,TCGA-A2-A3XY,NO,,TCGA-A2-A3XY-D43315,D420260B-7367-4532-AC11-A5A0966EBCBC,,,,,,816,1058,Ancillary,Denosumab,Antiresorptive,Other,,,,,NO,Clinical Progressive Disease,16,5,2013,TCGA-BRCA
700,TCGA-A2-A3XY,NO,,TCGA-A2-A3XY-D43314,D2AD9346-11EA-432E-94D0-DC4429648DC1,,,,,,1040,1061,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,16,5,2013,TCGA-BRCA
702,TCGA-A2-A3XZ,NO,,TCGA-A2-A3XZ-D34516,EC157BD8-01E2-4587-87D0-ED9A7863A136,,,,,,97,202,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2012,TCGA-BRCA
703,TCGA-A2-A3XZ,NO,,TCGA-A2-A3XZ-D34517,9E6E1263-16AB-4E0E-8C59-14347BB6F50C,,,,,,97,202,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,8,2012,TCGA-BRCA
704,TCGA-A2-A3XZ,NO,,TCGA-A2-A3XZ-D34518,3F688A9E-5E71-4676-BA57-190015FED400,,,,,,97,423,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,21,8,2012,TCGA-BRCA
706,TCGA-A2-A3Y0,NO,,TCGA-A2-A3Y0-D34571,FBC64FA5-C743-40B6-9565-79BFB168FF4E,,,,,,74,137,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
705,TCGA-A2-A3Y0,NO,,TCGA-A2-A3Y0-D34570,9F7B7F8B-718E-4740-93BC-324EE04D01E8,,,,,,74,137,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
707,TCGA-A2-A3Y0,NO,,TCGA-A2-A3Y0-D34587,27FAEC54-F24D-438B-8005-1AA132B3092A,,,,,,165,247,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
708,TCGA-A2-A3Y0,NO,,TCGA-A2-A3Y0-D34588,8E48C12C-49AB-4BAE-A24E-F9DA45AAA81F,,,,,,NA,NA,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
709,TCGA-A2-A3Y0,NO,,TCGA-A2-A3Y0-D34589,8A141947-57F7-47C1-9301-538DC497884B,,,,,,NA,NA,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,24,8,2012,TCGA-BRCA
713,TCGA-A2-A4RY,NO,,TCGA-A2-A4RY-D40661,026BFA4A-9212-4110-83E8-783895513760,,,,,,58,164,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
711,TCGA-A2-A4RY,NO,,TCGA-A2-A4RY-D40659,1BCAA28C-A1D9-45B4-993D-DC411B983F6C,,,,,,58,164,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
712,TCGA-A2-A4RY,NO,,TCGA-A2-A4RY-D40660,49B3D51C-F502-4AB9-9548-345C27375EA6,,,,,,58,164,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
716,TCGA-A2-A4S2,NO,,TCGA-A2-A4S2-D40763,30184077-58DE-45BD-94A3-1F57F5419536,,,,,,47,96,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,2,2013,TCGA-BRCA
715,TCGA-A2-A4S2,NO,,TCGA-A2-A4S2-D40762,72B353D4-7256-4161-B9C8-EA9FDC872D78,,,,,,47,96,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,28,2,2013,TCGA-BRCA
717,TCGA-A2-A4S2,NO,,TCGA-A2-A4S2-D40764,B81A498A-A3FC-4E99-A912-6B5CBC9E288D,,,,,,110,173,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,28,2,2013,TCGA-BRCA
4162,TCGA-A4-7287,NO,NA,TCGA-A4-7287-D57040,AA8D554D-EA01-441D-9ED8-86D8E21866DE,,,,,NA,254,282,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,28,2,2014,TCGA-KIRP
4163,TCGA-A4-7287,NO,NA,TCGA-A4-7287-D57042,E701CC9C-CD73-46BB-A40A-89CB97BEF8FB,,,,,NA,254,436,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,28,2,2014,TCGA-KIRP
4164,TCGA-A4-7287,NO,NA,TCGA-A4-7287-D57043,F7C82164-EBF6-4482-B240-1E92ED3F3933,,,,,NA,290,436,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,28,2,2014,TCGA-KIRP
4165,TCGA-A4-A57E,NO,NA,TCGA-A4-A57E-D64126,671EBC9B-7F03-4D28-9F49-6C14627049BC,,,,,NA,39,NA,Chemotherapy,Everolimus,MTOR inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,26,8,2014,TCGA-KIRP
9588,TCGA-A5-A1OH,NO,NA,TCGA-A5-A1OH-D34162,F76236DB-DF2C-4184-B035-5CFE33C5FE59,NA,,,,NA,251,321,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,8,2012,TCGA-UCEC
9605,TCGA-A5-A3LP,NO,NA,TCGA-A5-A3LP-D32261,7628FE0F-F9AC-4382-B6F0-32D4DDA643CC,NA,,,,NA,106,166,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,6,2012,TCGA-UCEC
9606,TCGA-A5-A7WK,NO,NA,TCGA-A5-A7WK-D54553,DA131098-AD4C-4A8B-8DEE-1A8ECFDFE051,NA,,,,NA,84,205,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,12,2013,TCGA-UCEC
9607,TCGA-A5-A7WK,NO,NA,TCGA-A5-A7WK-D63887,F3EC705A-ACFA-4653-852A-BEA24B063880,NA,,,,NA,357,443,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,20,8,2014,TCGA-UCEC
9610,TCGA-A5-AB3J,NO,NA,TCGA-A5-AB3J-D64510,B947E618-F799-4297-A396-8D9B78606682,NA,,,,NA,63,111,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,9,2014,TCGA-UCEC
9609,TCGA-A5-AB3J,NO,NA,TCGA-A5-AB3J-D64509,0E4BDCD1-F711-434F-A96E-DAFFFD4F0AEA,NA,,,,NA,63,112,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,9,2014,TCGA-UCEC
2958,TCGA-A6-2671,NO,,TCGA-A6-2671-D31177,28b4628d-26ff-4ffe-998d-3a1de2be56b8,,,,,,844,844,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2959,TCGA-A6-2671,NO,,TCGA-A6-2671-D31178,9ef7c5d5-470f-4586-8ff2-adb6b1db8667,,,,,,844,844,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2960,TCGA-A6-2671,NO,,TCGA-A6-2671-D31179,0b9b3648-918f-4f14-a9c8-5cd58d935ed7,,,,,,844,846,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2961,TCGA-A6-2671,NO,,TCGA-A6-2671-D31180,386e2918-33c5-4df0-a196-28864d9a87e3,,,,,,844,984,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2957,TCGA-A6-2671,NO,,TCGA-A6-2671-D31097,3254ea81-298b-461f-9e51-2daa00fb9c60,,,,,,844,984,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2963,TCGA-A6-2671,NO,,TCGA-A6-2671-D31184,f8603c4a-b9ed-4efa-a9d1-07b84ae5c330,,,,,,1041,1091,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
2962,TCGA-A6-2671,NO,,TCGA-A6-2671-D31182,b57bfe0a-f932-417b-b510-dc6c1800c1a7,,,,,,1041,1105,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,24,4,2012,TCGA-COAD
3036,TCGA-A6-5664,NO,,TCGA-A6-5664-D33771,07B9A3D8-5A9A-42A5-9C94-C102D4CFE178,,,,,,301,391,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,16,7,2012,TCGA-COAD
3038,TCGA-A6-5664,NO,,TCGA-A6-5664-D33773,AE58752C-D8C7-469A-A65B-72ABF738364E,,,,,,301,635,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,16,7,2012,TCGA-COAD
3037,TCGA-A6-5664,NO,,TCGA-A6-5664-D33772,8249DBD2-17BC-46F8-BF68-4FF5E4D0BA0A,,,,,,301,635,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,16,7,2012,TCGA-COAD
3035,TCGA-A6-5664,NO,,TCGA-A6-5664-D33770,3BA99B8C-D023-41EB-BD42-E479F3EBDEDF,,,,,,301,635,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,16,7,2012,TCGA-COAD
3039,TCGA-A6-5664,NO,,TCGA-A6-5664-D33774,D8CFB903-4B53-4FDB-B226-2893791A7ADF,,,,,,301,637,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,16,7,2012,TCGA-COAD
3072,TCGA-A6-6652,YES,,TCGA-A6-6652-D30907,3a8d9c47-535d-49bc-8901-149af8ad9273,,,,,,86,254,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Stable Disease,19,4,2012,TCGA-COAD
3085,TCGA-A6-A565,NO,,TCGA-A6-A565-D42144,5BD8C24D-85AD-4D45-8D64-5DF0775A2B08,,,,,,NA,NA,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,12,4,2013,TCGA-COAD
3083,TCGA-A6-A565,NO,,TCGA-A6-A565-D42141,9F6660B3-7566-45BC-8FAC-96CC0EFC39B4,,,,,,NA,NA,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,12,4,2013,TCGA-COAD
3084,TCGA-A6-A565,NO,,TCGA-A6-A565-D42143,297A845E-BC66-4A57-9FFD-7244BD48D447,,,,,,NA,NA,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,12,4,2013,TCGA-COAD
3086,TCGA-A6-A566,NO,,TCGA-A6-A566-D42252,74C0E183-B802-4EFC-BD08-FCBB9930035D,,,,,,76,237,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-COAD
3087,TCGA-A6-A566,NO,,TCGA-A6-A566-D42254,F111779F-8AA9-4640-9CCE-7CA1D108F7CE,,,,,,76,251,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-COAD
3088,TCGA-A6-A566,NO,,TCGA-A6-A566-D42262,843A4503-B4D5-4C02-8919-45C327BA724F,,,,,,76,251,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-COAD
3089,TCGA-A6-A566,NO,,TCGA-A6-A566-D42264,4F12D452-984F-40FF-A277-8CDEDCAA4B42,,,,,,76,253,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-COAD
3090,TCGA-A6-A56B,YES,,TCGA-A6-A56B-D42088,07E34E9E-9C88-42C3-9978-261BEA4751F6,,,,,,82,110,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,4,2013,TCGA-COAD
3092,TCGA-A6-A56B,YES,,TCGA-A6-A56B-D42090,0D9ACB99-4600-4500-A13E-6F8C9A486B11,,,,,,82,236,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,4,2013,TCGA-COAD
3091,TCGA-A6-A56B,YES,,TCGA-A6-A56B-D42089,4222D044-05CB-4518-9BAC-DB508925FB7E,,,,,,82,236,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,4,2013,TCGA-COAD
3093,TCGA-A6-A56B,YES,,TCGA-A6-A56B-D42091,06E9668D-3E5E-4CC8-A928-31E4FFE59F82,,,,,,82,238,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,4,2013,TCGA-COAD
3094,TCGA-A6-A56B,YES,,TCGA-A6-A56B-D42092,E4C65970-C55E-48AF-A90D-85AC6045F18C,,,,,,82,243,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,,,NO,Complete Response,10,4,2013,TCGA-COAD
3095,TCGA-A6-A5ZU,NO,,TCGA-A6-A5ZU-D51210,0A3C8862-F409-415A-AA9C-4FAF2B00D046,,,,,,105,245,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,13,11,2013,TCGA-COAD
3097,TCGA-A6-A5ZU,NO,,TCGA-A6-A5ZU-D51212,16A5338C-26CA-4F43-A103-F39855600088,,,,,,105,272,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,13,11,2013,TCGA-COAD
3096,TCGA-A6-A5ZU,NO,,TCGA-A6-A5ZU-D51211,B0A001F1-04BE-42CE-827C-E68CCC501CA3,,,,,,105,272,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,13,11,2013,TCGA-COAD
3098,TCGA-A6-A5ZU,NO,,TCGA-A6-A5ZU-D51213,8049EF92-87B1-4195-A843-E594E482D74A,,,,,,105,274,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,13,11,2013,TCGA-COAD
772,TCGA-A7-A2KD,NO,,TCGA-A7-A2KD-D32490,A17F619D-81A6-4A7B-BEB1-20FA1C828843,,,,,,57,435,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,30,5,2012,TCGA-BRCA
781,TCGA-A7-A3RF,NO,,TCGA-A7-A3RF-D40414,C60A018E-A8EC-4C00-AB28-40901C23F33E,,,,,,137,NA,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,YES,Clinical Progressive Disease,19,2,2013,TCGA-BRCA
791,TCGA-A7-A4SA,YES,,TCGA-A7-A4SA-D40423,90ABC9E4-87E8-4C1B-A001-A9A02F4B7AAB,,,,,,73,115,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,2,2013,TCGA-BRCA
790,TCGA-A7-A4SA,YES,,TCGA-A7-A4SA-D40422,D1394A9B-E263-4C3E-9B21-9C7C7A27F4DD,,,,,,73,115,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,19,2,2013,TCGA-BRCA
792,TCGA-A7-A4SA,YES,,TCGA-A7-A4SA-D40424,6BB3CF2B-3286-4031-A91D-48803A014612,,,,,,136,213,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,19,2,2013,TCGA-BRCA
795,TCGA-A7-A4SB,NO,,TCGA-A7-A4SB-D40445,9F679293-FBF6-4C18-8842-A0A4A2E10805,,,,,,61,124,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,2,2013,TCGA-BRCA
794,TCGA-A7-A4SB,NO,,TCGA-A7-A4SB-D40444,50FAB4F7-9961-47ED-A399-7EA0F55FF5EC,,,,,,61,124,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,20,2,2013,TCGA-BRCA
800,TCGA-A7-A4SD,NO,,TCGA-A7-A4SD-D40420,642ABB42-0832-4A3A-9FB0-AE825D90EEC6,,,,,,64,134,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,2,2013,TCGA-BRCA
799,TCGA-A7-A4SD,NO,,TCGA-A7-A4SD-D40418,AC6661B8-5744-4B0F-99D8-1C6C82FF86D4,,,,,,64,134,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,19,2,2013,TCGA-BRCA
802,TCGA-A7-A4SE,NO,,TCGA-A7-A4SE-D41892,B8237736-7799-4490-A1CA-2A15E2985B17,,,,,,49,91,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,4,2013,TCGA-BRCA
801,TCGA-A7-A4SE,NO,,TCGA-A7-A4SE-D41891,8C1D4FAD-B3C5-4009-94B8-51BE6B474423,,,,,,49,91,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,4,2013,TCGA-BRCA
803,TCGA-A7-A4SE,NO,,TCGA-A7-A4SE-D41893,5FA600E2-E487-4345-A4BE-E4A7AD3738EB,,,,,,105,154,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,4,2013,TCGA-BRCA
804,TCGA-A7-A4SF,NO,,TCGA-A7-A4SF-D40583,308EA6ED-2B83-4B5B-95E0-CBDEF48D7909,,,,,,89,202,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
805,TCGA-A7-A4SF,NO,,TCGA-A7-A4SF-D40584,68535884-BA16-4956-99F0-FB17F5DE630D,,,,,,89,202,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
806,TCGA-A7-A4SF,NO,,TCGA-A7-A4SF-D40585,1A67FA24-FD67-47D8-A0B6-75D33DABFB3A,,,,,,89,453,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
810,TCGA-A7-A5ZV,YES,,TCGA-A7-A5ZV-D43179,EADD43A7-E14F-4643-A3BE-C251663F4AA0,,,,,,95,137,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2013,TCGA-BRCA
809,TCGA-A7-A5ZV,YES,,TCGA-A7-A5ZV-D43178,8F1125F3-DBBB-47BC-BACF-5CE4963DC966,,,,,,95,137,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,5,2013,TCGA-BRCA
811,TCGA-A7-A5ZV,YES,,TCGA-A7-A5ZV-D43180,52DC65F2-30C0-4BDD-89AC-641853A9E429,,,,,,151,193,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,5,2013,TCGA-BRCA
812,TCGA-A7-A5ZW,NO,,TCGA-A7-A5ZW-D50165,4AF33B96-C484-42DE-8F9B-AAB6DC4E168D,,,,,,71,176,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,10,2013,TCGA-BRCA
813,TCGA-A7-A5ZW,NO,,TCGA-A7-A5ZW-D50166,C795DC4E-1F39-460D-9E49-17CB3709BE9E,,,,,,71,176,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,16,10,2013,TCGA-BRCA
816,TCGA-A7-A5ZX,NO,,TCGA-A7-A5ZX-D51333,F5C792BC-E5C5-4C56-9434-A746E1B17038,,,,,,76,118,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,11,2013,TCGA-BRCA
815,TCGA-A7-A5ZX,NO,,TCGA-A7-A5ZX-D51332,9C29891D-CFA8-48D4-A646-C3AD561F20DA,,,,,,76,118,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,11,2013,TCGA-BRCA
817,TCGA-A7-A5ZX,NO,,TCGA-A7-A5ZX-D51334,46461AEB-BAB0-45F1-A893-FCD00A28BBEA,,,,,,132,174,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,11,2013,TCGA-BRCA
818,TCGA-A7-A5ZX,NO,,TCGA-A7-A5ZX-D52815,056878FC-D30B-4BF4-8BD2-972B61510B2D,,,,,,268,NA,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,YES,Complete Response,6,12,2013,TCGA-BRCA
819,TCGA-A7-A6VV,NO,,TCGA-A7-A6VV-D57247,8A804A22-B193-4C71-8EBB-6FD22D9F605E,,,,,,160,266,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
820,TCGA-A7-A6VV,NO,,TCGA-A7-A6VV-D57248,52B5F633-7FB7-42E1-A8EC-60B50825FBCF,,,,,,160,266,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
823,TCGA-A7-A6VW,NO,,TCGA-A7-A6VW-D57254,02D81B38-5418-4F7D-B18B-0AE11DBE806B,,,,,,84,134,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
822,TCGA-A7-A6VW,NO,,TCGA-A7-A6VW-D57226,DD497F99-3155-4D4E-904E-FD5904316A52,,,,,,84,134,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
821,TCGA-A7-A6VW,NO,,TCGA-A7-A6VW-D57225,037B0D49-1CCC-47FB-9442-F8841E1663C5,,,,,,148,257,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
825,TCGA-A7-A6VX,NO,,TCGA-A7-A6VX-D50836,7F01C477-E69D-4E9E-81AB-2DB85686C1D2,,,,,,79,142,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2013,TCGA-BRCA
824,TCGA-A7-A6VX,NO,,TCGA-A7-A6VX-D50834,660703C0-DE54-4AB9-A7E1-9AC73C6D7D75,,,,,,79,142,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,31,10,2013,TCGA-BRCA
827,TCGA-A7-A6VY,NO,,TCGA-A7-A6VY-D57229,5D3D1784-E381-460E-B773-DE56BABA6BCF,,,,,,68,111,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
828,TCGA-A7-A6VY,NO,,TCGA-A7-A6VY-D57230,2DB83098-CA32-424E-ACFA-3207D2899E95,,,,,,68,111,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
829,TCGA-A7-A6VY,NO,,TCGA-A7-A6VY-D57231,5D349A3C-E310-48A5-A0E1-248ABE65246D,,,,,,126,167,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,3,2014,TCGA-BRCA
835,TCGA-A8-A06R,NO,,TCGA-A8-A06R-D37827,24AF886F-B700-4E8D-91FA-5A62222090E4,,,,,,59,151,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
833,TCGA-A8-A06R,NO,,TCGA-A8-A06R-D37825,D8FE6469-6DAB-4BCB-9DF8-8AD53DF522F2,,,,,,59,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
834,TCGA-A8-A06R,NO,,TCGA-A8-A06R-D37826,02116C14-0DE0-40A5-9224-0A2BBC4D0DEB,,,,,,59,151,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
836,TCGA-A8-A06R,NO,,TCGA-A8-A06R-D37828,A8ADA003-4EDE-4F08-BD6D-033E139A8077,,,,,,243,334,Hormone Therapy,Tamoxifen,Antiestrogen,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
840,TCGA-A8-A075,NO,,TCGA-A8-A075-D37847,4F50CB8E-0F25-40D0-A2A9-E840A63A5158,,,,,,31,122,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
839,TCGA-A8-A075,NO,,TCGA-A8-A075-D37846,01EB4E82-BDB4-4A0D-AE50-BE001501E918,,,,,,31,122,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
841,TCGA-A8-A075,NO,,TCGA-A8-A075-D37848,3B670A10-80C3-4879-BC47-89AD2311D0CA,,,,,,122,214,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
850,TCGA-A8-A07C,NO,,TCGA-A8-A07C-D37840,1A826A54-48E2-429B-A130-9112B0552A47,,,,,,0,62,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
848,TCGA-A8-A07C,NO,,TCGA-A8-A07C-D37838,80A825CD-F344-4738-AB3F-163220CF126F,,,,,,0,62,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
849,TCGA-A8-A07C,NO,,TCGA-A8-A07C-D37839,44BA63A5-D965-4A75-BB06-9C2DD6F50AD6,,,,,,0,62,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
851,TCGA-A8-A07C,NO,,TCGA-A8-A07C-D37841,4749D00E-48DA-45FB-BDBF-BAD8C06F1036,,,,,,92,123,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
855,TCGA-A8-A07F,NO,,TCGA-A8-A07F-D37885,2EF8C377-0721-408E-BEFA-873ECE792E98,,,,,,NA,31,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
853,TCGA-A8-A07F,NO,,TCGA-A8-A07F-D37883,9376A2EE-E979-4870-8EE1-39BC963B3B53,,,,,,NA,31,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
854,TCGA-A8-A07F,NO,,TCGA-A8-A07F-D37884,1E1543B7-C41E-4E32-B36C-8B255B09B7C0,,,,,,NA,31,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
859,TCGA-A8-A07G,NO,,TCGA-A8-A07G-D37881,E2B01A91-364F-43EC-ACE7-587DA7947387,,,,,,59,181,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
857,TCGA-A8-A07G,NO,,TCGA-A8-A07G-D37879,0211068A-96FE-4994-9F2A-BA4918363F47,,,,,,59,181,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
858,TCGA-A8-A07G,NO,,TCGA-A8-A07G-D37880,28A905FA-0749-46CF-9381-CFD29F1403E3,,,,,,59,181,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
863,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37875,D9C7F7BE-AA3C-45E5-B2B3-272DA8642C88,,,,,,61,122,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
861,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37873,2E3715CB-3802-4392-A7FD-4A36AE0E3D43,,,,,,61,122,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
862,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37874,DEE16E8F-6322-49BB-8B56-D708F62283F3,,,,,,61,122,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
864,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37876,AF49DCB1-E14E-4848-9903-7D13E60573C7,,,,,,122,183,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
866,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37878,5488CE4C-EA04-476A-AA6B-6FE37646BC75,,,,,,183,334,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
865,TCGA-A8-A07I,NO,,TCGA-A8-A07I-D37877,4626641D-270B-4338-980A-D4A594F94997,,,,,,183,NA,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,YES,Clinical Progressive Disease,6,12,2012,TCGA-BRCA
869,TCGA-A8-A07J,NO,,TCGA-A8-A07J-D37870,042C8BB6-D133-47F7-86D9-C19D091DC859,,,,,,31,92,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
867,TCGA-A8-A07J,NO,,TCGA-A8-A07J-D37868,30FC02A5-ACD9-4CE4-A312-69CCBD6291A6,,,,,,31,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
868,TCGA-A8-A07J,NO,,TCGA-A8-A07J-D37869,67EB5A96-AE11-405C-854F-6ABAE77D78A2,,,,,,31,92,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
870,TCGA-A8-A07J,NO,,TCGA-A8-A07J-D37871,4D185435-8F11-4933-9616-FE908DBDF03F,,,,,,92,153,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
892,TCGA-A8-A082,NO,,TCGA-A8-A082-D37890,122E4A81-1D23-44AB-8070-1F44572B6AE8,,,,,,92,92,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
891,TCGA-A8-A082,NO,,TCGA-A8-A082-D37889,A155B75A-412B-4A2E-921A-67A737A29E6A,,,,,,31,122,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
889,TCGA-A8-A082,NO,,TCGA-A8-A082-D37887,07C01032-C857-4682-B8E3-C03FA024ECB9,,,,,,31,122,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
890,TCGA-A8-A082,NO,,TCGA-A8-A082-D37888,EFA90125-FED8-4301-A595-3CB4798D1F22,,,,,,31,122,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
894,TCGA-A8-A082,NO,,TCGA-A8-A082-D37892,03AE2E15-1D31-4DAD-8D42-434C2FF4769A,,,,,,852,914,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
897,TCGA-A8-A086,NO,,TCGA-A8-A086-D37771,0C96C615-A569-425F-A761-07276A751736,,,,,,0,92,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
896,TCGA-A8-A086,NO,,TCGA-A8-A086-D37770,69FDE7B7-F6E1-48E5-B4EC-553EBEA6839C,,,,,,0,92,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
900,TCGA-A8-A08B,NO,,TCGA-A8-A08B-D37821,D7E15D1C-7E0D-4F82-86A7-8411A4207C23,,,,,,31,122,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
898,TCGA-A8-A08B,NO,,TCGA-A8-A08B-D37819,61251669-19D4-4215-A0A6-13B53CB464EC,,,,,,31,122,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
899,TCGA-A8-A08B,NO,,TCGA-A8-A08B-D37820,DD7BF60D-0661-4F71-8217-FBA9068C17CB,,,,,,31,122,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
902,TCGA-A8-A08B,NO,,TCGA-A8-A08B-D37823,4E401259-435D-4C0B-AD8D-33361A32FEE6,,,,,,214,579,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
901,TCGA-A8-A08B,NO,,TCGA-A8-A08B-D37822,E1FC34BF-AF83-49E2-9FB0-6CE574F0AAE7,,,,,,214,883,Hormone Therapy,Tamoxifen,Antiestrogen,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
906,TCGA-A8-A08C,NO,,TCGA-A8-A08C-D37817,FE9DA209-FD04-42A5-B165-8596370AC78C,,,,,,31,151,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
904,TCGA-A8-A08C,NO,,TCGA-A8-A08C-D37815,316BC7DA-9F45-49F7-92C4-16831B2B6BE7,,,,,,31,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
905,TCGA-A8-A08C,NO,,TCGA-A8-A08C-D37816,DE7131F0-268C-4FA4-B008-01D742EDF242,,,,,,31,151,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
910,TCGA-A8-A08F,NO,,TCGA-A8-A08F-D37758,D0945071-31AC-4310-AF0A-4AC89DC8D74D,,,,,,31,92,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
908,TCGA-A8-A08F,NO,,TCGA-A8-A08F-D37756,A407F51A-F51F-4CCD-B64B-41D298C30F9C,,,,,,31,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
909,TCGA-A8-A08F,NO,,TCGA-A8-A08F-D37757,BD575045-6AED-4137-9E4C-2BB9C02A1E89,,,,,,31,92,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
911,TCGA-A8-A08F,NO,,TCGA-A8-A08F-D37759,4213A223-3502-4936-813C-875A28B2F161,,,,,,92,123,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
915,TCGA-A8-A08G,NO,,TCGA-A8-A08G-D37835,AD33A302-4E92-4716-B438-F7605A26337D,,,,,,28,89,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
913,TCGA-A8-A08G,NO,,TCGA-A8-A08G-D37833,E6829D65-9323-4DFA-86D6-AB3D485C1105,,,,,,28,89,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
914,TCGA-A8-A08G,NO,,TCGA-A8-A08G-D37834,4C83B99B-AD52-428E-B14F-0623E65A872F,,,,,,28,89,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
916,TCGA-A8-A08G,NO,,TCGA-A8-A08G-D37836,0B6BC52D-FF9B-4B29-9078-94FD2D4A935F,,,,,,89,150,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
920,TCGA-A8-A08I,NO,,TCGA-A8-A08I-D37831,C33E9B1F-F94C-41BC-B949-028D039B668A,,,,,,31,153,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
918,TCGA-A8-A08I,NO,,TCGA-A8-A08I-D37829,9BEA877F-F02D-449C-96A0-557D85624425,,,,,,31,153,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
919,TCGA-A8-A08I,NO,,TCGA-A8-A08I-D37830,F5F19298-9376-430D-9F41-C332F2ABAB4F,,,,,,31,153,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
922,TCGA-A8-A08O,NO,,TCGA-A8-A08O-D37779,985B0E53-6F65-4082-B0F8-813791E8AFC3,,,,,,31,121,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Clinical Progressive Disease,6,12,2012,TCGA-BRCA
926,TCGA-A8-A08O,NO,,TCGA-A8-A08O-D37783,AF51E7FE-12FB-4680-9277-972D6F241035,,,,,,60,335,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,n/a,,,,NO,Clinical Progressive Disease,6,12,2012,TCGA-BRCA
924,TCGA-A8-A08O,NO,,TCGA-A8-A08O-D37781,11802BE2-DDBF-48C1-A327-EDE548A2FF37,,,,,,366,397,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,n/a,,,,NO,Clinical Progressive Disease,6,12,2012,TCGA-BRCA
923,TCGA-A8-A08O,NO,,TCGA-A8-A08O-D37780,4301A8E9-4F7C-4D4F-BD1B-6ACEB2E8A058,,,,,,790,790,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,n/a,,,,NO,Clinical Progressive Disease,6,12,2012,TCGA-BRCA
930,TCGA-A8-A08P,NO,,TCGA-A8-A08P-D37775,1253B515-4F10-40BF-B18B-2AA5B260D821,,,,,,60,182,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
928,TCGA-A8-A08P,NO,,TCGA-A8-A08P-D37773,BB038A0C-0856-4FB6-B98B-8CC6ACAAB26B,,,,,,60,182,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
931,TCGA-A8-A08P,NO,,TCGA-A8-A08P-D37776,12F7BB14-6DC6-4008-9BF1-55DA93552260,,,,,,60,182,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
929,TCGA-A8-A08P,NO,,TCGA-A8-A08P-D37774,234F1043-A0C4-49F6-A6ED-C6290863D7BF,,,,,,60,182,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
933,TCGA-A8-A08P,NO,,TCGA-A8-A08P-D37778,05503837-81F2-4017-88A9-C22758556147,,,,,,213,578,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
936,TCGA-A8-A08X,NO,,TCGA-A8-A08X-D37788,FA20A7B4-6AD1-4A7C-885A-4A7B13295649,,,,,,0,61,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
935,TCGA-A8-A08X,NO,,TCGA-A8-A08X-D37787,BE723714-41E5-4FCD-A43A-AF09F02ECE83,,,,,,0,61,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
937,TCGA-A8-A08X,NO,,TCGA-A8-A08X-D37789,1112F7D7-6984-4F61-85B5-5D60C66A006B,,,,,,91,153,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
939,TCGA-A8-A08X,NO,,TCGA-A8-A08X-D37791,68CC8611-6E89-4582-9597-FCA264BEE43C,,,,,,669,884,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
938,TCGA-A8-A08X,NO,,TCGA-A8-A08X-D37790,77710F3F-EECC-49E3-AA85-02773DE4D243,,,,,,182,1249,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
944,TCGA-A8-A091,NO,,TCGA-A8-A091-D37751,A318C975-5C70-465F-B50F-29E1A23C842A,,,,,,184,639,Hormone Therapy,Tamoxifen,Antiestrogen,Other,n/a,,,,NO,Stable Disease,6,12,2012,TCGA-BRCA
947,TCGA-A8-A091,NO,,TCGA-A8-A091-D37754,72915C6D-EEBE-4670-ABF0-E15D34050969,,,,,,580,669,Ancillary,Pamidronate,Antiresorptive,Other,n/a,,,,NO,Stable Disease,6,12,2012,TCGA-BRCA
948,TCGA-A8-A092,NO,,TCGA-A8-A092-D37793,3BB14198-BDE6-4F06-85E6-41F6C1519A1E,,,,,,30,91,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
950,TCGA-A8-A092,NO,,TCGA-A8-A092-D37795,5EC320E1-3655-436C-B8CC-5E65353FEC34,,,,,,30,153,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
949,TCGA-A8-A092,NO,,TCGA-A8-A092-D37794,7DEE3F98-1E1E-41EF-A92F-77AE88709E27,,,,,,30,153,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
955,TCGA-A8-A095,NO,,TCGA-A8-A095-D37813,023B7F41-CB22-43B7-81EE-6DC8B72DD4F3,,,,,,0,120,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
953,TCGA-A8-A095,NO,,TCGA-A8-A095-D37811,57584D49-5DD8-4991-A154-50BB92C2FB5A,,,,,,0,120,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
954,TCGA-A8-A095,NO,,TCGA-A8-A095-D37812,4968DB45-29C7-41D8-BC0A-204367F2EB4E,,,,,,0,120,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
958,TCGA-A8-A097,NO,,TCGA-A8-A097-D37809,E6EE618F-B8F8-4389-93CE-F97B35570AC1,,,,,,61,153,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
957,TCGA-A8-A097,NO,,TCGA-A8-A097-D37808,98353B03-FA94-480C-BB09-9F440783BCA7,,,,,,61,153,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
972,TCGA-A8-A09D,NO,,TCGA-A8-A09D-D37764,2832D3CB-D8F2-4D5E-BCF9-1352FF358AE8,,,,,,0,92,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
971,TCGA-A8-A09D,NO,,TCGA-A8-A09D-D37763,7501154C-AB3E-4BCF-8170-83C79CD130EF,,,,,,0,92,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
973,TCGA-A8-A09D,NO,,TCGA-A8-A09D-D37765,58419487-BBD7-4BC3-A34A-1791CFFDFD05,,,,,,92,153,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
974,TCGA-A8-A09D,NO,,TCGA-A8-A09D-D37766,B4C8E610-F345-484B-BC53-E1B72842ABE2,,,,,,274,1400,Hormone Therapy,Tamoxifen,Antiestrogen,Other,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
978,TCGA-A8-A09M,NO,,TCGA-A8-A09M-D37785,C1C79A95-B5D8-45E8-8FE0-B54E7E435634,,,,,,31,184,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
986,TCGA-A8-A0A4,NO,,TCGA-A8-A0A4-D37899,CE92BF3F-277B-41E8-9B20-867CE5DDAC50,,,,,,31,215,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
989,TCGA-A8-A0A6,NO,,TCGA-A8-A0A6-D37741,B93873B4-2604-43FB-8AF4-C7BF99021F9A,,,,,,61,184,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
988,TCGA-A8-A0A6,NO,,TCGA-A8-A0A6-D37740,2FD51391-D472-472E-9309-A80A518724D1,,,,,,61,184,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
990,TCGA-A8-A0A6,NO,,TCGA-A8-A0A6-D37742,0C70B64D-A56E-43D4-BC98-F0E21C22E396,,,,,,214,245,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,NA,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
996,TCGA-A8-A0AB,NO,,TCGA-A8-A0AB-D37907,CB9E17C3-E42E-4B04-9ADC-59AB74070C25,,,,,,61,184,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
994,TCGA-A8-A0AB,NO,,TCGA-A8-A0AB-D37905,C764E219-0133-4595-A695-9FC0D32C02E6,,,,,,61,184,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
995,TCGA-A8-A0AB,NO,,TCGA-A8-A0AB-D37906,24D0F28A-D91B-47A2-AE9C-BD963075AFE4,,,,,,61,184,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,6,12,2012,TCGA-BRCA
3100,TCGA-AA-3494,NO,,TCGA-AA-3494-D37441,22607192-21C1-46B1-9007-82F8207BD46F,,,,,,92,184,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3099,TCGA-AA-3494,NO,,TCGA-AA-3494-D37440,96AC2755-D00C-43F2-AF85-250EEE267909,,,,,,92,184,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3102,TCGA-AA-3494,NO,,TCGA-AA-3494-D37443,43259854-0480-42D0-98A2-F62606319067,,,,,,212,334,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3101,TCGA-AA-3494,NO,,TCGA-AA-3494-D37442,8D724D6C-49CF-4BD7-840D-2DF9295914B5,,,,,,184,792,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3103,TCGA-AA-3494,NO,,TCGA-AA-3494-D37444,2F9DDCC4-8761-4EF4-9C8C-9487B219A252,,,,,,334,1065,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3104,TCGA-AA-3494,NO,,TCGA-AA-3494-D37445,D326355B-264D-4391-9026-C1B14D59A663,,,,,,792,1065,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3105,TCGA-AA-3517,NO,,TCGA-AA-3517-D37446,4B85C082-B80A-4078-9ACE-04A97F890D2C,,,,,,821,1065,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3108,TCGA-AA-3517,NO,,TCGA-AA-3517-D37449,21ACA8B4-7BE6-4C0B-910C-F3B95A355C06,,,,,,1004,1065,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3109,TCGA-AA-3517,NO,,TCGA-AA-3517-D37450,0DADF926-9A5E-4BB7-A9EF-9122111FAC39,,,,,,821,1127,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3107,TCGA-AA-3517,NO,,TCGA-AA-3517-D37448,F1363524-2B4B-4BEF-AA3A-4C1332C21770,,,,,,821,1127,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3106,TCGA-AA-3517,NO,,TCGA-AA-3517-D37447,F87AD537-F5FE-44DB-8AF5-E6409F211742,,,,,,821,1155,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3112,TCGA-AA-3542,NO,,TCGA-AA-3542-D37455,FA7BF379-E96D-4367-95B2-B00912AE20E1,,,,,,30,214,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3111,TCGA-AA-3542,NO,,TCGA-AA-3542-D37454,C5B20829-CD88-4658-A64D-378175527DD5,,,,,,30,214,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3110,TCGA-AA-3542,NO,,TCGA-AA-3542-D37453,977CAA41-165B-4CFC-966E-54A9B8400418,,,,,,30,214,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3114,TCGA-AA-3548,NO,,TCGA-AA-3548-D37457,F7F32AFA-44B0-4A6A-9750-E45777A0FCE0,,,,,,31,304,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3113,TCGA-AA-3548,NO,,TCGA-AA-3548-D37456,93B49DE9-A03F-4B39-B6E3-8BD4788D0490,,,,,,31,304,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3115,TCGA-AA-3548,NO,,TCGA-AA-3548-D37458,E07A2591-6A1E-4F73-A3D3-516AC60E8D80,,,,,,31,304,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3118,TCGA-AA-3560,NO,,TCGA-AA-3560-D37465,1791EB2A-6782-4676-B313-4B8F73B36DD0,,,,,,31,212,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3117,TCGA-AA-3560,NO,,TCGA-AA-3560-D37464,BADECE76-E2D5-4E8F-AA08-EFAF10FA5EAB,,,,,,31,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3116,TCGA-AA-3560,NO,,TCGA-AA-3560-D37463,03F2E068-151A-44F5-A6DD-2D04EC99B0BF,,,,,,31,212,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3121,TCGA-AA-3562,NO,,TCGA-AA-3562-D37471,F7B983DE-0C58-48A5-A415-655D45D9C330,,,,,,62,182,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3120,TCGA-AA-3562,NO,,TCGA-AA-3562-D37470,72A86237-359D-4847-82EA-73CC155CEE90,,,,,,62,243,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3119,TCGA-AA-3562,NO,,TCGA-AA-3562-D37469,2E29FE7B-26FB-403C-A4E4-94AF2131E766,,,,,,62,243,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3122,TCGA-AA-3662,NO,,TCGA-AA-3662-D37403,7ABB665F-CA40-4858-A7EB-4D5B975E83F4,,,,,,62,184,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3124,TCGA-AA-3678,NO,,TCGA-AA-3678-D37452,12C68CEF-0CF7-4B84-9CF2-95B80C236707,,,,,,30,242,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3123,TCGA-AA-3678,NO,,TCGA-AA-3678-D37451,A670C33A-E236-4318-9A49-820A1091CD06,,,,,,30,242,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3131,TCGA-AA-3680,NO,,TCGA-AA-3680-D37468,AE2B4E60-C99E-48F0-8B68-5A121C279908,,,,,,31,90,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3130,TCGA-AA-3680,NO,,TCGA-AA-3680-D37467,60CA88E0-83DA-4B36-BE1D-F18C24A1D8E7,,,,,,31,90,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3129,TCGA-AA-3680,NO,,TCGA-AA-3680-D37466,CC56A6EE-BBEF-44F2-876A-0AB791B6F9B1,,,,,,31,90,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3135,TCGA-AA-3692,NO,,TCGA-AA-3692-D37489,FDE51FAB-DA6B-4B36-A1E9-31903F8BBFDA,,,,,,31,669,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3133,TCGA-AA-3692,NO,,TCGA-AA-3692-D37487,781EDB20-2832-4C12-A42B-CA09749FD454,,,,,,31,669,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3132,TCGA-AA-3692,NO,,TCGA-AA-3692-D37486,C5BC9915-EBBF-4648-A0FA-9F09297020A2,,,,,,31,669,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3134,TCGA-AA-3692,NO,,TCGA-AA-3692-D37488,CFE1096A-3879-429A-8A98-B8F0C2BBD23B,,,,,,31,883,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3136,TCGA-AA-3692,NO,,TCGA-AA-3692-D37490,086DF84A-9DAF-4E7C-8F35-043714901C01,,,,,,883,883,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3137,TCGA-AA-3713,NO,,TCGA-AA-3713-D37500,9597EA4B-6886-4161-8F9B-825AF0C1FD21,,,,,,244,456,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3140,TCGA-AA-3841,NO,,TCGA-AA-3841-D37474,4C4944D0-9643-4CFB-9322-92554CEE4DA5,,,,,,59,242,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3139,TCGA-AA-3841,NO,,TCGA-AA-3841-D37473,61C33BB9-928A-45B2-9AAE-FE545603CFCF,,,,,,59,242,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3138,TCGA-AA-3841,NO,,TCGA-AA-3841-D37472,906C70DA-8292-4D49-8219-0605D0D83B41,,,,,,59,242,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3144,TCGA-AA-3844,NO,,TCGA-AA-3844-D37478,44AB9D89-3E3C-461B-ADFD-22214943A595,,,,,,59,59,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3148,TCGA-AA-3844,NO,,TCGA-AA-3844-D37482,BAC19AFA-78D6-45CA-B1DB-BC08D71E505E,,,,,,393,393,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3147,TCGA-AA-3844,NO,,TCGA-AA-3844-D37481,0984FEF0-6099-46AD-9223-E34AFE4BC94C,,,,,,393,424,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3146,TCGA-AA-3844,NO,,TCGA-AA-3844-D37480,69922414-9463-4B03-9D7F-D4E028CF5C63,,,,,,393,424,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3145,TCGA-AA-3844,NO,,TCGA-AA-3844-D37479,E2943FD1-7025-4ADC-A4C1-E1DA1ABA85AF,,,,,,393,424,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3151,TCGA-AA-3860,NO,,TCGA-AA-3860-D37485,572E00AF-360A-426A-8377-D9A247751050,,,,,,31,184,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3150,TCGA-AA-3860,NO,,TCGA-AA-3860-D37484,66C6E947-FA93-4F75-B11C-3B9D3AB625D9,,,,,,31,184,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3149,TCGA-AA-3860,NO,,TCGA-AA-3860-D37483,A46935F0-B18B-4309-974A-98F5C9843423,,,,,,31,184,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3152,TCGA-AA-3869,NO,,TCGA-AA-3869-D37491,DA64549C-BBD5-4E27-B064-182E142FC782,,,,,,92,365,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3153,TCGA-AA-3869,NO,,TCGA-AA-3869-D37492,ECAD1937-2E65-4E73-959F-DF8DA17FBAD6,,,,,,365,396,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3156,TCGA-AA-3869,NO,,TCGA-AA-3869-D37495,689C50C2-8AC3-4B58-BA25-84BE69AE99F1,,,,,,365,580,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3154,TCGA-AA-3869,NO,,TCGA-AA-3869-D37493,7BB5F82C-B67C-4405-840E-B5EB1385A49D,,,,,,365,761,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3155,TCGA-AA-3869,NO,,TCGA-AA-3869-D37494,70A670E1-B68A-4FDE-804F-E54569FE7655,,,,,,365,761,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3157,TCGA-AA-3869,NO,,TCGA-AA-3869-D37496,634D660B-99EA-421D-A10D-A9B924C6AB3B,,,,,,608,761,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3160,TCGA-AA-3870,NO,,TCGA-AA-3870-D37499,C0DDC956-119F-4DAE-B704-8917CA66D803,,,,,,30,153,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3159,TCGA-AA-3870,NO,,TCGA-AA-3870-D37498,D94292F6-51D0-454D-B608-9D1D674D5981,,,,,,30,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3158,TCGA-AA-3870,NO,,TCGA-AA-3870-D37497,A524BF8C-3693-4873-8114-6CC5177E2C3D,,,,,,30,212,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3161,TCGA-AA-3930,NO,,TCGA-AA-3930-D37377,7BFAB3A6-37A3-4A3A-9D2D-FF9B6CAE4884,,,,,,NA,31,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3163,TCGA-AA-3955,NO,,TCGA-AA-3955-D37379,CDACF96B-2A58-4F42-8195-990F0E68F7C0,,,,,,28,150,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3162,TCGA-AA-3955,NO,,TCGA-AA-3955-D37378,923A811E-F19F-43E7-84A9-1C1FBA0ABD65,,,,,,28,181,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3166,TCGA-AA-3967,NO,,TCGA-AA-3967-D37422,845B10DA-CB7B-4517-ADFB-318C6F3A217E,,,,,,90,182,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3165,TCGA-AA-3967,NO,,TCGA-AA-3967-D37421,ED66B9C8-A20C-4B19-914C-BA8AFC2CB529,,,,,,60,213,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3164,TCGA-AA-3967,NO,,TCGA-AA-3967-D37420,88E98323-5636-42CA-B3E4-61BD63936922,,,,,,60,213,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3169,TCGA-AA-3971,NO,,TCGA-AA-3971-D37425,969A32A8-5D14-4A37-9062-DAF425EA1C5B,,,,,,31,215,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3168,TCGA-AA-3971,NO,,TCGA-AA-3971-D37424,F71B9357-6613-4BF8-8F2D-9B49B35F1912,,,,,,31,215,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3167,TCGA-AA-3971,NO,,TCGA-AA-3971-D37423,5F0380B5-59E5-4BB8-B7AC-1DD2C7E02145,,,,,,31,215,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3171,TCGA-AA-3972,NO,,TCGA-AA-3972-D37427,2DAFDB28-A410-42B2-AF63-E120355C65F7,,,,,,60,1246,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3170,TCGA-AA-3972,NO,,TCGA-AA-3972-D37426,45D2A60B-C35E-4BAC-9769-B1D5C0153FED,,,,,,60,1246,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3175,TCGA-AA-3972,NO,,TCGA-AA-3972-D37431,D468F9E0-47B4-4132-AD13-0ABB40C4E310,,,,,,1246,1369,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3174,TCGA-AA-3972,NO,,TCGA-AA-3972-D37430,A6074E5B-5C69-431C-837C-BFE344753B77,,,,,,1277,1369,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3173,TCGA-AA-3972,NO,,TCGA-AA-3972-D37429,96844749-3509-4378-99E8-349FDEC7EFE8,,,,,,1277,1369,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3172,TCGA-AA-3972,NO,,TCGA-AA-3972-D37428,DB748C7A-3F23-4440-959F-0652EF839B25,,,,,,1277,1369,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3177,TCGA-AA-3973,NO,,TCGA-AA-3973-D37433,8C12A90B-FDED-4D29-B7FA-DCDA7A730754,,,,,,31,305,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3176,TCGA-AA-3973,NO,,TCGA-AA-3973-D37432,02288D76-A58F-4E92-B19E-08FA0A8A09A3,,,,,,31,305,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3178,TCGA-AA-3973,NO,,TCGA-AA-3973-D37434,33052D56-5F11-49F8-BABA-6F23D89EB61D,,,,,,31,305,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3179,TCGA-AA-3973,NO,,TCGA-AA-3973-D37435,830E21DE-6412-4062-B970-4C321B01D3D4,,,,,,NA,305,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Stable Disease,3,12,2012,TCGA-COAD
3182,TCGA-AA-3976,NO,,TCGA-AA-3976-D37438,22945031-905D-47E4-814D-EB4815FCF8B5,,,,,,30,61,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3181,TCGA-AA-3976,NO,,TCGA-AA-3976-D37437,899F6FBF-C49A-43F7-9946-8B8993D26711,,,,,,30,242,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3180,TCGA-AA-3976,NO,,TCGA-AA-3976-D37436,71E44A11-E322-4B4A-9E01-EAA0DA75FD43,,,,,,30,242,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3183,TCGA-AA-3994,NO,,TCGA-AA-3994-D37439,09F57FC8-2E45-4B15-83F1-490E1762A214,,,,,,30,334,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3186,TCGA-AA-A00F,NO,,TCGA-AA-A00F-D37419,157B2E65-0CA0-485B-9762-7F17FCBD7934,,,,,,61,213,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3185,TCGA-AA-A00F,NO,,TCGA-AA-A00F-D37418,41FF725E-E12B-4A08-8828-37F0E889E44E,,,,,,61,213,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3184,TCGA-AA-A00F,NO,,TCGA-AA-A00F-D37417,A79924C7-E384-46D8-9AA7-C45D0D21E753,,,,,,61,213,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3187,TCGA-AA-A00J,NO,,TCGA-AA-A00J-D37416,B3019D2B-1967-4313-8010-AE45C7D73ADA,,,,,,31,245,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3190,TCGA-AA-A00Q,NO,,TCGA-AA-A00Q-D37415,2FFB89A0-6358-4261-AD46-64CC67C11629,,,,,,61,334,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3189,TCGA-AA-A00Q,NO,,TCGA-AA-A00Q-D37414,551F6AA8-2C03-4ACC-9760-585B262DAC5F,,,,,,61,334,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3188,TCGA-AA-A00Q,NO,,TCGA-AA-A00Q-D37413,14525E0B-771C-4858-85EA-04411066C462,,,,,,61,334,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3193,TCGA-AA-A00U,NO,,TCGA-AA-A00U-D37382,EA070337-0D97-467F-B588-9F256BE4C9F4,,,,,,61,214,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3192,TCGA-AA-A00U,NO,,TCGA-AA-A00U-D37381,DD9FE9D1-175B-495F-9E2D-9DF63C15AD70,,,,,,61,214,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3191,TCGA-AA-A00U,NO,,TCGA-AA-A00U-D37380,573E799A-7A71-49F9-A262-26BF0DCB98ED,,,,,,61,214,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3196,TCGA-AA-A010,NO,,TCGA-AA-A010-D37412,5E8AE646-9F65-4EE8-BED1-F1874A391471,,,,,,0,183,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3195,TCGA-AA-A010,NO,,TCGA-AA-A010-D37411,196D63A5-A0C3-4567-B52C-C80754DC5D60,,,,,,0,183,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3194,TCGA-AA-A010,NO,,TCGA-AA-A010-D37410,F4C201FC-604D-4378-BF80-1D0B46DC40EF,,,,,,0,183,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3198,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37405,C597CB1C-8B1F-4EAE-AACF-2ACB2C0B0267,,,,,,61,153,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3197,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37404,4F739C3B-57E6-4AB5-8F2A-79326FE773E6,,,,,,61,273,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3201,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37408,2F4FDF3B-F5D5-4507-975B-07A38AC4D75C,,,,,,214,273,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3199,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37406,9E59767B-446A-4F48-BFEF-20BDB4731B47,,,,,,214,273,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3200,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37407,F2A4FAE7-D172-454F-8F86-44237D0514DF,,,,,,273,304,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,,,YES,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3202,TCGA-AA-A01D,NO,,TCGA-AA-A01D-D37409,45839A4B-3333-43FE-ABE2-E6FCFE5D837D,,,,,,273,304,Targeted Molecular therapy,Panitumumab,HER1 inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3205,TCGA-AA-A01F,NO,,TCGA-AA-A01F-D37402,AED5627D-9A57-44F6-82C4-CDAC2CB1EE4C,,,,,,62,215,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3204,TCGA-AA-A01F,NO,,TCGA-AA-A01F-D37401,988E2E95-014A-4780-BDFE-813A1F8ACD26,,,,,,62,215,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3203,TCGA-AA-A01F,NO,,TCGA-AA-A01F-D37400,A2B884E1-ED59-4356-819B-62212890077A,,,,,,62,215,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3208,TCGA-AA-A01K,NO,,TCGA-AA-A01K-D37399,4BEE62E4-B052-4D7B-B1AE-7020CE37EC3F,,,,,,61,243,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3207,TCGA-AA-A01K,NO,,TCGA-AA-A01K-D37398,6796D8BC-15FF-4367-ADF9-C70A1F2D542B,,,,,,61,243,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3206,TCGA-AA-A01K,NO,,TCGA-AA-A01K-D37397,3A2C3BC3-3631-4F1C-BB13-DAC6A294936E,,,,,,61,243,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3209,TCGA-AA-A01R,NO,,TCGA-AA-A01R-D37394,D951161C-677D-4A62-9684-DD8794840413,,,,,,60,820,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3210,TCGA-AA-A01R,NO,,TCGA-AA-A01R-D37395,EF93527A-31EB-43F2-98FB-343C3AE08F54,,,,,,669,820,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3211,TCGA-AA-A01R,NO,,TCGA-AA-A01R-D37396,8EF3060A-3D3D-4F10-83A7-29CB9FDF2D8A,,,,,,669,820,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3212,TCGA-AA-A01T,NO,,TCGA-AA-A01T-D37392,45AADB1F-5899-4657-BE24-711FD3CEFC2C,,,,,,61,184,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3213,TCGA-AA-A01T,NO,,TCGA-AA-A01T-D37393,70E04694-EC9B-4596-B5C3-25BC492B1919,,,,,,61,184,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,3,12,2012,TCGA-COAD
3217,TCGA-AA-A02F,NO,,TCGA-AA-A02F-D37390,FFAE6F6B-0040-4DAB-8FD5-F053839270BC,,,,,,670,700,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3218,TCGA-AA-A02F,NO,,TCGA-AA-A02F-D37391,9C785800-15D7-46C2-95F4-282E60286F9C,,,,,,59,1096,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3215,TCGA-AA-A02F,NO,,TCGA-AA-A02F-D37388,71DCC297-9D24-453F-A455-1F3541C60CE2,,,,,,59,1127,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3214,TCGA-AA-A02F,NO,,TCGA-AA-A02F-D37387,F6A5DA6A-5BF9-4460-ACFE-CBA48519AAB4,,,,,,59,1127,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3216,TCGA-AA-A02F,NO,,TCGA-AA-A02F-D37389,FD42DB4E-C958-48D6-BE29-86FBF6F1B815,,,,,,59,1127,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Partial Response,3,12,2012,TCGA-COAD
3222,TCGA-AA-A02K,NO,,TCGA-AA-A02K-D37386,AD48478E-2CDC-4B13-B6E6-61CAE4FEE9E9,,,,,,31,275,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3220,TCGA-AA-A02K,NO,,TCGA-AA-A02K-D37384,DA114F4F-D777-4640-A175-AC51FF4D0346,,,,,,31,275,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3219,TCGA-AA-A02K,NO,,TCGA-AA-A02K-D37383,284D9612-89A5-4F4D-82AD-D73C214BF630,,,,,,31,275,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
3221,TCGA-AA-A02K,NO,,TCGA-AA-A02K-D37385,B72BBC44-9B88-4103-84CC-157C43ADFAE9,,,,,,31,275,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,3,12,2012,TCGA-COAD
1001,TCGA-AC-A23G,NO,,TCGA-AC-A23G-D43243,10502588-843C-4F06-BCB5-FC3640306A2F,,,,,,109,190,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2013,TCGA-BRCA
1002,TCGA-AC-A23G,NO,,TCGA-AC-A23G-D43244,AD503E66-08BD-4F4E-877D-4D9D499AB832,,,,,,109,190,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,5,2013,TCGA-BRCA
1003,TCGA-AC-A23G,NO,,TCGA-AC-A23G-D43245,24D15948-49E0-4B96-870D-492C786C0937,,,,,,190,220,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-BRCA
1004,TCGA-AC-A23G,NO,,TCGA-AC-A23G-D43246,8C1BBA20-CDAA-4C57-BAE6-BF46E12CFDE0,,,,,,237,NA,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,15,5,2013,TCGA-BRCA
1007,TCGA-AC-A2BK,NO,,TCGA-AC-A2BK-D43988,9DE66FB7-BCEC-4B84-B97E-1A9F68D8E87A,,,,,,73,136,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,6,2013,TCGA-BRCA
1008,TCGA-AC-A2BK,NO,,TCGA-AC-A2BK-D43990,1502DE28-84D8-4351-BCEE-9661DACD2B21,,,,,,73,136,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,10,6,2013,TCGA-BRCA
1010,TCGA-AC-A2BK,NO,,TCGA-AC-A2BK-D43992,8283B14A-D235-4D20-B272-9B4A8A095886,,,,,,149,164,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Complete Response,10,6,2013,TCGA-BRCA
1009,TCGA-AC-A2BK,NO,,TCGA-AC-A2BK-D43991,4869DCB0-723E-46A0-AB90-3D5FF038203A,,,,,,149,164,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,10,6,2013,TCGA-BRCA
1011,TCGA-AC-A2FB,NO,,TCGA-AC-A2FB-D45600,874799CE-92C6-4A14-9087-50637D5A0BFB,,,,,,101,205,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,7,2013,TCGA-BRCA
1012,TCGA-AC-A2FB,NO,,TCGA-AC-A2FB-D45601,83D4DEF8-DDC1-4477-B951-DA1E2EE02B89,,,,,,212,443,Chemotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,17,7,2013,TCGA-BRCA
1013,TCGA-AC-A2FB,NO,,TCGA-AC-A2FB-D45602,E9BB9D9C-C752-4FC4-AA16-B531C23C1BEF,,,,,,225,895,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,17,7,2013,TCGA-BRCA
1017,TCGA-AC-A2FE,NO,,TCGA-AC-A2FE-D47779,A99BF733-8B3D-4B21-921E-79FDE40A04AF,,,,,,67,173,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,8,2013,TCGA-BRCA
1015,TCGA-AC-A2FE,NO,,TCGA-AC-A2FE-D37369,516F7FB6-37E9-4E44-AD00-37D688CD51FA,,,,,,67,173,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,3,12,2012,TCGA-BRCA
1014,TCGA-AC-A2FE,NO,,TCGA-AC-A2FE-D37368,B60BCD38-9FFA-43B5-B2C0-C855C05883BB,,,,,,67,173,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,3,12,2012,TCGA-BRCA
1018,TCGA-AC-A2FE,NO,,TCGA-AC-A2FE-D47781,8AC64C61-1BA6-4891-B438-AFF91FC30F54,,,,,,2516,NA,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,28,8,2013,TCGA-BRCA
1019,TCGA-AC-A2FE,NO,,TCGA-AC-A2FE-D47782,E2A083D8-3A0B-465B-9603-BE32342ACC48,,,,,,2516,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,28,8,2013,TCGA-BRCA
1020,TCGA-AC-A2FF,NO,,TCGA-AC-A2FF-D56170,2F38E250-56D9-415C-8694-16634DED723D,,,,,,70,153,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1021,TCGA-AC-A2FF,NO,,TCGA-AC-A2FF-D56171,DF17DE1B-3B13-469B-B9AF-F461F5B9791D,,,,,,70,153,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1022,TCGA-AC-A2FF,NO,,TCGA-AC-A2FF-D56172,C4A61CA0-51A5-4811-8017-090A5DE9AA62,,,,,,153,245,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1023,TCGA-AC-A2FF,NO,,TCGA-AC-A2FF-D56173,CA6E2206-6437-4F20-B4CE-07925A8A8D79,,,,,,382,NA,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1024,TCGA-AC-A2FG,NO,,TCGA-AC-A2FG-D43222,1263ADA3-9E75-48E3-AC3C-891A3C9AF9AB,,,,,,39,NA,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,,Complete Response,15,5,2013,TCGA-BRCA
1025,TCGA-AC-A2FK,NO,,TCGA-AC-A2FK-D66198,A85E31F8-6790-4964-AC1A-C6253F9E413D,,,,,,51,174,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,10,2014,TCGA-BRCA
1028,TCGA-AC-A2FK,NO,,TCGA-AC-A2FK-D66201,67C16321-C0D6-4EE5-AA5C-25C290914D9E,,,,,,51,174,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,10,2014,TCGA-BRCA
1026,TCGA-AC-A2FK,NO,,TCGA-AC-A2FK-D66199,118A7D45-089C-4980-B978-FD970C000905,,,,,,51,174,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,3,10,2014,TCGA-BRCA
1027,TCGA-AC-A2FK,NO,,TCGA-AC-A2FK-D66200,96CBB13E-8C96-4CE4-B4FE-2FC707EC8044,,,,,,294,NA,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,3,10,2014,TCGA-BRCA
1031,TCGA-AC-A2QH,NO,,TCGA-AC-A2QH-D64102,35EB8EC6-E1A8-4C43-9FF1-8743A658A8F9,,,,,,94,208,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,8,2014,TCGA-BRCA
1033,TCGA-AC-A2QH,NO,,TCGA-AC-A2QH-D64104,CFAD5F9E-8CC3-430E-A4BC-F6079D09BC84,,,,,,94,208,Ancillary,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,26,8,2014,TCGA-BRCA
1032,TCGA-AC-A2QH,NO,,TCGA-AC-A2QH-D64103,5555AA7B-5597-4D92-BC2B-20E6EC3BB630,,,,,,94,208,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,26,8,2014,TCGA-BRCA
1034,TCGA-AC-A2QI,NO,,TCGA-AC-A2QI-D57049,7AE4D249-9E5B-463E-9352-BB540E0FD3AB,,,,,,100,275,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,2,2014,TCGA-BRCA
1035,TCGA-AC-A2QI,NO,,TCGA-AC-A2QI-D57050,811FCC91-6880-400D-B7BB-C848DF5A5C23,,,,,,100,275,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,28,2,2014,TCGA-BRCA
1036,TCGA-AC-A2QI,NO,,TCGA-AC-A2QI-D57051,ED0E149B-307C-4202-9AD7-09B21CE8FAB9,,,,,,100,275,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,28,2,2014,TCGA-BRCA
1037,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44024,C5CB5329-7C61-47A9-A6C2-1BA45837EE19,,,,,,69,111,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,6,2013,TCGA-BRCA
1038,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44025,ED128C91-BA77-4FBB-B670-962EA86F9365,,,,,,69,111,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,10,6,2013,TCGA-BRCA
1039,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44026,900E4830-C0E0-4B02-8648-811C3D9C6780,,,,,,125,202,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,10,6,2013,TCGA-BRCA
1040,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44873,D4B923DD-9936-4FD1-B31D-7EC1BD1E03EB,,,,,,322,385,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BRCA
1041,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44874,AE31D0D7-2D48-4096-8A15-44362B8615FB,,,,,,386,407,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BRCA
1042,TCGA-AC-A2QJ,NO,,TCGA-AC-A2QJ-D44876,A7788968-8449-4721-9548-BFB6C599C876,,,,,,349,418,Hormone Therapy,Fulvestrant,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BRCA
1043,TCGA-AC-A3BB,NO,,TCGA-AC-A3BB-D58955,29980E13-140D-4302-8067-9256665BC673,,,,,,92,197,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,4,2014,TCGA-BRCA
1045,TCGA-AC-A3BB,NO,,TCGA-AC-A3BB-D58957,260FF621-0F12-4118-8D3F-AA44CC70F345,,,,,,92,197,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,4,2014,TCGA-BRCA
1044,TCGA-AC-A3BB,NO,,TCGA-AC-A3BB-D58956,CAB74A66-0CCF-4E51-8F5A-FF613B5A43C7,,,,,,92,197,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,29,4,2014,TCGA-BRCA
1047,TCGA-AC-A3TM,NO,,TCGA-AC-A3TM-D60195,B113D625-D78D-45A4-ADD0-80AB8685389D,,,,,,132,213,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,5,2014,TCGA-BRCA
1048,TCGA-AC-A3TM,NO,,TCGA-AC-A3TM-D60196,B550D10F-C488-4B1D-9461-2F40087F552D,,,,,,132,213,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,31,5,2014,TCGA-BRCA
1053,TCGA-AC-A3W5,NO,,TCGA-AC-A3W5-D56179,44D7F9EC-9D9E-48D2-A04D-33F37CEC738A,,,,,,56,139,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1052,TCGA-AC-A3W5,NO,,TCGA-AC-A3W5-D56178,3299B6BC-BE87-4C84-91EA-AEF9CE77EACE,,,,,,56,139,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1054,TCGA-AC-A3W5,NO,,TCGA-AC-A3W5-D56180,8ABC79CD-6BDB-44B7-8F89-4E5762E620F8,,,,,,56,392,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,29,1,2014,TCGA-BRCA
1057,TCGA-AC-A3YI,NO,,TCGA-AC-A3YI-D61514,53B8EF0C-8F23-4867-B4D9-F4A71B62BED0,,,,,,82,167,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,6,2014,TCGA-BRCA
1059,TCGA-AC-A3YI,NO,,TCGA-AC-A3YI-D61516,710B0219-323F-4EF2-A310-54559049BEDB,,,,,,82,167,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,6,2014,TCGA-BRCA
1058,TCGA-AC-A3YI,NO,,TCGA-AC-A3YI-D61515,2509B84B-EC3A-457C-9E7B-7F7095910A28,,,,,,82,167,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,6,2014,TCGA-BRCA
1065,TCGA-AC-A62V,NO,,TCGA-AC-A62V-D60180,356FD6D4-61DF-485A-AB87-3A4A43CFC9B7,,,,,,114,245,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,31,5,2014,TCGA-BRCA
1064,TCGA-AC-A62V,NO,,TCGA-AC-A62V-D60179,1206FBA9-884A-4E22-8D01-5CFD61F171AD,,,,,,21,266,Ancillary,Denosumab,Antiresorptive,Other,,,,,NO,Partial Response,31,5,2014,TCGA-BRCA
3223,TCGA-AD-6889,YES,,TCGA-AD-6889-D47707,2285FF7F-F87C-4232-BE93-94606723E640,,,,,,42,NA,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,28,8,2013,TCGA-COAD
3224,TCGA-AD-6901,NO,,TCGA-AD-6901-D47119,CCB03758-E07C-42D8-B066-C6C9C73796AC,,,,,,61,214,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,22,8,2013,TCGA-COAD
3225,TCGA-AD-6964,NO,,TCGA-AD-6964-D47096,80AE8305-E49C-40BD-A961-158C125E4D50,,,,,,63,214,Chemotherapy,Oxaliplatin|5-Fluorouracil|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,,,,NO,Clinical Progressive Disease,22,8,2013,TCGA-COAD
3226,TCGA-AD-6965,NO,,TCGA-AD-6965-D47146,6FD88F0C-8E92-4A08-99F2-27BA67D1E2A1,,,,,,42,196,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,22,8,2013,TCGA-COAD
3230,TCGA-AD-6965,NO,,TCGA-AD-6965-D72561,3ED672C0-CD23-4467-B904-44021DC2B3A9,,,,,,42,196,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,16,7,2015,TCGA-COAD
3231,TCGA-AD-6965,NO,,TCGA-AD-6965-D72562,9904C076-BC2D-4783-B9E1-4E983C9C15D4,,,,,,42,196,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,16,7,2015,TCGA-COAD
8198,TCGA-AF-3914,NO,NA,TCGA-AF-3914-D41487,DB0F22AA-0122-4C85-9E00-07A45715A0B0,,,,,NA,924,1022,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,19,3,2013,TCGA-READ
8199,TCGA-AF-3914,NO,NA,TCGA-AF-3914-D41488,E946FC49-AEB3-4A51-B943-CDA7CC4A7A31,,,,,NA,924,1022,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,19,3,2013,TCGA-READ
8197,TCGA-AF-3914,NO,NA,TCGA-AF-3914-D41486,9BF0B463-F451-4BB4-BB19-1675656AE60F,,,,,NA,924,1022,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Stable Disease,19,3,2013,TCGA-READ
8200,TCGA-AF-3914,NO,NA,TCGA-AF-3914-D41489,A35156FA-AFFB-498C-AE11-E35ECC46908E,,,,,NA,924,1024,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,19,3,2013,TCGA-READ
8196,TCGA-AF-3914,NO,NA,TCGA-AF-3914-D41485,AC84D228-12BE-44DA-A004-F09C1B574F03,,,,,NA,924,1134,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,19,3,2013,TCGA-READ
8205,TCGA-AF-6136,NO,NA,TCGA-AF-6136-D31526,6a8a2d9a-dceb-4ed9-8bfc-76a4c6c10c28,,,,,NA,209,385,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,9,5,2012,TCGA-READ
8208,TCGA-AF-6136,NO,NA,TCGA-AF-6136-D31529,b031c881-0b3e-4778-bc63-28d0e2bf4c48,,,,,NA,209,453,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,9,5,2012,TCGA-READ
8207,TCGA-AF-6136,NO,NA,TCGA-AF-6136-D31528,1419103a-d51d-4461-bb13-1a18acce6ed3,,,,,NA,209,454,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,9,5,2012,TCGA-READ
8206,TCGA-AF-6136,NO,NA,TCGA-AF-6136-D31527,54ada04a-3ac3-487d-b98b-814256e83be5,,,,,NA,209,454,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Stable Disease,9,5,2012,TCGA-READ
8214,TCGA-AF-A56L,NO,NA,TCGA-AF-A56L-D42409,B297C576-C11B-4810-B6C6-C2859AF3D1DE,,,,,NA,52,255,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,18,4,2013,TCGA-READ
8216,TCGA-AF-A56L,NO,NA,TCGA-AF-A56L-D42411,B413308D-C7F5-4902-8FF1-D44C8696D792,,,,,NA,52,255,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,18,4,2013,TCGA-READ
8217,TCGA-AF-A56L,NO,NA,TCGA-AF-A56L-D42412,7CF68531-04CC-4FC7-B1CA-17DB824739E0,,,,,NA,52,255,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,18,4,2013,TCGA-READ
8215,TCGA-AF-A56L,NO,NA,TCGA-AF-A56L-D42410,C6E884C2-2F25-4791-8E07-CF6A9034F43D,,,,,NA,52,255,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,18,4,2013,TCGA-READ
8218,TCGA-AF-A56N,NO,NA,TCGA-AF-A56N-D42111,5A29766B-D0E7-47E8-BB9B-21A9A9E7F331,,,,,NA,54,95,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,11,4,2013,TCGA-READ
8219,TCGA-AF-A56N,NO,NA,TCGA-AF-A56N-D42114,9BCDA4FD-AF03-4003-9FD6-36343C7BB81C,,,,,NA,159,347,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,11,4,2013,TCGA-READ
8221,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37620,079392F9-28CE-40D9-8097-908D753F5F41,,,,,NA,92,274,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8220,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37619,FB261DCE-FD6C-4A15-AA2E-ABE3012E6B22,,,,,NA,92,274,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8222,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37621,1B4F9FA3-8976-4771-B187-EAFB66D56DB9,,,,,NA,92,274,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8225,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37624,5C31B440-ED68-435C-89C1-337C2C1B9498,,,,,NA,335,396,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8224,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37623,6B518DAA-0328-44A6-902E-ED9122718F0D,,,,,NA,335,396,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8223,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37622,A2894A8C-69C0-42F7-8A2F-F63A9150C893,,,,,NA,335,396,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8226,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37625,C91698E7-82FD-4FD9-B3C7-50E589A064F5,,,,,NA,427,580,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8227,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37626,7F381F5C-41AD-4C61-974F-48B497AA77D4,,,,,NA,427,580,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8228,TCGA-AG-3584,NO,NA,TCGA-AG-3584-D37627,B834783E-DAAC-45FF-9BDC-028EB4A7A879,,,,,NA,427,580,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8230,TCGA-AG-3593,NO,NA,TCGA-AG-3593-D37629,F0328A7A-9B62-404F-AC16-CA9495F2E404,,,,,NA,61,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8231,TCGA-AG-3600,NO,NA,TCGA-AG-3600-D37630,69707452-630C-4BFE-A48F-B625078F02D9,,,,,NA,31,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8234,TCGA-AG-3609,NO,NA,TCGA-AG-3609-D37633,AE9AEFB7-BB2B-4B63-B031-2CAF2DB86DC3,,,,,NA,31,90,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8233,TCGA-AG-3609,NO,NA,TCGA-AG-3609-D37632,5E269C7F-6E92-4C6D-BC05-F089CC7FCA62,,,,,NA,31,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8232,TCGA-AG-3609,NO,NA,TCGA-AG-3609-D37631,DA3F2436-7363-4949-967D-5030F2F0C5D2,,,,,NA,31,212,Chemotherapy,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8236,TCGA-AG-3611,NO,NA,TCGA-AG-3611-D37635,0D72C3B9-12DB-45F9-8E9B-575140447392,,,,,NA,850,973,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8235,TCGA-AG-3611,NO,NA,TCGA-AG-3611-D37634,40EA7062-DFF9-4BC9-9EBA-7AF603EFA401,,,,,NA,850,973,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8239,TCGA-AG-3612,NO,NA,TCGA-AG-3612-D37638,24C1B6B1-A537-45CC-AFFF-36F91F5F59D9,,,,,NA,59,212,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8238,TCGA-AG-3612,NO,NA,TCGA-AG-3612-D37637,ED6FBE6C-F021-4A62-8F36-809D25748C6B,,,,,NA,59,273,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8237,TCGA-AG-3612,NO,NA,TCGA-AG-3612-D37636,C4769825-6F3B-421E-B75C-5FEFBE760F7A,,,,,NA,59,273,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8242,TCGA-AG-3728,NO,NA,TCGA-AG-3728-D37641,294E64A4-AE56-42C8-A708-559C0DD9689A,,,,,NA,61,61,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8241,TCGA-AG-3728,NO,NA,TCGA-AG-3728-D37640,73B9ADC4-8BF1-4085-B885-844051A7F688,,,,,NA,61,61,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8240,TCGA-AG-3728,NO,NA,TCGA-AG-3728-D37639,53588706-BC6B-405C-A6D2-4C7953641320,,,,,NA,61,61,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8245,TCGA-AG-3731,NO,NA,TCGA-AG-3731-D37644,D24F50D6-FB52-4277-8AB4-AC5123C639C7,,,,,NA,92,184,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8244,TCGA-AG-3731,NO,NA,TCGA-AG-3731-D37643,0050963E-70D9-4754-BD4D-5CB6943EDB8A,,,,,NA,92,914,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8243,TCGA-AG-3731,NO,NA,TCGA-AG-3731-D37642,89CD8582-B07D-4C29-ABEB-E59268AC7FD7,,,,,NA,92,914,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8246,TCGA-AG-3731,NO,NA,TCGA-AG-3731-D37645,ABCED613-88E1-44F3-8477-B6B2A8C63CF9,,,,,NA,365,914,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8255,TCGA-AG-3893,NO,NA,TCGA-AG-3893-D37654,1680F252-BB88-454F-B1CC-FE1038F33269,,,,,NA,61,245,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8254,TCGA-AG-3893,NO,NA,TCGA-AG-3893-D37653,D8A5AC42-4F51-4626-BFAB-BF6CD4C44D3C,,,,,NA,61,245,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8256,TCGA-AG-3894,NO,NA,TCGA-AG-3894-D37655,E4102A2F-8A6F-4B7C-9E20-3970FC3DD124,,,,,NA,61,245,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8259,TCGA-AG-3909,NO,NA,TCGA-AG-3909-D37658,117DFF8F-E037-4B98-8108-AB8562BC27F8,,,,,NA,62,182,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8258,TCGA-AG-3909,NO,NA,TCGA-AG-3909-D37657,AAB0F90D-B954-464B-9589-2484E0399046,,,,,NA,62,243,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8257,TCGA-AG-3909,NO,NA,TCGA-AG-3909-D37656,9844876F-EB16-49BC-86DC-FCCAC4BD3B19,,,,,NA,62,243,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8263,TCGA-AG-4005,NO,NA,TCGA-AG-4005-D37662,380000BA-B2B9-4D32-BA25-4E518DE0341C,,,,,NA,61,213,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8262,TCGA-AG-4005,NO,NA,TCGA-AG-4005-D37661,DB8463A1-4C26-4AC4-9DEE-7392B21B8AA6,,,,,NA,61,213,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8261,TCGA-AG-4005,NO,NA,TCGA-AG-4005-D37660,217AFF88-4D43-42A3-9A3E-16D1662C2D28,,,,,NA,61,213,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8264,TCGA-AG-4008,NO,NA,TCGA-AG-4008-D37663,5DD8AC7E-EEB1-4222-99A5-6B18A6A0B3CD,,,,,NA,61,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8265,TCGA-AG-4008,NO,NA,TCGA-AG-4008-D37664,E2E9F3AE-4CA2-4A37-B87C-AD62DCF39099,,,,,NA,61,92,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8266,TCGA-AG-4022,NO,NA,TCGA-AG-4022-D37665,BA0BE627-3B95-403A-954D-635201C79CD6,,,,,NA,61,153,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8268,TCGA-AG-A00C,NO,NA,TCGA-AG-A00C-D37667,AB4C44C6-717B-46CA-8881-BCDB2B3C9D28,,,,,NA,61,213,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8269,TCGA-AG-A00C,NO,NA,TCGA-AG-A00C-D37668,66F94F54-0A6F-4BA1-8050-01A385AB66F3,,,,,NA,92,213,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8267,TCGA-AG-A00C,NO,NA,TCGA-AG-A00C-D37666,0480C952-95AB-4119-B285-88C9B48B46CF,,,,,NA,92,213,Chemotherapy,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8270,TCGA-AG-A00H,NO,NA,TCGA-AG-A00H-D37669,F74BAE20-BD17-4DF8-9A05-AF806FEAA77A,,,,,NA,90,121,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8272,TCGA-AG-A016,NO,NA,TCGA-AG-A016-D37671,078B47FD-21FB-4FD2-8F32-E9DD57433938,,,,,NA,31,61,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8271,TCGA-AG-A016,NO,NA,TCGA-AG-A016-D37670,D17DDE62-D61E-4DC5-B0BD-069B51F864DC,,,,,NA,31,245,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8273,TCGA-AG-A016,NO,NA,TCGA-AG-A016-D37672,A029C8B8-87C1-462D-B804-E918A20290E6,,,,,NA,61,245,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,n/a,,NA,,NO,Clinical Progressive Disease,5,12,2012,TCGA-READ
8274,TCGA-AG-A01L,NO,NA,TCGA-AG-A01L-D37673,8D57ECE2-11F5-4F08-8457-0FE7CAE7E643,,,,,NA,61,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8276,TCGA-AG-A01N,NO,NA,TCGA-AG-A01N-D37675,E059357B-5A89-48CC-B169-E79CDB764464,,,,,NA,273,457,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8278,TCGA-AG-A01W,NO,NA,TCGA-AG-A01W-D37677,E11038FD-3C7C-46DA-A03B-2AB5352DCDD5,,,,,NA,62,184,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8279,TCGA-AG-A01Y,NO,NA,TCGA-AG-A01Y-D37678,F99733D4-0119-416D-BCC9-791AD546EB61,,,,,NA,31,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8282,TCGA-AG-A020,NO,NA,TCGA-AG-A020-D37681,D2ADA08C-069D-430C-9642-E1F7DCC0513E,,,,,NA,31,212,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8281,TCGA-AG-A020,NO,NA,TCGA-AG-A020-D37680,3881A04C-1D82-4DD6-B894-53A283C12CBE,,,,,NA,31,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8280,TCGA-AG-A020,NO,NA,TCGA-AG-A020-D37679,AD098A28-2DA7-4BED-A331-5AA7358A8D28,,,,,NA,31,212,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8286,TCGA-AG-A02G,NO,NA,TCGA-AG-A02G-D37685,E6F1FA31-3AF9-45D0-A70B-38EF81B6A288,,,,,NA,28,242,Targeted Molecular therapy,Bevacizumab,Angiogenesis inhibitor,Other,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8285,TCGA-AG-A02G,NO,NA,TCGA-AG-A02G-D37684,A8310B34-29AD-410D-A5DE-FCDD7CBE7AEE,,,,,NA,28,242,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8284,TCGA-AG-A02G,NO,NA,TCGA-AG-A02G-D37683,A6893A84-4202-474B-9A3D-78E7E865113C,,,,,NA,28,1096,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8283,TCGA-AG-A02G,NO,NA,TCGA-AG-A02G-D37682,7458F01A-6F47-42AC-AB9F-525BFC8D3A2F,,,,,NA,28,1096,Chemotherapy,Folinic acid,Rescue agent,Other,n/a,,NA,,YES,Partial Response,5,12,2012,TCGA-READ
8287,TCGA-AG-A02G,NO,NA,TCGA-AG-A02G-D37686,2DCEA1E6-7D2F-46E0-9D15-4069C8FFC067,,,,,NA,851,1096,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,n/a,,NA,,NO,Partial Response,5,12,2012,TCGA-READ
8288,TCGA-AG-A02N,NO,NA,TCGA-AG-A02N-D37687,EB905BAF-E8D7-417B-AA1A-5FA9303ABF20,,,,,NA,28,89,Chemotherapy,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8290,TCGA-AG-A036,NO,NA,TCGA-AG-A036-D37689,5C971E83-8B85-45AE-86A7-2658BC205B5F,,,,,NA,92,215,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,n/a,,NA,,NO,Complete Response,5,12,2012,TCGA-READ
8291,TCGA-AH-6544,NO,NA,TCGA-AH-6544-D58962,A7E20535-8B56-47B9-9317-056575B2B34A,,,,,NA,68,229,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,29,4,2014,TCGA-READ
8294,TCGA-AH-6544,NO,NA,TCGA-AH-6544-D72541,1ED54217-BFD1-4649-BA20-441ACCFBBF6D,,,,,NA,68,229,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,13,7,2015,TCGA-READ
8295,TCGA-AH-6544,NO,NA,TCGA-AH-6544-D72542,135340EA-B051-4018-8B82-1B4FDE8149C5,,,,,NA,68,229,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Stable Disease,13,7,2015,TCGA-READ
8292,TCGA-AH-6544,NO,NA,TCGA-AH-6544-D58963,E0872852-6AFB-4304-9F95-06C0DAE1CC66,,,,,NA,68,365,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Stable Disease,29,4,2014,TCGA-READ
8293,TCGA-AH-6544,NO,NA,TCGA-AH-6544-D58964,26178324-9337-4FDE-9138-4CB722F26575,,,,,NA,243,365,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,29,4,2014,TCGA-READ
8296,TCGA-AH-6643,NO,NA,TCGA-AH-6643-D57835,A3494B7C-E0B1-4449-A8D8-3C4470AF9AB4,,,,,NA,41,202,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,27,3,2014,TCGA-READ
8297,TCGA-AH-6643,NO,NA,TCGA-AH-6643-D57836,8010F585-8B53-441B-9465-DED992A7E34E,,,,,NA,41,202,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,27,3,2014,TCGA-READ
8298,TCGA-AH-6643,NO,NA,TCGA-AH-6643-D57837,85D44224-0FAD-4FD4-B75C-8AFCAF6CBF8D,,,,,NA,41,202,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,27,3,2014,TCGA-READ
8300,TCGA-AH-6903,NO,NA,TCGA-AH-6903-D45596,3AC71EE5-4B1E-4DBE-856A-2B4841E4EDEE,,,,,NA,70,228,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,17,7,2013,TCGA-READ
8299,TCGA-AH-6903,NO,NA,TCGA-AH-6903-D45595,0136A943-A156-450D-89CE-22B658D58AED,,,,,NA,70,228,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,17,7,2013,TCGA-READ
8301,TCGA-AH-6903,,NA,TCGA-AH-6903-D45597,A49CFDD2-967B-4FC3-8902-594DAA1A2F3A,,,,,NA,70,228,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,17,7,2013,TCGA-READ
9612,TCGA-AJ-A23N,NO,NA,TCGA-AJ-A23N-D47002,6E45B1C4-453B-4EFB-82EB-0E2454D117C7,NA,,,,NA,89,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,21,8,2013,TCGA-UCEC
9613,TCGA-AJ-A23N,NO,NA,TCGA-AJ-A23N-D47003,D2E9275F-A4A8-4BA9-AD1D-93639EA4CCD8,NA,,,,NA,89,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,21,8,2013,TCGA-UCEC
9616,TCGA-AJ-A2QL,NO,NA,TCGA-AJ-A2QL-D43203,4F3B7D7F-44F2-4F6D-BCE8-BEFCEF897D2C,NA,,,,NA,110,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2013,TCGA-UCEC
9618,TCGA-AJ-A2QL,NO,NA,TCGA-AJ-A2QL-D43205,B4080D73-4B0F-4F3C-99D6-CFE826761AAF,NA,,,,NA,110,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2013,TCGA-UCEC
9617,TCGA-AJ-A2QL,NO,NA,TCGA-AJ-A2QL-D43204,E275FAC3-0AC4-4928-8021-B420F563DDE0,NA,,,,NA,110,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,5,2013,TCGA-UCEC
9619,TCGA-AJ-A2QM,NO,NA,TCGA-AJ-A2QM-D60108,B6C68A8E-18AE-4391-AC33-E65312537A5C,NA,,,,NA,46,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,5,2014,TCGA-UCEC
9620,TCGA-AJ-A2QM,NO,NA,TCGA-AJ-A2QM-D60109,FB5BCEB7-9935-4037-B737-E80CEF6F34D8,NA,,,,NA,46,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,5,2014,TCGA-UCEC
9621,TCGA-AJ-A3BD,NO,NA,TCGA-AJ-A3BD-D58986,3FCB21A4-FD2A-4040-95B8-3B6397B3E4FB,NA,,,,NA,37,125,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,4,2014,TCGA-UCEC
9622,TCGA-AJ-A3BD,NO,NA,TCGA-AJ-A3BD-D58987,F722F671-C70C-4C1B-92C2-7BBF3C0AA1B4,NA,,,,NA,37,125,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,4,2014,TCGA-UCEC
9624,TCGA-AJ-A3BF,NO,NA,TCGA-AJ-A3BF-D43708,9EAFBEF3-C687-4E65-AFB6-2895D2221593,NA,,,,NA,75,251,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,5,2013,TCGA-UCEC
9623,TCGA-AJ-A3BF,NO,NA,TCGA-AJ-A3BF-D43707,B70B0072-3E60-4B87-B5F1-59E70158E987,NA,,,,NA,75,251,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,31,5,2013,TCGA-UCEC
9625,TCGA-AJ-A3BG,NO,NA,TCGA-AJ-A3BG-D43758,0F5FBEEC-3739-487C-9183-F35693BE775E,NA,,,,NA,67,247,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,6,2013,TCGA-UCEC
9626,TCGA-AJ-A3BG,NO,NA,TCGA-AJ-A3BG-D43760,D0F37232-EE3C-4D29-9356-5F2DD29CC330,NA,,,,NA,67,247,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,6,2013,TCGA-UCEC
9630,TCGA-AJ-A3BI,NO,NA,TCGA-AJ-A3BI-D43704,168E2397-24D2-4A65-A6CD-B29A2C360180,NA,,,,NA,399,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,5,2013,TCGA-UCEC
9629,TCGA-AJ-A3BI,NO,NA,TCGA-AJ-A3BI-D43703,7BB8ECE4-8DE4-45BF-BDE8-5BD37D379F4D,NA,,,,NA,399,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,31,5,2013,TCGA-UCEC
9631,TCGA-AJ-A3EK,NO,NA,TCGA-AJ-A3EK-D45628,19CF2D0F-F0F2-4022-A95F-7ECBBA988851,NA,,,,NA,126,166,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,7,2013,TCGA-UCEC
9632,TCGA-AJ-A3EK,NO,NA,TCGA-AJ-A3EK-D45629,739D84CA-E206-428C-A852-CA1955C1F8BA,NA,,,,NA,126,166,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,7,2013,TCGA-UCEC
9633,TCGA-AJ-A3I9,NO,NA,TCGA-AJ-A3I9-D66210,FEB5FEE5-D836-45C0-8E36-AB467D7CCC17,NA,,,,NA,379,456,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,3,10,2014,TCGA-UCEC
9634,TCGA-AJ-A3I9,NO,NA,TCGA-AJ-A3I9-D66211,CC7E7973-9223-4A94-9844-A5D6D2FB49CA,NA,,,,NA,379,456,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,3,10,2014,TCGA-UCEC
9636,TCGA-AJ-A3NH,NO,NA,TCGA-AJ-A3NH-D46996,032779E0-E851-4BE4-820B-C3A3DA4A174A,NA,,,,NA,1,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9637,TCGA-AJ-A3NH,NO,NA,TCGA-AJ-A3NH-D46998,1489C5E5-DCF2-4B32-8E18-000BD5A2A6D1,NA,,,,NA,1,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9638,TCGA-AJ-A3OJ,NO,NA,TCGA-AJ-A3OJ-D47052,8001C500-87B1-4669-B411-188C137EC1A4,NA,,,,NA,81,230,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9639,TCGA-AJ-A3OJ,NO,NA,TCGA-AJ-A3OJ-D47053,771E84E0-20EC-4A93-A3FC-2A7C2C6EA290,NA,,,,NA,81,230,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9642,TCGA-AJ-A3OK,NO,NA,TCGA-AJ-A3OK-D45622,DDF9A56B-8EF8-4109-8F6E-189529E11EDA,NA,,,,NA,71,71,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,7,2013,TCGA-UCEC
9640,TCGA-AJ-A3OK,NO,NA,TCGA-AJ-A3OK-D45619,B89731B9-8B66-4B3E-BCA0-5B73E019445A,NA,,,,NA,71,134,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,7,2013,TCGA-UCEC
9641,TCGA-AJ-A3OK,NO,NA,TCGA-AJ-A3OK-D45620,E39263BA-D6DB-4346-A475-A521DB6AB5BE,NA,,,,NA,71,134,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,17,7,2013,TCGA-UCEC
9643,TCGA-AJ-A3OL,NO,NA,TCGA-AJ-A3OL-D47008,8888077B-E0BA-4F97-981B-D8BF33E45C57,NA,,,,NA,96,186,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9644,TCGA-AJ-A3OL,NO,NA,TCGA-AJ-A3OL-D47009,F43F3E37-E6BD-46CB-B2F4-39211DF04578,NA,,,,NA,96,186,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9645,TCGA-AJ-A3QS,NO,NA,TCGA-AJ-A3QS-D47015,E8F22E51-4803-4AEB-BED5-17610F99AADB,NA,,,,NA,114,174,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9646,TCGA-AJ-A3QS,NO,NA,TCGA-AJ-A3QS-D47016,0A2D5771-5CE4-4EBE-8714-51908E04CBDA,NA,,,,NA,NA,238,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9647,TCGA-AJ-A3QS,NO,NA,TCGA-AJ-A3QS-D47017,B866EAB5-4F40-40CB-9AA6-18C34C26DC62,NA,,,,NA,NA,238,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,8,2013,TCGA-UCEC
9648,TCGA-AJ-A4ZG,NO,NA,TCGA-AJ-A4ZG-D58974,3BAD017D-41EB-414E-98AD-1CF045E4F53E,NA,,,,NA,43,155,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,4,2014,TCGA-UCEC
9650,TCGA-AJ-A4ZG,NO,NA,TCGA-AJ-A4ZG-D58976,A7BEBB18-3531-4DF0-A454-0EB17682B7F9,NA,,,,NA,43,155,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,4,2014,TCGA-UCEC
9649,TCGA-AJ-A4ZG,NO,NA,TCGA-AJ-A4ZG-D58975,C08C838A-5189-454E-87D7-9D5D6E5587DD,NA,,,,NA,43,155,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,29,4,2014,TCGA-UCEC
4167,TCGA-AL-A5DJ,YES,NA,TCGA-AL-A5DJ-D43432,BAC8233F-CFC9-4E90-ADCE-94632ACD7ADA,,,,,NA,355,475,Targeted Molecular therapy,Temsirolimus,MTOR inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,21,5,2013,TCGA-KIRP
9691,TCGA-AP-A3K1,NO,NA,TCGA-AP-A3K1-D38426,E86FFFCA-37BD-485D-89ED-6C7C29996571,NA,,,,NA,74,94,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,14,12,2012,TCGA-UCEC
9692,TCGA-AP-A3K1,NO,NA,TCGA-AP-A3K1-D38427,131286E9-23BB-49BC-906B-7920CA6C1439,NA,,,,NA,74,94,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,14,12,2012,TCGA-UCEC
9693,TCGA-AP-A3K1,NO,NA,TCGA-AP-A3K1-D38428,8F5EF5CB-7E76-4E8D-ADE9-D17122AE1299,NA,,,,NA,144,186,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,14,12,2012,TCGA-UCEC
9695,TCGA-AP-A3K1,NO,NA,TCGA-AP-A3K1-D38430,BE8B156A-C9F4-4059-932A-76105B1F8BEE,NA,,,,NA,218,267,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,12,2012,TCGA-UCEC
9694,TCGA-AP-A3K1,NO,NA,TCGA-AP-A3K1-D38429,57F15663-9B00-450F-A66F-657538903AF8,NA,,,,NA,218,267,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,14,12,2012,TCGA-UCEC
9696,TCGA-AP-A5FX,NO,NA,TCGA-AP-A5FX-D43566,9FF793C4-98A5-48F8-95C6-43756F12F395,NA,,,,NA,84,190,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,5,2013,TCGA-UCEC
9697,TCGA-AP-A5FX,NO,NA,TCGA-AP-A5FX-D43567,617CCEA3-B4DB-4ED7-B47A-091839244529,NA,,,,NA,84,190,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,5,2013,TCGA-UCEC
1260,TCGA-AQ-A04H,NO,,TCGA-AQ-A04H-D40872,57AFEA30-9D59-45E4-A309-6717F0FBB64A,,,,,,29,133,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,3,2013,TCGA-BRCA
1261,TCGA-AQ-A04H,NO,,TCGA-AQ-A04H-D40873,A6C7F4F8-93C6-435A-A59A-88ED37540B88,,,,,,29,133,Chemotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,4,3,2013,TCGA-BRCA
1279,TCGA-AQ-A54O,NO,,TCGA-AQ-A54O-D40686,69C618BF-24A2-46C0-BA45-AAD9D605E8E6,,,,,,77,118,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
1278,TCGA-AQ-A54O,NO,,TCGA-AQ-A54O-D40684,D051B585-6A82-4408-B25B-3CB75C56A0C8,,,,,,77,118,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
1280,TCGA-AQ-A54O,NO,,TCGA-AQ-A54O-D40687,D56A18AB-9A5D-4B8F-B5FE-4CFDE2C87A45,,,,,,132,176,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,2,2013,TCGA-BRCA
1285,TCGA-AQ-A7U7,NO,,TCGA-AQ-A7U7-D54385,894571F0-1421-4634-8EF3-350800E2C13A,,,,,,123,165,Chemotherapy,Vincristine,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,12,2013,TCGA-BRCA
1283,TCGA-AQ-A7U7,NO,,TCGA-AQ-A7U7-D54381,EBE759A2-2DF0-4B0B-B155-47E54A053E90,,,,,,123,193,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,12,2013,TCGA-BRCA
1282,TCGA-AQ-A7U7,NO,,TCGA-AQ-A7U7-D54378,F857DE6F-EDB7-4A82-8BE1-58094AF4D53A,,,,,,123,193,Immunotherapy,Rituximab,Anti-CD20,Other,,,,,NO,Complete Response,18,12,2013,TCGA-BRCA
1286,TCGA-AQ-A7U7,NO,,TCGA-AQ-A7U7-D54386,F2C99A5C-0BC4-4921-952F-76BF03F2B539,,,,,,123,193,Hormone Therapy,Prednisone,Corticosteroid,Other,,,,,NO,Complete Response,18,12,2013,TCGA-BRCA
1284,TCGA-AQ-A7U7,NO,,TCGA-AQ-A7U7-D54382,5AC8BA1D-DEBC-48E8-83C5-2866BCF86F9B,,,,,,123,193,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,18,12,2013,TCGA-BRCA
9746,TCGA-AX-A2H5,,NA,TCGA-AX-A2H5-D31627,0AFBEB24-6412-46F6-AEDC-86C5B467EA5B,NA,,,,NA,87,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,5,2012,TCGA-UCEC
9747,TCGA-AX-A2H5,,NA,TCGA-AX-A2H5-D31628,C0052967-B2FB-43B6-A100-E42026C41CDE,NA,,,,NA,87,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,5,2012,TCGA-UCEC
9748,TCGA-AX-A2HC,,NA,TCGA-AX-A2HC-D31747,4379F374-9DD4-42B4-BC0C-062928C2E36C,NA,,,,NA,121,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,8,5,2012,TCGA-UCEC
9750,TCGA-AX-A2HF,,NA,TCGA-AX-A2HF-D31636,3DF9A8C9-C911-41A9-8A5B-D4CE9B23EECC,NA,,,,NA,35,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,5,2012,TCGA-UCEC
9751,TCGA-AX-A2HF,,NA,TCGA-AX-A2HF-D31638,B9AC5C39-4A2A-4B0F-97E0-E5E78A9C6D83,NA,,,,NA,35,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,5,2012,TCGA-UCEC
3244,TCGA-AY-A8YK,NO,,TCGA-AY-A8YK-D66237,8E470806-DD81-425B-AAD4-C6CFF304F12C,,,,,,83,111,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Complete Response,6,10,2014,TCGA-COAD
3243,TCGA-AY-A8YK,NO,,TCGA-AY-A8YK-D66236,B61E9618-2291-43AD-97BE-8C4C0B8DF4FD,,,,,,69,146,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,6,10,2014,TCGA-COAD
3242,TCGA-AY-A8YK,NO,,TCGA-AY-A8YK-D66229,809D0B32-3328-4D10-8884-A1A6FAAA9656,,,,,,69,286,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,6,10,2014,TCGA-COAD
3246,TCGA-AZ-4308,NO,,TCGA-AZ-4308-D31198,fb00dbc1-fe8e-499f-a828-6f339a1095ba,,,,,,50,191,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Complete Response,25,4,2012,TCGA-COAD
3247,TCGA-AZ-4308,NO,,TCGA-AZ-4308-D72532,2D0F4E33-22EC-4990-80E0-158C353540BB,,,,,,53,196,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,11,7,2015,TCGA-COAD
3250,TCGA-AZ-4616,NO,,TCGA-AZ-4616-D31069,ee6f05bf-df9b-4ced-8826-a19eafb73cc6,,,,,,113,NA,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Stable Disease,23,4,2012,TCGA-COAD
3254,TCGA-AZ-4682,NO,,TCGA-AZ-4682-D31203,5e969a71-8847-4099-91f4-03911df0d7ab,,,,,,100,NA,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,25,4,2012,TCGA-COAD
3253,TCGA-AZ-4682,NO,,TCGA-AZ-4682-D31202,c8a170f2-d094-44f4-a6a1-e2b2b06f7ae6,,,,,,100,NA,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,25,4,2012,TCGA-COAD
3252,TCGA-AZ-4682,NO,,TCGA-AZ-4682-D31200,4198e4c8-9a65-40d9-9a74-0e231eb35917,,,,,,100,NA,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,25,4,2012,TCGA-COAD
3255,TCGA-AZ-4684,NO,,TCGA-AZ-4684-D30846,2bb28cde-e6d2-4b5b-be40-2e267a44ce8b,,,,,,22,NA,Chemotherapy,Oxaliplatin|5-Fluorouracil|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,,,,NO,Clinical Progressive Disease,25,4,2012,TCGA-COAD
3257,TCGA-AZ-6600,NO,,TCGA-AZ-6600-D34150,BC76525A-EFC5-4518-8284-ED321B464F5E,,,,,,122,144,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-COAD
3258,TCGA-AZ-6600,NO,,TCGA-AZ-6600-D34151,D03EF7A0-DCCB-4070-9D2D-89B401069535,,,,,,122,144,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-COAD
3256,TCGA-AZ-6600,NO,,TCGA-AZ-6600-D34149,B95F4311-53FF-4CA7-975C-9F2B508C6EA8,,,,,,122,144,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-COAD
3259,TCGA-AZ-6605,NO,,TCGA-AZ-6605-D34155,06300BAA-C980-4F05-B262-22DD1912B178,,,,,,56,105,Chemotherapy,Oxaliplatin|5-Fluorouracil|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,,,,NO,Stable Disease,31,7,2012,TCGA-COAD
3260,TCGA-AZ-6606,NO,,TCGA-AZ-6606-D34173,911D9E4B-F7D6-4148-8474-7711805F5561,,,,,,59,103,Chemotherapy,5-Fluorouracil|Irinotecan|Folinic acid,Antimetabolite|Topoisomerase inhibitor|Rescue agent,Antimetabolite|Topoisomerase inhibitor|Other,NA,,,,NO,Clinical Progressive Disease,1,8,2012,TCGA-COAD
3261,TCGA-AZ-6606,NO,,TCGA-AZ-6606-D34174,410BCD90-40D4-47F1-82A9-917465D28CD4,,,,,,165,165,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,1,8,2012,TCGA-COAD
3998,TCGA-B0-4718,NO,NA,TCGA-B0-4718-D71492,CD80DE57-91F5-4915-970A-63855FA51F49,,,,,NA,99,1231,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,26,3,2015,TCGA-KIRC
3999,TCGA-B0-4718,YES,NA,TCGA-B0-4718-D71493,2FDAAE91-FC6E-47C8-B600-0C2719CD0119,,,,,NA,1363,1685,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,26,3,2015,TCGA-KIRC
4001,TCGA-B0-4841,NO,NA,TCGA-B0-4841-D31237,af206997-7393-4f9e-a9d0-6dee745c7585,,,,,NA,47,108,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,NA,,,,NO,Clinical Progressive Disease,25,4,2012,TCGA-KIRC
4004,TCGA-B0-5094,NO,NA,TCGA-B0-5094-D31511,e973d23d-8bec-4f9b-99c0-e10fbb0d6468,,,,,NA,124,228,Chemotherapy,Temsirolimus,MTOR inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,4,5,2012,TCGA-KIRC
4005,TCGA-B0-5107,NO,NA,TCGA-B0-5107-D31607,1e2025bb-698c-4a31-9302-fe90f67db312,,,,,NA,11,NA,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,7,5,2012,TCGA-KIRC
4008,TCGA-B0-5694,NO,NA,TCGA-B0-5694-D31875,4ac87a38-e1a6-4778-8a93-48f6dc837641,,,,,NA,441,469,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,10,5,2012,TCGA-KIRC
4010,TCGA-B0-5712,NO,NA,TCGA-B0-5712-D31971,fcf69248-81ae-4ab6-a197-b2b486da9e71,,,,,NA,177,NA,,Zoledronic acid,Antiresorptive,Other,NA,,,,NO,Stable Disease,14,5,2012,TCGA-KIRC
9796,TCGA-B5-A1MS,NO,NA,TCGA-B5-A1MS-D31925,7DF45FB4-56F8-4FAE-ABC2-84AB51BA8561,NA,,,,NA,2916,2985,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,11,5,2012,TCGA-UCEC
9797,TCGA-B5-A1MS,NO,NA,TCGA-B5-A1MS-D31928,F0CD5E1C-529C-4907-98B2-99C60A7D2153,NA,,,,NA,3041,3090,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,11,5,2012,TCGA-UCEC
1535,TCGA-B6-A402,NO,,TCGA-B6-A402-D40948,35A74783-A336-48EF-8D16-8CE8F0E6FF7D,,,,,,30,93,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,7,3,2013,TCGA-BRCA
1536,TCGA-B6-A402,NO,,TCGA-B6-A402-D40949,A9104E79-C312-4005-9AF6-7BC7CCEF7C19,,,,,,30,93,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,7,3,2013,TCGA-BRCA
1537,TCGA-B6-A402,NO,,TCGA-B6-A402-D40950,DE8DFC8E-AD88-486E-85C9-DEDAC34CD8AA,,,,,,112,191,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,7,3,2013,TCGA-BRCA
1538,TCGA-B6-A402,NO,,TCGA-B6-A402-D59670,AA69A790-B2B4-49B2-B8C3-907251C7338C,,,,,,2176,2232,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,3,6,2014,TCGA-BRCA
8870,TCGA-B7-A5TI,NO,,TCGA-B7-A5TI-D68105,3D445D2E-4D6C-4F38-816D-11557D91CB96,,,,,NA,10,231,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,13,11,2014,TCGA-STAD
8871,TCGA-B7-A5TK,NO,,TCGA-B7-A5TK-D68108,21DF9812-CE12-45E9-8ED5-D0783ABD6A21,,,,,NA,13,55,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,13,11,2014,TCGA-STAD
8872,TCGA-B7-A5TN,NO,,TCGA-B7-A5TN-D68110,044E255F-164A-423E-A529-BE16C9D53E72,,,,,NA,23,166,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,13,11,2014,TCGA-STAD
4168,TCGA-B9-4114,NO,NA,TCGA-B9-4114-D30868,52D39883-0543-4F39-90EE-F30376CFBA4D,,,,,NA,722,755,,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Stable Disease,17,4,2012,TCGA-KIRP
3635,TCGA-BA-A4IF,YES,NA,TCGA-BA-A4IF-D51699,72A21393-F5D6-495E-84DB-000D013180AC,NA,,NA,,NA,25,53,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,11,2013,TCGA-HNSC
3636,TCGA-BA-A4IG,NO,NA,TCGA-BA-A4IG-D55785,737DB7A8-CBB2-4758-ADD3-3A873069F0E3,NA,,NA,,NA,79,140,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,15,1,2014,TCGA-HNSC
3637,TCGA-BA-A4IH,NO,NA,TCGA-BA-A4IH-D55787,100E1715-44FF-4BB6-9704-C2925F3056AD,NA,,NA,,NA,87,129,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,1,2014,TCGA-HNSC
3638,TCGA-BA-A6D8,NO,NA,TCGA-BA-A6D8-D45515,E48C2867-CB04-45D0-9247-25DDEA0676A6,NA,,NA,,NA,112,154,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,7,2013,TCGA-HNSC
3639,TCGA-BA-A6DA,NO,NA,TCGA-BA-A6DA-D45523,13D2DADB-5EF5-4C42-9962-C48136399B87,NA,,NA,,NA,68,110,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,7,2013,TCGA-HNSC
3640,TCGA-BA-A6DD,NO,NA,TCGA-BA-A6DD-D45576,F7273590-003F-4BFA-B78A-0035C0B93757,NA,,NA,,NA,96,163,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,7,2013,TCGA-HNSC
3641,TCGA-BA-A6DI,NO,NA,TCGA-BA-A6DI-D45611,68373786-E3EC-411F-BF99-B2F086C61929,NA,,NA,,NA,18,53,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,7,2013,TCGA-HNSC
3642,TCGA-BA-A6DJ,NO,NA,TCGA-BA-A6DJ-D45625,508B061D-2F5E-4CF9-BFE5-6FA9F6CCB2F6,NA,,NA,,NA,105,140,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,7,2013,TCGA-HNSC
3643,TCGA-BA-A6DL,YES,NA,TCGA-BA-A6DL-D58934,3CA53D1F-7B87-46DB-A1C5-5143BB2EBA01,NA,,NA,,NA,21,56,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,4,2014,TCGA-HNSC
3644,TCGA-BA-A6DL,YES,NA,TCGA-BA-A6DL-D58935,39281D5B-B576-4367-A6A0-0C35CD494FC4,NA,,NA,,NA,21,56,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,4,2014,TCGA-HNSC
3645,TCGA-BA-A6DL,YES,NA,TCGA-BA-A6DL-D58936,34CCA937-9C4B-481A-BAC8-04A2B89D1435,NA,,NA,,NA,21,56,Chemotherapy,Lapatinib,HER1 inhibitor|HER2 inhibitor,Other,,,,,NO,Complete Response,29,4,2014,TCGA-HNSC
3656,TCGA-BB-7864,NO,NA,TCGA-BB-7864-D65448,6B71BB1A-DA2D-4125-94C8-52E7AB2D1407,NA,,NA,,NA,136,179,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,9,2014,TCGA-HNSC
3657,TCGA-BB-7866,NO,NA,TCGA-BB-7866-D65427,1D7CB457-F6EF-47BB-BF72-32DCF869F276,NA,,NA,,NA,71,116,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,9,2014,TCGA-HNSC
3658,TCGA-BB-7872,NO,NA,TCGA-BB-7872-D65437,297C2D7D-9543-4B23-B6E7-374CB2C7CC64,NA,,NA,,NA,112,154,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,9,2014,TCGA-HNSC
3659,TCGA-BB-A5HU,NO,NA,TCGA-BB-A5HU-D42910,6C67DA57-560F-46C6-A3F3-6E663790DC1E,NA,,NA,,NA,69,97,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,6,2013,TCGA-HNSC
3660,TCGA-BB-A5HY,NO,NA,TCGA-BB-A5HY-D43907,E51C395A-C307-44A2-A0A7-C9284F235383,NA,,NA,,NA,84,121,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,6,2013,TCGA-HNSC
4221,TCGA-BC-A8YO,NO,NA,TCGA-BC-A8YO-D57375,B8B6D701-E9E5-44C2-9D90-692659730A0A,NA,,NA,,NA,54,186,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Partial Response,10,3,2014,TCGA-LIHC
9826,TCGA-BG-A0VT,NO,NA,TCGA-BG-A0VT-D55425,D3FA983D-287C-4BC0-A71D-B0A408AA2406,NA,,,,NA,79,208,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,1,2014,TCGA-UCEC
9827,TCGA-BG-A0VT,NO,NA,TCGA-BG-A0VT-D55548,02BC066A-E639-44C6-B309-2E8119F2428B,NA,,,,NA,79,208,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,8,1,2014,TCGA-UCEC
9829,TCGA-BG-A0VZ,NO,NA,TCGA-BG-A0VZ-D34126,F90FD7F2-A96B-40EC-BA0F-597E495ABEFE,NA,,,,NA,114,145,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,30,7,2012,TCGA-UCEC
9830,TCGA-BG-A0VZ,NO,NA,TCGA-BG-A0VZ-D34094,2F1E7C63-DC90-45FC-8369-C60AB386FDAE,NA,,,,NA,103,165,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,13,5,2014,TCGA-UCEC
9828,TCGA-BG-A0VZ,NO,NA,TCGA-BG-A0VZ-D34093,CEBA52A4-E390-4A1F-A816-2DF5419FCC62,NA,,,,NA,103,175,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,7,2012,TCGA-UCEC
9832,TCGA-BG-A2AE,NO,NA,TCGA-BG-A2AE-D56536,FFCED0E8-5EDD-4DFA-BEF9-3A40085BEF56,NA,,,,NA,99,120,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,2,2014,TCGA-UCEC
9831,TCGA-BG-A2AE,NO,NA,TCGA-BG-A2AE-D56535,B2C5C7D7-A0FB-47E6-9AB8-A7A7FF20033A,NA,,,,NA,99,209,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,2,2014,TCGA-UCEC
9833,TCGA-BG-A2AE,NO,NA,TCGA-BG-A2AE-D56539,BAB8CA9B-473B-4FAA-BE89-AA4154331DDF,NA,,,,NA,120,209,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,2,2014,TCGA-UCEC
9834,TCGA-BG-A2L7,NO,NA,TCGA-BG-A2L7-D63225,32E13037-A275-4FAC-8D36-32FDD3E2958A,NA,,,,NA,85,189,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,8,2014,TCGA-UCEC
9836,TCGA-BG-A3PP,NO,NA,TCGA-BG-A3PP-D33395,A9469417-2AD1-4220-92EB-AEAEC9FCA5A0,NA,,,,NA,74,186,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,7,2012,TCGA-UCEC
9835,TCGA-BG-A3PP,NO,NA,TCGA-BG-A3PP-D33394,5513F425-D8FE-44B8-A61A-D3577405C74D,NA,,,,NA,74,186,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,7,2012,TCGA-UCEC
1549,TCGA-BH-A0AV,NO,,TCGA-BH-A0AV-D59176,BA9B227E-1B4A-469B-BCC4-E008C2CA2DAA,,,,,,146,259,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1548,TCGA-BH-A0AV,NO,,TCGA-BH-A0AV-D59175,3FC0BA35-5F5A-4C4B-B4F7-34A5A6C872EF,,,,,,146,259,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1558,TCGA-BH-A0AZ,YES,,TCGA-BH-A0AZ-D58605,862279A3-EF42-4533-8CE4-301C7CD7D3D8,,,,,,126,209,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,4,2014,TCGA-BRCA
1557,TCGA-BH-A0AZ,YES,,TCGA-BH-A0AZ-D58604,A79EE713-028A-4292-8C92-BDC9735D026F,,,,,,126,209,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,4,2014,TCGA-BRCA
1559,TCGA-BH-A0AZ,YES,,TCGA-BH-A0AZ-D58606,99401709-0B70-4391-88F9-E458D2839E9E,,,,,,209,293,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,4,2014,TCGA-BRCA
1560,TCGA-BH-A0AZ,YES,,TCGA-BH-A0AZ-D58608,BA304867-79FD-4DED-96AF-D5D57DA4D09C,,,,,,126,482,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Complete Response,15,4,2014,TCGA-BRCA
1562,TCGA-BH-A0B0,YES,,TCGA-BH-A0B0-D59206,9A3AEC18-4AD6-47E3-B8CA-EA762943F950,,,,,,82,194,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1561,TCGA-BH-A0B0,YES,,TCGA-BH-A0B0-D59205,7588271F-B241-4AE6-AE91-0065CCD2FE37,,,,,,82,194,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1574,TCGA-BH-A0B5,NO,,TCGA-BH-A0B5-D59185,C9BF525E-EE34-4064-99CD-996F6EB4C09E,,,,,,NA,257,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1573,TCGA-BH-A0B5,NO,,TCGA-BH-A0B5-D59184,05D47456-5206-4EA3-A5A3-8CF061849DEF,,,,,,63,NA,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1572,TCGA-BH-A0B5,NO,,TCGA-BH-A0B5-D59183,17D3063F-CC13-421E-A738-803D7C558475,,,,,,63,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1575,TCGA-BH-A0B7,NO,,TCGA-BH-A0B7-D58721,341C74D1-788A-4312-A88D-96B3FAAB73CE,,,,,,105,168,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1576,TCGA-BH-A0B7,NO,,TCGA-BH-A0B7-D58722,4F4B553E-E1BA-43B5-AA88-811D9E6FE6A1,,,,,,196,378,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1596,TCGA-BH-A0BL,NO,,TCGA-BH-A0BL-D59191,9D3B5CF6-D53E-4A6E-9E36-96AEF566A22F,,,,,,72,142,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1595,TCGA-BH-A0BL,NO,,TCGA-BH-A0BL-D59190,3DFD3BA5-2A34-4B70-AC12-5D1FAFE94711,,,,,,72,142,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1597,TCGA-BH-A0BL,NO,,TCGA-BH-A0BL-D59192,A18467A5-0B9F-4D1C-97E4-44F1D31AE8F3,,,,,,163,240,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1602,TCGA-BH-A0BS,NO,,TCGA-BH-A0BS-D63400,993049EF-D3F7-4F12-B97F-3D6AE4023498,,,,,,44,207,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,8,2014,TCGA-BRCA
1601,TCGA-BH-A0BS,NO,,TCGA-BH-A0BS-D63392,FCDA8776-2D25-4001-B9CC-956E0043F6A8,,,,,,44,207,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,7,8,2014,TCGA-BRCA
1604,TCGA-BH-A0BT,NO,,TCGA-BH-A0BT-D59148,857A1D7C-790E-4A2E-9420-9E23B1F2B32F,,,,,,97,139,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1603,TCGA-BH-A0BT,NO,,TCGA-BH-A0BT-D59146,162F9144-80E7-4C0F-BF74-1D23DDE80EF5,,,,,,97,139,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1610,TCGA-BH-A0BW,NO,,TCGA-BH-A0BW-D59134,E47D5A3A-3F23-45FE-AFF6-035D2D0D84BA,,,,,,51,114,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1609,TCGA-BH-A0BW,NO,,TCGA-BH-A0BW-D59133,AFDD7926-10D2-458F-9188-C9634F0A81A6,,,,,,51,114,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1612,TCGA-BH-A0BZ,NO,,TCGA-BH-A0BZ-D58690,025FAF2B-F67F-42A2-86B3-DFC2BBB21487,,,,,,76,167,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1611,TCGA-BH-A0BZ,NO,,TCGA-BH-A0BZ-D58689,B11042C3-48A4-4427-AD8F-54AE2DE97D00,,,,,,76,167,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1613,TCGA-BH-A0BZ,NO,,TCGA-BH-A0BZ-D58691,27F92F87-436A-44BE-A7AE-0AE19498D67C,,,,,,167,197,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1618,TCGA-BH-A0C1,NO,,TCGA-BH-A0C1-D63402,5104D7EB-AA20-495D-B052-EA95B8DB9658,,,,,,119,1167,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,7,8,2014,TCGA-BRCA
1617,TCGA-BH-A0C1,NO,,TCGA-BH-A0C1-D63401,61C5552F-F0F5-40A2-9749-2A2F13D9FFDA,,,,,,119,1167,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,7,8,2014,TCGA-BRCA
1620,TCGA-BH-A0C3,NO,,TCGA-BH-A0C3-D63541,0540668E-ECBB-43B1-AEE3-51C9F20C42B1,,,,,,109,209,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,12,8,2014,TCGA-BRCA
1619,TCGA-BH-A0C3,NO,,TCGA-BH-A0C3-D63540,4DF39809-E3F7-4075-A18D-2883605F6B37,,,,,,109,209,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,12,8,2014,TCGA-BRCA
1622,TCGA-BH-A0C7,NO,,TCGA-BH-A0C7-D59180,34A1744E-AFE4-4ECB-A86D-0AA9F44D0ABF,,,,,,50,113,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1623,TCGA-BH-A0C7,NO,,TCGA-BH-A0C7-D59181,04AB53D8-4D37-4845-B139-414A9D08CFC3,,,,,,50,113,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1621,TCGA-BH-A0C7,NO,,TCGA-BH-A0C7-D59179,716C77CF-18B0-4B77-BE11-C5B4B61DFCED,,,,,,50,113,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1625,TCGA-BH-A0DD,NO,,TCGA-BH-A0DD-D60388,7421BB29-2783-495B-8C92-73DC7451EEB8,,,,,,105,217,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,6,2014,TCGA-BRCA
1624,TCGA-BH-A0DD,NO,,TCGA-BH-A0DD-D60387,5889C498-95E3-4F7F-AFCD-CC096717CD6C,,,,,,105,217,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,6,2014,TCGA-BRCA
1628,TCGA-BH-A0DG,NO,,TCGA-BH-A0DG-D63661,B7B05AD1-68C3-489B-A7EB-F57176297F1B,,,,,,48,166,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,8,2014,TCGA-BRCA
1626,TCGA-BH-A0DG,NO,,TCGA-BH-A0DG-D63659,9B494472-AB4F-4900-8EA9-FBFB49E1C6A9,,,,,,48,166,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,8,2014,TCGA-BRCA
1627,TCGA-BH-A0DG,NO,,TCGA-BH-A0DG-D63660,3BDFD427-B336-4AB3-A362-7E6587C297E7,,,,,,48,166,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,8,2014,TCGA-BRCA
1634,TCGA-BH-A0DI,YES,,TCGA-BH-A0DI-D58708,CD0C2F47-0F49-4143-8B90-4DD1AEF83C03,,,,,,131,194,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1633,TCGA-BH-A0DI,YES,,TCGA-BH-A0DI-D58707,062DAD22-5616-49FF-9EE5-1C0763405FEE,,,,,,131,194,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1635,TCGA-BH-A0DI,YES,,TCGA-BH-A0DI-D58709,443925EA-94E1-4E24-96E1-9D9EAC2A280A,,,,,,215,319,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1637,TCGA-BH-A0DL,NO,,TCGA-BH-A0DL-D60392,ED098E0D-9D8B-45CE-BCD7-8583BBCAAE58,,,,,,58,121,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,6,2014,TCGA-BRCA
1638,TCGA-BH-A0DL,NO,,TCGA-BH-A0DL-D60393,31BEEEBA-90EE-411E-AD7B-89ABD5BE59B9,,,,,,58,205,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,6,2014,TCGA-BRCA
1647,TCGA-BH-A0DT,NO,,TCGA-BH-A0DT-D59152,0F068054-E971-4558-AD6A-D6CD1FB72167,,,,,,118,287,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1645,TCGA-BH-A0DT,NO,,TCGA-BH-A0DT-D59150,3624978D-3FC4-4B29-A10C-B30306A0483B,,,,,,118,287,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1646,TCGA-BH-A0DT,NO,,TCGA-BH-A0DT-D59151,C4190558-6F95-4A8A-9E8D-218E6E89D189,,,,,,118,287,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1648,TCGA-BH-A0DV,NO,,TCGA-BH-A0DV-D63673,C3346CC5-8B94-4A86-A119-C6A580D232C8,,,,,,48,176,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,8,2014,TCGA-BRCA
1650,TCGA-BH-A0DV,NO,,TCGA-BH-A0DV-D63675,BB94428A-1E62-47AC-BB42-8CA90FF6F1BD,,,,,,48,177,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,8,2014,TCGA-BRCA
1649,TCGA-BH-A0DV,NO,,TCGA-BH-A0DV-D63674,6D3D306F-FA11-4AED-93F7-6388AEE8F089,,,,,,48,177,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,8,2014,TCGA-BRCA
1652,TCGA-BH-A0DX,NO,,TCGA-BH-A0DX-D59138,1FA0D545-9D52-4FDC-B43B-62C04A51EC4E,,,,,,79,143,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1651,TCGA-BH-A0DX,NO,,TCGA-BH-A0DX-D59137,174495DC-4D02-47CB-8306-FF4E876B9A7E,,,,,,79,143,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1653,TCGA-BH-A0DX,NO,,TCGA-BH-A0DX-D59140,9D0C1A3D-2B12-41EB-AF5F-8A97855518FE,,,,,,143,171,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1654,TCGA-BH-A0DX,NO,,TCGA-BH-A0DX-D59141,E8FE1855-0A33-4663-A2E3-605059890515,,,,,,143,171,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1675,TCGA-BH-A0E9,NO,,TCGA-BH-A0E9-D59113,D3529E84-7664-4493-AF4D-F8B121B6983B,,,,,,96,503,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1673,TCGA-BH-A0E9,NO,,TCGA-BH-A0E9-D59110,ED0808E6-A224-44C7-8353-2A9DF81486C5,,,,,,96,503,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1674,TCGA-BH-A0E9,NO,,TCGA-BH-A0E9-D59111,303A080F-9FE8-4C7A-B424-44DF8F97B57C,,,,,,96,503,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,5,2014,TCGA-BRCA
1676,TCGA-BH-A0EA,NO,,TCGA-BH-A0EA-D58578,90419813-A572-48FF-972A-949B5811D2F8,,,,,,84,363,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,4,2014,TCGA-BRCA
1677,TCGA-BH-A0EA,NO,,TCGA-BH-A0EA-D58581,FECD8A5A-10AD-4DB7-91F2-08A6B16C19B9,,,,,,363,522,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,4,2014,TCGA-BRCA
1688,TCGA-BH-A0H5,NO,,TCGA-BH-A0H5-D58731,AE71C06F-4D9D-4EE7-B6D1-14FF06F8C6E8,,,,,,174,NA,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1689,TCGA-BH-A0H5,NO,,TCGA-BH-A0H5-D58732,C099D047-9A31-4CB6-8F0B-FEAF89B6F351,,,,,,174,NA,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1728,TCGA-BH-A0HY,YES,,TCGA-BH-A0HY-D43318,136D0D8F-953A-40A9-AB68-828686DD333B,,,,,,88,190,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,5,2013,TCGA-BRCA
1727,TCGA-BH-A0HY,YES,,TCGA-BH-A0HY-D43317,7EC3CB4B-FC47-4903-8C56-460C10384B08,,,,,,88,190,Hormone Therapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,16,5,2013,TCGA-BRCA
1729,TCGA-BH-A0HY,YES,,TCGA-BH-A0HY-D43319,6C77D915-C2F7-4ED7-A3BE-5658AA5B8580,,,,,,88,427,Chemotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,16,5,2013,TCGA-BRCA
1733,TCGA-BH-A0W5,NO,,TCGA-BH-A0W5-D34071,985E78AA-4536-424D-A1B5-8510D98A84D5,,,,,,22,144,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,29,7,2012,TCGA-BRCA
1735,TCGA-BH-A0W7,NO,,TCGA-BH-A0W7-D34075,1D1011B2-5862-44A0-8E76-C71A08C733ED,,,,,,76,138,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,7,2012,TCGA-BRCA
1734,TCGA-BH-A0W7,NO,,TCGA-BH-A0W7-D34074,0A4EE347-EE11-4426-A666-055E6317A805,,,,,,76,138,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,29,7,2012,TCGA-BRCA
1736,TCGA-BH-A0W7,NO,,TCGA-BH-A0W7-D34076,47152466-BCD7-423E-ACBE-8E1CC909F134,,,,,,168,1233,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,29,7,2012,TCGA-BRCA
1737,TCGA-BH-A0W7,NO,,TCGA-BH-A0W7-D34077,F892639C-D682-4FC7-AE4B-6FF21F295085,,,,,,1171,1324,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,29,7,2012,TCGA-BRCA
1739,TCGA-BH-A18F,NO,,TCGA-BH-A18F-D59197,60625A51-8E18-4F71-B2D7-27A2C7FB9C2C,,,,,,101,189,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1738,TCGA-BH-A18F,NO,,TCGA-BH-A18F-D59196,9FCC797A-A7A9-48C4-8908-C2C04931C24A,,,,,,101,189,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1741,TCGA-BH-A18H,NO,,TCGA-BH-A18H-D59202,0E5715EA-719D-42AE-8516-6AD9DA3F885F,,,,,,34,118,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1740,TCGA-BH-A18H,NO,,TCGA-BH-A18H-D59201,79B05235-CBBB-4B01-819B-84C9483B56B7,,,,,,34,118,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1742,TCGA-BH-A18H,NO,,TCGA-BH-A18H-D59203,8719BC2E-D714-4B56-8035-F3E2D07DD9CF,,,,,,118,219,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2014,TCGA-BRCA
1744,TCGA-BH-A18I,NO,,TCGA-BH-A18I-D58712,B4CF288C-CBDD-493D-8CB6-198994F91639,,,,,,121,220,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1743,TCGA-BH-A18I,NO,,TCGA-BH-A18I-D58711,62D6ACAF-3359-411A-9715-AC1D93B3EB27,,,,,,121,220,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,4,2014,TCGA-BRCA
1745,TCGA-BH-A202,NO,,TCGA-BH-A202-D64230,0D4881E9-AE20-4588-920D-75E5D8AB81ED,,,,,,47,169,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-BRCA
1746,TCGA-BH-A202,NO,,TCGA-BH-A202-D64231,C3C5CF2E-3889-4D44-A699-9F66D21CE0E1,,,,,,47,169,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,27,8,2014,TCGA-BRCA
1747,TCGA-BH-A28O,NO,,TCGA-BH-A28O-D64238,CAD6922D-31F1-401F-AAA4-FCD9176D8DE1,,,,,,338,430,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-BRCA
1748,TCGA-BH-A28O,NO,,TCGA-BH-A28O-D64239,103854BD-AAE1-4387-84DC-33377016C730,,,,,,338,430,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,27,8,2014,TCGA-BRCA
1749,TCGA-BH-A2L8,NO,,TCGA-BH-A2L8-D43167,D1B01084-E040-4E41-ACAC-3A7D4A79E959,,,,,,136,197,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2013,TCGA-BRCA
1752,TCGA-BH-A5IZ,NO,,TCGA-BH-A5IZ-D66934,E11C1618-C47C-4EA9-8EC5-B0D84CC12E53,,,,,,77,140,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,10,2014,TCGA-BRCA
1750,TCGA-BH-A5IZ,NO,,TCGA-BH-A5IZ-D56581,EB4E7F2F-14F6-4609-94C9-937F41DF8521,,,,,,77,140,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,13,2,2014,TCGA-BRCA
1751,TCGA-BH-A5IZ,NO,,TCGA-BH-A5IZ-D56582,3B0DE458-656A-4A35-8FC0-B76E3C7A33E1,,,,,,161,161,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,13,2,2014,TCGA-BRCA
1754,TCGA-BH-A8G0,YES,,TCGA-BH-A8G0-D57781,1554145F-6AD9-4A57-92CC-2C65179DF840,,,,,,155,267,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,3,2014,TCGA-BRCA
1753,TCGA-BH-A8G0,YES,,TCGA-BH-A8G0-D57780,D9246CEE-989C-4F55-8C8E-F44C20C26427,,,,,,155,267,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,3,2014,TCGA-BRCA
9497,TCGA-BJ-A2N7,NO,NA,TCGA-BJ-A2N7-D33389,AF17932F-E57E-40BC-8CC2-9208A64D992C,NA,NA,NA,,NA,16,NA,Hormone Therapy,Synthroid,Hormone,Other,NA,,NA,,NO,Stable Disease,29,6,2012,TCGA-THCA
19,TCGA-BL-A0C8,NO,,TCGA-BL-A0C8-D32669,CC079D30-D4A6-473B-ACCC-8167CA062261,NA,,NA,,NA,680,722,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Clinical Progressive Disease,13,6,2012,TCGA-BLCA
8886,TCGA-BR-6457,NO,,TCGA-BR-6457-D30818,0E8A2B84-2A74-4A66-8F9D-CB2C1DC6D95B,,,,,NA,31,126,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,17,4,2012,TCGA-STAD
8885,TCGA-BR-6457,NO,,TCGA-BR-6457-D30817,20F9746C-645D-4ABD-ADC4-8BACE2E1BBAB,,,,,NA,31,126,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,17,4,2012,TCGA-STAD
8889,TCGA-BR-6458,NO,,TCGA-BR-6458-D30864,843BC274-766C-438D-8603-FD34A0DD704A,,,,,NA,58,98,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,17,4,2012,TCGA-STAD
8887,TCGA-BR-6458,NO,,TCGA-BR-6458-D30862,329B1450-1CBA-4CF7-A0A2-F6EA2E19F46C,,,,,NA,58,167,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,17,4,2012,TCGA-STAD
8888,TCGA-BR-6458,NO,,TCGA-BR-6458-D30863,2CE0589D-6B0E-40B9-98B7-8CDD365F4C80,,,,,NA,58,167,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,17,4,2012,TCGA-STAD
8891,TCGA-BR-6563,NO,,TCGA-BR-6563-D40651,85F8652E-5C14-44F8-9F42-1BEB7FEF8158,,,,,NA,157,330,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,26,2,2013,TCGA-STAD
8893,TCGA-BR-6563,NO,,TCGA-BR-6563-D40655,D97E90FB-801B-458A-8FB0-768EC4B13B19,,,,,NA,157,330,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,26,2,2013,TCGA-STAD
8892,TCGA-BR-6563,NO,,TCGA-BR-6563-D40653,84F5091F-4FCF-49AF-984B-902DEF77524F,,,,,NA,157,330,Chemotherapy,Vincristine,Antimitotic,Antimitotic,NA,,NA,,NO,Complete Response,26,2,2013,TCGA-STAD
8890,TCGA-BR-6563,NO,,TCGA-BR-6563-D40649,CF9D5B5A-E824-42E3-83D0-12C88C7F9F78,,,,,NA,157,330,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,26,2,2013,TCGA-STAD
8894,TCGA-BR-6706,NO,,TCGA-BR-6706-D31136,715BDE47-0B8B-49F9-822F-674F612F117C,,,,,NA,56,147,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,24,4,2012,TCGA-STAD
8896,TCGA-BR-6706,NO,,TCGA-BR-6706-D31138,2436ADA9-C071-4061-A8B1-39F90E7130FF,,,,,NA,56,147,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,24,4,2012,TCGA-STAD
8895,TCGA-BR-6706,NO,,TCGA-BR-6706-D31137,61B2F2A3-D013-4AB7-BECC-DDB957F6366E,,,,,NA,56,147,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,24,4,2012,TCGA-STAD
8901,TCGA-BR-6707,NO,,TCGA-BR-6707-D40122,6AFF62B3-4BA0-4BFD-B451-FE8172EE9B2A,,,,,NA,426,491,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,13,2,2013,TCGA-STAD
8903,TCGA-BR-6707,NO,,TCGA-BR-6707-D40136,9D139348-6DC9-4EE1-B638-75BE15D7848F,,,,,NA,426,491,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,13,2,2013,TCGA-STAD
8902,TCGA-BR-6707,NO,,TCGA-BR-6707-D40125,A76318ED-0715-445A-9342-52629BA75F3D,,,,,NA,426,491,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,13,2,2013,TCGA-STAD
8907,TCGA-BR-6709,NO,,TCGA-BR-6709-D40140,E3F514A5-EE64-4E72-8A52-85A3A43E8AA0,,,,,NA,61,206,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Partial Response,13,2,2013,TCGA-STAD
8906,TCGA-BR-6709,NO,,TCGA-BR-6709-D31224,6C068635-DBC3-4E67-9F40-AC44B0357F25,,,,,NA,61,206,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Partial Response,25,4,2012,TCGA-STAD
8904,TCGA-BR-6709,NO,,TCGA-BR-6709-D31221,4864A635-4F6F-4C10-9485-704AC74F5A4B,,,,,NA,61,206,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Partial Response,25,4,2012,TCGA-STAD
8905,TCGA-BR-6709,NO,,TCGA-BR-6709-D31222,F0C88A74-DF3A-4D22-AEDF-7F0E70E0680F,,,,,NA,61,206,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Partial Response,25,4,2012,TCGA-STAD
8909,TCGA-BR-6710,NO,,TCGA-BR-6710-D31241,9E8C3054-20C3-473D-A67C-7DB67BC91F45,,,,,NA,78,85,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,25,4,2012,TCGA-STAD
8908,TCGA-BR-6710,NO,,TCGA-BR-6710-D31240,8ECA218B-1057-4600-936D-A13A13AE9967,,,,,NA,78,85,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,25,4,2012,TCGA-STAD
8911,TCGA-BR-6802,NO,,TCGA-BR-6802-D55552,87FBC3EE-A36B-487B-9AAD-EF6CF8BFA1E5,,,,,NA,847,854,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,8,1,2014,TCGA-STAD
8910,TCGA-BR-6802,NO,,TCGA-BR-6802-D55551,C441D6D1-CFEC-4B73-B8F3-3F8611A92695,,,,,NA,847,854,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,8,1,2014,TCGA-STAD
8912,TCGA-BR-6802,NO,,TCGA-BR-6802-D55554,3DC5F8EC-083B-4BDA-8B47-2CCB843ECD9C,,,,,NA,875,940,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,8,1,2014,TCGA-STAD
8922,TCGA-BR-7959,NO,,TCGA-BR-7959-D39862,3880CA8D-5764-4491-92DF-20C3C89BA3C2,,,,,NA,35,127,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,5,2,2013,TCGA-STAD
8925,TCGA-BR-8291,NO,,TCGA-BR-8291-D41697,584B220E-2507-46F1-8637-1102A6B4FF15,,,,,NA,39,137,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8924,TCGA-BR-8291,NO,,TCGA-BR-8291-D41696,E26893D2-FE11-4D1C-B1D7-144430B206B1,,,,,NA,39,137,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8923,TCGA-BR-8291,NO,,TCGA-BR-8291-D41695,26144004-F993-42B6-85B0-A551B6560AEE,,,,,NA,39,137,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8927,TCGA-BR-8296,NO,,TCGA-BR-8296-D53167,911881EA-DF47-4C2D-9EDD-9E3CE3FCE56E,,,,,NA,44,180,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,24,1,2014,TCGA-STAD
8928,TCGA-BR-8296,NO,,TCGA-BR-8296-D53166,D1885FC4-DF71-4086-8FAB-F30BB5DF3D78,,,,,NA,44,180,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,24,1,2014,TCGA-STAD
8926,TCGA-BR-8296,NO,,TCGA-BR-8296-D53160,883E7772-5357-421B-85DA-331D4187433B,,,,,NA,44,180,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,24,1,2014,TCGA-STAD
8930,TCGA-BR-8297,NO,,TCGA-BR-8297-D53182,ABB09F9E-B07E-49A4-8596-AA2B28F56838,,,,,NA,67,97,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8931,TCGA-BR-8297,NO,,TCGA-BR-8297-D53190,8CF026A8-C838-4DFC-B518-BEEBF4DF9F00,,,,,NA,67,97,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8929,TCGA-BR-8297,NO,,TCGA-BR-8297-D53178,5136C06C-8AAC-4409-B8E6-093BD0F0AD51,,,,,NA,67,97,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8933,TCGA-BR-8362,NO,,TCGA-BR-8362-D53222,399C0ADA-6AAB-4323-9D45-37FC06D62F50,,,,,NA,24,154,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8934,TCGA-BR-8362,NO,,TCGA-BR-8362-D53224,81189E50-888D-4571-A824-50BA383B1C86,,,,,NA,24,154,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8932,TCGA-BR-8362,NO,,TCGA-BR-8362-D53221,732BB094-D0C1-4990-BC97-28A86AD82C9B,,,,,NA,24,154,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8935,TCGA-BR-8362,NO,,TCGA-BR-8362-D53227,3D5BE428-69B9-46E5-B1E0-FF6088F64E0E,,,,,NA,370,375,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8936,TCGA-BR-8362,NO,,TCGA-BR-8362-D53229,2187C5A2-169D-47DE-8241-B5C1C986C3F8,,,,,NA,370,375,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8937,TCGA-BR-8362,NO,,TCGA-BR-8362-D53230,E378C034-A069-42B4-8CF9-8667B1EF2FD1,,,,,NA,370,375,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,10,12,2013,TCGA-STAD
8938,TCGA-BR-8367,NO,,TCGA-BR-8367-D40165,BC75D8B6-0D76-47BC-885B-DCFD18EE3CAF,,,,,NA,61,163,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,13,2,2013,TCGA-STAD
8939,TCGA-BR-8367,NO,,TCGA-BR-8367-D40166,3CA60D71-63FC-4034-8162-554BC4A29562,,,,,NA,61,229,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,13,2,2013,TCGA-STAD
8940,TCGA-BR-8367,NO,,TCGA-BR-8367-D40167,2708C1A4-9D1E-4119-8746-32E749EAE3FF,,,,,NA,61,229,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,13,2,2013,TCGA-STAD
8943,TCGA-BR-8367,NO,,TCGA-BR-8367-D55903,76E85FC6-ECE8-47D0-88CE-CE9E7B33EFF4,,,,,NA,189,611,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,17,1,2014,TCGA-STAD
8941,TCGA-BR-8367,NO,,TCGA-BR-8367-D55901,777057FE-2A44-418C-BDF7-4AC6362CFDB8,,,,,NA,189,611,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,17,1,2014,TCGA-STAD
8942,TCGA-BR-8367,NO,,TCGA-BR-8367-D55902,49A7FB08-D143-4F26-B559-7045FAB31983,,,,,NA,189,611,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,17,1,2014,TCGA-STAD
8946,TCGA-BR-8370,NO,,TCGA-BR-8370-D41720,53DC2805-138F-4C32-9C80-E78660E5F4EC,,,,,NA,34,101,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8944,TCGA-BR-8370,NO,,TCGA-BR-8370-D41718,2B007983-2174-4949-AB60-59813177CDB2,,,,,NA,34,101,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8945,TCGA-BR-8370,NO,,TCGA-BR-8370-D41719,6D0CF2F4-7914-4814-ACFA-A2CF3C5DF667,,,,,NA,34,101,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,26,3,2013,TCGA-STAD
8948,TCGA-BR-8371,NO,,TCGA-BR-8371-D41723,39523C55-7A3A-4A20-9378-88B060DD0AF6,,,,,NA,81,98,Chemotherapy,Polyplatillen,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8947,TCGA-BR-8371,NO,,TCGA-BR-8371-D41722,06207711-8147-42E4-938A-A602B8425ECD,,,,,NA,31,189,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8949,TCGA-BR-8371,NO,,TCGA-BR-8371-D41725,1A29866F-A3AB-406F-ADD0-E2AA26F08165,,,,,NA,31,189,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8951,TCGA-BR-8371,NO,,TCGA-BR-8371-D41731,DE1CD845-D8FA-4318-AAFC-3A9053C205BC,,,,,NA,119,189,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8950,TCGA-BR-8371,NO,,TCGA-BR-8371-D41728,D3A9D9D2-E811-4F2C-8816-FCA1D0200F11,,,,,NA,337,351,Chemotherapy,Polyplatillen,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8952,TCGA-BR-8371,NO,,TCGA-BR-8371-D41732,49322124-6697-43E0-8BBB-424DA948A388,,,,,NA,337,351,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,26,3,2013,TCGA-STAD
8954,TCGA-BR-8372,NO,,TCGA-BR-8372-D53202,B686B5C4-1EBD-4647-8AA4-CE4A544BEABF,,,,,NA,31,174,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8955,TCGA-BR-8372,NO,,TCGA-BR-8372-D53204,6D0352BA-28AF-4EBC-863E-FC948E4F7720,,,,,NA,31,174,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8953,TCGA-BR-8372,NO,,TCGA-BR-8372-D53201,4DB82487-E263-4102-99E7-7EC2DAB13F5B,,,,,NA,31,174,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8956,TCGA-BR-8373,NO,,TCGA-BR-8373-D40169,78B475A5-C995-4AD6-BDFD-19A87889ED5D,,,,,NA,55,84,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,13,2,2013,TCGA-STAD
8957,TCGA-BR-8373,NO,,TCGA-BR-8373-D40170,D853330E-86D9-43F4-B5C8-E54132D3399B,,,,,NA,55,84,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,13,2,2013,TCGA-STAD
8958,TCGA-BR-8373,NO,,TCGA-BR-8373-D57688,360A35DC-AE12-4DB1-A11B-FC5DB2F0F704,,,,,NA,55,84,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,19,3,2014,TCGA-STAD
8959,TCGA-BR-8380,NO,,TCGA-BR-8380-D64092,523D5ED3-96F6-4CA5-8A77-ED8DAA5ADFB8,,,,,NA,69,190,Chemotherapy,Polyplatillen,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,26,8,2014,TCGA-STAD
8960,TCGA-BR-8380,NO,,TCGA-BR-8380-D65474,1D379E6A-1888-4119-B693-F50005318DC2,,,,,NA,69,190,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,15,12,2014,TCGA-STAD
8961,TCGA-BR-8380,NO,,TCGA-BR-8380-D65476,227B492A-CBAA-45B6-A90B-13A7402F2EFB,,,,,NA,69,190,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,15,12,2014,TCGA-STAD
8962,TCGA-BR-8381,NO,,TCGA-BR-8381-D42015,C2B0E7FB-E1DA-4B20-B143-57B2638F3BBA,,,,,NA,35,161,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,9,4,2013,TCGA-STAD
8964,TCGA-BR-8381,NO,,TCGA-BR-8381-D42018,08EFC579-4985-430F-9871-ADC8A1A9E6A1,,,,,NA,35,161,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,4,2013,TCGA-STAD
8963,TCGA-BR-8381,NO,,TCGA-BR-8381-D42017,8C009156-7F0B-4F2F-8E69-9A9DFE7D3658,,,,,NA,35,161,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,9,4,2013,TCGA-STAD
8968,TCGA-BR-8590,NO,,TCGA-BR-8590-D53256,2C4B31CD-54A0-4540-9FCB-F6AAE16381EC,,,,,NA,42,203,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8969,TCGA-BR-8590,NO,,TCGA-BR-8590-D53257,6327A80C-7AE5-4A40-BE50-D547E2A2AD38,,,,,NA,42,203,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8967,TCGA-BR-8590,NO,,TCGA-BR-8590-D53253,325CB6D7-65E1-40C6-B0B4-63B9CB24A935,,,,,NA,42,203,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,10,12,2013,TCGA-STAD
8971,TCGA-BR-8592,NO,,TCGA-BR-8592-D53277,06B7264E-34CB-4CC7-AB90-8F9174C237EC,,,,,NA,39,113,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,27,1,2014,TCGA-STAD
8972,TCGA-BR-8592,NO,,TCGA-BR-8592-D53278,7782D6BF-9D71-43B9-9501-593A884F94DE,,,,,NA,39,113,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,27,1,2014,TCGA-STAD
8970,TCGA-BR-8592,NO,,TCGA-BR-8592-D53276,C914FED2-B0DD-4957-A07E-DB167239AE8F,,,,,NA,39,113,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,27,1,2014,TCGA-STAD
8973,TCGA-BR-8680,NO,,TCGA-BR-8680-D48354,85D9F46B-ED79-4A17-A571-6FFFE1ACEDEF,,,,,NA,39,150,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8974,TCGA-BR-8680,NO,,TCGA-BR-8680-D48356,9C291267-1086-4C46-8246-A311629B13F3,,,,,NA,39,150,Chemotherapy,Eribulin,Antimitotic,Antimitotic,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8976,TCGA-BR-8680,NO,,TCGA-BR-8680-D48358,50EF1ACB-4270-425D-A523-E55A8E9FEF9E,,,,,NA,39,150,Ancillary,Methylprednisolone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8975,TCGA-BR-8680,NO,,TCGA-BR-8680-D48357,77B95195-E8D9-4E5D-964E-6972CB801422,,,,,NA,39,150,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8977,TCGA-BR-8682,NO,,TCGA-BR-8682-D48360,6FEB3C22-7D84-4166-805D-5A5A3C66903D,,,,,NA,60,181,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,7,10,2013,TCGA-STAD
8980,TCGA-BR-8682,NO,,TCGA-BR-8682-D48363,DE872954-0DAF-4036-84E2-E18B9DA3C859,,,,,NA,60,181,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,7,10,2013,TCGA-STAD
8979,TCGA-BR-8682,NO,,TCGA-BR-8682-D48362,384CDBA6-34F9-4A2A-92CE-93A1C2C071D8,,,,,NA,60,181,Ancillary,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,7,10,2013,TCGA-STAD
8978,TCGA-BR-8682,NO,,TCGA-BR-8682-D48361,4A3F18D6-CDB8-4611-B6FC-AE541A9402B6,,,,,NA,60,181,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,7,10,2013,TCGA-STAD
8983,TCGA-BR-8690,NO,,TCGA-BR-8690-D48714,C0D1267D-9626-45F5-B66D-CB6580F1A8F5,,,,,NA,58,122,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,19,9,2013,TCGA-STAD
8984,TCGA-BR-8690,NO,,TCGA-BR-8690-D48720,65D1D06D-D48A-4C86-B6C2-D1AAB0F0F5CB,,,,,NA,118,122,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,19,9,2013,TCGA-STAD
8982,TCGA-BR-8690,NO,,TCGA-BR-8690-D48713,74EE5D8C-B363-406C-A99B-953F95273FC2,,,,,NA,118,122,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,19,9,2013,TCGA-STAD
8981,TCGA-BR-8690,NO,,TCGA-BR-8690-D48712,7FF54FB1-80DD-4E70-B211-7EBC8955C5C9,,,,,NA,58,196,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,19,9,2013,TCGA-STAD
8985,TCGA-BR-A44T,NO,,TCGA-BR-A44T-D46406,C1431FDD-005A-465F-8795-AA4F2ACFDABD,,,,,NA,47,196,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,7,8,2013,TCGA-STAD
8986,TCGA-BR-A44T,NO,,TCGA-BR-A44T-D46407,6DD0DFAA-BDF7-49DE-B36D-97C3DE91998A,,,,,NA,47,196,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,7,8,2013,TCGA-STAD
8987,TCGA-BR-A44T,NO,,TCGA-BR-A44T-D60631,54B88AB0-93C0-4219-BCAC-E560497ACF94,,,,,NA,682,714,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,13,6,2014,TCGA-STAD
8988,TCGA-BR-A44T,NO,,TCGA-BR-A44T-D60632,1764350C-63FD-4DFD-B592-6465C29A1419,,,,,NA,682,714,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Stable Disease,13,6,2014,TCGA-STAD
8989,TCGA-BR-A44T,NO,,TCGA-BR-A44T-D60633,CFD30708-A79C-41AA-9A12-82E2FEF8411B,,,,,NA,682,714,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,13,6,2014,TCGA-STAD
8990,TCGA-BR-A4IU,NO,,TCGA-BR-A4IU-D48368,5DAEB4B4-652A-4DD6-BA78-9A0DFCAF848E,,,,,NA,47,156,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8992,TCGA-BR-A4IU,NO,,TCGA-BR-A4IU-D48370,9FD32065-1967-44E0-844B-17E05071FE4D,,,,,NA,47,156,Ancillary,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8991,TCGA-BR-A4IU,NO,,TCGA-BR-A4IU-D48369,2CB12066-9402-4FCB-BA2B-C2A739F3178C,,,,,NA,47,156,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8993,TCGA-BR-A4IV,NO,,TCGA-BR-A4IV-D48374,9607C0FC-B41D-4206-AF5A-1D07B21ED651,,,,,NA,51,166,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8995,TCGA-BR-A4IV,NO,,TCGA-BR-A4IV-D48376,44223653-15E7-4147-A96F-D94FC6087DD3,,,,,NA,51,166,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8996,TCGA-BR-A4IV,NO,,TCGA-BR-A4IV-D48379,B93DFA57-F320-4EAB-A63C-729C88CF3EFD,,,,,NA,51,166,Ancillary,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8994,TCGA-BR-A4IV,NO,,TCGA-BR-A4IV-D48375,088714CC-ACF2-45A6-9333-D17F30500A7D,,,,,NA,51,166,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8997,TCGA-BR-A4IY,NO,,TCGA-BR-A4IY-D48380,E88DF1F0-B216-4AB7-BFFE-F01D9777ECF0,,,,,NA,47,177,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8999,TCGA-BR-A4IY,NO,,TCGA-BR-A4IY-D48382,87E368CF-2B82-4C16-88DA-AA73CBF97A74,,,,,NA,47,177,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
9000,TCGA-BR-A4IY,NO,,TCGA-BR-A4IY-D48383,311865C2-C577-46CF-AC6B-981D398F1C6A,,,,,NA,47,177,Ancillary,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
8998,TCGA-BR-A4IY,NO,,TCGA-BR-A4IY-D48381,0CE8FB91-8C39-4B33-92EA-63F8711B7651,,,,,NA,47,177,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,9,2013,TCGA-STAD
9003,TCGA-BR-A4J2,NO,,TCGA-BR-A4J2-D49241,CB3C98C3-DA33-46D7-B123-084170F6FC77,,,,,NA,51,125,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,27,9,2013,TCGA-STAD
9001,TCGA-BR-A4J2,NO,,TCGA-BR-A4J2-D49238,EAEBE00E-E594-4195-8B15-1067464DF4D5,,,,,NA,51,125,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,27,9,2013,TCGA-STAD
9004,TCGA-BR-A4J2,NO,,TCGA-BR-A4J2-D49242,7A15B382-6A69-4EDC-8843-BDD9BB1E821A,,,,,NA,51,125,Ancillary,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Complete Response,27,9,2013,TCGA-STAD
9005,TCGA-BR-A4J2,NO,,TCGA-BR-A4J2-D49245,C7E39B7B-030B-4FD1-BC4E-9626D8E57C68,,,,,NA,51,125,Ancillary,Sargramostim,Immunostimulator,Other,NA,,NA,,NO,Complete Response,27,9,2013,TCGA-STAD
9002,TCGA-BR-A4J2,NO,,TCGA-BR-A4J2-D49239,AA7CD2AC-63EB-47E4-8D92-95889DFCDEA1,,,,,NA,51,125,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,27,9,2013,TCGA-STAD
9006,TCGA-BR-A4J8,NO,,TCGA-BR-A4J8-D51399,250C42A3-9507-42DD-B09A-16E3FAAC1A9E,,,,,NA,65,77,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,18,11,2013,TCGA-STAD
9010,TCGA-BR-A4QI,NO,,TCGA-BR-A4QI-D66455,899F037D-B548-4CB9-B8F2-27231B13F601,,,,,NA,383,551,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,15,10,2014,TCGA-STAD
9011,TCGA-BR-A4QI,NO,,TCGA-BR-A4QI-D66456,D5539FD8-CD62-4E80-B376-1B7C3A341BF7,,,,,NA,383,551,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,15,10,2014,TCGA-STAD
9012,TCGA-BR-A4QI,NO,,TCGA-BR-A4QI-D66457,9F1F2449-F67D-48B0-B24E-02408C00666A,,,,,NA,383,551,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,15,10,2014,TCGA-STAD
9017,TCGA-BR-A4QL,NO,,TCGA-BR-A4QL-D51456,771861FC-3CAA-44CA-8B64-CE00FA2F6962,,,,,NA,31,48,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9016,TCGA-BR-A4QL,NO,,TCGA-BR-A4QL-D51455,5B4FE56D-41B5-481E-B382-E7B0D479EC6C,,,,,NA,31,48,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9015,TCGA-BR-A4QL,NO,,TCGA-BR-A4QL-D51454,7C73C91F-0AC8-4C52-AAF5-87165029234B,,,,,NA,59,90,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9013,TCGA-BR-A4QL,NO,,TCGA-BR-A4QL-D51452,C8A99731-355D-40FE-BE66-8A3934502D5D,,,,,NA,59,90,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9014,TCGA-BR-A4QL,NO,,TCGA-BR-A4QL-D51453,DE301F9E-1B4A-4324-BA8A-0ECA616E025D,,,,,NA,59,90,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9020,TCGA-BR-A4QM,NO,,TCGA-BR-A4QM-D51462,A5C5001D-85FE-44E1-A2E9-7411B147D1B5,,,,,NA,42,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9018,TCGA-BR-A4QM,NO,,TCGA-BR-A4QM-D51459,C8119E42-7DA9-4387-9F23-D406593E1B46,,,,,NA,42,106,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
9019,TCGA-BR-A4QM,NO,,TCGA-BR-A4QM-D51461,CF7E4BDE-561E-4C8D-8186-AE4FF8041F5F,,,,,NA,42,106,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,19,11,2013,TCGA-STAD
21,TCGA-BT-A20N,NO,,TCGA-BT-A20N-D44813,E926C775-6E1D-4366-9740-C919D36E9569,NA,,NA,,NA,198,323,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,27,6,2013,TCGA-BLCA
20,TCGA-BT-A20N,NO,,TCGA-BT-A20N-D44812,C5775BA6-A233-4EF4-B47C-9C5F34A26DB8,NA,,NA,,NA,198,323,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,27,6,2013,TCGA-BLCA
23,TCGA-BT-A20T,NO,,TCGA-BT-A20T-D44884,599CD847-F63B-4AD2-84AC-4699DF3DFF12,NA,,NA,,NA,161,263,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
22,TCGA-BT-A20T,NO,,TCGA-BT-A20T-D44883,EEE09E52-7699-40FF-BC3C-8F4EC8F10A18,NA,,NA,,NA,161,263,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
25,TCGA-BT-A20T,YES,,TCGA-BT-A20T-D44887,52004135-3449-4E37-8287-0752F6BFCD19,NA,,NA,,NA,263,331,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
24,TCGA-BT-A20T,YES,,TCGA-BT-A20T-D44886,5D769B70-A269-485A-9A41-53B85FCE51AA,NA,,NA,,NA,263,331,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
26,TCGA-BT-A20T,NO,,TCGA-BT-A20T-D44888,F569D2B8-AD43-41C9-8529-8435E1DE6319,NA,,NA,,NA,419,419,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
27,TCGA-BT-A2LA,NO,,TCGA-BT-A2LA-D44911,6350D8AB-C844-4B7E-B614-DFD7938FB5BD,NA,,NA,,NA,96,180,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,28,6,2013,TCGA-BLCA
28,TCGA-BT-A2LA,NO,,TCGA-BT-A2LA-D44913,904A4772-EDFC-4C8F-9DF8-14144E3C0AEF,NA,,NA,,NA,96,180,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,28,6,2013,TCGA-BLCA
29,TCGA-BT-A2LD,NO,,TCGA-BT-A2LD-D44921,128128BF-D5E7-48BF-ACDB-05921F2B99F5,NA,,NA,,NA,458,611,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
30,TCGA-BT-A2LD,NO,,TCGA-BT-A2LD-D44922,60CACF08-2DDB-465D-B22A-E4A02C79D163,NA,,NA,,NA,458,611,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,28,6,2013,TCGA-BLCA
34,TCGA-BT-A42B,NO,,TCGA-BT-A42B-D42492,66146DE1-BD24-4411-9D76-F0F510B98EA4,NA,,NA,,NA,121,190,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,22,4,2013,TCGA-BLCA
33,TCGA-BT-A42B,NO,,TCGA-BT-A42B-D42491,ADBAB3EA-7337-4FCC-9C10-E070E6D14AD5,NA,,NA,,NA,121,190,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,22,4,2013,TCGA-BLCA
35,TCGA-BT-A42B,NO,,TCGA-BT-A42B-D42493,4ADB46D8-DD6A-4ADB-B16E-54DCC4EE1E69,NA,,NA,,NA,121,190,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,22,4,2013,TCGA-BLCA
36,TCGA-BT-A42E,NO,,TCGA-BT-A42E-D50187,59D232F6-DB12-4D16-A157-F88EAB0E2A32,NA,,NA,,NA,49,154,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,17,10,2013,TCGA-BLCA
37,TCGA-BT-A42E,NO,,TCGA-BT-A42E-D50188,35D81628-2375-4EC8-A6B1-A1AA79E07684,NA,,NA,,NA,49,154,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,17,10,2013,TCGA-BLCA
4222,TCGA-BW-A5NP,NO,NA,TCGA-BW-A5NP-D42457,164C944A-AF81-454A-BAAE-E3F547B863F9,NA,,NA,,NA,128,289,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,26,3,2014,TCGA-LIHC
38,TCGA-C4-A0EZ,NO,,TCGA-C4-A0EZ-D35652,FA22598C-5DC7-4CC0-B126-B61778FC9C6A,NA,,NA,,NA,123,212,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,5,12,2012,TCGA-BLCA
39,TCGA-C4-A0EZ,NO,,TCGA-C4-A0EZ-D35654,4F972928-7DC0-4105-9EDB-736DE4C98E58,NA,,NA,,NA,123,212,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,5,12,2012,TCGA-BLCA
40,TCGA-C4-A0EZ,NO,,TCGA-C4-A0EZ-D35655,0FD0C954-A1F7-4E90-9E6C-E8BF11419D64,NA,,NA,,NA,243,243,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,5,12,2012,TCGA-BLCA
2735,TCGA-C5-A1BQ,NO,NA,TCGA-C5-A1BQ-D34132,A9F43408-7749-4CDF-9C60-6D3B1C4AE50F,NA,,NA,,NA,11,47,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,7,2012,TCGA-CESC
2738,TCGA-C5-A1M6,NO,NA,TCGA-C5-A1M6-D33209,8437E363-F915-4549-9B5A-B5E612653094,NA,,NA,,NA,341,489,Chemotherapy,Vincristine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-CESC
2740,TCGA-C5-A1M6,NO,NA,TCGA-C5-A1M6-D33211,37FC5233-BCCA-45AA-BCC1-7312562622AC,NA,,NA,,NA,341,489,Hormone Therapy,Hydrocortisone,Corticosteroid,Other,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-CESC
2739,TCGA-C5-A1M6,NO,NA,TCGA-C5-A1M6-D33210,1D46A633-9DAF-4335-BD53-C5D30B1E79B0,NA,,NA,,NA,341,489,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-CESC
2737,TCGA-C5-A1M6,NO,NA,TCGA-C5-A1M6-D33208,C82C2709-144B-4A16-A2AB-5A74C1C6427D,NA,,NA,,NA,341,489,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-CESC
1759,TCGA-C8-A12Z,NO,,TCGA-C8-A12Z-D70813,302C0CC5-6BC8-4CEF-8936-0BE869DB8E4C,,,,,,102,107,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1757,TCGA-C8-A12Z,NO,,TCGA-C8-A12Z-D70811,DC8851E6-AC37-4E31-80EE-4C4CB77EAFE6,,,,,,102,107,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1758,TCGA-C8-A12Z,NO,,TCGA-C8-A12Z-D70812,01F0FCA1-431B-40BF-9290-D82BCD61BA7C,,,,,,102,107,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1762,TCGA-C8-A131,NO,,TCGA-C8-A131-D70830,F291DB2B-45ED-4BD2-98A3-63F012802AC3,,,,,,34,57,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1760,TCGA-C8-A131,NO,,TCGA-C8-A131-D70828,D5B3D28A-4333-4455-9FCB-220B0A14A5FB,,,,,,34,57,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1761,TCGA-C8-A131,NO,,TCGA-C8-A131-D70829,FF1D85A6-7EFA-489D-B455-FF6D8C7D3E33,,,,,,34,57,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1765,TCGA-C8-A134,NO,,TCGA-C8-A134-D70825,BD0FF962-3C67-4CB2-880F-11E2B2F8EF7F,,,,,,38,41,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1763,TCGA-C8-A134,NO,,TCGA-C8-A134-D70823,1808C5EE-0291-4C9E-9F3F-50A3ECD730CE,,,,,,38,41,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1764,TCGA-C8-A134,NO,,TCGA-C8-A134-D70824,3F5F3438-79BA-43E0-B135-7E37333FD8E2,,,,,,38,41,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1768,TCGA-C8-A135,NO,,TCGA-C8-A135-D70820,C5031114-238E-45D7-9918-30514B75F06A,,,,,,40,51,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1766,TCGA-C8-A135,NO,,TCGA-C8-A135-D70818,E75ED433-A561-43B5-B3E0-5F8E12B99B40,,,,,,40,51,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1769,TCGA-C8-A135,NO,,TCGA-C8-A135-D70821,CD8B26E1-2982-4CDF-ACD5-FE6293F7B193,,,,,,40,51,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1767,TCGA-C8-A135,NO,,TCGA-C8-A135-D70819,2930DEE3-D647-42B8-9950-5BB8905B9DA2,,,,,,40,51,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1771,TCGA-C8-A1HM,NO,,TCGA-C8-A1HM-D70808,B2D0CDD7-747C-49EC-B329-F2427BA79DDB,,,,,,26,49,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1772,TCGA-C8-A1HM,NO,,TCGA-C8-A1HM-D70809,F67F216B-625D-4CDE-B551-FEBD1B76FE0F,,,,,,26,49,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1770,TCGA-C8-A1HM,NO,,TCGA-C8-A1HM-D70807,276724DA-C121-44EA-8584-13AB426F8DDD,,,,,,26,49,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1775,TCGA-C8-A1HO,NO,,TCGA-C8-A1HO-D70805,957DBA00-04EE-4C3E-A23E-68E9C478CD59,,,,,,-49,-45,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1773,TCGA-C8-A1HO,NO,,TCGA-C8-A1HO-D70803,3D258720-7215-4352-8F11-753D26984EF0,,,,,,-49,-45,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1774,TCGA-C8-A1HO,NO,,TCGA-C8-A1HO-D70804,25995E3D-C18A-42AE-B575-DF8521244005,,,,,,-49,-45,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1776,TCGA-C8-A26V,NO,,TCGA-C8-A26V-D70800,10D4E1C4-0036-44D9-8206-D14CECDEA307,,,,,,247,613,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1778,TCGA-C8-A26W,NO,,TCGA-C8-A26W-D70798,C80FD468-DF82-483E-8999-EF2110391C96,,,,,,23,193,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1777,TCGA-C8-A26W,NO,,TCGA-C8-A26W-D70797,6FA5FD97-F91B-4EA5-8434-AD7296AE38C1,,,,,,23,193,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1780,TCGA-C8-A26X,NO,,TCGA-C8-A26X-D70794,CFD4307C-F098-4A9C-A34B-E337C15B7BDC,,,,,,200,207,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1779,TCGA-C8-A26X,NO,,TCGA-C8-A26X-D70793,C99DA711-C86E-4BA8-8AD6-9274208C28D7,,,,,,200,207,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1781,TCGA-C8-A26X,NO,,TCGA-C8-A26X-D70795,69033C6A-572E-4B72-BB72-027C7F663381,,,,,,200,207,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1782,TCGA-C8-A26Z,NO,,TCGA-C8-A26Z-D70836,D3391CBA-5CB0-47AE-9813-D21384BF7466,,,,,,11,NA,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,YES,Complete Response,9,3,2015,TCGA-BRCA
1788,TCGA-C8-A27A,NO,,TCGA-C8-A27A-D70789,9E9A47A2-2C29-46A6-8CB5-842A186DA178,,,,,,411,434,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1786,TCGA-C8-A27A,NO,,TCGA-C8-A27A-D70787,839564A6-2E39-4BCE-9DCC-20EF59A3ABBB,,,,,,411,434,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1789,TCGA-C8-A27A,NO,,TCGA-C8-A27A-D70790,C72AD225-877E-4C85-904D-850850DAD36A,,,,,,411,434,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1787,TCGA-C8-A27A,NO,,TCGA-C8-A27A-D70788,1E7B539F-54D5-456B-B74C-EBEB8406CD24,,,,,,411,434,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1791,TCGA-C8-A27B,NO,,TCGA-C8-A27B-D70783,C4415E67-02A8-44F6-A28B-1ADA98E0EFC9,,,,,,62,85,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1790,TCGA-C8-A27B,NO,,TCGA-C8-A27B-D70782,DA6B28FB-BAD1-4A40-9E5F-0B1F39CF0496,,,,,,62,85,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1793,TCGA-C8-A27B,NO,,TCGA-C8-A27B-D70785,18D1F0D1-A458-40F2-B27C-6E5C94FED213,,,,,,62,85,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1792,TCGA-C8-A27B,NO,,TCGA-C8-A27B-D70784,AB7C57F0-657B-482F-BAD3-11C849B1AD7D,,,,,,62,85,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,3,2015,TCGA-BRCA
1794,TCGA-C8-A3M8,NO,,TCGA-C8-A3M8-D70780,1A0AC881-C2A3-4989-8D7D-837481DF0F5B,,,,,,79,NA,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,YES,Complete Response,9,3,2015,TCGA-BRCA
1797,TCGA-C8-A8HP,NO,,TCGA-C8-A8HP-D69613,FDA16E46-3280-4A4A-914B-F4BC3F889323,,,,,,31,224,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,1,2015,TCGA-BRCA
1795,TCGA-C8-A8HP,NO,,TCGA-C8-A8HP-D69611,97270AB3-9E3D-45C5-9D19-C829F713523B,,,,,,31,224,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,15,1,2015,TCGA-BRCA
1796,TCGA-C8-A8HP,NO,,TCGA-C8-A8HP-D69612,E21CE453-A911-46D4-8A86-10840F94F4FB,,,,,,31,224,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,1,2015,TCGA-BRCA
1800,TCGA-C8-A8HR,NO,,TCGA-C8-A8HR-D69799,33674CC5-6A4D-42DB-87A8-270B36FA8974,,,,,,43,237,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,1,2015,TCGA-BRCA
1798,TCGA-C8-A8HR,NO,,TCGA-C8-A8HR-D69797,AAB14121-BF30-4BA7-B0DE-7F26E3723D24,,,,,,43,237,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,20,1,2015,TCGA-BRCA
1799,TCGA-C8-A8HR,NO,,TCGA-C8-A8HR-D69798,F6A77EA7-2ED3-4BFD-AC8F-21E9DE5FA242,,,,,,43,237,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,20,1,2015,TCGA-BRCA
1803,TCGA-C8-A9FZ,NO,,TCGA-C8-A9FZ-D69969,614A0F5A-4696-4BB3-8D04-8673AD02C486,,,,,,29,99,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,1,2015,TCGA-BRCA
1802,TCGA-C8-A9FZ,NO,,TCGA-C8-A9FZ-D69968,F8280902-5A96-471B-9127-AA1A6C7235C8,,,,,,29,99,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,23,1,2015,TCGA-BRCA
1801,TCGA-C8-A9FZ,NO,,TCGA-C8-A9FZ-D69967,5EE9E222-CE90-4A1B-91F3-2A38CF4DC1ED,,,,,,29,99,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,23,1,2015,TCGA-BRCA
3262,TCGA-CA-5254,NO,,TCGA-CA-5254-D70898,6190AB74-8B52-4AE1-AE80-30570CA4BD5A,,,,,,50,204,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3263,TCGA-CA-5254,NO,,TCGA-CA-5254-D70899,B70702AA-8E86-45A0-BF1D-43057580E3D6,,,,,,50,204,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3264,TCGA-CA-5254,NO,,TCGA-CA-5254-D70900,7C8A2022-E668-46AD-A54F-04CFC91BA4D1,,,,,,50,204,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3265,TCGA-CA-5255,NO,,TCGA-CA-5255-D70893,5BCC76C0-2AA1-4924-ABBC-BFEED0763489,,,,,,164,331,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3266,TCGA-CA-5255,NO,,TCGA-CA-5255-D70894,E910330C-3E93-4D6E-9D24-CF762F6FEA96,,,,,,164,331,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3267,TCGA-CA-5255,NO,,TCGA-CA-5255-D70896,F33C7ED2-B534-4BF8-9791-20E4CFC321B2,,,,,,164,331,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3268,TCGA-CA-5256,NO,,TCGA-CA-5256-D70889,528CCCB5-6DF2-456B-BDF6-1CE1FB302BA5,,,,,,20,206,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3269,TCGA-CA-5256,NO,,TCGA-CA-5256-D70890,25467727-76C8-4DBE-BB26-2F51C287E804,,,,,,20,206,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3270,TCGA-CA-5256,NO,,TCGA-CA-5256-D70891,A8E9F2B5-BB30-43C6-81DA-577AEFBC529C,,,,,,20,206,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3271,TCGA-CA-5796,NO,,TCGA-CA-5796-D70884,92A15186-B406-49DF-A981-9E54C965CEB6,,,,,,30,183,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3272,TCGA-CA-5796,NO,,TCGA-CA-5796-D70885,1B08A697-B28B-4C55-A3F5-C60EDC93DF2E,,,,,,30,183,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3273,TCGA-CA-5796,NO,,TCGA-CA-5796-D70887,5D7CAFE8-C18A-445B-9AB4-094EB5D34245,,,,,,30,183,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3274,TCGA-CA-6715,NO,,TCGA-CA-6715-D70876,2A89E239-0062-4F9E-8946-8BD697383709,,,,,,44,227,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3275,TCGA-CA-6715,NO,,TCGA-CA-6715-D70878,A3B59973-3FCE-44E7-99DE-11330368700D,,,,,,44,227,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3276,TCGA-CA-6715,NO,,TCGA-CA-6715-D70879,56419CB6-A31A-4499-A503-8EBEDBCC1950,,,,,,44,227,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3277,TCGA-CA-6716,NO,,TCGA-CA-6716-D70865,5685C16B-388E-4342-84D9-0156CCCC3F43,,,,,,42,226,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3278,TCGA-CA-6716,NO,,TCGA-CA-6716-D70867,5260D8B7-8E40-4BB5-BA69-A1C26F5C97F2,,,,,,42,226,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3279,TCGA-CA-6716,NO,,TCGA-CA-6716-D70869,1824EB06-30F9-4726-A683-F2313A935926,,,,,,42,226,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3280,TCGA-CA-6717,NO,,TCGA-CA-6717-D70860,0CBC9366-A33A-4693-8D94-0F35F6A6D07B,,,,,,128,318,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3281,TCGA-CA-6717,NO,,TCGA-CA-6717-D70861,885F39FF-3425-4DF0-9AA1-21700116EE9A,,,,,,128,318,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
3282,TCGA-CA-6717,NO,,TCGA-CA-6717-D70862,9D0EF700-AC63-4DFE-A616-CF5C42039D73,,,,,,128,318,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,10,3,2015,TCGA-COAD
4223,TCGA-CC-A8HV,NO,NA,TCGA-CC-A8HV-D69786,6872A373-FAF3-48CD-8D7D-A20B18E9A041,NA,,NA,,NA,158,188,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,19,1,2015,TCGA-LIHC
9022,TCGA-CD-5802,NO,,TCGA-CD-5802-D71013,FD070DE3-6A25-4733-BAF5-E0D9DB5874B8,,,,,NA,123,217,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9023,TCGA-CD-5802,NO,,TCGA-CD-5802-D71014,44EE0CF3-EBD9-431B-82A9-D1E0F9C19ED9,,,,,NA,123,217,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9021,TCGA-CD-5802,NO,,TCGA-CD-5802-D71012,8C28E613-9630-474D-8414-CAA50E0F473E,,,,,NA,123,217,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9025,TCGA-CD-5804,NO,,TCGA-CD-5804-D70987,06F96C25-20D4-46F4-B6A3-AAC61462AC31,,,,,NA,0,0,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9026,TCGA-CD-5804,NO,,TCGA-CD-5804-D70988,E0C91FBE-70FD-4AF7-A779-9FEE454E4E69,,,,,NA,0,0,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9024,TCGA-CD-5804,NO,,TCGA-CD-5804-D70986,14CBDF92-8813-4D2B-9CE7-A1EF141AA798,,,,,NA,0,0,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9028,TCGA-CD-8524,NO,,TCGA-CD-8524-D71010,5764278D-F684-4502-873B-CF0C8D57BC2F,,,,,NA,64,168,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,12,3,2015,TCGA-STAD
9029,TCGA-CD-8524,NO,,TCGA-CD-8524-D71011,57ACFF4D-102E-471A-AB34-EB004A213E71,,,,,NA,64,168,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,12,3,2015,TCGA-STAD
9027,TCGA-CD-8524,NO,,TCGA-CD-8524-D71009,0A7EC882-C204-46DA-89E6-EA358F353380,,,,,NA,64,168,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,12,3,2015,TCGA-STAD
9031,TCGA-CD-8525,NO,,TCGA-CD-8525-D71007,CDD0A3A9-C58B-4FDE-BF5E-D50EBADB36AB,,,,,NA,62,157,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9032,TCGA-CD-8525,NO,,TCGA-CD-8525-D71008,7D043D0F-40AA-4288-B5BA-8567F9A04045,,,,,NA,62,157,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9030,TCGA-CD-8525,NO,,TCGA-CD-8525-D71006,E5715F42-8754-439D-9142-074B419DE385,,,,,NA,62,157,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9034,TCGA-CD-8526,NO,,TCGA-CD-8526-D70975,BB040B53-AA70-4E65-9F82-1E8FEB3EC19C,,,,,NA,62,111,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9035,TCGA-CD-8526,NO,,TCGA-CD-8526-D70976,43190BA9-4F9B-4061-ACBB-33C79D30D8DF,,,,,NA,62,111,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9033,TCGA-CD-8526,NO,,TCGA-CD-8526-D70974,E8635ECC-0E31-419C-A35F-159E87193100,,,,,NA,62,111,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9037,TCGA-CD-8527,NO,,TCGA-CD-8527-D70971,021DEDAC-5385-4644-935D-112C0C381E33,,,,,NA,34,60,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,11,3,2015,TCGA-STAD
9038,TCGA-CD-8527,NO,,TCGA-CD-8527-D70972,B1D55FC2-A4E7-4619-BABD-0859F68D7C4D,,,,,NA,34,60,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,11,3,2015,TCGA-STAD
9036,TCGA-CD-8527,NO,,TCGA-CD-8527-D70970,D1EC9F9F-DA05-4C23-9F29-CF23F24E2BA5,,,,,NA,34,60,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,11,3,2015,TCGA-STAD
9041,TCGA-CD-8528,NO,,TCGA-CD-8528-D71005,82FA7470-7B62-4BD9-B780-6E403C8DA7A9,,,,,NA,105,231,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9040,TCGA-CD-8528,NO,,TCGA-CD-8528-D71004,8314ED6C-B20C-46BC-8769-A51E3BF125AA,,,,,NA,105,232,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9039,TCGA-CD-8528,NO,,TCGA-CD-8528-D71003,DE755720-EF36-4B5A-9B82-AD5417F85B40,,,,,NA,105,232,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9043,TCGA-CD-8529,NO,,TCGA-CD-8529-D70967,6FEA86DF-2F54-4214-87B5-744CDB6A0AD5,,,,,NA,50,148,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9044,TCGA-CD-8529,NO,,TCGA-CD-8529-D70968,4A2225B5-1A24-4928-A360-B76086B98ACA,,,,,NA,50,148,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9042,TCGA-CD-8529,NO,,TCGA-CD-8529-D70966,EF88DBFE-A5E1-452A-BB65-E714F54718C2,,,,,NA,50,148,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9046,TCGA-CD-8530,NO,,TCGA-CD-8530-D71001,21AF61CF-F2CF-4457-B8F7-399CAA2FE0E3,,,,,NA,75,176,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9047,TCGA-CD-8530,NO,,TCGA-CD-8530-D71002,54C5A1E1-F645-4E8C-99BA-B27AE6D97178,,,,,NA,75,176,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9045,TCGA-CD-8530,NO,,TCGA-CD-8530-D71000,F8A66EE1-A2A5-452A-BD47-9BB4430A3245,,,,,NA,75,176,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9049,TCGA-CD-8531,NO,,TCGA-CD-8531-D70998,E8A3276E-BA68-4AC1-8667-017C71CEE93B,,,,,NA,106,197,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9050,TCGA-CD-8531,NO,,TCGA-CD-8531-D70999,8A235D07-A810-4162-B7CE-C45E5DC95658,,,,,NA,106,197,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9048,TCGA-CD-8531,NO,,TCGA-CD-8531-D70963,65A270A1-296A-427E-8B4F-73FEA1AAC0E5,,,,,NA,106,197,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,12,3,2015,TCGA-STAD
9051,TCGA-CD-8533,NO,,TCGA-CD-8533-D70959,37E718D6-509F-4D7B-A3F0-306F9FB6E219,,,,,NA,226,245,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,11,3,2015,TCGA-STAD
9053,TCGA-CD-8535,NO,,TCGA-CD-8535-D70955,60BEAD84-ACB8-4886-B19B-A0FFC0C9B55D,,,,,NA,138,234,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9054,TCGA-CD-8535,NO,,TCGA-CD-8535-D70956,6AADB438-9F15-45E6-8B23-AC64BB461799,,,,,NA,138,234,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9052,TCGA-CD-8535,NO,,TCGA-CD-8535-D70954,F575C51D-7059-4E2D-A268-A13EE9363CA6,,,,,NA,138,234,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9056,TCGA-CD-8536,NO,,TCGA-CD-8536-D70951,F22F097F-3618-41DA-BB33-29F23C2EF4C0,,,,,NA,54,135,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9057,TCGA-CD-8536,NO,,TCGA-CD-8536-D70952,C71F7C1C-FEED-41FF-AFEF-E0C54162B7EB,,,,,NA,54,135,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9055,TCGA-CD-8536,NO,,TCGA-CD-8536-D70950,FBAFB7D9-C8E3-4ABD-885D-D41C2667EB4A,,,,,NA,54,135,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,11,3,2015,TCGA-STAD
9059,TCGA-CD-A486,NO,,TCGA-CD-A486-D58109,DC5F1783-D6E6-447E-B491-1A0C0F74A4C3,,,,,NA,37,57,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9060,TCGA-CD-A486,NO,,TCGA-CD-A486-D58110,F5ED343B-469D-40F3-8845-D675CF3F9285,,,,,NA,37,57,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9058,TCGA-CD-A486,NO,,TCGA-CD-A486-D58108,C99A96B7-16A1-4C44-8941-9C047156BC2B,,,,,NA,37,57,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9062,TCGA-CD-A487,NO,,TCGA-CD-A487-D58113,1D0FE4FC-5BBB-4762-B87A-B7E38932F709,,,,,NA,24,284,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9063,TCGA-CD-A487,NO,,TCGA-CD-A487-D58114,D3FC6643-09AE-4E2F-8B86-FDFAB0DC24B6,,,,,NA,24,284,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9061,TCGA-CD-A487,NO,,TCGA-CD-A487-D58112,2FE1DAEC-5BE5-495E-9136-FBBF6746937A,,,,,NA,24,284,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-STAD
9064,TCGA-CD-A48A,NO,,TCGA-CD-A48A-D69717,93546A16-CBD8-4220-9E86-B1D23E230E72,,,,,NA,38,66,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,16,1,2015,TCGA-STAD
9066,TCGA-CD-A4MH,NO,,TCGA-CD-A4MH-D69939,1116B2BF-2E4C-4EA9-8DAE-8C4FA273BC3C,,,,,NA,118,212,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,22,1,2015,TCGA-STAD
9067,TCGA-CD-A4MH,NO,,TCGA-CD-A4MH-D69941,6294FCF2-38E5-488E-A069-DAF2E23E63E8,,,,,NA,118,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,22,1,2015,TCGA-STAD
9065,TCGA-CD-A4MH,NO,,TCGA-CD-A4MH-D69938,F6BB0854-1B4F-4C68-AA1F-0936BB98BEC4,,,,,NA,118,212,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,22,1,2015,TCGA-STAD
9068,TCGA-CD-A4MJ,NO,,TCGA-CD-A4MJ-D69724,90FA6E72-6EFD-4E99-B8BF-E8EBD4B07A3B,,,,,NA,86,186,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,16,1,2015,TCGA-STAD
9069,TCGA-CD-A4MJ,NO,,TCGA-CD-A4MJ-D69727,7AEEAF05-90E0-4978-ABB5-996550C4C75E,,,,,NA,86,186,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,30,1,2015,TCGA-STAD
9070,TCGA-CD-A4MJ,NO,,TCGA-CD-A4MJ-D70218,3D234948-2889-4BC9-A60E-FF7144CA9B31,,,,,NA,86,186,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,30,1,2015,TCGA-STAD
9498,TCGA-CE-A481,NO,NA,TCGA-CE-A481-D58074,B721B5F8-897E-46EB-876B-85F8D30DA6F3,NA,NA,NA,,NA,172,322,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-THCA
9499,TCGA-CE-A482,NO,NA,TCGA-CE-A482-D58076,E07C6C0F-A3E5-42FB-81CD-610694D614E2,NA,NA,NA,,NA,142,294,,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,31,3,2014,TCGA-THCA
41,TCGA-CF-A47S,NO,,TCGA-CF-A47S-D58097,1FD4DDD8-1A40-41E2-8205-C2D3D867EA24,NA,,NA,,NA,109,317,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Complete Response,31,3,2014,TCGA-BLCA
42,TCGA-CF-A47S,NO,,TCGA-CF-A47S-D58099,A24892D9-7521-435D-BD2F-26048C87B600,NA,,NA,,NA,109,324,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,31,3,2014,TCGA-BLCA
43,TCGA-CF-A47T,NO,,TCGA-CF-A47T-D58104,ABE51B78-4B56-45F8-8215-649E93F7FC88,NA,,NA,,NA,127,149,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,31,3,2014,TCGA-BLCA
44,TCGA-CF-A47T,NO,,TCGA-CF-A47T-D58105,9DE2F76A-A905-4792-8303-AB37F3EE90AB,NA,,NA,,NA,127,149,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,31,3,2014,TCGA-BLCA
9071,TCGA-CG-4305,NO,,TCGA-CG-4305-D37560,4FE50F2D-809A-4BCB-B02E-CC5155BDE7E6,,,,,NA,607,669,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,4,12,2012,TCGA-STAD
9072,TCGA-CG-4305,NO,,TCGA-CG-4305-D37561,693829F4-9F41-4BBE-BD11-A194EF952C3F,,,,,NA,607,699,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,4,12,2012,TCGA-STAD
9073,TCGA-CG-4305,NO,,TCGA-CG-4305-D37562,1491B5A4-ABEC-4743-94E5-7C70ADB82202,,,,,NA,607,699,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,4,12,2012,TCGA-STAD
9074,TCGA-CG-4444,NO,,TCGA-CG-4444-D37563,51475E4B-5DD7-44D3-95E4-647A56B55C04,,,,,NA,31,92,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,4,12,2012,TCGA-STAD
9076,TCGA-CG-4460,NO,,TCGA-CG-4460-D37565,F9D9E4EA-31E9-4DF5-A970-1AAC9AEED876,,,,,NA,61,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9075,TCGA-CG-4460,NO,,TCGA-CG-4460-D37564,6216F809-3AD8-418D-847A-D67A7E879C36,,,,,NA,61,153,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9078,TCGA-CG-4460,NO,,TCGA-CG-4460-D37567,CB78CAF9-7D16-458A-BA6B-4C74E7D107FF,,,,,NA,487,608,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9079,TCGA-CG-4460,NO,,TCGA-CG-4460-D37568,A95C258D-1B4A-4C04-81DC-98B72C417655,,,,,NA,487,608,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9077,TCGA-CG-4460,NO,,TCGA-CG-4460-D37566,A007C145-28E1-4292-8581-801186428A69,,,,,NA,487,608,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9086,TCGA-CG-4472,NO,,TCGA-CG-4472-D37575,0D337B25-42A4-4B8A-8C4A-199AF1C63554,,,,,NA,122,273,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Partial Response,4,12,2012,TCGA-STAD
9090,TCGA-CG-4477,NO,,TCGA-CG-4477-D37579,9B02C9BB-92BA-4E72-8B87-C52D3C233812,,,,,NA,426,457,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9091,TCGA-CG-4477,NO,,TCGA-CG-4477-D37580,8F85533D-2939-417D-B5B0-1AB68FA71A11,,,,,NA,426,457,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9093,TCGA-CG-5717,NO,,TCGA-CG-5717-D37582,83198ACC-3ABA-46A0-BD76-E83B633E034B,,,,,NA,151,212,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9092,TCGA-CG-5717,NO,,TCGA-CG-5717-D37581,E8A29207-AB7D-40CD-888D-29BBAA62AE93,,,,,NA,151,212,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9094,TCGA-CG-5717,NO,,TCGA-CG-5717-D37583,ECAD283C-296E-408E-B401-1B06C531253A,,,,,NA,151,212,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9095,TCGA-CG-5724,NO,,TCGA-CG-5724-D37584,ADDADFDC-26FB-43B1-AAA7-D38323D40063,,,,,NA,153,305,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9099,TCGA-CG-5725,NO,,TCGA-CG-5725-D37588,A7A83AA9-3E61-4233-ACE2-366DAA7ED6F7,,,,,NA,334,334,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9097,TCGA-CG-5725,NO,,TCGA-CG-5725-D37586,3FF1A034-1B02-4F39-828B-CA8D8CCF045D,,,,,NA,NA,NA,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9096,TCGA-CG-5725,NO,,TCGA-CG-5725-D37585,C75FFCB1-97DF-4D25-9129-5739E83D3172,,,,,NA,NA,NA,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9100,TCGA-CG-5725,NO,,TCGA-CG-5725-D37589,9E38E9CB-FA44-4B04-835D-829AC5CB50B4,,,,,NA,NA,NA,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9098,TCGA-CG-5725,NO,,TCGA-CG-5725-D37587,F88EE3CF-8DE0-4FF5-B03D-FF90EFFA1FE1,,,,,NA,NA,NA,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9101,TCGA-CG-5732,NO,,TCGA-CG-5732-D37590,609D8C85-26DE-432C-9FE0-E18EAA150E2A,,,,,NA,366,427,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,NA,,NO,Complete Response,4,12,2012,TCGA-STAD
9104,TCGA-CG-5732,NO,,TCGA-CG-5732-D37593,83DEEF80-C1C0-4AFF-B8E8-F37541ADE93A,,,,,NA,1949,2070,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9102,TCGA-CG-5732,NO,,TCGA-CG-5732-D37591,D14745F0-59EE-45E0-A1FA-25700BC24934,,,,,NA,1949,2070,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9103,TCGA-CG-5732,NO,,TCGA-CG-5732-D37592,778332E6-A480-4F21-AB69-BB6BDEE373F4,,,,,NA,1949,2070,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
9105,TCGA-CG-5732,NO,,TCGA-CG-5732-D37594,1387F8E8-9C86-49C8-A102-24354B63F116,,,,,NA,2070,2070,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,4,12,2012,TCGA-STAD
8031,TCGA-CH-5741,NO,NA,TCGA-CH-5741-D37729,614689F1-AD81-4EDE-A7ED-BEC1E836A7DC,NA,NA,NA,,NA,61,334,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,6,12,2012,TCGA-PRAD
8305,TCGA-CI-6620,NO,NA,TCGA-CI-6620-D69558,ED3B3488-DA97-4D97-A0A2-C1E0F5900F16,,,,,NA,39,160,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,1,2015,TCGA-READ
8304,TCGA-CI-6620,NO,NA,TCGA-CI-6620-D69557,9B427929-3285-4A24-8FDD-0ADFCB371A7B,,,,,NA,39,160,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,13,1,2015,TCGA-READ
8303,TCGA-CI-6620,NO,NA,TCGA-CI-6620-D69556,1F45E610-2ED5-4BF2-9A0B-213C8802E4ED,,,,,NA,39,160,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Clinical Progressive Disease,13,1,2015,TCGA-READ
3287,TCGA-CK-4950,NO,,TCGA-CK-4950-D72393,1AC65ADB-8FFA-41F4-B7F5-36245EE1E553,,,,,,49,237,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,9,6,2015,TCGA-COAD
3289,TCGA-CK-4950,NO,,TCGA-CK-4950-D72395,41B9C695-3F5C-4EC0-B94D-60E1AE573021,,,,,,49,237,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,9,6,2015,TCGA-COAD
3288,TCGA-CK-4950,NO,,TCGA-CK-4950-D72394,A516255A-FACF-432D-BCC2-21F20A2A4338,,,,,,49,237,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,9,6,2015,TCGA-COAD
3300,TCGA-CM-4748,NO,,TCGA-CM-4748-D33829,6589D529-DF32-4845-817C-4B19554CF287,,,,,,153,214,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Stable Disease,19,7,2012,TCGA-COAD
3302,TCGA-CM-4748,NO,,TCGA-CM-4748-D33832,711D3DA5-341B-4192-9BEE-893C7345A568,,,,,,304,335,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Stable Disease,19,7,2012,TCGA-COAD
3301,TCGA-CM-4748,NO,,TCGA-CM-4748-D33830,276FBB94-B1E7-4154-961B-0B78CE2BCFBE,,,,,,276,365,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Stable Disease,19,7,2012,TCGA-COAD
3303,TCGA-CM-4748,NO,,TCGA-CM-4748-D33833,575D70B6-ED2E-42D8-8622-7DE4314F43B0,,,,,,396,518,Chemotherapy,Floxuridine,Antimetabolite,Antimetabolite,NA,,,,NO,Stable Disease,19,7,2012,TCGA-COAD
3304,TCGA-CM-4748,NO,,TCGA-CM-4748-D33835,76DE2CCB-26BA-4C2B-AD02-F3CEE6D3643A,,,,,,396,518,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Stable Disease,19,7,2012,TCGA-COAD
3668,TCGA-CN-4731,NO,NA,TCGA-CN-4731-D36092,CC4F8925-0183-4D8D-A86A-EE7453FD1848,NA,,NA,,NA,827,869,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,18,10,2012,TCGA-HNSC
3669,TCGA-CN-4731,YES,NA,TCGA-CN-4731-D36094,8F881032-DBC0-4BC4-8C23-E3BA38095655,NA,,NA,,NA,937,958,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,18,10,2012,TCGA-HNSC
3679,TCGA-CN-4741,NO,NA,TCGA-CN-4741-D69608,95F7AC03-5CD2-42ED-917F-6FFFD246600F,NA,,NA,,NA,1771,1778,Immunotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,15,1,2015,TCGA-HNSC
3705,TCGA-CN-6989,NO,NA,TCGA-CN-6989-D69735,7BCBBA95-799A-442F-BFFA-CD83EEE406DF,NA,,NA,,NA,791,855,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,16,1,2015,TCGA-HNSC
3706,TCGA-CN-6989,NO,NA,TCGA-CN-6989-D69737,79273609-8760-4E9F-9DA7-9B24C8E37E3C,NA,,NA,,NA,889,917,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,16,1,2015,TCGA-HNSC
3709,TCGA-CN-6996,YES,NA,TCGA-CN-6996-D33162,0BE502FB-1A48-4A91-B05E-929D2A583681,NA,,NA,,NA,378,378,Targeted Molecular therapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-HNSC
3714,TCGA-CN-6998,NO,NA,TCGA-CN-6998-D33173,4B4A9843-9FB8-48D0-BE16-CD314DE5D251,NA,,NA,,NA,64,131,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,22,6,2012,TCGA-HNSC
3715,TCGA-CN-A498,NO,NA,TCGA-CN-A498-D37342,8B958690-5FC9-4AFE-9ECE-9F05B8741A8C,NA,,NA,,NA,59,101,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,12,2012,TCGA-HNSC
3716,TCGA-CN-A498,NO,NA,TCGA-CN-A498-D61912,79F7F568-96AC-4286-BCC9-CE5ECB8708D7,NA,,NA,,NA,480,487,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-HNSC
3717,TCGA-CN-A498,NO,NA,TCGA-CN-A498-D61915,D130A939-969A-487E-8B57-7CF8BCE46175,NA,,NA,,NA,674,723,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-HNSC
3718,TCGA-CN-A498,NO,NA,TCGA-CN-A498-D61916,60A67D06-0F31-41C7-A60E-3D2B35313513,NA,,NA,,NA,744,751,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-HNSC
3719,TCGA-CN-A498,NO,NA,TCGA-CN-A498-D61917,C5E1363B-CDBF-4358-B624-9AD128BCE5E3,NA,,NA,,NA,744,751,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-HNSC
3720,TCGA-CN-A49A,NO,NA,TCGA-CN-A49A-D37354,C4008AB6-6D23-45C5-983B-3FEC893E9710,NA,,NA,,NA,76,126,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,12,2012,TCGA-HNSC
3721,TCGA-CN-A49C,NO,NA,TCGA-CN-A49C-D37365,A2AD03BA-6A36-4964-A14E-6D6A3739CE96,NA,,NA,,NA,26,78,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,3,12,2012,TCGA-HNSC
3722,TCGA-CN-A63T,NO,NA,TCGA-CN-A63T-D44206,5D84D47F-741E-44AF-928F-BD8F153359E1,NA,,NA,,NA,64,64,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,6,2013,TCGA-HNSC
3725,TCGA-CN-A63W,YES,NA,TCGA-CN-A63W-D44214,EB206B69-FC69-41FF-9047-C3C45209F28D,NA,,NA,,NA,69,138,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,6,2013,TCGA-HNSC
3724,TCGA-CN-A63W,YES,NA,TCGA-CN-A63W-D44213,57F1F312-FBF1-4BEF-AEE0-FE5862A7388B,NA,,NA,,NA,69,138,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,6,2013,TCGA-HNSC
3723,TCGA-CN-A63W,YES,NA,TCGA-CN-A63W-D44212,62901677-998E-4F33-A650-916BE200F0C7,NA,,NA,,NA,69,138,Chemotherapy,Panitumumab,HER1 inhibitor,Other,,,,,NO,Complete Response,17,6,2013,TCGA-HNSC
3726,TCGA-CN-A641,NO,NA,TCGA-CN-A641-D44226,FF077EB0-9EF5-4000-8170-C36DBCE43733,NA,,NA,,NA,187,239,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,6,2013,TCGA-HNSC
3727,TCGA-CN-A6UY,NO,NA,TCGA-CN-A6UY-D52026,BB2A54D2-09B6-4368-9778-D94FE222F2D2,NA,,NA,,NA,59,106,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,11,2013,TCGA-HNSC
3728,TCGA-CN-A6V1,YES,NA,TCGA-CN-A6V1-D52253,DDE9CCD8-1220-4675-8DBF-3FE6208E46D4,NA,,NA,,NA,13,34,Immunotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,2,12,2013,TCGA-HNSC
3729,TCGA-CN-A6V3,NO,NA,TCGA-CN-A6V3-D52271,19331F82-7748-4F8C-B0A3-9324E970BD23,NA,,NA,,NA,130,151,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,12,2013,TCGA-HNSC
3730,TCGA-CN-A6V6,NO,NA,TCGA-CN-A6V6-D52321,1001ED02-4CE0-4DE5-AF67-E3029ACB9F10,NA,,NA,,NA,74,116,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,12,2013,TCGA-HNSC
3731,TCGA-CN-A6V7,NO,NA,TCGA-CN-A6V7-D52379,F812718C-07AE-4CDB-A5EF-25A900F6F65C,NA,,NA,,NA,83,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,12,2013,TCGA-HNSC
3738,TCGA-CQ-A4CH,NO,NA,TCGA-CQ-A4CH-D39504,BFA3063F-BAC1-47D7-B5B8-D95B3CB44D14,NA,,NA,,NA,120,148,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,24,1,2013,TCGA-HNSC
3744,TCGA-CR-5247,NO,NA,TCGA-CR-5247-D31389,a26d314a-0f30-4458-81fa-dd201670068c,NA,,NA,,NA,19,80,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3743,TCGA-CR-5247,NO,NA,TCGA-CR-5247-D31388,7d7f6836-eb8b-4b3f-99e3-8eeff2599064,NA,,NA,,NA,19,80,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3748,TCGA-CR-5248,NO,NA,TCGA-CR-5248-D31397,be081099-79de-443b-a363-e03eb1e82c60,NA,,NA,,NA,137,179,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3747,TCGA-CR-5248,NO,NA,TCGA-CR-5248-D31396,932949ae-1676-4692-bbae-c76a444b0da4,NA,,NA,,NA,137,179,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3751,TCGA-CR-5248,YES,NA,TCGA-CR-5248-D31400,5D20FE8A-0C34-41A9-B117-2CEA2634C63D,NA,,NA,,NA,1124,1152,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,2,5,2012,TCGA-HNSC
3749,TCGA-CR-5248,YES,NA,TCGA-CR-5248-D31398,6cbfc16d-513d-46ca-8d1a-503c1f252f03,NA,,NA,,NA,1124,1152,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,2,5,2012,TCGA-HNSC
3750,TCGA-CR-5248,YES,NA,TCGA-CR-5248-D31399,8D2D6687-BCF0-4537-B77D-8D5910C34325,NA,,NA,,NA,1124,1152,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,2,5,2012,TCGA-HNSC
3796,TCGA-CR-6491,NO,NA,TCGA-CR-6491-D48386,6F1DECF0-9FA8-4FB1-B012-34FE166CDE44,NA,,NA,,NA,191,201,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3797,TCGA-CR-6491,NO,NA,TCGA-CR-6491-D48387,DEDA62B1-19CC-4414-A551-BB26684707C1,NA,,NA,,NA,191,201,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3799,TCGA-CR-6493,NO,NA,TCGA-CR-6493-D48391,3CD427A7-86D8-4899-8A89-F9A1AFCE4570,NA,,NA,,NA,100,150,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3798,TCGA-CR-6493,NO,NA,TCGA-CR-6493-D48390,45240C23-AFA5-410C-BF86-CD9AE5E75F21,NA,,NA,,NA,100,150,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3808,TCGA-CR-7383,NO,NA,TCGA-CR-7383-D31296,c94ca080-9be6-4783-93e7-5136c884689a,NA,,NA,,NA,462,483,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,30,4,2012,TCGA-HNSC
3807,TCGA-CR-7383,NO,NA,TCGA-CR-7383-D31295,5a5fcf41-1159-447b-ab81-b1c907ecdbee,NA,,NA,,NA,462,483,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,30,4,2012,TCGA-HNSC
3818,TCGA-CR-7389,NO,NA,TCGA-CR-7389-D31445,dee165a1-2b0b-45ed-aab8-7f023c2ef8dd,NA,,NA,,NA,31,73,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3817,TCGA-CR-7389,NO,NA,TCGA-CR-7389-D31444,b376a0f8-a455-4d12-af7d-366f26231773,NA,,NA,,NA,31,73,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,2,5,2012,TCGA-HNSC
3819,TCGA-CR-7393,NO,NA,TCGA-CR-7393-D48405,E92A0F79-D2AE-45A5-8F93-D2FC5E135AD9,NA,,NA,,NA,-303,105,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3820,TCGA-CR-7393,NO,NA,TCGA-CR-7393-D48406,1FEEC2B3-39D9-4D4A-9F17-0D1C3711ADEC,NA,,NA,,NA,63,105,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3822,TCGA-CR-7397,NO,NA,TCGA-CR-7397-D48415,01E6303C-30A7-4178-A9AA-E2505DC4B8C3,NA,,NA,,NA,63,99,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3821,TCGA-CR-7397,NO,NA,TCGA-CR-7397-D48414,5952F59E-E18F-4652-8F1C-60058DEEA28A,NA,,NA,,NA,63,99,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,9,2013,TCGA-HNSC
3828,TCGA-CR-7404,NO,NA,TCGA-CR-7404-D31329,6ae2d638-977f-4268-bcaf-f28c42e032ed,NA,,NA,,NA,85,135,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,4,2012,TCGA-HNSC
3827,TCGA-CR-7404,NO,NA,TCGA-CR-7404-D31328,81337c17-1592-4632-bf4c-c4025217872a,NA,,NA,,NA,85,135,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,30,4,2012,TCGA-HNSC
3829,TCGA-CR-7404,NO,NA,TCGA-CR-7404-D31330,6db87718-9327-44a3-92f3-0fe89b16b4bb,NA,,NA,,NA,298,354,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Partial Response,30,4,2012,TCGA-HNSC
3832,TCGA-CR-7404,NO,NA,TCGA-CR-7404-D31333,ff9ed268-d746-4ee3-a453-67521f65380a,NA,,NA,,NA,606,634,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,30,4,2012,TCGA-HNSC
46,TCGA-CU-A3YL,NO,,TCGA-CU-A3YL-D35301,9EE4E1B8-45DB-43B7-BE7B-42EE9CF40FD7,NA,,NA,,NA,155,224,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,24,9,2012,TCGA-BLCA
45,TCGA-CU-A3YL,NO,,TCGA-CU-A3YL-D35300,1A2FAC2C-0FAC-4B89-B634-1FC9392C9FFF,NA,,NA,,NA,155,224,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,24,9,2012,TCGA-BLCA
9917,TCGA-D1-A3DA,NO,NA,TCGA-D1-A3DA-D41462,1135FE1C-5304-452B-A439-4E4735D58A88,NA,,,,NA,50,197,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,5,2015,TCGA-UCEC
9918,TCGA-D1-A3DA,NO,NA,TCGA-D1-A3DA-D41466,A049BBCE-FA19-4CD6-B42C-6E49CDA1792C,NA,,,,NA,56,197,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,5,2015,TCGA-UCEC
9919,TCGA-D1-A3JQ,NO,NA,TCGA-D1-A3JQ-D41511,CD25CB70-0A77-4D34-BA51-EDAC23F112FA,NA,,,,NA,67,173,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2014,TCGA-UCEC
9920,TCGA-D1-A3JQ,NO,NA,TCGA-D1-A3JQ-D41514,22AB22A1-0398-439A-ACAA-367AE01F9672,NA,,,,NA,67,173,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,21,10,2014,TCGA-UCEC
9921,TCGA-D1-A3JQ,NO,NA,TCGA-D1-A3JQ-D41414,25EAB43E-3F2B-4849-84A0-C1EBB97A7104,NA,,,,NA,68,174,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,21,10,2014,TCGA-UCEC
8598,TCGA-D3-A1Q1,YES,,TCGA-D3-A1Q1-D32608,A837F724-5440-4324-A350-41DB9FB876E7,NA,NA,NA,,NA,247,341,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,2,10,2012,TCGA-SKCM
8601,TCGA-D3-A1Q3,NO,,TCGA-D3-A1Q3-D38975,762FC34B-A295-4E09-97E7-2C3D3B8C26BC,NA,NA,NA,,NA,362,362,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,1,2013,TCGA-SKCM
8603,TCGA-D3-A1Q9,YES,,TCGA-D3-A1Q9-D35421,15D5B49C-2D37-4943-B44E-90D166DFE2EF,NA,NA,NA,,NA,356,504,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,10,10,2012,TCGA-SKCM
8611,TCGA-D3-A2JP,NO,,TCGA-D3-A2JP-D34981,160686B9-7309-471D-BFA8-ADB8AC5C7D42,NA,NA,NA,,NA,73,193,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Partial Response,10,10,2012,TCGA-SKCM
8617,TCGA-D3-A51E,NO,,TCGA-D3-A51E-D40981,EB610C14-F778-4869-B67A-BE410FA64332,NA,NA,NA,,NA,2506,2506,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8616,TCGA-D3-A51E,NO,,TCGA-D3-A51E-D40982,271D7904-A8BC-48CA-B8D4-A58916360347,NA,NA,NA,,NA,2506,2506,Chemotherapy,Dactinomycin,RNA synthesis inhibitor,Other,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8618,TCGA-D3-A51G,NO,,TCGA-D3-A51G-D40989,79A61C3E-FC51-4563-99E0-B60316D6187E,NA,NA,NA,,NA,NA,NA,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8619,TCGA-D3-A51G,NO,,TCGA-D3-A51G-D40990,A451E42C-4793-4296-9DBB-558D3767FD7D,NA,NA,NA,,NA,NA,NA,Chemotherapy,Dactinomycin,RNA synthesis inhibitor,Other,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8622,TCGA-D3-A51H,NO,,TCGA-D3-A51H-D41005,B1A2E0A8-B6F8-4258-B9FA-CED9C63A87E9,NA,NA,NA,,NA,894,1045,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8624,TCGA-D3-A51H,NO,,TCGA-D3-A51H-D41007,1827B56F-5FFA-4EAF-8725-9F8BC9567EDD,NA,NA,NA,,NA,894,1045,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8623,TCGA-D3-A51H,NO,,TCGA-D3-A51H-D41006,5E6840F1-6465-468C-AB36-3E4B1DFB33EB,NA,NA,NA,,NA,894,1045,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Complete Response,11,3,2013,TCGA-SKCM
8626,TCGA-D3-A8GB,NO,,TCGA-D3-A8GB-D53565,EFF7B87B-EAE2-4A32-90DD-C9DBD89C9B40,NA,NA,NA,,NA,74,318,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,12,12,2013,TCGA-SKCM
3369,TCGA-D5-6533,NO,,TCGA-D5-6533-D34457,752BD87B-FBD0-4A45-AA82-C60FF3B4B3F3,,,,,,67,195,Chemotherapy,Oxaliplatin|5-Fluorouraci|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,,,,NO,Complete Response,15,8,2012,TCGA-COAD
3850,TCGA-D6-A6EK,NO,NA,TCGA-D6-A6EK-D58032,485A12A9-3B31-4D9C-8578-94E44D9B3427,NA,,NA,,NA,39,105,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,31,3,2014,TCGA-HNSC
9116,TCGA-D7-6520,NO,,TCGA-D7-6520-D34561,9AE50E97-7268-45C0-8619-DA5B94299BCC,,,,,NA,249,321,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,23,8,2012,TCGA-STAD
9121,TCGA-D7-6520,NO,,TCGA-D7-6520-D64898,AB5C6559-7F18-4F29-BBBB-3E8E18B8562A,,,,,NA,249,321,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,15,9,2014,TCGA-STAD
9120,TCGA-D7-6520,NO,,TCGA-D7-6520-D64897,2A244617-5F9F-456C-9358-C96486AA3678,,,,,NA,249,321,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,15,9,2014,TCGA-STAD
9119,TCGA-D7-6520,NO,,TCGA-D7-6520-D64896,BB3A3B0B-8AE9-49DE-8C28-791F348F2375,,,,,NA,249,321,Chemotherapy,Dexamethasone,Corticosteroid,Other,NA,,NA,,NO,Clinical Progressive Disease,15,9,2014,TCGA-STAD
9134,TCGA-D7-8579,NO,,TCGA-D7-8579-D52679,F6774DC9-E844-4EF4-BD30-965D1E0FDEB6,,,,,NA,97,213,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,5,12,2013,TCGA-STAD
9140,TCGA-D7-A747,NO,,TCGA-D7-A747-D61636,4A0774C6-70B3-4A03-8DE5-46E3F0FEC975,,,,,NA,85,208,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,2,7,2014,TCGA-STAD
9141,TCGA-D7-A747,NO,,TCGA-D7-A747-D61639,19AF3680-BE81-43D4-9667-36FA05D0F8AB,,,,,NA,85,208,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,2,7,2014,TCGA-STAD
9139,TCGA-D7-A747,NO,,TCGA-D7-A747-D58326,329B574E-FD62-402C-BAB1-1B86157ABB42,,,,,NA,85,208,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,7,4,2014,TCGA-STAD
9143,TCGA-D7-A748,NO,,TCGA-D7-A748-D58330,11C1813D-4CA0-4DC8-A02D-BDAE40E1420D,,,,,NA,40,72,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,7,4,2014,TCGA-STAD
9144,TCGA-D7-A748,NO,,TCGA-D7-A748-D61641,4EF5718C-A697-461C-9D3C-1B49F9F263EA,,,,,NA,104,104,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,2,7,2014,TCGA-STAD
9145,TCGA-D7-A748,NO,,TCGA-D7-A748-D61642,9A645470-B657-41A6-8022-AFD121297378,,,,,NA,104,104,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,2,7,2014,TCGA-STAD
9142,TCGA-D7-A748,NO,,TCGA-D7-A748-D58331,D328BEA0-529E-4E17-B022-5A1C459086C9,,,,,NA,104,104,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,7,4,2014,TCGA-STAD
1889,TCGA-D8-A3Z6,NO,,TCGA-D8-A3Z6-D51368,FA44D3C7-5509-4E8A-8B5F-C6C804AE85E3,,,,,,22,86,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,18,11,2013,TCGA-BRCA
1892,TCGA-D8-A3Z6,NO,,TCGA-D8-A3Z6-D59241,25ADCD91-C55B-445C-8B2D-4008D97434AE,,,,,,22,86,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,6,5,2014,TCGA-BRCA
1890,TCGA-D8-A3Z6,NO,,TCGA-D8-A3Z6-D51370,FEEC29B8-84BD-4F1D-AF6E-93F1592B2E13,,,,,,108,185,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,18,11,2013,TCGA-BRCA
1895,TCGA-D8-A73W,NO,,TCGA-D8-A73W-D72199,A09294E3-9DBD-4A35-B806-8C3B050532A1,,,,,,-709,-620,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,29,4,2015,TCGA-BRCA
8631,TCGA-DA-A3F2,YES,,TCGA-DA-A3F2-D70095,F9793217-BAC0-429C-AE53-19B1A3061AB7,NA,NA,NA,,NA,475,772,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Partial Response,27,1,2015,TCGA-SKCM
8633,TCGA-DA-A3F5,YES,,TCGA-DA-A3F5-D70099,B57C37D6-D217-41C2-892B-023D2702F4A5,NA,NA,NA,,NA,6660,6814,Immunotherapy,Pembrolizumab,Anti-PD1,Other,,,,,NO,Stable Disease,29,1,2015,TCGA-SKCM
8632,TCGA-DA-A3F5,NO,,TCGA-DA-A3F5-D70098,C93A647C-35B2-46B3-8D21-057387775391,NA,NA,NA,,NA,6830,6869,Targeted Molecular therapy,Vemurafenib,Proapoptotic,Other,,,,,NO,Clinical Progressive Disease,27,1,2015,TCGA-SKCM
8336,TCGA-DC-6156,NO,NA,TCGA-DC-6156-D44758,45C103CA-FAFA-4BE8-96BB-786E15D2D8CA,,,,,NA,395,761,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,26,6,2013,TCGA-READ
4225,TCGA-DD-A11D,NO,NA,TCGA-DD-A11D-D43740,2DB8D5F3-1FDA-4725-86C3-2549F8DD8D73,NA,,NA,,NA,586,641,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,2,6,2013,TCGA-LIHC
4226,TCGA-DD-A11D,YES,NA,TCGA-DD-A11D-D43741,4BBDB795-AA63-453D-88B3-677EB922902E,NA,,NA,,NA,709,1105,Chemotherapy,ABT-888|Temozolomide,PARP inhibitor|Alkylating agent,Other,,,,,NO,Partial Response,2,6,2013,TCGA-LIHC
4227,TCGA-DD-A11D,NO,NA,TCGA-DD-A11D-D43742,D511991F-BE5E-4BF0-BD66-6448564DE07C,NA,,NA,,NA,1408,1474,Chemotherapy,Temozolomide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,2,6,2013,TCGA-LIHC
4231,TCGA-DD-A1EH,NO,NA,TCGA-DD-A1EH-D45810,7F848383-13AF-41E4-890D-56CDCC89F3F2,NA,,NA,,NA,553,721,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,22,7,2013,TCGA-LIHC
4230,TCGA-DD-A1EH,NO,NA,TCGA-DD-A1EH-D45786,3A35F09B-03D7-48FA-9823-F28D51834CD4,NA,,NA,,NA,358,863,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Partial Response,22,7,2013,TCGA-LIHC
4232,TCGA-DD-A1EH,YES,NA,TCGA-DD-A1EH-D45811,2F99B152-0487-4404-BD4E-57B8429496BD,NA,,NA,,NA,862,975,Chemotherapy,Cisplatin|Gemcitabine|Everolimus,Alkylating agent|Antimetabolite|MTOR inhibitor,Alkylating agent|Antimetabolite|Other,,,,,NO,Clinical Progressive Disease,22,7,2013,TCGA-LIHC
4233,TCGA-DD-A1EJ,NO,NA,TCGA-DD-A1EJ-D42213,432C8670-CC86-4488-92AC-E4C37DB72327,NA,,NA,,NA,264,887,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-LIHC
4234,TCGA-DD-A1EK,NO,NA,TCGA-DD-A1EK-D42207,91BF0C5B-D368-4354-930D-07933F900F0F,NA,,NA,,NA,188,349,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,15,4,2013,TCGA-LIHC
4235,TCGA-DD-A3A4,NO,NA,TCGA-DD-A3A4-D42698,6A8F862A-4110-49E6-8866-C53975BFECBF,NA,,NA,,NA,459,486,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,27,4,2013,TCGA-LIHC
4237,TCGA-DD-A4ND,NO,NA,TCGA-DD-A4ND-D43026,8E76F1B7-7EFB-4AF9-A238-BF6BDDD6587F,NA,,NA,,NA,20,218,Chemotherapy,Cyclophosphamide|Doxorubicin,Alkylating agent|Topoisomerase inhibitor,Alkylating agent|Topoisomerase inhibitor,,,,,NO,Complete Response,13,5,2013,TCGA-LIHC
4239,TCGA-DD-A4NH,NO,NA,TCGA-DD-A4NH-D43119,46FAF023-C8C4-42D9-9042-5DFA619DA676,NA,,NA,,NA,162,305,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,13,5,2013,TCGA-LIHC
4241,TCGA-DD-A4NS,NO,NA,TCGA-DD-A4NS-D43384,4ECFB11B-261D-4F2A-9E49-090F4C27457C,NA,,NA,,NA,1116,1314,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,20,5,2013,TCGA-LIHC
4244,TCGA-DD-A4NS,YES,NA,TCGA-DD-A4NS-D59877,36919E0E-FE64-42DA-A63C-712E27F3AF55,NA,,NA,,NA,1349,1425,Chemotherapy,Temozolomide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,22,5,2014,TCGA-LIHC
4242,TCGA-DD-A4NS,YES,NA,TCGA-DD-A4NS-D43386,05CF4554-4A7D-44D1-8AC1-B3A150B3961C,NA,,NA,,NA,1349,1425,Chemotherapy,ABT-888,PARP inhibitor,Other,,,,,NO,Clinical Progressive Disease,20,5,2013,TCGA-LIHC
9932,TCGA-DI-A2QY,NO,NA,TCGA-DI-A2QY-D60674,CA7FE5CE-C641-464F-AC82-7C12F0C3D39F,NA,,,,NA,92,239,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,13,6,2014,TCGA-UCEC
48,TCGA-DK-A1A7,NO,,TCGA-DK-A1A7-D72496,CEC69360-02B7-4FDE-9BCB-E92657C2E258,NA,,NA,,NA,133,246,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,8,7,2015,TCGA-BLCA
52,TCGA-DK-A1AC,NO,,TCGA-DK-A1AC-D72501,7F75EDEF-455B-4FBE-A354-E37576C31487,NA,,NA,,NA,178,242,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,8,7,2015,TCGA-BLCA
56,TCGA-DK-A3IQ,NO,,TCGA-DK-A3IQ-D38698,70BA0E25-A08A-4327-B527-C11B8935C88E,NA,,NA,,NA,277,417,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,20,12,2012,TCGA-BLCA
58,TCGA-DK-A3IU,NO,,TCGA-DK-A3IU-D38825,F3DF4793-4AAA-4016-B88B-2797DCD1D9E0,NA,,NA,,NA,521,578,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,27,12,2012,TCGA-BLCA
57,TCGA-DK-A3IU,NO,,TCGA-DK-A3IU-D38824,A2C1A3DA-2C5B-4B1E-BE7A-4FED623CA6EF,NA,,NA,,NA,521,578,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,27,12,2012,TCGA-BLCA
60,TCGA-DK-A3IV,NO,,TCGA-DK-A3IV-D38830,8CEBEFB0-57C2-4AB5-9120-A03E28ECB960,NA,,NA,,NA,17,87,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,27,12,2012,TCGA-BLCA
59,TCGA-DK-A3IV,NO,,TCGA-DK-A3IV-D38827,162913EB-0994-47A2-950C-E51ABFA2A821,NA,,NA,,NA,17,87,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,27,12,2012,TCGA-BLCA
62,TCGA-DK-A3WW,NO,,TCGA-DK-A3WW-D38323,04EE4CC6-7324-447B-97B9-BE0341C3CD10,NA,,NA,,NA,127,177,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,13,12,2012,TCGA-BLCA
61,TCGA-DK-A3WW,NO,,TCGA-DK-A3WW-D34647,17EF6B8E-713B-4960-9A68-37EC4E2F805F,NA,,NA,,NA,127,177,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,31,8,2012,TCGA-BLCA
63,TCGA-DK-A3WW,NO,,TCGA-DK-A3WW-D38324,2BCC635F-253A-462B-BDCA-6F75B56D0570,NA,,NA,,NA,127,177,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,13,12,2012,TCGA-BLCA
65,TCGA-DK-A3WX,NO,,TCGA-DK-A3WX-D38325,9AE90D8B-3ABA-415D-8B04-3BAF436820EC,NA,,NA,,NA,56,105,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,12,2012,TCGA-BLCA
64,TCGA-DK-A3WX,NO,,TCGA-DK-A3WX-D34802,1523238C-7C7D-44D4-951C-3859EA70468B,NA,,NA,,NA,56,105,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,31,8,2012,TCGA-BLCA
67,TCGA-DK-A3WY,YES,,TCGA-DK-A3WY-D38326,45EF4B2A-939C-4B66-8309-CCC91660646F,NA,,NA,,NA,132,235,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,13,12,2012,TCGA-BLCA
66,TCGA-DK-A3WY,YES,,TCGA-DK-A3WY-D34806,4A25FB83-75D4-4072-AC09-BE58DBE9C8B2,NA,,NA,,NA,132,235,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,31,8,2012,TCGA-BLCA
68,TCGA-DK-A6B2,NO,,TCGA-DK-A6B2-D48134,8854B40F-584C-4AF1-8488-7BA61B50B207,NA,,NA,,NA,283,370,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,6,9,2013,TCGA-BLCA
70,TCGA-DK-A6B5,NO,,TCGA-DK-A6B5-D48138,320A8318-5E26-41D8-963A-11D88542F86E,NA,,NA,,NA,248,348,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,6,9,2013,TCGA-BLCA
71,TCGA-DK-A6B5,NO,,TCGA-DK-A6B5-D48139,E15A97F1-68D6-4A22-B69E-50AD72C91B7A,NA,,NA,,NA,248,348,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,6,9,2013,TCGA-BLCA
69,TCGA-DK-A6B5,NO,,TCGA-DK-A6B5-D48137,3FFFF824-C57F-4100-B504-E0672D3D9F66,NA,,NA,,NA,248,348,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,6,9,2013,TCGA-BLCA
73,TCGA-DK-A6B6,NO,,TCGA-DK-A6B6-D48128,E1F69D35-AE98-483D-88E3-1F82EFE74FBE,NA,,NA,,NA,43,113,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,6,9,2013,TCGA-BLCA
72,TCGA-DK-A6B6,NO,,TCGA-DK-A6B6-D48127,2041396B-C7B9-41E9-A0AE-8535D21FC31F,NA,,NA,,NA,43,113,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,6,9,2013,TCGA-BLCA
75,TCGA-DK-AA6M,YES,,TCGA-DK-AA6M-D69747,8A269839-4BD4-49AD-AEAB-2A02D841044E,NA,,NA,,NA,735,820,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,16,1,2015,TCGA-BLCA
74,TCGA-DK-AA6M,YES,,TCGA-DK-AA6M-D69746,C63CB31F-1C6B-4766-B1FE-AF1DDC37383F,NA,,NA,,NA,735,820,,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,16,1,2015,TCGA-BLCA
77,TCGA-DK-AA6P,YES,,TCGA-DK-AA6P-D69749,A2C44B1C-D97E-4BEE-B533-447B609EE994,NA,,NA,,NA,27,99,,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,16,1,2015,TCGA-BLCA
76,TCGA-DK-AA6P,YES,,TCGA-DK-AA6P-D69748,867D9644-9CE9-4F05-BCBE-E98A5C12FF94,NA,,NA,,NA,27,99,,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,16,1,2015,TCGA-BLCA
78,TCGA-DK-AA6R,NO,,TCGA-DK-AA6R-D69751,AF28FF1A-7607-4AB9-9180-D0292F8ED1B4,NA,,NA,,NA,125,204,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,16,1,2015,TCGA-BLCA
81,TCGA-DK-AA6S,NO,,TCGA-DK-AA6S-D65596,4E8F6A0C-588C-4FCA-BA02-BCA414A7E257,NA,,NA,,NA,575,710,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,25,9,2014,TCGA-BLCA
80,TCGA-DK-AA6S,NO,,TCGA-DK-AA6S-D65595,7C12264A-4248-4E62-A2D8-8019A6B747EC,NA,,NA,,NA,575,710,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,25,9,2014,TCGA-BLCA
82,TCGA-DK-AA6S,NO,,TCGA-DK-AA6S-D65597,E8070EE0-F024-4531-984D-F82E332BC4F7,NA,,NA,,NA,575,710,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,25,9,2014,TCGA-BLCA
84,TCGA-DK-AA6T,NO,,TCGA-DK-AA6T-D72251,A8580409-6B13-4526-9A0B-34C7ADACFC66,NA,,NA,,NA,75,110,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,30,4,2015,TCGA-BLCA
83,TCGA-DK-AA6T,NO,,TCGA-DK-AA6T-D72250,E005F128-2354-4914-9820-1D7061766112,NA,,NA,,NA,75,110,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,30,4,2015,TCGA-BLCA
86,TCGA-DK-AA6U,NO,,TCGA-DK-AA6U-D72253,19EFBAA9-333A-453F-A8D4-0CC510265974,NA,,NA,,NA,13,90,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,30,4,2015,TCGA-BLCA
85,TCGA-DK-AA6U,NO,,TCGA-DK-AA6U-D72252,8717DA3C-6BC0-43D9-8B8E-D0A7544AC307,NA,,NA,,NA,13,90,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,30,4,2015,TCGA-BLCA
87,TCGA-DK-AA6W,NO,,TCGA-DK-AA6W-D72254,C345C9A2-9EBB-4498-BB87-A5062A9E9F5C,NA,,NA,,NA,263,328,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,30,4,2015,TCGA-BLCA
88,TCGA-DK-AA76,NO,,TCGA-DK-AA76-D61822,463A618D-7086-4797-BF6E-5AB843256101,NA,,NA,,NA,54,114,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,8,7,2014,TCGA-BLCA
89,TCGA-DK-AA76,NO,,TCGA-DK-AA76-D61823,1773BFBE-9FA4-44A0-AE26-0699056C9968,NA,,NA,,NA,54,114,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,8,7,2014,TCGA-BLCA
3374,TCGA-DM-A0XF,NO,,TCGA-DM-A0XF-D30352,85F76F5C-1C87-421C-AE2C-9346148FFA56,,,,,,45,174,Chemotherapy,5-Fluorouracil|Folinic acid,Antimetabolite|Rescue agent,Antimetabolite|Other,NA,,,,NO,Complete Response,10,4,2012,TCGA-COAD
3861,TCGA-DQ-7589,NO,NA,TCGA-DQ-7589-D33012,a4180d87-8158-4da3-8ee9-c3e8e2e373ef,NA,,NA,,NA,9,34,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,25,7,2012,TCGA-HNSC
3863,TCGA-DQ-7589,NO,NA,TCGA-DQ-7589-D33014,6e256d49-b28d-4a32-9d14-20a9f02755a2,NA,,NA,,NA,9,34,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,25,7,2012,TCGA-HNSC
3862,TCGA-DQ-7589,NO,NA,TCGA-DQ-7589-D33013,0d61b8e3-b176-42f3-b99b-fff69007fd9a,NA,,NA,,NA,9,34,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,25,7,2012,TCGA-HNSC
3864,TCGA-DQ-7589,NO,NA,TCGA-DQ-7589-D33015,35bec474-aed7-466b-a515-ff6126d3c5be,NA,,NA,,NA,119,154,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3865,TCGA-DQ-7589,NO,NA,TCGA-DQ-7589-D33016,3d9261b2-d77c-4e21-9243-13ba42d7747f,NA,,NA,,NA,119,154,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3866,TCGA-DQ-7590,NO,NA,TCGA-DQ-7590-D33020,5acafa10-e370-4aca-8f29-bcfb2eb86e4a,NA,,NA,,NA,45,87,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3867,TCGA-DQ-7590,NO,NA,TCGA-DQ-7590-D33021,c2cd31df-7cdc-4229-b365-dadb03887c0d,NA,,NA,,NA,45,87,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3871,TCGA-DQ-7593,NO,NA,TCGA-DQ-7593-D33035,ba7fced5-d534-490e-8041-ddd95e8df92b,NA,,NA,,NA,25,67,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3872,TCGA-DQ-7593,NO,NA,TCGA-DQ-7593-D33036,15a3c061-b666-4dbf-916a-fcbf82997a5b,NA,,NA,,NA,25,67,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3874,TCGA-DQ-7594,NO,NA,TCGA-DQ-7594-D33042,77f5ce85-f72e-4ba3-9d07-3fc43549d753,NA,,NA,,NA,12,53,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3873,TCGA-DQ-7594,NO,NA,TCGA-DQ-7594-D33041,30e4d1cd-f366-44fc-8a63-d3e0375fa382,NA,,NA,,NA,12,53,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3875,TCGA-DQ-7595,NO,NA,TCGA-DQ-7595-D33046,fca19bda-16e6-464d-892e-478bcd016b6d,NA,,NA,,NA,34,62,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3876,TCGA-DQ-7596,NO,NA,TCGA-DQ-7596-D33026,A2B77C67-79C9-4899-89F0-63316D7139FE,NA,,NA,,NA,13,60,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Partial Response,25,7,2012,TCGA-HNSC
3878,TCGA-DQ-7596,NO,NA,TCGA-DQ-7596-D33029,927CC806-EB90-47AC-A80F-A6631E1FC388,NA,,NA,,NA,203,266,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
3877,TCGA-DQ-7596,NO,NA,TCGA-DQ-7596-D33028,C7272631-BBBE-4109-BBF2-2A1F12F340AD,NA,,NA,,NA,203,266,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,25,7,2012,TCGA-HNSC
2800,TCGA-DS-A5RQ,NO,NA,TCGA-DS-A5RQ-D43181,20A70A61-B65B-4EE9-BA68-1B3738C291A3,NA,,NA,,NA,63,98,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2013,TCGA-CESC
2801,TCGA-DS-A7WF,NO,NA,TCGA-DS-A7WF-D54752,6BBFFE71-CD5D-4340-89B0-709C35F6FA63,NA,,NA,,NA,80,397,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,23,12,2013,TCGA-CESC
2802,TCGA-DS-A7WH,NO,NA,TCGA-DS-A7WH-D54774,77253106-F449-4E19-800E-3EB594A38AD4,NA,,NA,,NA,74,112,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,12,2013,TCGA-CESC
2803,TCGA-DS-A7WI,NO,NA,TCGA-DS-A7WI-D54772,7D8F75F1-23CB-44C0-B948-3494D6D754CE,NA,,NA,,NA,80,108,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,12,2013,TCGA-CESC
4152,TCGA-DV-A4VX,YES,NA,TCGA-DV-A4VX-D39044,7880BC8A-7E1D-42DB-A721-6B336D67A093,,,,,NA,56,482,Targeted Molecular therapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Stable Disease,3,12,2013,TCGA-KIRC
4153,TCGA-DV-A4VX,YES,NA,TCGA-DV-A4VX-D39045,0E637E76-7F7E-442D-B3DE-F1737B52A179,,,,,NA,482,1503,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,3,12,2013,TCGA-KIRC
8431,TCGA-DX-A3LU,NO,NA,TCGA-DX-A3LU-D65076,EBF0585E-7F9B-4A38-81C3-CE360EE3E706,NA,,NA,,NA,451,492,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8432,TCGA-DX-A3LU,NO,NA,TCGA-DX-A3LU-D65077,8E48013C-3685-4DA0-B409-181AAD2E9E94,NA,,NA,,NA,451,492,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8435,TCGA-DX-A3U6,NO,NA,TCGA-DX-A3U6-D65075,189AE7BF-E279-41C5-8F1E-2D9996AEDF8B,NA,,NA,,NA,554,966,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,18,9,2014,TCGA-SARC
8436,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65085,594DDFF8-FF53-49A8-9128-6A36B86F3D05,NA,,NA,,NA,350,549,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,18,9,2014,TCGA-SARC
8437,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65086,F8E35288-0F88-4B05-9AD0-7D3675A89384,NA,,NA,,NA,350,606,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,18,9,2014,TCGA-SARC
8438,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65087,845AB61D-39D8-41B0-9683-6B99A9DA8928,NA,,NA,,NA,741,922,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,18,9,2014,TCGA-SARC
8439,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65088,E91F4B1E-FA07-42EA-AE25-F8CB3540CD14,NA,,NA,,NA,741,922,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8440,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65089,E94F344D-5843-4A36-BE02-2C0F48B1FAB9,NA,,NA,,NA,942,945,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8441,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65090,7D66E221-BFA1-43A3-A68F-93BF12D7D4E9,NA,,NA,,NA,969,1126,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8442,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65092,8708AEE3-C54B-4CF4-B059-2C68BB6DBB32,NA,,NA,,NA,1133,1182,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8443,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65093,B93EA1CC-B0AE-47E1-86B7-C6B65907D6CB,NA,,NA,,NA,1258,1301,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8444,TCGA-DX-A3U7,NO,NA,TCGA-DX-A3U7-D65094,00BC2544-855A-4E58-89E4-F5DC86A187CF,NA,,NA,,NA,1352,1427,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8445,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65139,EEFE83A8-CE01-44A8-BE8B-BB946B538F69,NA,,NA,,NA,629,709,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,18,9,2014,TCGA-SARC
8446,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65141,CEE8BF98-3310-4B1C-A3F8-1DCF61FFEB7F,NA,,NA,,NA,1045,1119,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8447,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65143,D9231AE2-F09C-490A-BF8B-E95910B19D8A,NA,,NA,,NA,1045,1119,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8448,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65144,6E763C09-F1EA-47F1-AC41-C3CCEB635CD5,NA,,NA,,NA,1144,1287,Chemotherapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8449,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65145,23DFB046-1F7A-4A6F-856E-FEE658C59F0E,NA,,NA,,NA,1308,1329,Chemotherapy,Trabectedin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8450,TCGA-DX-A3UC,NO,NA,TCGA-DX-A3UC-D65146,CBFB8972-2494-4A04-843B-27837D311A80,NA,,NA,,NA,1675,1675,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,18,9,2014,TCGA-SARC
8454,TCGA-DX-A6B7,NO,NA,TCGA-DX-A6B7-D45499,9329C693-E4D4-4C52-AE1B-18130585B441,NA,,NA,,NA,65,72,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,16,9,2014,TCGA-SARC
8453,TCGA-DX-A6B7,NO,NA,TCGA-DX-A6B7-D45497,76209A84-5125-4EB7-9FCD-6B759DFB0B07,NA,,NA,,NA,65,86,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,16,9,2014,TCGA-SARC
8455,TCGA-DX-A6B8,NO,NA,TCGA-DX-A6B8-D45502,B58C7E85-E693-47DB-BDA6-54C936C6B22D,NA,,NA,,NA,NA,255,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,16,9,2014,TCGA-SARC
8464,TCGA-DX-A6YX,NO,NA,TCGA-DX-A6YX-D64694,F8BBDC77-3BC9-4EB0-843C-E91E4209B203,NA,,NA,,NA,285,407,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-SARC
8465,TCGA-DX-A6YX,NO,NA,TCGA-DX-A6YX-D64697,BAF5ECD2-3691-45DB-950E-F697DEFA0E0B,NA,,NA,,NA,292,407,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-SARC
8466,TCGA-DX-A6YX,NO,NA,TCGA-DX-A6YX-D64698,395A4BE2-93F9-45A9-841E-6BC6BF7515E7,NA,,NA,,NA,444,484,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-SARC
8469,TCGA-DX-A7EN,NO,NA,TCGA-DX-A7EN-D60720,80C2A2F2-EFDD-4E75-93BA-A245A18DC96D,NA,,NA,,NA,34,216,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,13,6,2014,TCGA-SARC
8470,TCGA-DX-A7EN,NO,NA,TCGA-DX-A7EN-D60721,0BD1DF00-FC15-4194-8214-AC5D214EA20E,NA,,NA,,NA,34,216,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,13,6,2014,TCGA-SARC
8476,TCGA-DX-A7EQ,NO,NA,TCGA-DX-A7EQ-D60701,915DE7E1-221A-4819-B8B2-B86DEC0356FC,NA,,NA,,NA,293,349,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8475,TCGA-DX-A7EQ,NO,NA,TCGA-DX-A7EQ-D60700,1EEFA959-7108-4272-88F7-A8E284234A7D,NA,,NA,,NA,403,424,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8474,TCGA-DX-A7EQ,NO,NA,TCGA-DX-A7EQ-D60699,BCDEC186-03C6-40B6-86B3-72B14D481767,NA,,NA,,NA,451,508,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8472,TCGA-DX-A7EQ,NO,NA,TCGA-DX-A7EQ-D60697,4F185FCC-D9B9-41DC-971D-38A1463EF528,NA,,NA,,NA,559,675,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8473,TCGA-DX-A7EQ,NO,NA,TCGA-DX-A7EQ-D60698,D1842C93-E9EC-4C31-9FF9-4DEF0D902B28,NA,,NA,,NA,559,675,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8478,TCGA-DX-A8BT,NO,NA,TCGA-DX-A8BT-D70335,3A9369AD-BAC5-40FB-A347-516D0D22F29C,NA,,NA,,NA,697,773,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,2,2015,TCGA-SARC
8479,TCGA-DX-A8BT,NO,NA,TCGA-DX-A8BT-D70336,C99620DF-64EF-47AE-9C97-4D5477E2387E,NA,,NA,,NA,697,773,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,5,2,2015,TCGA-SARC
8485,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60707,D9969726-D45C-43B9-8CBD-A01BD43A7474,NA,,NA,,NA,123,228,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8484,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60706,7A9B6B27-AF3F-4EF6-9340-642035408FD4,NA,,NA,,NA,123,228,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8483,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60705,795DFCAD-BA50-4624-AABE-25649A5DA2CD,NA,,NA,,NA,590,647,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8482,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60704,F5154121-D71B-449A-A174-9AD136B351C8,NA,,NA,,NA,678,1035,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8481,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60703,0D8DD5C7-8632-4273-9D7F-6D877CDC6C4C,NA,,NA,,NA,678,1035,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8480,TCGA-DX-A8BU,NO,NA,TCGA-DX-A8BU-D60702,65C5ED45-BA64-48E3-A23E-479F1815C93E,NA,,NA,,NA,1080,1081,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8489,TCGA-DX-A8BV,NO,NA,TCGA-DX-A8BV-D60711,CD219A80-1126-4EB9-965A-23318CDB8DDF,NA,,NA,,NA,415,446,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,13,6,2014,TCGA-SARC
8488,TCGA-DX-A8BV,NO,NA,TCGA-DX-A8BV-D60710,AEF5DDBE-A922-418A-A316-F80A3F1DFF62,NA,,NA,,NA,415,446,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,13,6,2014,TCGA-SARC
8487,TCGA-DX-A8BV,NO,NA,TCGA-DX-A8BV-D60709,EEB9D58C-71C5-4612-B9DD-8B52E06B89D1,NA,,NA,,NA,750,903,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8486,TCGA-DX-A8BV,NO,NA,TCGA-DX-A8BV-D60708,BD318FB3-80E6-4636-BBB6-A162FA5B0E7F,NA,,NA,,NA,750,903,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SARC
8491,TCGA-DX-AB2E,NO,NA,TCGA-DX-AB2E-D68336,75B14BCA-1B14-4F1D-B3C7-1FE089E7130A,NA,,NA,,NA,133,222,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,14,11,2014,TCGA-SARC
8490,TCGA-DX-AB2E,NO,NA,TCGA-DX-AB2E-D68335,A9807230-AA1E-4ABB-95D7-02DB246D4919,NA,,NA,,NA,133,222,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,14,11,2014,TCGA-SARC
8494,TCGA-DX-AB3B,NO,NA,TCGA-DX-AB3B-D64995,21B1FE2A-BDE4-4BDE-94BC-8092D9E422E2,NA,,NA,,NA,158,269,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,17,9,2014,TCGA-SARC
8493,TCGA-DX-AB3B,NO,NA,TCGA-DX-AB3B-D64994,D9361777-D032-42C0-8C40-ADC628EDDF2B,NA,,NA,,NA,158,269,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,17,9,2014,TCGA-SARC
8497,TCGA-DX-AB3C,NO,NA,TCGA-DX-AB3C-D64712,08402FF2-FD58-4EA4-8686-6A93A227C7D4,NA,,NA,,NA,48,89,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,9,9,2014,TCGA-SARC
8495,TCGA-DX-AB3C,NO,NA,TCGA-DX-AB3C-D64710,697FCF21-D87F-4975-AFD9-99FE8CB1E0BD,NA,,NA,,NA,48,181,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,9,9,2014,TCGA-SARC
8496,TCGA-DX-AB3C,NO,NA,TCGA-DX-AB3C-D64711,6709787C-A6E0-43F4-8EA6-9891DB23CC58,NA,,NA,,NA,90,181,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,9,9,2014,TCGA-SARC
8345,TCGA-DY-A0XA,NO,NA,TCGA-DY-A0XA-D30448,3A895248-930E-46DE-99A6-2D6B7732C640,,,,,NA,47,239,Chemotherapy,5-Fluorouracil|Folinic acid,Antimetabolite|Rescue agent,Antimetabolite|Other,,,NA,,NO,Complete Response,10,4,2012,TCGA-READ
8346,TCGA-DY-A1DC,NO,NA,TCGA-DY-A1DC-D30402,1DD51FDD-A9D3-4ECD-B3DF-F74DABB7F28D,,,,,NA,771,828,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,10,4,2012,TCGA-READ
8347,TCGA-DY-A1DE,NO,NA,TCGA-DY-A1DE-D30446,D369621F-ABAD-4DC9-B8ED-BAC84CF0BFB5,,,,,NA,46,78,Chemotherapy,5-Fluorouracil|Folinic acid,Antimetabolite|Rescue agent,Antimetabolite|Other,,,NA,,NO,Complete Response,10,4,2012,TCGA-READ
8348,TCGA-DY-A1DE,NO,NA,TCGA-DY-A1DE-D30447,2B357047-E9A9-473A-9D6C-0DFD7D0DE8C8,,,,,NA,291,379,Chemotherapy,5-Fluorouracil|Folinic acid,Antimetabolite|Rescue agent,Antimetabolite|Other,,,NA,,NO,Complete Response,10,4,2012,TCGA-READ
2078,TCGA-E2-A1IE,NO,,TCGA-E2-A1IE-D70374,FC87038A-95A3-4E05-9442-79BF251AF39F,,,,,,1844,1928,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,16,3,2015,TCGA-BRCA
2079,TCGA-E2-A1IE,NO,,TCGA-E2-A1IE-D70375,6A7EB17B-231B-4C2C-B1B0-8825B0BD71CA,,,,,,1928,2187,Hormone Therapy,Fulvestrant,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,16,3,2015,TCGA-BRCA
2145,TCGA-E2-A3DX,NO,,TCGA-E2-A3DX-D35827,82FCFACE-DFFB-46A2-B4AB-EEB1D20CF49C,,,,,,119,427,Chemotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,9,10,2012,TCGA-BRCA
2150,TCGA-E2-A572,NO,,TCGA-E2-A572-D48250,D7049B0E-CA68-4603-B147-7FE56C43BF18,,,,,,147,200,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,10,9,2013,TCGA-BRCA
2153,TCGA-E2-A573,NO,,TCGA-E2-A573-D44502,3A195E08-569B-4623-BF02-4176DE92D98C,,,,,,104,167,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,6,2013,TCGA-BRCA
2152,TCGA-E2-A573,NO,,TCGA-E2-A573-D44501,3AF01D86-64C7-405F-887D-1A0D27831968,,,,,,104,167,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,20,6,2013,TCGA-BRCA
9503,TCGA-E3-A3DY,NO,NA,TCGA-E3-A3DY-D68585,AA098FB9-34C4-421D-B841-AE2663052533,NA,NA,NA,,NA,267,NA,Hormone Therapy,Synthroid,Hormone,Other,NA,,NA,,YES,Complete Response,1,12,2014,TCGA-THCA
9507,TCGA-E3-A3E0,NO,NA,TCGA-E3-A3E0-D35693,5E5A8C75-424F-4092-994C-D20F40B8D0DD,NA,NA,NA,,NA,182,NA,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,5,10,2012,TCGA-THCA
95,TCGA-E5-A2PC,NO,,TCGA-E5-A2PC-D33525,66F39A5C-1A16-4EA3-B226-E2BFEC047106,NA,,NA,,NA,NA,139,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,5,7,2012,TCGA-BLCA
92,TCGA-E5-A2PC,NO,,TCGA-E5-A2PC-D33522,840DE356-7316-43B4-B965-CB0211FE9A6D,NA,,NA,,NA,NA,139,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,7,2012,TCGA-BLCA
93,TCGA-E5-A2PC,NO,,TCGA-E5-A2PC-D33523,9D582767-B547-411F-9EC9-E5DD43A53072,NA,,NA,,NA,NA,139,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,5,7,2012,TCGA-BLCA
94,TCGA-E5-A2PC,NO,,TCGA-E5-A2PC-D33524,EA31A3BA-4FDF-4FBB-8B12-C9B82B0E0FF1,NA,,NA,,NA,NA,139,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,5,7,2012,TCGA-BLCA
101,TCGA-E5-A4U1,NO,,TCGA-E5-A4U1-D64526,5E9878DB-0C67-4111-A7A8-3D3A8F797097,NA,,NA,,NA,1024,1150,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,4,9,2014,TCGA-BLCA
9938,TCGA-E6-A8L9,NO,NA,TCGA-E6-A8L9-D58266,08FF35F7-8848-4C42-8ADE-A37D56A87028,NA,,,,NA,68,173,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,4,2014,TCGA-UCEC
9937,TCGA-E6-A8L9,NO,NA,TCGA-E6-A8L9-D58267,DCF63FF7-75E5-4FEF-A592-9D9AB93B9049,NA,,,,NA,75,173,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,4,2014,TCGA-UCEC
2163,TCGA-E9-A1N3,NO,,TCGA-E9-A1N3-D39764,B6DFF894-6069-4D41-8556-D15BC03DD3BF,,,,,,15,68,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,2,2013,TCGA-BRCA
2161,TCGA-E9-A1N3,NO,,TCGA-E9-A1N3-D39762,21C8B531-6DB2-4EDA-91D6-9A71B698CFFA,,,,,,15,68,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,1,2,2013,TCGA-BRCA
2162,TCGA-E9-A1N3,NO,,TCGA-E9-A1N3-D39763,896CF3A1-1C37-4ECE-8AAD-2408414FF8D7,,,,,,15,68,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,2,2013,TCGA-BRCA
2175,TCGA-E9-A1N6,NO,,TCGA-E9-A1N6-D63546,5A20287E-F225-416A-9A83-86038A1BE690,,,,,,447,574,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,12,8,2014,TCGA-BRCA
2174,TCGA-E9-A1N6,NO,,TCGA-E9-A1N6-D63545,9C2EBE7E-9BD0-4B27-A254-6B5EF6E962A3,,,,,,447,574,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,12,8,2014,TCGA-BRCA
2176,TCGA-E9-A1N6,NO,,TCGA-E9-A1N6-D63562,E69B2ABD-369B-40EF-BC6B-8FE52DC62E45,,,,,,575,678,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,13,8,2014,TCGA-BRCA
2187,TCGA-E9-A1NC,NO,,TCGA-E9-A1NC-D32908,DDF2090C-2AB2-4A9F-A37C-2D6945B8AA8E,,,,,,10,122,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2186,TCGA-E9-A1NC,NO,,TCGA-E9-A1NC-D32906,86434E5A-26BE-4F46-AF34-769FA7208481,,,,,,10,122,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2185,TCGA-E9-A1NC,NO,,TCGA-E9-A1NC-D32903,E78A504B-9523-4183-AF5D-ACF86478BB82,,,,,,10,122,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2188,TCGA-E9-A1NC,NO,,TCGA-E9-A1NC-D32909,A78DF706-2990-4314-934D-7EFD5C578BD5,,,,,,134,708,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2192,TCGA-E9-A1NE,NO,,TCGA-E9-A1NE-D32915,84F7B524-80E6-4D79-871F-8AD30E6A9987,,,,,,10,121,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2193,TCGA-E9-A1NE,NO,,TCGA-E9-A1NE-D32916,55ECA12D-C3E9-48D5-8BC7-77BC7D789290,,,,,,10,121,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2191,TCGA-E9-A1NE,NO,,TCGA-E9-A1NE-D32914,F4561048-074E-457D-A181-125FDEB51F22,,,,,,10,121,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,15,6,2012,TCGA-BRCA
2202,TCGA-E9-A1NG,NO,,TCGA-E9-A1NG-D39777,8D15500A-996F-42AD-9B5C-4B59FBEB68D6,,,,,,34,786,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,1,2,2013,TCGA-BRCA
2205,TCGA-E9-A1NI,NO,,TCGA-E9-A1NI-D35023,FD81C1FD-32D3-41C2-91E3-B62B8B916AE7,,,,,,0,80,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,9,2012,TCGA-BRCA
2206,TCGA-E9-A1NI,NO,,TCGA-E9-A1NI-D35027,216067BB-58F6-4991-9A18-2FCE36C80910,,,,,,0,80,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,13,9,2012,TCGA-BRCA
2204,TCGA-E9-A1NI,NO,,TCGA-E9-A1NI-D35022,9DFDBBC7-631F-4C94-A923-948195F59A36,,,,,,0,80,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,13,9,2012,TCGA-BRCA
2212,TCGA-E9-A1R2,NO,,TCGA-E9-A1R2-D55474,57A9F155-B541-4EFD-8BFE-CBD7447C24D1,,,,,,36,144,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2210,TCGA-E9-A1R2,NO,,TCGA-E9-A1R2-D55472,659FE77A-7EC8-4976-A86E-8D54BB201D8E,,,,,,36,144,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2211,TCGA-E9-A1R2,NO,,TCGA-E9-A1R2-D55473,102D03D1-BC76-4688-BFA9-5EFD862C35D7,,,,,,36,144,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2264,TCGA-E9-A1RI,NO,,TCGA-E9-A1RI-D46349,6D4635CF-24FA-4141-B052-0F162D685C5A,,,,,,418,425,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,,,NO,Complete Response,6,8,2013,TCGA-BRCA
2270,TCGA-E9-A226,NO,,TCGA-E9-A226-D55887,2C88B47F-36AA-43AF-95BB-33939622235F,,,,,,790,937,Ancillary,Pamidronate,Antiresorptive,Other,,,,,NO,Partial Response,17,1,2014,TCGA-BRCA
2271,TCGA-E9-A227,NO,,TCGA-E9-A227-D55475,3A15749D-3272-4218-A622-DE1C45896D3B,,,,,,92,197,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2299,TCGA-E9-A243,NO,,TCGA-E9-A243-D39523,617EAD96-72A4-41EE-B9EE-608F4B12E6DB,,,,,,305,520,Ancillary,Pamidronate,Antiresorptive,Other,,,,,NO,Stable Disease,24,1,2013,TCGA-BRCA
2313,TCGA-E9-A2JS,NO,,TCGA-E9-A2JS-D34103,786F4DB8-BC47-4FEF-9D2E-624B59F1E9A2,,,,,,17,191,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2315,TCGA-E9-A2JS,NO,,TCGA-E9-A2JS-D34106,8049BD0B-2078-4946-AFA8-BF2EEB3FD34E,,,,,,17,191,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2314,TCGA-E9-A2JS,NO,,TCGA-E9-A2JS-D34104,11E5178D-A5E2-4AC3-BAD0-0664514A1B41,,,,,,17,191,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2317,TCGA-E9-A2JS,NO,,TCGA-E9-A2JS-D55896,43929A44-3CE4-467E-85DC-FCF130402CFB,,,,,,677,713,Hormone Therapy,Goserelin,LHRH agonist,Other,,,,,NO,Clinical Progressive Disease,17,1,2014,TCGA-BRCA
2319,TCGA-E9-A3HO,NO,,TCGA-E9-A3HO-D34120,D0C4B016-5BD8-4E67-A168-03CBC0840AD8,,,,,,26,26,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2320,TCGA-E9-A3HO,NO,,TCGA-E9-A3HO-D34121,E5BBB372-92D7-41A2-8819-BFEBB1F526B3,,,,,,26,26,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2321,TCGA-E9-A3HO,NO,,TCGA-E9-A3HO-D34122,B87D3CDD-0D31-4353-9E68-879DB3A804D4,,,,,,26,26,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,30,7,2012,TCGA-BRCA
2324,TCGA-E9-A3HO,NO,,TCGA-E9-A3HO-D40291,FC15DB60-9371-4C3A-8C2C-34D254C7B264,,,,,,61,64,Hormone Therapy,Goserelin,LHRH agonist,Other,,,,,NO,Complete Response,15,2,2013,TCGA-BRCA
2323,TCGA-E9-A3HO,NO,,TCGA-E9-A3HO-D40290,B80F3DF7-5616-4DEB-B5B1-9AFD2E7A34EA,,,,,,313,337,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,,,NO,Complete Response,15,2,2013,TCGA-BRCA
2325,TCGA-E9-A3Q9,NO,,TCGA-E9-A3Q9-D40591,1D3313F6-A11D-433B-9DE9-C6710E726905,,,,,,28,51,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
2327,TCGA-E9-A3Q9,NO,,TCGA-E9-A3Q9-D40593,E7C7F8BC-C6B2-4F17-9D8B-484C4B903746,,,,,,28,51,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
2326,TCGA-E9-A3Q9,NO,,TCGA-E9-A3Q9-D40592,EE1ADBED-9135-4EE3-84F2-42AB43FA667F,,,,,,28,51,Chemotherapy,Mitoxantrone,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,25,2,2013,TCGA-BRCA
2329,TCGA-E9-A3X8,NO,,TCGA-E9-A3X8-D41706,2813ED05-F03A-4919-B4DE-12415797A897,,,,,,14,160,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,3,2013,TCGA-BRCA
2331,TCGA-E9-A3X8,NO,,TCGA-E9-A3X8-D41709,B42520B3-C869-4100-A31A-852F9255A6A2,,,,,,14,160,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,26,3,2013,TCGA-BRCA
2330,TCGA-E9-A3X8,NO,,TCGA-E9-A3X8-D41708,D74CCEFE-BE26-4C75-A3ED-DE683060F21F,,,,,,14,160,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,26,3,2013,TCGA-BRCA
2333,TCGA-E9-A5FK,NO,,TCGA-E9-A5FK-D56477,310AAC92-87DD-46B7-8666-4F20C9B2A400,,,,,,21,200,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,2,2014,TCGA-BRCA
2335,TCGA-E9-A5FK,NO,,TCGA-E9-A5FK-D56479,255555A4-D618-436B-9BDC-9D9FDC22430D,,,,,,21,200,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,10,2,2014,TCGA-BRCA
2334,TCGA-E9-A5FK,NO,,TCGA-E9-A5FK-D56478,DE81480C-4511-40D7-8778-F558CCA5717A,,,,,,21,200,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,10,2,2014,TCGA-BRCA
2338,TCGA-E9-A6HE,NO,,TCGA-E9-A6HE-D56815,A670D2BD-0DD4-415F-91E3-B74DFC267B86,,,,,,104,174,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,2,2014,TCGA-BRCA
2337,TCGA-E9-A6HE,NO,,TCGA-E9-A6HE-D56814,75161762-89C2-45DD-B3F6-2C5CE67185BB,,,,,,104,174,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,24,2,2014,TCGA-BRCA
2339,TCGA-E9-A6HE,NO,,TCGA-E9-A6HE-D56816,33B0A4BB-DC7E-43C0-86E2-93A6B112CAC5,,,,,,104,307,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,2,2014,TCGA-BRCA
2804,TCGA-EA-A3QD,NO,NA,TCGA-EA-A3QD-D58164,342CF8C0-1020-45FF-9C5C-D96128CB5368,NA,,NA,,NA,75,109,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,4,2014,TCGA-CESC
2805,TCGA-EA-A43B,NO,NA,TCGA-EA-A43B-D58725,43CFF346-D800-4B3C-A1D3-FCF8590970A9,NA,,NA,,NA,70,70,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,4,2014,TCGA-CESC
2806,TCGA-EA-A43B,NO,NA,TCGA-EA-A43B-D58726,BD1405B3-FE04-4F41-8E66-1F933D432F75,NA,,NA,,NA,70,70,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,4,2014,TCGA-CESC
2807,TCGA-EA-A44S,NO,NA,TCGA-EA-A44S-D49901,354F8B4C-1002-4F0A-B507-FAD0C8C1C3A5,NA,,NA,,NA,20,155,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,14,10,2013,TCGA-CESC
2808,TCGA-EA-A44S,NO,NA,TCGA-EA-A44S-D49902,051D1E1E-D001-4288-B8F9-C4119DC36A1A,NA,,NA,,NA,20,155,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,,,,,NO,Stable Disease,14,10,2013,TCGA-CESC
2809,TCGA-EA-A44S,NO,NA,TCGA-EA-A44S-D49903,D4AEB293-B03B-47C2-A043-2EF0415A0447,NA,,NA,,NA,299,369,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,14,10,2013,TCGA-CESC
2811,TCGA-EA-A44S,NO,NA,TCGA-EA-A44S-D49907,C564DE36-51A0-4F7B-AE3D-900803489E96,NA,,NA,,NA,299,369,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,,,,,NO,Stable Disease,14,10,2013,TCGA-CESC
2810,TCGA-EA-A44S,NO,NA,TCGA-EA-A44S-D49905,B4FFE834-F2D2-4DB7-8EF5-4FD29B245D21,NA,,NA,,NA,299,369,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,14,10,2013,TCGA-CESC
2812,TCGA-EA-A4BA,NO,NA,TCGA-EA-A4BA-D49909,18657CF1-F5AA-48A1-BAB8-1B511F341EA4,NA,,NA,,NA,38,134,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,10,2013,TCGA-CESC
2813,TCGA-EA-A4BA,NO,NA,TCGA-EA-A4BA-D49910,1780B434-014B-456D-9F14-298A819FC3EB,NA,,NA,,NA,38,134,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,10,2013,TCGA-CESC
2814,TCGA-EA-A4BA,NO,NA,TCGA-EA-A4BA-D49911,B4F30A70-2AB7-4FA1-888B-AC1E7096ACAC,NA,,NA,,NA,38,134,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,10,2013,TCGA-CESC
8645,TCGA-EB-A3XC,NO,,TCGA-EB-A3XC-D53292,69B2DD42-50A5-46BB-9334-690DCA9981D8,NA,NA,NA,,NA,410,558,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,12,2013,TCGA-SKCM
8646,TCGA-EB-A3Y6,NO,,TCGA-EB-A3Y6-D48718,B6189DEC-7891-431D-8FC1-6C94E38A1C15,NA,NA,NA,,NA,51,126,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,9,2013,TCGA-SKCM
8648,TCGA-EB-A4OY,NO,,TCGA-EB-A4OY-D57679,B4CA0CDA-62F1-4958-9A87-142FBE04AEB8,NA,NA,NA,,NA,52,593,Chemotherapy,Lomustine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,3,2014,TCGA-SKCM
8647,TCGA-EB-A4OY,NO,,TCGA-EB-A4OY-D57678,1D2C877F-129D-4450-BB06-F8083F29D269,NA,NA,NA,,NA,52,593,Hormone Therapy,Toremifen,Antiestrogen,Other,,,,,NO,Complete Response,19,3,2014,TCGA-SKCM
8649,TCGA-EB-A550,NO,,TCGA-EB-A550-D57902,559E24F9-7CBD-4562-BBAA-A9B2BA4713C7,NA,NA,NA,,NA,6,264,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,1,4,2014,TCGA-SKCM
8651,TCGA-EB-A553,NO,,TCGA-EB-A553-D51478,167F27BA-CD19-4162-9631-BB326EA96C32,NA,NA,NA,,NA,51,115,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,11,2013,TCGA-SKCM
8650,TCGA-EB-A553,NO,,TCGA-EB-A553-D51476,03D7B471-967E-4F06-8BBA-736177847908,NA,NA,NA,,NA,51,115,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,11,2013,TCGA-SKCM
8652,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49918,2F5F58F6-2C3E-4CFE-AF76-7A0D3DF97101,NA,NA,NA,,NA,23,157,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8656,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49922,E7FC2055-7F70-431B-91BD-D974459FD778,NA,NA,NA,,NA,23,157,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8654,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49920,EE02D679-0160-4712-BB4A-3F86C546A767,NA,NA,NA,,NA,23,157,Ancillary,Ondasetron,Antiemetic,Other,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8653,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49919,4B936778-B6D3-4CDA-886F-19C0AF67DF4F,NA,NA,NA,,NA,23,157,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8658,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49924,294C8564-DE5C-4FC3-9FEE-EF9988C95177,NA,NA,NA,,NA,23,157,Immunotherapy,Ciclosporin,Calcineurin inhibitor,Other,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8655,TCGA-EB-A57M,NO,,TCGA-EB-A57M-D49921,D298A479-C148-45D3-8839-B34372551942,NA,NA,NA,,NA,23,157,Ancillary,Dexamethasone,Corticosteroid,Other,,,,,NO,Complete Response,14,10,2013,TCGA-SKCM
8661,TCGA-EB-A5FP,NO,,TCGA-EB-A5FP-D56486,375F46B1-DD5B-4A32-A44B-23173C2A5C0C,NA,NA,NA,,NA,24,52,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,2,2014,TCGA-SKCM
8660,TCGA-EB-A5FP,NO,,TCGA-EB-A5FP-D56485,F8885A2A-715B-4A8C-9540-D0F93518A4BD,NA,NA,NA,,NA,24,52,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,2,2014,TCGA-SKCM
8662,TCGA-EB-A5KH,NO,,TCGA-EB-A5KH-D51003,EF692434-8B47-4DE8-B334-EAE51D25D88F,NA,NA,NA,,NA,557,615,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,11,2013,TCGA-SKCM
8664,TCGA-EB-A5KH,NO,,TCGA-EB-A5KH-D51007,E357E722-254F-48E5-AA19-948FEBEEB45A,NA,NA,NA,,NA,557,615,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,11,2013,TCGA-SKCM
8663,TCGA-EB-A5KH,NO,,TCGA-EB-A5KH-D51004,D8333D42-D4F5-42F4-9854-A73C1AF1368B,NA,NA,NA,,NA,557,615,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,11,2013,TCGA-SKCM
8665,TCGA-EB-A5KH,NO,,TCGA-EB-A5KH-D51009,7111438A-B4F8-488D-8C88-C2E3855D37A7,NA,NA,NA,,NA,557,615,Immunotherapy,Sargramostim,Immunostimulator,Other,,,,,NO,Complete Response,5,11,2013,TCGA-SKCM
8667,TCGA-EB-A5SH,NO,,TCGA-EB-A5SH-D63497,6CB72320-3FDF-49E8-8F34-C664D257AC87,NA,NA,NA,,NA,1091,1125,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-SKCM
8666,TCGA-EB-A5SH,NO,,TCGA-EB-A5SH-D63496,E70456D7-5430-4EE5-9851-56DA11371D2F,NA,NA,NA,,NA,1091,1125,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-SKCM
8668,TCGA-EB-A5SH,NO,,TCGA-EB-A5SH-D63499,6D740B57-728E-4088-8903-A7CF2ED3A687,NA,NA,NA,,NA,1154,1217,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,11,8,2014,TCGA-SKCM
8669,TCGA-EB-A5UL,NO,,TCGA-EB-A5UL-D56488,74263AA6-4C3A-4A11-B704-EA3D080C9874,NA,NA,NA,,NA,140,280,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,2,2014,TCGA-SKCM
8670,TCGA-EB-A5UL,NO,,TCGA-EB-A5UL-D56489,97C9D614-1F6D-43A2-A996-4E11AA49F9ED,NA,NA,NA,,NA,140,280,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Complete Response,10,2,2014,TCGA-SKCM
8671,TCGA-EB-A5UL,NO,,TCGA-EB-A5UL-D56490,6479F494-4E76-4E18-859A-6DB0688256FF,NA,NA,NA,,NA,140,280,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,,,,,NO,Complete Response,10,2,2014,TCGA-SKCM
8672,TCGA-EB-A6QY,NO,,TCGA-EB-A6QY-D57710,DF7DB810-BA7C-4477-A02C-30AD8505D5BF,NA,NA,NA,,NA,56,192,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,3,2014,TCGA-SKCM
8673,TCGA-EB-A6QY,NO,,TCGA-EB-A6QY-D57711,BEDB2A67-17E6-4B73-BAB6-8407535AC306,NA,NA,NA,,NA,56,192,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,3,2014,TCGA-SKCM
8674,TCGA-EB-A6QY,NO,,TCGA-EB-A6QY-D57712,54D415E8-AF68-468D-98C2-E615BA28D9CE,NA,NA,NA,,NA,210,218,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,21,3,2014,TCGA-SKCM
8675,TCGA-EB-A6QZ,NO,,TCGA-EB-A6QZ-D58784,DB6755F9-6D31-4854-BFA8-C114DB48FA89,NA,NA,NA,,NA,153,244,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,13,6,2014,TCGA-SKCM
8676,TCGA-EB-A6QZ,NO,,TCGA-EB-A6QZ-D60719,605A2A10-34C1-441D-9204-423B124EADCC,NA,NA,NA,,NA,153,244,Chemotherapy,Vincristine,Antimitotic,Antimitotic,,,,,NO,Partial Response,13,6,2014,TCGA-SKCM
8677,TCGA-EB-A6R0,NO,,TCGA-EB-A6R0-D57914,210DEFBD-E099-4B52-AD8A-64D8CB9DE0D3,NA,NA,NA,,NA,19,321,Chemotherapy,Lomustine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,3,2014,TCGA-SKCM
8678,TCGA-EB-A85J,NO,,TCGA-EB-A85J-D61879,40D2E43A-C9F4-4DF8-9BA2-A3822FF2FD1A,NA,NA,NA,,NA,13,92,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,7,2014,TCGA-SKCM
8679,TCGA-EB-A85J,NO,,TCGA-EB-A85J-D61890,87EFDA20-155F-42FA-9A1C-9FA06BC7B267,NA,NA,NA,,NA,13,92,Chemotherapy,Vincristine,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,7,2014,TCGA-SKCM
8681,TCGA-EE-A185,NO,,TCGA-EE-A185-D49739,108A678F-5BC0-4735-984D-EAC14C7B91B0,NA,NA,NA,,NA,104,126,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,10,2013,TCGA-SKCM
8683,TCGA-EE-A29C,YES,,TCGA-EE-A29C-D59903,F9B42ED5-1FB0-42B7-B5D1-E93E4FC27EE5,NA,NA,NA,,NA,1114,1502,Targeted Molecular therapy,GSK Braf Inhibitor,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,22,5,2014,TCGA-SKCM
8684,TCGA-EE-A29C,NO,,TCGA-EE-A29C-D65639,8CF1E4C0-8CD8-497F-9B12-31549514175F,NA,NA,NA,,NA,1500,1623,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Stable Disease,26,9,2014,TCGA-SKCM
8685,TCGA-EE-A29C,NO,,TCGA-EE-A29C-D65640,71EE9B6E-39C6-49C4-ABDA-742B2372BDB4,NA,NA,NA,,NA,2262,2413,Targeted Molecular therapy,Dabrafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,26,9,2014,TCGA-SKCM
8686,TCGA-EE-A29C,NO,,TCGA-EE-A29C-D68734,ED7938C2-23C8-4CC7-A1EE-0194D139C83C,NA,NA,NA,,NA,2262,2413,Targeted Molecular therapy,Trametinib,MEK inhibitor,Other,,,,,NO,Clinical Progressive Disease,15,12,2014,TCGA-SKCM
8690,TCGA-EE-A29Q,NO,,TCGA-EE-A29Q-D55046,42291B0A-AB03-4AF8-926A-05B66EB1354C,NA,NA,NA,,NA,1837,1858,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,27,12,2013,TCGA-SKCM
8692,TCGA-EE-A29V,NO,,TCGA-EE-A29V-D45165,1A0E97AB-0953-45E7-9511-631C5BF5096E,NA,NA,NA,,NA,715,787,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,7,2013,TCGA-SKCM
8701,TCGA-EE-A2GS,YES,,TCGA-EE-A2GS-D59676,3AB0B595-ABB7-4F0A-8874-65FCA35E36BC,NA,NA,NA,,NA,1596,1978,Targeted Molecular therapy,Dabrafenib,Antiproliferative,Other,BRAF inhibitor,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8702,TCGA-EE-A2GS,NO,,TCGA-EE-A2GS-D59679,E407CD8E-90B5-4F51-A238-896EC472A58C,NA,NA,NA,,NA,1979,2075,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8705,TCGA-EE-A2GS,NO,,TCGA-EE-A2GS-D59683,51B722AA-2F6A-4BC0-8A5A-0764CF606D73,NA,NA,NA,,NA,2372,NA,Targeted Molecular therapy,Vemurafenib,Proapoptotic,Other,,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8707,TCGA-EE-A2M5,YES,,TCGA-EE-A2M5-D46109,B4E58FE1-8315-4F3B-989E-5AE298B9BD10,NA,NA,NA,,NA,559,559,Chemotherapy,PNU-159548,Topoisomerase inhibitor,Topoisomerase inhibitor,chemotherapy,,,,NO,Clinical Progressive Disease,1,8,2013,TCGA-SKCM
8709,TCGA-EE-A2MD,NO,,TCGA-EE-A2MD-D46560,2F37EDE4-3256-43C1-A7CF-48488B0B027B,NA,NA,NA,,NA,1377,1408,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,8,8,2013,TCGA-SKCM
8714,TCGA-EE-A2ML,YES,,TCGA-EE-A2ML-D59747,D59E75DB-7F98-4A9B-911D-2FD63B98F034,NA,NA,NA,,NA,5973,6156,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,chemotherapy,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8715,TCGA-EE-A2ML,NO,,TCGA-EE-A2ML-D59748,FE3FA6A8-83D4-4DBD-9928-5950DD881AD0,NA,NA,NA,,NA,6279,6339,Chemotherapy,Fotemustine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8718,TCGA-EE-A2MM,NO,,TCGA-EE-A2MM-D49870,BEEC3CD8-ED73-499C-ABD0-4FD852B361DE,NA,NA,NA,,NA,4412,4618,Vaccine,Autologous vaccine,Autologous vaccine,Other,,,,,NO,Clinical Progressive Disease,13,10,2013,TCGA-SKCM
8719,TCGA-EE-A2MN,NO,,TCGA-EE-A2MN-D49879,75608E15-565C-4D1E-9D33-29498AB5D639,NA,NA,NA,,NA,1290,1338,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,10,2013,TCGA-SKCM
8720,TCGA-EE-A2MQ,NO,,TCGA-EE-A2MQ-D49927,2180FF50-2FA8-403E-B5C6-6BB357B8806A,NA,NA,NA,,NA,1176,1207,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,15,10,2013,TCGA-SKCM
8722,TCGA-EE-A3AD,,,TCGA-EE-A3AD-D55196,7BA46207-8053-4C9C-A381-2F2DFF3C4894,NA,NA,NA,,NA,632,NA,Targeted Molecular therapy,BRAF inhibitor,BRAF inhibitor,Other,,,,,NO,Clinical Progressive Disease,21,5,2014,TCGA-SKCM
8724,TCGA-EE-A3AF,NO,,TCGA-EE-A3AF-D49565,7549637E-4237-459B-8A8E-BF8EB2B931F3,NA,NA,NA,,NA,384,404,Chemotherapy,Fotemustine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,4,10,2013,TCGA-SKCM
8727,TCGA-EE-A3AH,YES,,TCGA-EE-A3AH-D50105,0F0B5AAF-1D31-4330-95DD-71853276402F,NA,NA,NA,,NA,3977,4104,Chemotherapy,PI88,Angiogenesis inhibitor,Other,chemotherapy,,,,NO,Clinical Progressive Disease,15,10,2013,TCGA-SKCM
8729,TCGA-EE-A3JI,NO,,TCGA-EE-A3JI-D59754,A2BFB1F4-4C5F-49BD-9C72-1EDD7311422D,NA,NA,NA,,NA,4529,4571,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
8730,TCGA-EE-A3JI,NO,,TCGA-EE-A3JI-D59755,E1A09352-5F0F-43B4-9C09-DDBE436D1BA4,NA,NA,NA,,NA,4608,NA,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,20,5,2014,TCGA-SKCM
2815,TCGA-EK-A2H0,YES,NA,TCGA-EK-A2H0-D31970,3CF33478-3029-494E-AE79-DF669875863C,NA,,NA,,NA,54,90,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2012,TCGA-CESC
2817,TCGA-EK-A2RL,NO,NA,TCGA-EK-A2RL-D58212,74B640D3-522E-4D42-9C30-BA9132FDE318,NA,,NA,,NA,912,968,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,2,4,2014,TCGA-CESC
9947,TCGA-EO-A1Y5,NO,NA,TCGA-EO-A1Y5-D56548,DE3D9B2C-395E-4336-B8D3-BF53D4A0AF1B,NA,,,,NA,NA,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,,Complete Response,12,2,2014,TCGA-UCEC
9948,TCGA-EO-A1Y5,NO,NA,TCGA-EO-A1Y5-D56549,F1010094-972C-4393-8692-F13BF3DF4EA6,NA,,,,NA,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,,Complete Response,12,2,2014,TCGA-UCEC
9950,TCGA-EO-A22X,NO,NA,TCGA-EO-A22X-D39979,E43618B8-4EA4-4509-88FE-96F6C6917847,NA,,,,NA,NA,205,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,2,2013,TCGA-UCEC
9951,TCGA-EO-A22X,NO,NA,TCGA-EO-A22X-D39981,FC7FC150-BE27-440E-9A6D-C267DB7A9EEA,NA,,,,NA,NA,205,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,2,2013,TCGA-UCEC
9952,TCGA-EO-A2CG,NO,NA,TCGA-EO-A2CG-D56881,28646D52-41D7-48BD-AE33-873840D5ECAC,NA,,,,NA,114,243,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,2,2014,TCGA-UCEC
9953,TCGA-EO-A2CG,NO,NA,TCGA-EO-A2CG-D56884,9100F8AD-3D0F-433E-A172-B739230B7817,NA,,,,NA,114,243,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2014,TCGA-UCEC
9955,TCGA-EO-A2CH,NO,NA,TCGA-EO-A2CH-D56868,49824B45-BDBD-4464-B634-34EDF361FB2A,NA,,,,NA,98,190,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,25,2,2014,TCGA-UCEC
9954,TCGA-EO-A2CH,NO,NA,TCGA-EO-A2CH-D56867,A279CDF8-5A8C-4A2F-ADCF-6C0CC35047AD,NA,,,,NA,98,276,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,25,2,2014,TCGA-UCEC
9956,TCGA-EO-A2CH,NO,NA,TCGA-EO-A2CH-D56870,EFD83836-6B57-413E-92BD-726D33E21538,NA,,,,NA,312,402,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,25,2,2014,TCGA-UCEC
9957,TCGA-EO-A3AV,NO,NA,TCGA-EO-A3AV-D48631,F45A33D2-7384-4E99-BE4A-28059BE1EC37,NA,,,,NA,96,216,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,9,2013,TCGA-UCEC
9958,TCGA-EO-A3AV,NO,NA,TCGA-EO-A3AV-D56829,32083A34-F5E9-41FF-A054-C6340A99ACBE,NA,,,,NA,96,216,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,2,2014,TCGA-UCEC
9960,TCGA-EO-A3B1,NO,NA,TCGA-EO-A3B1-D39920,6657249F-7B31-4120-8EFC-520B52034B6E,NA,,,,NA,63,234,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,2,2014,TCGA-UCEC
9961,TCGA-EO-A3B1,NO,NA,TCGA-EO-A3B1-D56864,0AD25756-99D7-4745-A7EF-084969E5B859,NA,,,,NA,63,234,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,25,2,2014,TCGA-UCEC
9959,TCGA-EO-A3B1,NO,NA,TCGA-EO-A3B1-D48643,88CFF985-56F3-40FF-A124-978DEC024914,NA,,,,NA,64,247,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,9,2013,TCGA-UCEC
9962,TCGA-EO-A3KU,NO,NA,TCGA-EO-A3KU-D39923,D98C6197-DA67-4647-8ED6-579FA73D9AA8,NA,,,,NA,72,265,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,2,2013,TCGA-UCEC
9964,TCGA-EO-A3KU,NO,NA,TCGA-EO-A3KU-D48716,F06DA8DF-9A22-473F-8E07-72C9FCD5E3AE,NA,,,,NA,2,276,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,9,2013,TCGA-UCEC
9963,TCGA-EO-A3KU,NO,NA,TCGA-EO-A3KU-D39924,A8777E89-BE11-4650-8E25-F52619900C99,NA,,,,NA,63,NA,,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,2,2013,TCGA-UCEC
9150,TCGA-EQ-A4SO,NO,,TCGA-EQ-A4SO-D51280,EDDFA66F-3E02-4268-9B87-2D5795D6F20B,,,,,NA,179,222,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,14,11,2013,TCGA-STAD
9149,TCGA-EQ-A4SO,NO,,TCGA-EQ-A4SO-D51273,9572BB9B-E0A8-4CFA-8169-361391E2F556,,,,,NA,83,300,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,14,11,2013,TCGA-STAD
9148,TCGA-EQ-A4SO,NO,,TCGA-EQ-A4SO-D51270,CD2B70A6-F1A4-4942-9F77-049AFAE3DE45,,,,,NA,83,300,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,14,11,2013,TCGA-STAD
8737,TCGA-ER-A19H,NO,,TCGA-ER-A19H-D32359,D9F6730E-185D-4B1E-BF87-98D3E5885262,NA,NA,NA,,NA,3627,3716,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,5,2012,TCGA-SKCM
8740,TCGA-ER-A19M,NO,,TCGA-ER-A19M-D33562,8905B3C5-3484-4A73-B08F-B26CB937FD3B,NA,NA,NA,,NA,1019,1093,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Clinical Progressive Disease,6,7,2012,TCGA-SKCM
2380,TCGA-EW-A1OY,NO,,TCGA-EW-A1OY-D32268,B36F48F2-F93A-4964-B8B9-7CF74F5CB0B1,,,,,,180,308,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,30,5,2012,TCGA-BRCA
2398,TCGA-EW-A1P3,NO,,TCGA-EW-A1P3-D32282,0E200A24-933F-4B50-8382-45D54BFC5B59,,,,,,167,233,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,30,5,2012,TCGA-BRCA
2393,TCGA-EW-A1P3,NO,,TCGA-EW-A1P3-D32283,ADEE31EE-3558-4B60-9FB9-AE7031EEA45D,,,,,,261,1175,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Stable Disease,23,5,2012,TCGA-BRCA
2443,TCGA-EW-A2FR,NO,,TCGA-EW-A2FR-D32316,48579EAC-39AF-415C-B6DF-893430FC303F,,,,,,97,174,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,23,5,2012,TCGA-BRCA
2445,TCGA-EW-A2FS,NO,,TCGA-EW-A2FS-D32291,9720934C-6807-40ED-95F9-E25B66C9BF52,,,,,,140,1166,Hormone Therapy,Goserelin,LHRH agonist,Other,,,,,NO,Stable Disease,23,5,2012,TCGA-BRCA
2461,TCGA-EW-A3U0,NO,,TCGA-EW-A3U0-D42035,FD889A7B-41D1-42B5-A58A-BE562B865525,,,,,,85,127,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,4,2013,TCGA-BRCA
2462,TCGA-EW-A3U0,NO,,TCGA-EW-A3U0-D42036,7D3EE7E9-9692-488D-866E-054AF4EC0EAD,,,,,,85,127,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,4,2013,TCGA-BRCA
2464,TCGA-EW-A3U0,NO,,TCGA-EW-A3U0-D42038,2ACE8F03-CCD2-49E1-BB73-5DC383D76E8C,,,,,,148,197,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,4,2013,TCGA-BRCA
2463,TCGA-EW-A3U0,NO,,TCGA-EW-A3U0-D42037,39091340-4E3F-492C-9FA3-3FC1468ADDDD,,,,,,148,197,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,4,2013,TCGA-BRCA
2467,TCGA-EW-A424,NO,,TCGA-EW-A424-D38943,DA732694-A93F-487C-BB75-9D25A4235E0C,,,,,,118,181,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,1,2013,TCGA-BRCA
2466,TCGA-EW-A424,NO,,TCGA-EW-A424-D38941,A0C151E8-818E-4052-8F12-45E3CAC90A8C,,,,,,118,181,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,1,2013,TCGA-BRCA
2818,TCGA-EX-A3L1,YES,NA,TCGA-EX-A3L1-D38133,D5445E7B-B1F0-466E-9421-73072DDC7669,NA,,NA,,NA,96,131,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,12,2012,TCGA-CESC
2819,TCGA-EX-A449,NO,NA,TCGA-EX-A449-D47410,F031D1DD-20A0-4CFE-93B8-51E09B7099EC,NA,,NA,,NA,47,109,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2013,TCGA-CESC
2820,TCGA-EX-A449,NO,NA,TCGA-EX-A449-D47412,1CA76EBB-F1FB-4769-BE88-45DF8439B867,NA,,NA,,NA,109,200,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2013,TCGA-CESC
2821,TCGA-EX-A449,NO,NA,TCGA-EX-A449-D47413,6D6F9C3B-74AC-4E3B-8DEF-41396B7471D1,NA,,NA,,NA,109,200,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,27,8,2013,TCGA-CESC
9991,TCGA-EY-A2ON,NO,NA,TCGA-EY-A2ON-D34166,FC059943-BA02-4E02-B2C9-3A8222FB859F,NA,,,,NA,63,236,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-UCEC
9990,TCGA-EY-A2ON,NO,NA,TCGA-EY-A2ON-D34165,347ECDE5-07E3-406D-B5B8-38374BC3211B,NA,,,,NA,63,236,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-UCEC
9992,TCGA-EY-A2ON,NO,NA,TCGA-EY-A2ON-D34167,927F964B-C56F-4273-BBB8-5E8F6E940535,NA,,,,NA,254,352,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,31,7,2012,TCGA-UCEC
9997,TCGA-EY-A3L3,YES,NA,TCGA-EY-A3L3-D38202,4247ED11-E833-438D-89A6-7034E5B9E95C,NA,,,,NA,119,231,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,12,2012,TCGA-UCEC
9996,TCGA-EY-A3L3,YES,NA,TCGA-EY-A3L3-D38201,6AC34DE1-0DA4-4121-92C8-4D606A4150A0,NA,,,,NA,119,231,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,11,12,2012,TCGA-UCEC
9999,TCGA-EY-A3QX,NO,NA,TCGA-EY-A3QX-D40910,E3193309-538E-46AF-8042-6D6D5F2B1A62,NA,,,,NA,66,187,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,6,3,2013,TCGA-UCEC
9998,TCGA-EY-A3QX,NO,NA,TCGA-EY-A3QX-D40909,A93B97A0-7966-4862-9959-9799991D54BE,NA,,,,NA,66,187,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,3,2013,TCGA-UCEC
10000,TCGA-EY-A4KR,NO,NA,TCGA-EY-A4KR-D44428,A9344829-A816-4F95-AEA0-B6915253259D,NA,,,,NA,46,179,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,19,6,2013,TCGA-UCEC
10001,TCGA-EY-A4KR,NO,NA,TCGA-EY-A4KR-D44496,D85A2FDB-3A08-413C-B014-3B84DEB10D72,NA,,,,NA,46,179,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,20,6,2013,TCGA-UCEC
10002,TCGA-EY-A54A,NO,NA,TCGA-EY-A54A-D44463,252913A3-F113-4639-9090-7C5697D1DE80,NA,,,,NA,49,259,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,6,2013,TCGA-UCEC
10003,TCGA-EY-A54A,NO,NA,TCGA-EY-A54A-D44464,A18E520C-8948-498F-A4AB-1E1F8A239299,NA,,,,NA,49,259,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,20,6,2013,TCGA-UCEC
9152,TCGA-F1-A448,NO,,TCGA-F1-A448-D36510,F8F5A539-3E12-4643-BB34-E6ADCCC2E2D1,,,,,NA,98,119,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,31,10,2012,TCGA-STAD
9151,TCGA-F1-A448,NO,,TCGA-F1-A448-D36509,FDD21475-195B-4A98-A73F-93B1AB0DF95E,,,,,NA,98,119,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,31,10,2012,TCGA-STAD
9153,TCGA-F1-A448,NO,,TCGA-F1-A448-D36511,2E8456F0-6FFA-4F5D-9F69-D77692059B4A,,,,,NA,161,175,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,31,10,2012,TCGA-STAD
9154,TCGA-F1-A72C,NO,,TCGA-F1-A72C-D53060,2170E1D0-F575-410D-A6A1-0810B07B47E1,,,,,NA,166,181,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,12,2013,TCGA-STAD
7821,TCGA-F2-6879,NO,NA,TCGA-F2-6879-D32760,13761A1C-2E8A-4EDE-A483-7CB45F8CB682,NA,NA,NA,NA,NA,190,225,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,11,6,2012,TCGA-PAAD
7822,TCGA-F2-6880,NO,NA,TCGA-F2-6880-D32768,B6FE6D9A-71F1-4AA4-BF22-1C307A445202,NA,NA,NA,NA,NA,77,167,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,6,2012,TCGA-PAAD
7823,TCGA-F2-7273,NO,NA,TCGA-F2-7273-D32735,7D8E7585-90F2-4F4C-B0CD-4D7806C8E6C4,NA,NA,NA,NA,NA,53,90,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,11,6,2012,TCGA-PAAD
7824,TCGA-F2-7273,NO,NA,TCGA-F2-7273-D32742,8915893A-77EF-4F04-97BE-BCE60A909919,NA,NA,NA,NA,NA,123,221,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,11,6,2012,TCGA-PAAD
7829,TCGA-F2-7276,NO,NA,TCGA-F2-7276-D32755,728CB3BF-FE79-4BF0-8339-34EA10B6AABE,NA,NA,NA,NA,NA,41,141,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,11,6,2012,TCGA-PAAD
7830,TCGA-F2-A44G,NO,NA,TCGA-F2-A44G-D36523,3BEE293D-C5C9-4F0B-B6C2-8138FD65E71F,NA,NA,NA,NA,NA,60,75,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,1,11,2012,TCGA-PAAD
7831,TCGA-F2-A44G,NO,NA,TCGA-F2-A44G-D36524,3ED9EC46-A212-437A-9563-AC8510729AEF,NA,NA,NA,NA,NA,98,144,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,1,11,2012,TCGA-PAAD
7832,TCGA-F2-A44H,NO,NA,TCGA-F2-A44H-D42193,134B172B-2894-4B4D-BA2A-0B5354E94549,NA,NA,NA,NA,NA,98,196,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,15,4,2013,TCGA-PAAD
7833,TCGA-F2-A44H,NO,NA,TCGA-F2-A44H-D50686,A9963423-7BF2-4BAF-BC02-61D5A7557D92,NA,NA,NA,NA,NA,228,267,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,29,10,2013,TCGA-PAAD
7834,TCGA-F2-A8YN,NO,NA,TCGA-F2-A8YN-D57390,ACEE50CF-FDE5-4B46-ABB0-EE89EC546285,NA,NA,NA,NA,NA,116,147,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,10,3,2014,TCGA-PAAD
3380,TCGA-F4-6569,NO,,TCGA-F4-6569-D63480,6AC4AB3C-AA5A-4D66-B031-2ED464C10E17,,,,,,23,201,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,11,8,2014,TCGA-COAD
3379,TCGA-F4-6569,NO,,TCGA-F4-6569-D63479,07B6950E-FF2F-4B33-BFF0-9CB598F7EFE2,,,,,,23,201,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,11,8,2014,TCGA-COAD
3381,TCGA-F4-6805,NO,,TCGA-F4-6805-D35065,8EEA3753-54B7-4A29-9F52-588A974F7AA9,,,,,,29,111,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,14,9,2012,TCGA-COAD
3384,TCGA-F4-6806,NO,,TCGA-F4-6806-D35436,C8070FFD-ED9D-4F92-8CC9-CDA03C1EF7FF,,,,,,42,158,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3383,TCGA-F4-6806,NO,,TCGA-F4-6806-D35435,CE89B929-B40D-4B1D-8F2A-17FA387A40C0,,,,,,42,158,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3382,TCGA-F4-6806,NO,,TCGA-F4-6806-D35434,21322B68-CA4A-4EBD-B6C2-2DE312E8C191,,,,,,42,158,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3386,TCGA-F4-6806,NO,,TCGA-F4-6806-D35439,3CC4372C-CC95-4B06-B228-9917C5A2C310,,,,,,173,263,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3385,TCGA-F4-6806,NO,,TCGA-F4-6806-D35438,DB534232-0D51-49A2-8358-24D5BBA3A286,,,,,,173,263,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3387,TCGA-F4-6806,NO,,TCGA-F4-6806-D35440,270B1EAE-76FD-4BA8-82A9-61109D1AC48E,,,,,,361,412,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3388,TCGA-F4-6806,NO,,TCGA-F4-6806-D35441,039AEB96-42C2-4F56-B70A-9C5F9D2CA39F,,,,,,361,412,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,27,9,2012,TCGA-COAD
3389,TCGA-F4-6806,NO,,TCGA-F4-6806-D55585,2843DF68-7A05-4F45-A0BD-415396178241,,,,,,641,760,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,9,1,2014,TCGA-COAD
3392,TCGA-F4-6806,NO,,TCGA-F4-6806-D55588,0457213A-4DDB-44D8-BAC8-B2125E5CD62C,,,,,,641,760,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,9,1,2014,TCGA-COAD
3390,TCGA-F4-6806,NO,,TCGA-F4-6806-D55586,4A462DE8-23F3-43E1-B382-753F79648D56,,,,,,641,760,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,9,1,2014,TCGA-COAD
3391,TCGA-F4-6806,NO,,TCGA-F4-6806-D55587,8FBAFE5C-1DDC-4C8A-B9B1-1EE6000053B5,,,,,,641,760,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Partial Response,9,1,2014,TCGA-COAD
3393,TCGA-F4-6806,NO,,TCGA-F4-6806-D55589,870532C3-7644-44F2-A51B-2B95044B6D5D,,,,,,760,883,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Partial Response,9,1,2014,TCGA-COAD
3397,TCGA-F4-6807,YES,,TCGA-F4-6807-D35070,7599BE98-8FE6-4E14-A6BF-8F31624CF90F,,,,,,73,284,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,14,9,2012,TCGA-COAD
3399,TCGA-F4-6856,NO,,TCGA-F4-6856-D63488,62D6AB27-A225-4519-9D76-92ACDD34CADF,,,,,,11,41,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,11,8,2014,TCGA-COAD
3398,TCGA-F4-6856,NO,,TCGA-F4-6856-D63483,033361EE-254A-46F4-99D4-61E8F52D027B,,,,,,11,41,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,11,8,2014,TCGA-COAD
8362,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D53525,2B9D27E5-E361-4657-8DA6-21B9D8454DFD,,,,,NA,770,813,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,12,12,2013,TCGA-READ
8365,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D53531,E3940B66-3CF4-4484-A360-2A1E70F345EB,,,,,NA,847,952,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,12,12,2013,TCGA-READ
8363,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D53527,2F82A9D7-83B1-4A8F-9EC8-D81BDCBF24B4,,,,,NA,847,952,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,12,12,2013,TCGA-READ
8364,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D53530,08406C00-17CA-42E1-BB5F-919DD9BE7FD8,,,,,NA,847,952,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,12,12,2013,TCGA-READ
8368,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D65909,EB1AB997-77FB-4F19-A8CE-2B4F475F4548,,,,,NA,1065,1157,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,1,10,2014,TCGA-READ
8367,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D65907,752ADA80-5EDC-4F56-AEF4-F64C81591C01,,,,,NA,1065,1157,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Stable Disease,1,10,2014,TCGA-READ
8366,TCGA-F5-6571,NO,NA,TCGA-F5-6571-D65905,AF8F3EF6-1533-41EA-9E07-49767EF773FB,,,,,NA,1065,1157,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,1,10,2014,TCGA-READ
8374,TCGA-F5-6702,NO,NA,TCGA-F5-6702-D46352,A119CEAA-1B12-4770-B8B6-D4D1D7A38F0F,,,,,NA,340,551,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,6,8,2013,TCGA-READ
8373,TCGA-F5-6702,NO,NA,TCGA-F5-6702-D46351,4A439625-FA84-45EC-817B-67C23AFE1E37,,,,,NA,370,641,Chemotherapy,Polyplatillen,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,6,8,2013,TCGA-READ
8372,TCGA-F5-6702,NO,NA,TCGA-F5-6702-D46350,AE38DEA3-6C5A-423C-B49F-86D4DCE40ED9,,,,,NA,370,641,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,6,8,2013,TCGA-READ
8377,TCGA-F5-6863,NO,NA,TCGA-F5-6863-D35414,A8C20AB5-CB1C-4F37-B128-2926781CD0FF,,,,,NA,196,251,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,26,9,2012,TCGA-READ
8376,TCGA-F5-6863,NO,NA,TCGA-F5-6863-D35413,C49E0FEE-4847-4946-83B7-457EE6C96D86,,,,,NA,196,251,Chemotherapy,Folinic acid,Rescue agent,Other,,,NA,,NO,Stable Disease,26,9,2012,TCGA-READ
8375,TCGA-F5-6863,NO,NA,TCGA-F5-6863-D35412,52352390-D906-4CD9-A1EF-85A68856259C,,,,,NA,196,251,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,26,9,2012,TCGA-READ
8378,TCGA-F5-6863,NO,NA,TCGA-F5-6863-D35415,DDBA0B34-8873-49AE-865D-C33764098442,,,,,NA,261,289,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,26,9,2012,TCGA-READ
8379,TCGA-F5-6864,NO,NA,TCGA-F5-6864-D33874,A7C58EE8-6D8E-465B-879A-863167346D8A,,,,,NA,17,191,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,23,7,2012,TCGA-READ
8380,TCGA-F5-6864,NO,NA,TCGA-F5-6864-D33875,591BBBE2-4B58-48F4-B353-932C79B86C0F,,,,,NA,17,191,Ancillary,Folinic acid,Rescue agent,Other,,,NA,,NO,Complete Response,23,7,2012,TCGA-READ
3879,TCGA-F7-A50J,NO,NA,TCGA-F7-A50J-D49371,27B33D55-BFC3-47A5-8C02-6D8441EA9F55,NA,,NA,,NA,70,114,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,9,2013,TCGA-HNSC
7840,TCGA-FB-A4P6,NO,NA,TCGA-FB-A4P6-D64775,0CC1DA1A-A97B-4EC7-801D-1D36EF97C522,NA,NA,NA,NA,NA,698,726,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,11,9,2014,TCGA-PAAD
7839,TCGA-FB-A4P6,NO,NA,TCGA-FB-A4P6-D64773,AAAF1927-1F22-4610-A5D0-2EFAE17D4B9E,NA,NA,NA,NA,NA,698,726,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,9,2014,TCGA-PAAD
7838,TCGA-FB-A4P6,NO,NA,TCGA-FB-A4P6-D64771,48FD303C-E210-4B7E-9483-B63C40E2B29D,NA,NA,NA,NA,NA,698,726,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Complete Response,11,9,2014,TCGA-PAAD
7841,TCGA-FB-A545,NO,NA,TCGA-FB-A545-D50065,12C134AB-37C2-4970-92BF-F094586E1636,NA,NA,NA,NA,NA,113,224,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,15,10,2013,TCGA-PAAD
7842,TCGA-FB-A545,NO,NA,TCGA-FB-A545-D50066,5D411E86-8272-4A22-B74A-27E90285AA9D,NA,NA,NA,NA,NA,113,224,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,15,10,2013,TCGA-PAAD
7845,TCGA-FB-A545,NO,NA,TCGA-FB-A545-D68477,BE475105-81D3-42EC-9D76-EA0B87EEF6D8,NA,NA,NA,NA,NA,457,634,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,21,11,2014,TCGA-PAAD
7843,TCGA-FB-A545,NO,NA,TCGA-FB-A545-D68474,53876060-6371-4E7C-B359-B8B366B558D7,NA,NA,NA,NA,NA,457,634,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,21,11,2014,TCGA-PAAD
7844,TCGA-FB-A545,NO,NA,TCGA-FB-A545-D68476,7BCB4F68-7088-4776-9131-61DCAD285EB7,NA,NA,NA,NA,NA,457,634,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Clinical Progressive Disease,21,11,2014,TCGA-PAAD
7846,TCGA-FB-A5VM,NO,NA,TCGA-FB-A5VM-D56658,248BF671-BAE8-472C-AE1D-EEAE108AD9B8,NA,NA,NA,NA,NA,77,162,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,24,2,2014,TCGA-PAAD
7849,TCGA-FB-A78T,NO,NA,TCGA-FB-A78T-D59979,00E0EBEE-A229-4D5F-AF04-607C4EA880A5,NA,NA,NA,NA,NA,106,115,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,27,5,2014,TCGA-PAAD
7850,TCGA-FB-AAPP,NO,NA,TCGA-FB-AAPP-D59927,C57DC06F-DDED-43C3-84E0-A6E15DCFEFCE,NA,NA,NA,NA,NA,89,150,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,15,9,2014,TCGA-PAAD
7851,TCGA-FB-AAPP,NO,NA,TCGA-FB-AAPP-D64872,A31D658A-C9E9-4865-A979-AE8FA4EE5060,NA,NA,NA,NA,NA,181,303,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,15,9,2014,TCGA-PAAD
7852,TCGA-FB-AAPP,NO,NA,TCGA-FB-AAPP-D64875,736592EB-D5F9-4555-A55E-107510F0E4CD,NA,NA,NA,NA,NA,181,303,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,15,9,2014,TCGA-PAAD
7854,TCGA-FB-AAPY,NO,NA,TCGA-FB-AAPY-D64907,6F38A444-8DCF-4C53-B7C8-2E4B2F1F1030,NA,NA,NA,NA,NA,92,243,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,15,9,2014,TCGA-PAAD
7857,TCGA-FB-AAQ6,NO,NA,TCGA-FB-AAQ6-D59934,E3EE3B38-556A-4CD8-B327-8DCDBCBE5572,NA,NA,NA,NA,NA,92,156,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,15,9,2014,TCGA-PAAD
8038,TCGA-FC-A4JI,NO,NA,TCGA-FC-A4JI-D48398,4B578CBB-1746-4AFD-A8AF-E05F391AB4D3,NA,NA,NA,,NA,52,143,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,12,9,2013,TCGA-PRAD
103,TCGA-FD-A3B4,NO,,TCGA-FD-A3B4-D35162,335EC112-7819-4AB3-9F92-8D4B664F4300,NA,,NA,,NA,115,157,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,19,9,2012,TCGA-BLCA
102,TCGA-FD-A3B4,NO,,TCGA-FD-A3B4-D35160,5940A678-2FBC-4D43-B89A-5C9260706B92,NA,,NA,,NA,115,157,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,19,9,2012,TCGA-BLCA
109,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33648,10D93D30-4AC6-484F-8772-54A424C9799B,NA,,NA,,NA,274,275,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
106,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33686,29A19447-3D72-4510-B886-5FCB0CA749EC,NA,,NA,,NA,274,275,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
107,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33687,18F7755E-C287-409E-9372-DD03A9A5645D,NA,,NA,,NA,274,275,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
108,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33688,9F42AC4D-A0A4-4F5D-B058-D06F76527AD7,NA,,NA,,NA,274,380,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
105,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33689,2F5A329A-927F-442B-B822-D3FEE2DC0652,NA,,NA,,NA,315,436,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
104,TCGA-FD-A3SJ,NO,,TCGA-FD-A3SJ-D33690,D46CF87F-BDB1-4A91-A6E9-DC55A849448A,NA,,NA,,NA,401,436,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
114,TCGA-FD-A3SO,NO,,TCGA-FD-A3SO-D33761,9B5A5F82-649E-4766-9335-08E0AB8066EF,NA,,NA,,NA,65,141,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,16,7,2012,TCGA-BLCA
115,TCGA-FD-A3SO,NO,,TCGA-FD-A3SO-D33762,AD1913FA-7D64-48EC-8466-E69C289C73EA,NA,,NA,,NA,66,141,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,16,7,2012,TCGA-BLCA
120,TCGA-FD-A3SQ,NO,,TCGA-FD-A3SQ-D33675,81447471-FB3B-4D05-B527-98E45F069D2B,NA,,NA,,NA,78,151,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
121,TCGA-FD-A3SQ,NO,,TCGA-FD-A3SQ-D33653,8D7B7DDD-FDC7-4951-B8A2-445454530940,NA,,NA,,NA,78,151,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,16,7,2012,TCGA-BLCA
127,TCGA-FD-A43S,NO,,TCGA-FD-A43S-D37179,4A856656-F609-4E8A-9DC5-FB385BFA1330,NA,,NA,,NA,111,175,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,29,11,2012,TCGA-BLCA
126,TCGA-FD-A43S,NO,,TCGA-FD-A43S-D37178,04F50A93-E799-4689-B04D-4ED2F5117807,NA,,NA,,NA,111,175,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,29,11,2012,TCGA-BLCA
128,TCGA-FD-A43U,NO,,TCGA-FD-A43U-D37162,30047ACF-3C71-424A-96A3-91A9B5088E03,NA,,NA,,NA,97,187,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,29,11,2012,TCGA-BLCA
129,TCGA-FD-A43U,NO,,TCGA-FD-A43U-D37161,1A5B47F2-E3BC-4326-A144-6A2149549E64,NA,,NA,,NA,97,187,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,29,11,2012,TCGA-BLCA
131,TCGA-FD-A5BS,NO,,TCGA-FD-A5BS-D42845,D9E3F149-3C29-49FA-91B5-5BC112FBA477,NA,,NA,,NA,777,854,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,1,5,2013,TCGA-BLCA
130,TCGA-FD-A5BS,NO,,TCGA-FD-A5BS-D42843,5EB61728-0F85-4E66-A57A-E18B2A18A99F,NA,,NA,,NA,777,854,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,1,5,2013,TCGA-BLCA
134,TCGA-FD-A5C1,NO,,TCGA-FD-A5C1-D42881,45375F4F-6BC8-465E-98F1-108048498790,NA,,NA,,NA,1421,1491,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,2,5,2013,TCGA-BLCA
135,TCGA-FD-A5C1,NO,,TCGA-FD-A5C1-D42882,6E578A68-195F-420D-BE0E-7E95AFF64298,NA,,NA,,NA,1421,1491,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,2,5,2013,TCGA-BLCA
137,TCGA-FD-A62S,NO,,TCGA-FD-A62S-D59248,7810A477-A6E8-4F7D-9010-A459ACF20768,NA,,NA,,NA,243,292,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,6,5,2014,TCGA-BLCA
136,TCGA-FD-A62S,NO,,TCGA-FD-A62S-D59247,70601C33-808B-4205-B4A0-5E13B0222A74,NA,,NA,,NA,243,292,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,6,5,2014,TCGA-BLCA
142,TCGA-FD-A6TC,NO,,TCGA-FD-A6TC-D65163,D8EC9D40-C854-49D3-A8D3-728EEA56AF35,NA,,NA,,NA,88,144,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,19,9,2014,TCGA-BLCA
10004,TCGA-FI-A2CY,NO,NA,TCGA-FI-A2CY-D31802,67056E36-2999-4086-9004-ACE65EE6B379,NA,,,,NA,51,171,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10006,TCGA-FI-A2CY,NO,NA,TCGA-FI-A2CY-D31804,AB47B1E1-C904-4EF0-BCF5-0EC7EE6FA257,NA,,,,NA,101,171,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10007,TCGA-FI-A2D2,NO,NA,TCGA-FI-A2D2-D31805,0BF2296A-8A54-4506-9A83-20546DE55E9D,NA,,,,NA,87,191,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2012,TCGA-UCEC
10008,TCGA-FI-A2D2,NO,NA,TCGA-FI-A2D2-D31806,1ABE5B06-85E2-4848-91D4-A94B3BE8D219,NA,,,,NA,87,191,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2012,TCGA-UCEC
10009,TCGA-FI-A2D4,NO,NA,TCGA-FI-A2D4-D31807,5A0D5B78-FE7E-4707-9DDF-1B0A94D7C029,NA,,,,NA,47,167,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,11,5,2012,TCGA-UCEC
10010,TCGA-FI-A2D4,NO,NA,TCGA-FI-A2D4-D31808,204FA8FE-18AB-494E-9753-516BC392720D,NA,,,,NA,47,167,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,11,5,2012,TCGA-UCEC
10011,TCGA-FI-A2D5,NO,NA,TCGA-FI-A2D5-D31762,D94E793F-5F81-4E18-8650-783FE58AEEBC,NA,,,,NA,133,245,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10012,TCGA-FI-A2D5,NO,NA,TCGA-FI-A2D5-D31763,5BEBBD5C-0735-41BE-B369-1E10A0DEE1EE,NA,,,,NA,133,245,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10013,TCGA-FI-A2EU,NO,NA,TCGA-FI-A2EU-D31786,EE97F906-C5C8-4EAE-BE16-D0C1EA923337,NA,,,,NA,44,166,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10014,TCGA-FI-A2EU,NO,NA,TCGA-FI-A2EU-D31788,AD5397A3-A6C7-477F-9AF6-D7B0F7F1B025,NA,,,,NA,44,1971,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10015,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31789,9A7D7BC1-0B90-4A85-BD13-ABEE0E29153F,NA,,,,NA,69,179,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10016,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31790,6A220731-BF58-4BA0-8456-EC0FBC280442,NA,,,,NA,69,179,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10017,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31791,55689775-DD6B-4E9C-AB00-8D75A39A5FBE,NA,,,,NA,1194,1273,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10018,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31792,656C3B13-C073-42F4-AAA0-DCE9720F4DA2,NA,,,,NA,1194,1273,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10019,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31793,AF6163E1-112C-4EC7-8224-1446635F13AC,NA,,,,NA,1326,1369,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10020,TCGA-FI-A2EW,NO,NA,TCGA-FI-A2EW-D31794,0F405948-4CF7-4038-BD75-514E94F070D1,NA,,,,NA,1369,1431,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,14,5,2012,TCGA-UCEC
10021,TCGA-FI-A2EX,NO,NA,TCGA-FI-A2EX-D31795,0ECA6508-11F3-42A7-9CB3-5872F1461881,NA,,,,NA,38,150,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,5,2012,TCGA-UCEC
10022,TCGA-FI-A2EX,NO,NA,TCGA-FI-A2EX-D31796,B72831D6-8FC8-45BB-BABD-47AA4035A915,NA,,,,NA,38,150,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,5,2012,TCGA-UCEC
10023,TCGA-FI-A2EX,NO,NA,TCGA-FI-A2EX-D31797,91F83297-BCB4-494C-AEF1-8B31AEB3E31A,NA,,,,NA,213,274,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Partial Response,15,5,2012,TCGA-UCEC
10024,TCGA-FI-A2EY,NO,NA,TCGA-FI-A2EY-D31800,97048882-64BE-4634-8361-2DCF7360D631,NA,,,,NA,27,172,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,5,2012,TCGA-UCEC
10025,TCGA-FI-A2EY,NO,NA,TCGA-FI-A2EY-D31801,07DFD2BF-B19E-4F1A-9FA2-5850FA9EBB56,NA,,,,NA,27,172,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,11,5,2012,TCGA-UCEC
10026,TCGA-FI-A2F8,NO,NA,TCGA-FI-A2F8-D31810,26AA6385-BECF-40CF-98C0-6CC43F3B50E3,NA,,,,NA,36,141,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10027,TCGA-FI-A2F8,NO,NA,TCGA-FI-A2F8-D31812,BFAD841D-D24F-4BFB-ABB1-429765A427E2,NA,,,,NA,36,141,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
10028,TCGA-FI-A2F8,NO,NA,TCGA-FI-A2F8-D31813,66CA2923-6C4F-4545-B9AB-26EF42D42C0E,NA,,,,NA,36,141,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,5,2012,TCGA-UCEC
144,TCGA-FJ-A3Z7,NO,,TCGA-FJ-A3Z7-D35226,47E93333-1850-4C38-8E1D-5A7864798362,NA,,NA,,NA,70,70,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,27,9,2012,TCGA-BLCA
145,TCGA-FJ-A3Z7,NO,,TCGA-FJ-A3Z7-D35227,7DBE2237-5295-4C81-ABB9-B097799A7E3B,NA,,NA,,NA,70,70,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,27,9,2012,TCGA-BLCA
147,TCGA-FJ-A3Z9,NO,,TCGA-FJ-A3Z9-D39902,62362BC9-BED1-4D5D-A0B2-92104A2AA5BB,NA,,NA,,NA,46,89,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,5,2,2013,TCGA-BLCA
146,TCGA-FJ-A3Z9,NO,,TCGA-FJ-A3Z9-D39901,E9218D07-B328-4398-A40D-51E36F5B70F6,NA,,NA,,NA,32,122,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,5,2,2013,TCGA-BLCA
150,TCGA-FJ-A871,NO,,TCGA-FJ-A871-D56216,4B766531-8A57-4E13-A7A9-A1EC9B1D7F3A,NA,,NA,,NA,84,91,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,7,2,2014,TCGA-BLCA
154,TCGA-FJ-A871,NO,,TCGA-FJ-A871-D56222,1CCD314B-CA6D-4689-BC55-517977BB239F,NA,,NA,,NA,113,189,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,7,2,2014,TCGA-BLCA
151,TCGA-FJ-A871,NO,,TCGA-FJ-A871-D56218,108BD781-9598-4C1E-8FE8-D1D61B9C7630,NA,,NA,,NA,84,205,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,7,2,2014,TCGA-BLCA
152,TCGA-FJ-A871,NO,,TCGA-FJ-A871-D56219,471F6C0B-5E2C-4A14-93A5-2F1FB12C6B3F,NA,,NA,,NA,113,205,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,7,2,2014,TCGA-BLCA
153,TCGA-FJ-A871,NO,,TCGA-FJ-A871-D56221,508CF5FA-BE2F-4FE1-988D-8D8E4B68505B,NA,,NA,,NA,113,205,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,7,2,2014,TCGA-BLCA
9155,TCGA-FP-7829,NO,,TCGA-FP-7829-D44169,851E73E0-FBF1-41E9-B49D-05DC1E0F5BD2,,,,,NA,53,85,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,14,6,2013,TCGA-STAD
9156,TCGA-FP-7916,NO,,TCGA-FP-7916-D46168,7496D73B-36AF-4253-ACFE-F45CBA69BC4A,,,,,NA,108,142,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,2,8,2013,TCGA-STAD
9157,TCGA-FP-7998,NO,,TCGA-FP-7998-D46164,23CA0289-C7D4-452E-9D12-140A908B6A89,,,,,NA,168,501,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,2,8,2013,TCGA-STAD
9158,TCGA-FP-7998,NO,,TCGA-FP-7998-D46165,C2CB4B51-3622-45B8-AABD-79F98468E09B,,,,,NA,168,501,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,2,8,2013,TCGA-STAD
9159,TCGA-FP-8209,NO,,TCGA-FP-8209-D32948,AE7DED9A-F501-4686-AAF2-85D5C096A93C,,,,,NA,31,NA,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,17,6,2012,TCGA-STAD
9160,TCGA-FP-8209,NO,,TCGA-FP-8209-D32949,7BB42B9B-770C-4432-81A5-F2047CC83293,,,,,NA,31,NA,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,17,6,2012,TCGA-STAD
9161,TCGA-FP-8210,NO,,TCGA-FP-8210-D32936,59E3DAAA-12B0-4EDF-81BA-6E4F54B73A39,,,,,NA,31,62,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,16,6,2012,TCGA-STAD
9162,TCGA-FP-8210,NO,,TCGA-FP-8210-D32937,985A6C89-6AB8-4056-9E7C-E006C0272562,,,,,NA,31,62,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Clinical Progressive Disease,16,6,2012,TCGA-STAD
9163,TCGA-FP-8210,NO,,TCGA-FP-8210-D32938,EC0BDDF1-693E-4E39-AFFD-8006DFDB4568,,,,,NA,31,62,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,16,6,2012,TCGA-STAD
9165,TCGA-FP-8211,NO,,TCGA-FP-8211-D44177,05D02386-6DA2-4F5F-BDF2-3A989E33430E,,,,,NA,110,279,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,14,6,2013,TCGA-STAD
9164,TCGA-FP-8211,NO,,TCGA-FP-8211-D44176,34AF3A1E-1369-4474-94F4-685DA61EE187,,,,,NA,110,357,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,14,6,2013,TCGA-STAD
9166,TCGA-FP-A4BE,NO,,TCGA-FP-A4BE-D44166,33A9FF03-438A-46B5-A15B-36C039BA77E8,,,,,NA,102,239,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,14,6,2013,TCGA-STAD
9167,TCGA-FP-A9TM,NO,,TCGA-FP-A9TM-D72124,D440BC94-9385-41B6-9453-459F1BDD926D,,,,,NA,110,142,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,16,4,2015,TCGA-STAD
9168,TCGA-FP-A9TM,NO,,TCGA-FP-A9TM-D72125,7B0A2628-C09F-4800-8785-084F66AB61C3,,,,,NA,110,142,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,16,4,2015,TCGA-STAD
8755,TCGA-FR-A3YN,YES,,TCGA-FR-A3YN-D35304,6F4B77B1-79A0-404F-AA23-1DA625843E16,NA,NA,NA,,NA,2324,2387,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Complete Response,24,9,2012,TCGA-SKCM
8756,TCGA-FR-A3YO,NO,,TCGA-FR-A3YO-D35306,EB7F62DE-63D0-46E6-918C-91D76FA67219,NA,NA,NA,,NA,NA,NA,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Stable Disease,24,9,2012,TCGA-SKCM
8757,TCGA-FR-A44A,NO,,TCGA-FR-A44A-D36533,B4B54E08-6033-4A25-9C4A-3E12F48604B6,NA,NA,NA,,NA,2769,3134,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,1,11,2012,TCGA-SKCM
8759,TCGA-FR-A728,YES,,TCGA-FR-A728-D55557,B6DA4C3C-D6DA-44D6-8E7D-402461E003EA,NA,NA,NA,,NA,100,119,Chemotherapy,Dabrafenib,Antiproliferative,Other,,,,,NO,Partial Response,8,1,2014,TCGA-SKCM
8760,TCGA-FR-A728,YES,,TCGA-FR-A728-D55558,CABC63ED-6661-4C29-8EA2-FA5511964A9B,NA,NA,NA,,NA,100,119,Chemotherapy,Trametinib,MEK inhibitor,Other,,,,,NO,Partial Response,8,1,2014,TCGA-SKCM
8762,TCGA-FR-A7U8,YES,,TCGA-FR-A7U8-D54414,4D760785-4509-4E2E-8278-99B4C938A789,NA,NA,NA,,NA,89,208,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Partial Response,18,12,2013,TCGA-SKCM
8765,TCGA-FR-A8YC,YES,,TCGA-FR-A8YC-D57417,6A4EF828-9108-4D8F-ACAD-30422C32DF04,NA,NA,NA,,NA,1020,1020,Chemotherapy,2B3-101,Topoisomerase inhibitor,Topoisomerase inhibitor,liposomal doxorubicin conjugated to glutathione,,,,NO,Clinical Progressive Disease,11,3,2014,TCGA-SKCM
8766,TCGA-FR-A8YD,NO,,TCGA-FR-A8YD-D57428,8F6DA52E-4C2C-47EF-866A-50272C234141,NA,NA,NA,,NA,812,880,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Stable Disease,11,3,2014,TCGA-SKCM
8767,TCGA-FS-A1ZE,YES,,TCGA-FS-A1ZE-D62035,7762BB1A-E8F6-4DF3-B9CC-B92F213CD077,NA,NA,NA,,NA,651,761,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8768,TCGA-FS-A1ZE,YES,,TCGA-FS-A1ZE-D62036,9E87E85D-D028-49BD-A25A-570A54909894,NA,NA,NA,,NA,762,853,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8769,TCGA-FS-A1ZE,YES,,TCGA-FS-A1ZE-D62037,2D51DC19-E8CC-4DF1-930C-698AA19EAE3C,NA,NA,NA,,NA,896,1034,Targeted Molecular therapy,Angiocal,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8771,TCGA-FS-A1ZE,NO,,TCGA-FS-A1ZE-D66925,5E7D38CF-5687-4848-AFAB-C3DBA39E24E2,NA,NA,NA,,NA,1188,1249,Chemotherapy,Carboplatin,Alkylating agent|Antimitotic,Alkylating agent|Antimitotic,,,,,NO,Clinical Progressive Disease,28,10,2014,TCGA-SKCM
8770,TCGA-FS-A1ZE,NO,,TCGA-FS-A1ZE-D62039,EA4287BB-3EC7-4070-B547-CCA6E591A5CB,NA,NA,NA,,NA,1188,1249,Chemotherapy,Carboplatin|Paclitaxel,Alkylating agent|Antimitotic,Alkylating agent|Antimitotic,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8772,TCGA-FS-A1ZS,NO,,TCGA-FS-A1ZS-D62240,1DA58199-D6CD-4CF8-ADAF-59F04EB78068,NA,NA,NA,,NA,2566,2790,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Stable Disease,15,7,2014,TCGA-SKCM
8773,TCGA-FS-A1ZT,NO,,TCGA-FS-A1ZT-D62242,7BE14272-B795-4782-BA4E-938A64A8227C,NA,NA,NA,,NA,398,1053,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Stable Disease,15,7,2014,TCGA-SKCM
8774,TCGA-FS-A1ZW,NO,,TCGA-FS-A1ZW-D62253,125D0F7B-4176-4DD7-B911-D366B3DD599F,NA,NA,NA,,NA,700,1005,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Stable Disease,15,7,2014,TCGA-SKCM
8776,TCGA-FS-A4F0,NO,,TCGA-FS-A4F0-D62030,AF5AB1F3-9D07-4C97-A272-6BE687C1D370,NA,NA,NA,,NA,82,568,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Stable Disease,11,7,2014,TCGA-SKCM
8777,TCGA-FS-A4F0,NO,,TCGA-FS-A4F0-D62031,2D32AFB5-F3B4-41E8-A29D-6BD93EB2EB77,NA,NA,NA,,NA,1359,1521,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8775,TCGA-FS-A4F0,YES,,TCGA-FS-A4F0-D62026,0D667BAE-1A9F-4131-ADCA-09371B34D1BE,NA,NA,NA,,NA,1543,1603,Chemotherapy,Treosulfan,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,11,7,2014,TCGA-SKCM
8778,TCGA-FS-A4F0,YES,,TCGA-FS-A4F0-D70506,7E48CFDF-D865-4A66-BD8F-13981DA5AD94,NA,NA,NA,,NA,1543,1603,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,25,2,2015,TCGA-SKCM
2822,TCGA-FU-A23L,NO,NA,TCGA-FU-A23L-D56155,74452C14-7355-4AD6-958B-BCB5BF4E44E9,NA,,NA,,NA,80,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,1,2014,TCGA-CESC
2823,TCGA-FU-A3HY,NO,NA,TCGA-FU-A3HY-D64211,6B9972B5-AE6C-4658-BA1B-30CDE0D8C214,NA,,NA,,NA,60,91,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
2824,TCGA-FU-A3HZ,NO,NA,TCGA-FU-A3HZ-D64229,11063673-DD72-418C-8090-19921AB04C0C,NA,,NA,,NA,53,114,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
2825,TCGA-FU-A3WB,NO,NA,TCGA-FU-A3WB-D64235,7C60D850-1A5A-45EF-BF33-1DA000A277BA,NA,,NA,,NA,65,116,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
2826,TCGA-FU-A3WB,NO,NA,TCGA-FU-A3WB-D64236,80E759F8-CE9D-4730-A538-D10A3C87F4C7,NA,,NA,,NA,65,116,Ancillary,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
2827,TCGA-FU-A40J,NO,NA,TCGA-FU-A40J-D64220,7ADAFA1B-FAE9-4369-A13A-0D7734550AC0,NA,,NA,,NA,104,306,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
2828,TCGA-FU-A40J,NO,NA,TCGA-FU-A40J-D64221,CB60C6D5-AFC3-4B83-9DBF-D649951043AF,NA,,NA,,NA,104,306,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,27,8,2014,TCGA-CESC
4247,TCGA-FV-A3I0,NO,NA,TCGA-FV-A3I0-D57855,CE83DB6D-029E-4406-84CE-771A43CC490D,NA,,NA,,NA,166,586,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,27,3,2014,TCGA-LIHC
8780,TCGA-FW-A3R5,NO,,TCGA-FW-A3R5-D42774,E3483732-A7D0-4D36-A161-AADFE003D9A4,NA,NA,NA,,NA,714,993,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,30,4,2013,TCGA-SKCM
8781,TCGA-FW-A3TV,NO,,TCGA-FW-A3TV-D58959,E0B26F0B-5AE2-42A2-8D55-8C54C43405E9,NA,NA,NA,,NA,33,58,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Clinical Progressive Disease,29,4,2014,TCGA-SKCM
8498,TCGA-FX-A3RE,NO,NA,TCGA-FX-A3RE-D66009,E6423623-8D9D-4F05-82E7-F87E9F26EDA4,NA,,NA,,NA,63,136,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,1,10,2014,TCGA-SARC
8500,TCGA-FX-A48G,NO,NA,TCGA-FX-A48G-D64194,C79952AA-F29F-4FD7-B8CD-F639490F23D2,NA,,NA,,NA,54,168,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,27,8,2014,TCGA-SARC
8499,TCGA-FX-A48G,NO,NA,TCGA-FX-A48G-D64193,F655E223-1B79-448A-BC37-D531A839463E,NA,,NA,,NA,54,168,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,27,8,2014,TCGA-SARC
8501,TCGA-FX-A48G,NO,NA,TCGA-FX-A48G-D64196,EAF176DE-3FC3-4598-9674-2384C283A943,NA,,NA,,NA,174,289,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,27,8,2014,TCGA-SARC
8502,TCGA-FX-A48G,NO,NA,TCGA-FX-A48G-D64197,79DC51AA-ADA8-4E0D-9B1C-FAB2A9B5901E,NA,,NA,,NA,309,414,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,27,8,2014,TCGA-SARC
8503,TCGA-FX-A48G,NO,NA,TCGA-FX-A48G-D64198,FD5F07E2-247C-44F7-9E91-14AFDD2E30E7,NA,,NA,,NA,503,593,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,27,8,2014,TCGA-SARC
8504,TCGA-FX-A8OO,NO,NA,TCGA-FX-A8OO-D72528,530C1BE6-14C5-401F-9247-EBE4171AC3B9,NA,,NA,,NA,118,243,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,10,7,2015,TCGA-SARC
9520,TCGA-FY-A3W9,NO,NA,TCGA-FY-A3W9-D58945,08EC1650-7458-4AC0-99D1-3FB5CA2A356E,NA,NA,NA,,NA,214,NA,Hormone Therapy,Levothyroxine,Hormone,Other,NA,,NA,,YES,Complete Response,29,4,2014,TCGA-THCA
7858,TCGA-FZ-5919,NO,NA,TCGA-FZ-5919-D66277,0E27A519-8898-4218-B97B-15F2684E54BC,NA,NA,NA,NA,NA,73,157,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,7,10,2014,TCGA-PAAD
7860,TCGA-FZ-5922,YES,NA,TCGA-FZ-5922-D44191,4D0845F4-717A-479F-B2DB-BC0E8449EA86,NA,NA,NA,NA,NA,76,442,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7859,TCGA-FZ-5922,YES,NA,TCGA-FZ-5922-D44190,000F980B-6FAE-4B9D-9405-4FBC5B47F7F8,NA,NA,NA,NA,NA,639,800,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7861,TCGA-FZ-5923,NO,NA,TCGA-FZ-5923-D66468,A673928C-1CC3-4677-86BE-D0BB48D45CEA,NA,NA,NA,NA,NA,42,444,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,16,10,2014,TCGA-PAAD
7862,TCGA-FZ-5924,NO,NA,TCGA-FZ-5924-D66415,C0CD7BE8-3FF4-4CF6-A51E-A987408651DE,NA,NA,NA,NA,NA,257,362,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,14,10,2014,TCGA-PAAD
159,TCGA-G2-A2EC,YES,,TCGA-G2-A2EC-D32976,F177C0BC-4D08-4D17-B546-1B4C4560AC32,NA,,NA,,NA,24,75,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
155,TCGA-G2-A2EC,YES,,TCGA-G2-A2EC-D32966,5F880A8D-BB78-4B6D-93D7-F74316C6BA12,NA,,NA,,NA,24,75,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
156,TCGA-G2-A2EC,YES,,TCGA-G2-A2EC-D32970,FB24E0AB-685D-4F11-BBB4-5B9BF10D1175,NA,,NA,,NA,24,75,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
158,TCGA-G2-A2EC,YES,,TCGA-G2-A2EC-D32974,33CA9D74-59C9-41FF-9CB0-770323D2CEC2,NA,,NA,,NA,24,75,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
157,TCGA-G2-A2EC,YES,,TCGA-G2-A2EC-D32972,0C042234-F74E-44C6-B315-2AED33B22050,NA,,NA,,NA,24,75,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
163,TCGA-G2-A2EF,YES,,TCGA-G2-A2EF-D33001,27866927-5E9F-496E-98E2-383756CF2470,NA,,NA,,NA,58,170,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
160,TCGA-G2-A2EF,YES,,TCGA-G2-A2EF-D32982,694CAEDC-6696-4C04-8FFA-8185A917C637,NA,,NA,,NA,58,170,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
161,TCGA-G2-A2EF,YES,,TCGA-G2-A2EF-D32999,CE48C3DC-2CAB-4EA1-BFAE-B2F8A374D129,NA,,NA,,NA,58,170,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
162,TCGA-G2-A2EF,YES,,TCGA-G2-A2EF-D33000,6AD678ED-C233-48AB-A30B-A55F7ACA8888,NA,,NA,,NA,58,170,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,18,6,2012,TCGA-BLCA
166,TCGA-G2-A2EJ,YES,,TCGA-G2-A2EJ-D33049,5EE666E4-D150-4D48-8E5C-AF20E5AF64F2,NA,,NA,,NA,38,38,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
167,TCGA-G2-A2EJ,YES,,TCGA-G2-A2EJ-D33051,C1846A1C-F3C8-4FEF-B4AC-ABEF8DD94EBE,NA,,NA,,NA,38,38,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
164,TCGA-G2-A2EJ,YES,,TCGA-G2-A2EJ-D33047,DEDCF85F-17C4-4009-B43B-02B15C96A350,NA,,NA,,NA,38,38,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
165,TCGA-G2-A2EJ,YES,,TCGA-G2-A2EJ-D33048,5DA2805D-F33C-495D-AC31-F558AD5AF82B,NA,,NA,,NA,38,38,Ancillary,Mesna,Cytoprotectant,Other,Chemoprotectant,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
171,TCGA-G2-A2EK,YES,,TCGA-G2-A2EK-D33057,9A57D186-A1F1-4A86-9BE8-3ABE6184F3E0,NA,,NA,,NA,16,51,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
168,TCGA-G2-A2EK,YES,,TCGA-G2-A2EK-D33053,BC31F705-AC1F-451C-B617-642C19AC6154,NA,,NA,,NA,16,51,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
170,TCGA-G2-A2EK,YES,,TCGA-G2-A2EK-D33056,C4EB7979-5C32-4875-8828-4EB57A8DD1B8,NA,,NA,,NA,16,51,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
169,TCGA-G2-A2EK,YES,,TCGA-G2-A2EK-D33055,6BC25833-7CCC-488D-B705-7D6096D35669,NA,,NA,,NA,16,51,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
173,TCGA-G2-A2EL,YES,,TCGA-G2-A2EL-D33062,46912AB3-5EC9-44D6-A76B-87E4B79BFCA8,NA,,NA,,NA,84,147,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
172,TCGA-G2-A2EL,YES,,TCGA-G2-A2EL-D33061,CE05EB69-BFCC-4DDE-BBAC-801411756E33,NA,,NA,,NA,84,147,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,19,6,2012,TCGA-BLCA
176,TCGA-G2-A3IB,NO,,TCGA-G2-A3IB-D66249,AD2CE47B-EDF1-41B7-A6F5-37EB9F7FA188,NA,,NA,,NA,143,145,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,6,10,2014,TCGA-BLCA
174,TCGA-G2-A3IB,NO,,TCGA-G2-A3IB-D66245,97C76471-15CA-4401-8DC2-CF41E785A05C,NA,,NA,,NA,143,145,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,6,10,2014,TCGA-BLCA
177,TCGA-G2-A3IB,NO,,TCGA-G2-A3IB-D66250,E79E0B30-0DD8-4B1A-A0C0-F8B62FB21AB4,NA,,NA,,NA,143,145,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,6,10,2014,TCGA-BLCA
175,TCGA-G2-A3IB,NO,,TCGA-G2-A3IB-D66248,6027EDD0-09D5-4740-BFBB-683474BD2E46,NA,,NA,,NA,143,145,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,6,10,2014,TCGA-BLCA
178,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36968,ED0AF2E2-5F42-43D0-8D82-0BF7B8D15228,NA,,NA,,NA,29,68,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,20,11,2012,TCGA-BLCA
180,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36975,EF18CA04-7D1C-4580-B62B-20451BF14EAF,NA,,NA,,NA,29,68,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,20,11,2012,TCGA-BLCA
179,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36970,E18F0291-65B2-48A7-9BFF-43C214FEEF5E,NA,,NA,,NA,29,68,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,20,11,2012,TCGA-BLCA
184,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36983,70591683-FCF3-48E0-8E19-6D1559B9419D,NA,,NA,,NA,81,100,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,20,11,2012,TCGA-BLCA
181,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36977,B7D591DE-0ACE-4254-AA10-A217C5B92575,NA,,NA,,NA,81,100,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,20,11,2012,TCGA-BLCA
183,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36980,E6E275FF-BDEA-4F7A-B8DA-3579D9A765F8,NA,,NA,,NA,81,100,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,20,11,2012,TCGA-BLCA
182,TCGA-G2-A3IE,NO,,TCGA-G2-A3IE-D36978,A871439A-808A-4E69-A22A-014DB1C06E0A,NA,,NA,,NA,81,100,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,20,11,2012,TCGA-BLCA
186,TCGA-G2-AA3C,NO,,TCGA-G2-AA3C-D62137,FDF7A539-5619-45CA-8915-57C16EE5D42E,NA,,NA,,NA,111,200,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,11,7,2014,TCGA-BLCA
187,TCGA-G2-AA3C,NO,,TCGA-G2-AA3C-D62138,FB9A4401-CFEB-4B78-ABD2-AC6B25A42295,NA,,NA,,NA,111,200,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,11,7,2014,TCGA-BLCA
188,TCGA-G2-AA3D,YES,,TCGA-G2-AA3D-D64839,3B181732-907C-4A8B-ACFB-C2287A106CA5,NA,,NA,,NA,15,35,Chemotherapy,Erlotinib,HER1 inhibitor,Other,,,NA,,NO,Complete Response,12,9,2014,TCGA-BLCA
192,TCGA-G2-AA3D,NO,,TCGA-G2-AA3D-D64847,7CFD35E6-3228-419D-9266-FA974BB82E8F,NA,,NA,,NA,135,178,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,12,9,2014,TCGA-BLCA
189,TCGA-G2-AA3D,NO,,TCGA-G2-AA3D-D64842,856A8F22-E5B2-4D1D-8FF4-71A85E8004F7,NA,,NA,,NA,135,178,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,12,9,2014,TCGA-BLCA
191,TCGA-G2-AA3D,NO,,TCGA-G2-AA3D-D64846,C2128A11-E854-4827-A6D6-504653DCA925,NA,,NA,,NA,135,178,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,12,9,2014,TCGA-BLCA
190,TCGA-G2-AA3D,NO,,TCGA-G2-AA3D-D64845,F77B4195-85D3-48AD-81A1-8574236272DE,NA,,NA,,NA,135,178,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,12,9,2014,TCGA-BLCA
196,TCGA-G2-AA3F,NO,,TCGA-G2-AA3F-D71340,C72DF01F-E6DA-497E-BD93-20A799528BA7,NA,,NA,,NA,5,54,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,24,3,2015,TCGA-BLCA
193,TCGA-G2-AA3F,NO,,TCGA-G2-AA3F-D71336,AED7E12F-8A43-4630-87A9-9366CCD4D04E,NA,,NA,,NA,5,54,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,24,3,2015,TCGA-BLCA
194,TCGA-G2-AA3F,NO,,TCGA-G2-AA3F-D71338,E5AF71CF-5C34-4A39-82EB-2923D31956B4,NA,,NA,,NA,5,54,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,24,3,2015,TCGA-BLCA
195,TCGA-G2-AA3F,NO,,TCGA-G2-AA3F-D71339,C3D86C6B-69FE-4161-A290-F5EA18182DA5,NA,,NA,,NA,5,54,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,24,3,2015,TCGA-BLCA
4250,TCGA-G3-A25S,YES,NA,TCGA-G3-A25S-D45076,A74505A0-B326-4F72-8BBF-BF23538A5960,NA,,NA,,NA,313,348,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,Sunitinib VS Sorafenib,,,,NO,Clinical Progressive Disease,4,7,2013,TCGA-LIHC
4251,TCGA-G3-A25S,NO,NA,TCGA-G3-A25S-D45077,128B2718-B773-4D49-876C-19E3615F5E36,NA,,NA,,NA,351,369,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,4,7,2013,TCGA-LIHC
4252,TCGA-G3-A3CG,NO,NA,TCGA-G3-A3CG-D40229,97F4F766-A4E0-4356-BC34-568E8F1B07D7,NA,,NA,,NA,367,577,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,,,NO,Stable Disease,14,2,2013,TCGA-LIHC
4254,TCGA-G3-A3CJ,NO,NA,TCGA-G3-A3CJ-D40237,2579D68E-1CDC-4AB5-8F3B-E366F68B5152,NA,,NA,,NA,346,367,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,14,2,2013,TCGA-LIHC
4255,TCGA-G3-A5SI,NO,NA,TCGA-G3-A5SI-D59275,EF0713F1-6FF0-47EA-92BC-BE9682F0B8A6,NA,,NA,,NA,599,733,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,7,5,2014,TCGA-LIHC
4154,TCGA-G6-A5PC,NO,NA,TCGA-G6-A5PC-D44703,5DC3019B-3C23-44EF-9AE9-FF381CF2320F,,,,,NA,62,208,Targeted Molecular therapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,25,6,2013,TCGA-KIRC
4156,TCGA-G6-A8L6,NO,NA,TCGA-G6-A8L6-D58225,2D08B0B9-FCAE-43BE-92B4-1D58B09E5E00,,,,,NA,73,211,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Stable Disease,3,4,2014,TCGA-KIRC
4157,TCGA-G6-A8L6,NO,NA,TCGA-G6-A8L6-D58226,55CA8E78-C80B-4957-8A71-16D55025F6D7,,,,,NA,252,272,Chemotherapy,Axitnib,Angiogenesis inhibitor,Other,NA,,,,NO,Stable Disease,3,4,2014,TCGA-KIRC
4194,TCGA-G7-7501,NO,NA,TCGA-G7-7501-D32504,A6B2BEC9-9011-47FC-A542-517FF36A5A04,,,,,NA,110,506,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,30,5,2012,TCGA-KIRP
4196,TCGA-G7-A8LD,NO,NA,TCGA-G7-A8LD-D58201,5F699533-4420-4A60-97CE-888019539FE6,,,,,NA,340,417,Targeted Molecular therapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Clinical Progressive Disease,3,4,2014,TCGA-KIRP
4195,TCGA-G7-A8LD,NO,NA,TCGA-G7-A8LD-D58202,5D0D4B93-7C54-4E1D-891C-0264F8294D61,,,,,NA,424,446,Targeted Molecular therapy,Everolimus,MTOR inhibitor,Other,NA,,,,NO,Stable Disease,2,4,2014,TCGA-KIRP
8044,TCGA-G9-A9S0,NO,NA,TCGA-G9-A9S0-D60766,F7B52ECE-C4B6-460B-93FE-80E2B0FBB5E1,NA,NA,NA,,NA,444,528,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-PRAD
8045,TCGA-G9-A9S0,NO,NA,TCGA-G9-A9S0-D60767,47E9F8B2-F44D-49A1-ACED-7B3CE938AD99,NA,NA,NA,,NA,591,654,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-PRAD
8046,TCGA-G9-A9S0,NO,NA,TCGA-G9-A9S0-D60768,4F7E50A0-C217-4635-A1E3-677D4B516094,NA,NA,NA,,NA,727,727,Chemotherapy,Cabazitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-PRAD
8043,TCGA-G9-A9S0,NO,NA,TCGA-G9-A9S0-D60764,77C8FAC6-FFCB-4ED2-9C2C-DFD81649CDFE,NA,NA,NA,,NA,115,762,Hormone Therapy,Goserelin,LHRH agonist,Other,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-PRAD
198,TCGA-GC-A3YS,NO,,TCGA-GC-A3YS-D64046,F4260A3B-FA17-4169-8CF2-0CBDDD5FE2AF,NA,,NA,,NA,73,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,25,8,2014,TCGA-BLCA
197,TCGA-GC-A3YS,NO,,TCGA-GC-A3YS-D64044,FFFA5369-7D67-40A5-A120-A4CD5588F4B7,NA,,NA,,NA,73,146,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,25,8,2014,TCGA-BLCA
199,TCGA-GC-A3YS,NO,,TCGA-GC-A3YS-D64047,2E38DC3B-C361-45E6-B640-4FF41CEC51DD,NA,,NA,,NA,106,146,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,25,8,2014,TCGA-BLCA
206,TCGA-GD-A3OS,NO,,TCGA-GD-A3OS-D42522,ACBC4B23-5E53-4C87-B64E-6EB9D530A59F,NA,,NA,,NA,499,549,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-BLCA
8783,TCGA-GF-A3OT,NO,,TCGA-GF-A3OT-D33548,1186E0F3-0CCF-442F-B0D1-5A21422B21E8,NA,NA,NA,,NA,95,216,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,7,2012,TCGA-SKCM
8785,TCGA-GF-A3OT,NO,,TCGA-GF-A3OT-D33550,52AF2AFE-648C-4C38-9D6A-A4F98F4AE74F,NA,NA,NA,,NA,95,216,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,5,7,2012,TCGA-SKCM
8784,TCGA-GF-A3OT,NO,,TCGA-GF-A3OT-D33549,D6878F25-0FA5-4C49-BBD7-E8CB3CCBD96F,NA,NA,NA,,NA,95,216,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,5,7,2012,TCGA-SKCM
8786,TCGA-GF-A3OT,NO,,TCGA-GF-A3OT-D33551,48514E36-5918-4104-AC4E-5D0B107FD361,NA,NA,NA,,NA,249,249,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,5,7,2012,TCGA-SKCM
2475,TCGA-GM-A2D9,NO,,TCGA-GM-A2D9-D47254,64CF04C2-4790-4726-A0F7-9B4EF1148E1D,,,,,,559,1265,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2476,TCGA-GM-A2D9,NO,,TCGA-GM-A2D9-D47255,3BAECB5B-8DFC-452B-93BF-ED08CA82E4EC,,,,,,1266,1354,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2477,TCGA-GM-A2D9,NO,,TCGA-GM-A2D9-D47256,1BAEBAA5-762C-4559-8CFF-34C352DD5B0A,,,,,,1362,1455,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2478,TCGA-GM-A2D9,NO,,TCGA-GM-A2D9-D47257,F83B835B-003A-4E5D-AA90-9504C8171A8D,,,,,,1470,1567,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2481,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47214,FBF6B10E-F9FA-412E-8317-7BC12FDECECD,,,,,,74,147,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,8,2013,TCGA-BRCA
2479,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47211,1CE4C77C-03D8-4A3E-9B4E-17A37FEBF574,,,,,,74,147,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,23,8,2013,TCGA-BRCA
2480,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47213,9DBAC4E4-29D1-4620-BB0E-E85862C78A16,,,,,,74,147,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,23,8,2013,TCGA-BRCA
2482,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47215,A308134D-A87B-4D38-A1B5-AD5A5BACFF22,,,,,,203,276,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,23,8,2013,TCGA-BRCA
2483,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47217,F1691109-2DFB-4D93-B667-029E43AFA481,,,,,,203,276,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Complete Response,23,8,2013,TCGA-BRCA
2484,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47219,FDBDD508-2625-4646-B410-82178F238FB5,,,,,,3061,3131,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2485,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47220,A9D3732A-4B83-435F-AFE7-98604C52FEAF,,,,,,3061,3131,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2486,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47221,E6B44B72-350F-4D39-ACA6-4751D537EC29,,,,,,3141,3415,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2487,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47222,34A11D07-D395-44A8-B0FA-B6785948D3FE,,,,,,3434,4307,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2488,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47223,B90F3A89-5CDC-406E-B9B8-C850C6C5DD76,,,,,,4347,4435,Hormone Therapy,Megestrol,Progestin,Other,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2490,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47225,D8B2FED7-8269-47D8-90DC-E1A16E08E05F,,,,,,4470,4494,Chemotherapy,Trabectedin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2489,TCGA-GM-A2DA,YES,,TCGA-GM-A2DA-D47224,66BF0675-E5AC-453D-B319-3E0DCE3C4C2A,,,,,,4470,4494,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2491,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47228,A7B8633B-19CD-4008-887D-77BE720AF867,,,,,,4515,4720,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2492,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47229,E41E7973-FE0F-4D97-A8DB-69BFE8B0D08C,,,,,,4721,5015,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2493,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47230,F503B87E-A4F9-4FA8-9508-93B7658C1FDA,,,,,,5021,5455,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2494,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47231,B9F6747C-A8E8-4DFF-B2FF-6378094F03E1,,,,,,5455,5678,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2495,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47232,3411631A-3C34-4A06-A5E7-DB6F0E49CA25,,,,,,5684,5797,Chemotherapy,Ixabepilone,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2496,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47234,BAE1A1F1-6EDC-4E7E-BA5E-632C9F3E6AA9,,,,,,5797,6028,Immunotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2497,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47236,28B70E98-675A-4649-A171-1CCC398CFB9F,,,,,,5909,6029,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2498,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47237,D2F15985-953A-4B07-B205-27967C46571D,,,,,,6051,6213,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2500,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47240,4CDD3F8E-EFF0-49C7-972E-40AE2CAB2B7A,,,,,,6372,6422,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,23,8,2013,TCGA-BRCA
2499,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47238,89719FBA-E180-4F48-AE3B-75CBFB127146,,,,,,6051,6536,Chemotherapy,Lapatinib,HER1 inhibitor|HER2 inhibitor,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2501,TCGA-GM-A2DA,NO,,TCGA-GM-A2DA-D47241,EEBDC3B3-BCF1-4629-9C08-8129305599B7,,,,,,6372,6536,Immunotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Stable Disease,23,8,2013,TCGA-BRCA
2502,TCGA-GM-A2DB,NO,,TCGA-GM-A2DB-D47159,FCDFC8F4-07C3-4F53-A0E4-135FC08A31D6,,,,,,91,167,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2505,TCGA-GM-A2DB,NO,,TCGA-GM-A2DB-D47163,9DB393BE-D1F8-4423-BE3A-1201B189B8E6,,,,,,181,248,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2503,TCGA-GM-A2DB,NO,,TCGA-GM-A2DB-D47161,8109884C-3338-42A4-8167-9ABEF5678D23,,,,,,181,248,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2504,TCGA-GM-A2DB,NO,,TCGA-GM-A2DB-D47162,9C452D7D-4120-4BFE-B788-AEF890F1DA60,,,,,,181,248,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2506,TCGA-GM-A2DC,YES,,TCGA-GM-A2DC-D47063,679FB4FD-B762-4872-806F-4EE16E16D89D,,,,,,57,119,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2507,TCGA-GM-A2DC,YES,,TCGA-GM-A2DC-D47064,5E67582A-3CD1-4483-9C0E-C98EF42102E3,,,,,,57,119,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2510,TCGA-GM-A2DC,YES,,TCGA-GM-A2DC-D47067,DD73F85B-7DFB-4F68-ACDB-DA28D8449C86,,,,,,140,208,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2509,TCGA-GM-A2DC,YES,,TCGA-GM-A2DC-D47066,4D71435A-BF64-420E-BAAA-4892EADB051F,,,,,,140,208,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2511,TCGA-GM-A2DC,NO,,TCGA-GM-A2DC-D47068,9A846B76-30FF-41CC-854D-8BFDBE8D172E,,,,,,294,341,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2512,TCGA-GM-A2DC,NO,,TCGA-GM-A2DC-D47069,01F8744B-71EA-4966-BDDF-8D9D5CFD632C,,,,,,355,383,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2515,TCGA-GM-A2DD,NO,,TCGA-GM-A2DD-D47073,30DC9EB0-B305-4BC7-B006-221E80F1AE25,,,,,,90,202,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2513,TCGA-GM-A2DD,NO,,TCGA-GM-A2DD-D47071,2664E496-34C1-4DFB-893B-7102CD0171B3,,,,,,90,202,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2514,TCGA-GM-A2DD,NO,,TCGA-GM-A2DD-D47072,A4DAE917-9FC6-409F-9FDD-1E8F876394CA,,,,,,90,202,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2516,TCGA-GM-A2DF,NO,,TCGA-GM-A2DF-D47077,9309E85C-511C-4D64-A9FD-153D7D059F76,,,,,,82,159,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2519,TCGA-GM-A2DF,NO,,TCGA-GM-A2DF-D47080,0DE09D9B-CDA0-4E1C-A438-47238333BAF8,,,,,,166,229,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2517,TCGA-GM-A2DF,NO,,TCGA-GM-A2DF-D47078,BD3CED99-2972-42AC-A40F-65D713B00CF1,,,,,,166,229,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2518,TCGA-GM-A2DF,NO,,TCGA-GM-A2DF-D47079,9759BFEA-6BA0-47F3-8697-D4BE5FD98515,,,,,,166,229,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2520,TCGA-GM-A2DH,NO,,TCGA-GM-A2DH-D47082,556C375B-CFAB-497E-AE7A-22BC00FC3826,,,,,,86,163,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2523,TCGA-GM-A2DH,NO,,TCGA-GM-A2DH-D47085,4B6748E0-604F-422B-9752-189DFFF16BD8,,,,,,170,233,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2521,TCGA-GM-A2DH,NO,,TCGA-GM-A2DH-D47083,BA77ECF0-0A86-4F8A-9268-57921470CEC6,,,,,,170,233,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2522,TCGA-GM-A2DH,NO,,TCGA-GM-A2DH-D47084,5D627B00-9BA1-4D32-971B-CCE6AF02327A,,,,,,170,233,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2524,TCGA-GM-A2DI,NO,,TCGA-GM-A2DI-D47090,7B5D9D98-20F4-4180-8CAC-4343CFA7FCD3,,,,,,70,133,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2527,TCGA-GM-A2DI,NO,,TCGA-GM-A2DI-D47093,2D81179B-0BEB-492F-8B9F-5FA57D8F59D0,,,,,,154,217,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2525,TCGA-GM-A2DI,NO,,TCGA-GM-A2DI-D47091,5CFA2517-8901-4EA6-A4C7-92DA88C6C423,,,,,,154,217,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2526,TCGA-GM-A2DI,NO,,TCGA-GM-A2DI-D47092,7D31035E-0AC6-403A-B734-CA72E210C75F,,,,,,154,217,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2528,TCGA-GM-A2DK,NO,,TCGA-GM-A2DK-D47097,F92A5EEC-9F0D-4B49-8D7C-15E038B017EA,,,,,,79,1893,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2529,TCGA-GM-A2DL,NO,,TCGA-GM-A2DL-D47100,64A06228-D44D-48D4-920A-2EF984608DE9,,,,,,158,1989,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2531,TCGA-GM-A2DM,YES,,TCGA-GM-A2DM-D47106,AADE02DF-74F2-4DD1-A0AE-1429B9186906,,,,,,81,169,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2534,TCGA-GM-A2DM,YES,,TCGA-GM-A2DM-D47109,7C8F3B47-B784-4B27-9FB2-7B466008E490,,,,,,176,218,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2532,TCGA-GM-A2DM,YES,,TCGA-GM-A2DM-D47107,140AE260-F266-41E9-9467-8C7E03D3AB54,,,,,,176,218,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2533,TCGA-GM-A2DM,YES,,TCGA-GM-A2DM-D47108,873034B7-62ED-4DD0-AD5C-84DAB7801B20,,,,,,176,218,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2535,TCGA-GM-A2DM,NO,,TCGA-GM-A2DM-D47110,B5B25354-BF47-47EA-B68D-748265329F82,,,,,,279,772,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2536,TCGA-GM-A2DN,YES,,TCGA-GM-A2DN-D47126,2F3C7A0D-A528-4393-8A8C-E4BA2A55F39A,,,,,,167,244,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2539,TCGA-GM-A2DN,YES,,TCGA-GM-A2DN-D47129,9CB21DFD-9BDD-4A32-A8A7-1E5F2519AC34,,,,,,251,314,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2537,TCGA-GM-A2DN,YES,,TCGA-GM-A2DN-D47127,23F229E0-8687-49C9-A84B-FF6D954A025E,,,,,,251,314,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2538,TCGA-GM-A2DN,YES,,TCGA-GM-A2DN-D47128,F64D6F34-B6B3-4B1A-88DE-96B8C8A07835,,,,,,251,314,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2540,TCGA-GM-A2DN,NO,,TCGA-GM-A2DN-D47130,F102C2E8-AC64-42D3-8420-DD1DF9F856C0,,,,,,335,1063,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2541,TCGA-GM-A2DO,NO,,TCGA-GM-A2DO-D47154,C19E8E9F-4856-4D78-8214-60750D868B76,,,,,,219,2051,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,22,8,2013,TCGA-BRCA
2544,TCGA-GM-A3NW,NO,,TCGA-GM-A3NW-D40401,0C26CDE2-DE29-4331-B678-BF68B7E1F9F8,,,,,,65,181,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,19,2,2013,TCGA-BRCA
2543,TCGA-GM-A3NW,NO,,TCGA-GM-A3NW-D40399,5A6BEDB9-C5EB-404D-B70B-EA0253B4FC05,,,,,,65,181,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,18,2,2013,TCGA-BRCA
2545,TCGA-GM-A3NW,NO,,TCGA-GM-A3NW-D40400,F06F057C-E684-4B61-92FE-F22B0EF9A3F4,,,,,,65,181,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,19,2,2013,TCGA-BRCA
2542,TCGA-GM-A3NW,NO,,TCGA-GM-A3NW-D40402,94E98AC3-6333-4A5B-A854-BE225AD37D6F,,,,,,205,2055,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Stable Disease,18,2,2013,TCGA-BRCA
2547,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D35512,E32E194C-8D7D-4B56-BB63-4D33F4B1082A,,,,,,163,247,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2550,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D35519,34EC610D-426F-433C-94ED-1FB1BC4FF569,,,,,,261,324,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2548,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D35515,40EF982A-EAA8-4F0A-A86D-5ED6DA2150F7,,,,,,261,324,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2549,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D35516,53DCF90D-749C-447D-BA77-62545A2CCAAA,,,,,,261,324,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2551,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D41971,D44E9F6A-E7B4-4C08-BF20-B6A744CD1C78,,,,,,434,473,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,8,4,2013,TCGA-BRCA
2552,TCGA-GM-A3XG,NO,,TCGA-GM-A3XG-D41972,1E050AB5-3F95-403F-9CD2-15E62549A9B0,,,,,,813,843,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,8,4,2013,TCGA-BRCA
2555,TCGA-GM-A3XL,NO,,TCGA-GM-A3XL-D35525,AC30090D-D89E-4942-B93B-C44B8BBA2641,,,,,,100,163,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2553,TCGA-GM-A3XL,NO,,TCGA-GM-A3XL-D35523,E53B3221-61CB-48E0-A761-E99D86612033,,,,,,100,163,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2554,TCGA-GM-A3XL,NO,,TCGA-GM-A3XL-D35524,3C18A200-60E1-402E-B214-AE55C2033154,,,,,,100,163,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2556,TCGA-GM-A3XL,NO,,TCGA-GM-A3XL-D35526,A7375485-9703-446C-A59F-3E2E7F2A3E83,,,,,,191,248,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2557,TCGA-GM-A3XN,NO,,TCGA-GM-A3XN-D35531,FC4B09BC-E04D-4AAD-8ADC-943214589F12,,,,,,134,211,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2560,TCGA-GM-A3XN,NO,,TCGA-GM-A3XN-D35535,8AD2952D-C463-426C-BCFF-674C4A1821B8,,,,,,218,282,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2558,TCGA-GM-A3XN,NO,,TCGA-GM-A3XN-D35532,7594E8FE-166B-40DC-82BA-FAB360C98DB2,,,,,,218,282,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2559,TCGA-GM-A3XN,NO,,TCGA-GM-A3XN-D35534,D27177DE-0207-41D5-AA50-1BF7FAE5FBDC,,,,,,218,282,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,1,10,2012,TCGA-BRCA
2561,TCGA-GM-A3XN,NO,,TCGA-GM-A3XN-D41968,5A81151E-DC13-4510-B131-29DB3185B815,,,,,,416,1591,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Complete Response,8,4,2013,TCGA-BRCA
2563,TCGA-GM-A4E0,YES,,TCGA-GM-A4E0-D37113,76CCB5FF-A056-43DA-8555-AEDB5683ADAE,,,,,,121,184,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,26,11,2012,TCGA-BRCA
2564,TCGA-GM-A4E0,YES,,TCGA-GM-A4E0-D37115,4C24BBBE-85D7-4F91-867A-F3565F4E8AFB,,,,,,121,184,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,26,11,2012,TCGA-BRCA
2567,TCGA-GM-A4E0,YES,,TCGA-GM-A4E0-D37118,84DD5400-4F97-4F5B-BD39-228348DC7862,,,,,,226,289,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,11,2012,TCGA-BRCA
2565,TCGA-GM-A4E0,YES,,TCGA-GM-A4E0-D37116,503948AA-4087-417D-8768-32F533FEBEBE,,,,,,226,289,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,26,11,2012,TCGA-BRCA
2566,TCGA-GM-A4E0,YES,,TCGA-GM-A4E0-D37117,D672E4DB-472F-4FCA-A031-1EAA79128C90,,,,,,226,289,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,26,11,2012,TCGA-BRCA
2570,TCGA-GM-A5PV,NO,,TCGA-GM-A5PV-D42166,F72DFCCB-CAB4-4F6D-8B1B-FC0364E48134,,,,,,107,174,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,4,2013,TCGA-BRCA
2569,TCGA-GM-A5PV,NO,,TCGA-GM-A5PV-D42156,1316596D-D637-490A-BC7F-1E1C61EB3AE0,,,,,,107,174,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,4,2013,TCGA-BRCA
2571,TCGA-GM-A5PX,NO,,TCGA-GM-A5PX-D42160,D2BD571D-6658-48CB-88FE-77DAC9870F9C,,,,,,112,236,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,12,4,2013,TCGA-BRCA
2572,TCGA-GM-A5PX,NO,,TCGA-GM-A5PX-D42161,761DB280-F416-45BF-B1C0-88A1E9EFA3EF,,,,,,265,339,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Complete Response,12,4,2013,TCGA-BRCA
8791,TCGA-GN-A4U4,YES,,TCGA-GN-A4U4-D46802,48687698-3009-4D4E-8693-339068E62E60,NA,NA,NA,,NA,245,647,Chemotherapy,Axitinib,Angiogenesis inhibitor,Other,Axitnib,,,,NO,Partial Response,19,8,2013,TCGA-SKCM
8792,TCGA-GN-A4U4,NO,,TCGA-GN-A4U4-D46803,AB166A1C-9C3F-4D46-B14A-CABAA55EDF0B,NA,NA,NA,,NA,637,707,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Partial Response,19,8,2013,TCGA-SKCM
8793,TCGA-GN-A4U5,NO,,TCGA-GN-A4U5-D46800,D437D4B7-BEBA-4E21-B266-29C50FD7238C,NA,NA,NA,,NA,211,435,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,19,8,2013,TCGA-SKCM
8797,TCGA-GN-A4U9,NO,,TCGA-GN-A4U9-D61278,ABA25B40-E4EC-4E58-8CF7-84B6989E8EE6,NA,NA,NA,,NA,60,60,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,6,2014,TCGA-SKCM
8796,TCGA-GN-A4U9,NO,,TCGA-GN-A4U9-D46811,104BF2C9-701E-4587-AF21-E91ED4AC09E4,NA,NA,NA,,NA,165,249,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Partial Response,19,8,2013,TCGA-SKCM
8799,TCGA-GN-A4U9,YES,,TCGA-GN-A4U9-D61281,026B90A1-398A-49A0-9EBE-CE0B7F3BE347,NA,NA,NA,,NA,523,579,Chemotherapy,Axitinib,Angiogenesis inhibitor,Other,chemotherapy,,,,NO,Clinical Progressive Disease,26,6,2014,TCGA-SKCM
8800,TCGA-GN-A8LK,NO,,TCGA-GN-A8LK-D58257,61C2C4C7-384F-4ACD-99CB-9B4287758D0D,NA,NA,NA,,NA,1248,1269,Chemotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,3,4,2014,TCGA-SKCM
8802,TCGA-GN-A8LK,YES,,TCGA-GN-A8LK-D58249,6F02B9B4-2E3C-407B-B449-0BAADD6BC667,NA,NA,NA,,NA,1407,1428,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,3,4,2014,TCGA-SKCM
8801,TCGA-GN-A8LK,NO,,TCGA-GN-A8LK-D58248,A0C95321-3246-438C-BC36-81C43E81DC6A,NA,NA,NA,,NA,1493,1513,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,3,4,2014,TCGA-SKCM
8803,TCGA-GN-A8LN,NO,,TCGA-GN-A8LN-D67402,BCE3BE49-6608-4A70-9687-0ACFA271E31A,NA,NA,NA,,NA,464,464,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Partial Response,4,11,2014,TCGA-SKCM
8810,TCGA-GN-A9SD,NO,,TCGA-GN-A9SD-D61267,9297715F-2400-4139-AF60-263A265A2C54,NA,NA,NA,,NA,1268,1268,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,26,6,2014,TCGA-SKCM
8807,TCGA-GN-A9SD,NO,,TCGA-GN-A9SD-D61261,F65A7C23-E8EE-4C17-83E2-FE0459FC7B01,NA,NA,NA,,NA,1268,1268,Chemotherapy,Dactinomycin,RNA synthesis inhibitor,Other,,,,,NO,Clinical Progressive Disease,26,6,2014,TCGA-SKCM
8808,TCGA-GN-A9SD,NO,,TCGA-GN-A9SD-D61262,CED20E6D-56DA-4652-A6E8-441AC129A7F2,NA,NA,NA,,NA,1366,1366,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,26,6,2014,TCGA-SKCM
8809,TCGA-GN-A9SD,NO,,TCGA-GN-A9SD-D61264,CCF59FEE-AB6E-4C88-A9D5-A1FF349E15F8,NA,NA,NA,,NA,1519,1687,Chemotherapy,Vemurafenib,Proapoptotic,Other,,,,,NO,Clinical Progressive Disease,26,6,2014,TCGA-SKCM
207,TCGA-GU-A42R,NO,,TCGA-GU-A42R-D66344,37B5BF80-1114-4AC1-A162-AEA65A922BFD,NA,,NA,,NA,105,344,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,10,10,2014,TCGA-BLCA
208,TCGA-GU-A42R,NO,,TCGA-GU-A42R-D66345,AC9DC3F1-BB17-4D91-B956-0AB30EF5F8AD,NA,,NA,,NA,105,344,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,10,10,2014,TCGA-BLCA
209,TCGA-GV-A3JW,NO,,TCGA-GV-A3JW-D41958,468BA57F-D035-4485-AACC-4B98C6DA1D64,NA,,NA,,NA,291,321,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,8,4,2013,TCGA-BLCA
210,TCGA-GV-A3JW,NO,,TCGA-GV-A3JW-D41960,2D58D7E3-0704-4B8C-9F30-70D128D38753,NA,,NA,,NA,291,321,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,8,4,2013,TCGA-BLCA
212,TCGA-GV-A3QF,NO,,TCGA-GV-A3QF-D34428,C3084EB0-5C6B-4C02-8C48-9A1153E1241B,NA,,NA,,NA,197,246,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,14,8,2012,TCGA-BLCA
213,TCGA-GV-A3QF,NO,,TCGA-GV-A3QF-D34429,9B75FBD1-AA78-46F4-A764-2940950BAF52,NA,,NA,,NA,197,261,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,14,8,2012,TCGA-BLCA
214,TCGA-GV-A3QH,NO,,TCGA-GV-A3QH-D34426,9CF70C19-B60F-494B-948B-D1E6355C2A91,NA,,NA,,NA,135,170,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,14,8,2012,TCGA-BLCA
215,TCGA-GV-A3QH,NO,,TCGA-GV-A3QH-D34427,31442F55-E1D1-40C8-B27E-2AF7845AC2BF,NA,,NA,,NA,135,170,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,14,8,2012,TCGA-BLCA
216,TCGA-GV-A3QI,NO,,TCGA-GV-A3QI-D68565,94144F45-DE4A-4761-ACAA-075FEFF890D8,NA,,NA,,NA,771,895,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,26,11,2014,TCGA-BLCA
219,TCGA-GV-A40E,NO,,TCGA-GV-A40E-D46771,80544398-4595-44E5-9650-9587BA3A39A8,NA,,NA,,NA,56,98,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,9,9,2013,TCGA-BLCA
220,TCGA-GV-A40E,NO,,TCGA-GV-A40E-D46772,33632558-830A-43A8-90A6-7E36DF5AE959,NA,,NA,,NA,56,98,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,9,9,2013,TCGA-BLCA
7864,TCGA-H6-8124,NO,NA,TCGA-H6-8124-D34032,508EEB59-7B5C-48F2-9BA5-AC26611E312B,NA,NA,NA,NA,NA,166,205,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,26,7,2012,TCGA-PAAD
3883,TCGA-H7-A6C4,NO,NA,TCGA-H7-A6C4-D52044,0F0597F1-75B8-449A-BBFB-E6C6A65DF58B,NA,,NA,,NA,NA,113,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,11,2013,TCGA-HNSC
3884,TCGA-H7-A6C4,NO,NA,TCGA-H7-A6C4-D52046,48D634EA-A71B-4D0A-AFF3-BD9490F2C76E,NA,,NA,,NA,NA,321,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,27,11,2013,TCGA-HNSC
3882,TCGA-H7-A6C4,,NA,TCGA-H7-A6C4-D52043,C9C7CB40-30B9-4383-A2E0-7972E9914041,NA,,NA,,NA,74,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,11,2013,TCGA-HNSC
7865,TCGA-H8-A6C1,,NA,TCGA-H8-A6C1-D52309,D8929BA0-40EB-44C7-A554-FF76CFBC7B33,NA,NA,NA,NA,NA,79,233,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,2,12,2013,TCGA-PAAD
8510,TCGA-HB-A43Z,NO,NA,TCGA-HB-A43Z-D50689,5F09268D-2947-4627-8C4A-FA104BF5676A,NA,,NA,,NA,42,105,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,29,10,2013,TCGA-SARC
8511,TCGA-HB-A43Z,NO,NA,TCGA-HB-A43Z-D50690,2D31D09A-B7C4-4656-A447-2E9140CE27E1,NA,,NA,,NA,42,105,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,29,10,2013,TCGA-SARC
8512,TCGA-HB-A43Z,NO,NA,TCGA-HB-A43Z-D50691,D483DCCF-3CAE-40DA-AE10-5B0960B9102C,NA,,NA,,NA,126,189,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,29,10,2013,TCGA-SARC
8048,TCGA-HC-7742,NO,NA,TCGA-HC-7742-D72544,0CC1808F-7441-4F7B-A58A-6FFED3869170,NA,NA,NA,,NA,211,NA,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,YES,Partial Response,13,7,2015,TCGA-PRAD
8051,TCGA-HC-A9TE,NO,NA,TCGA-HC-A9TE-D72406,989AB91F-04CE-463E-AD31-5384C711656E,NA,NA,NA,,NA,216,417,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Stable Disease,10,6,2015,TCGA-PRAD
3888,TCGA-HD-7229,NO,NA,TCGA-HD-7229-D64310,15A8D8D6-99D9-46CF-B88D-29C97991D2C7,NA,,NA,,NA,187,187,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,28,8,2014,TCGA-HNSC
3890,TCGA-HD-7229,NO,NA,TCGA-HD-7229-D64312,86DDF2DE-FA13-426F-80AC-325EB7A10A02,NA,,NA,,NA,187,187,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,28,8,2014,TCGA-HNSC
3889,TCGA-HD-7229,NO,NA,TCGA-HD-7229-D64311,2A72E5DE-3D94-41EA-A33D-C6ED26D8A9C2,NA,,NA,,NA,187,187,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,28,8,2014,TCGA-HNSC
3891,TCGA-HD-7753,NO,NA,TCGA-HD-7753-D64315,69A92CC1-BEF7-4E0B-8305-F98D83B905C9,NA,,NA,,NA,71,85,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,28,8,2014,TCGA-HNSC
3892,TCGA-HD-8224,NO,NA,TCGA-HD-8224-D51231,78079EB9-5B8A-4EB2-A11B-32931552F7F7,NA,,NA,,NA,90,147,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,13,11,2013,TCGA-HNSC
3893,TCGA-HD-8314,NO,NA,TCGA-HD-8314-D64326,01833303-65F6-411B-BE41-32AEADD47BDA,NA,,NA,,NA,79,121,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,8,2014,TCGA-HNSC
2830,TCGA-HG-A2PA,NO,NA,TCGA-HG-A2PA-D33513,D5B1F254-E5C8-48D9-9402-A558837BF830,NA,,NA,,NA,NA,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,5,7,2012,TCGA-CESC
2829,TCGA-HG-A2PA,NO,NA,TCGA-HG-A2PA-D33512,EE17B0E2-CE3E-43C0-80C9-57134F94BA7C,NA,,NA,,NA,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,5,7,2012,TCGA-CESC
2831,TCGA-HG-A9SC,NO,NA,TCGA-HG-A9SC-D60991,64D96D07-DE09-491B-8668-3102380DA868,NA,,NA,,NA,69,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,6,2014,TCGA-CESC
8054,TCGA-HI-7168,NO,NA,TCGA-HI-7168-D66331,40EC4A2B-7BA7-4D93-8CAC-FB9A4E814D2E,NA,NA,NA,,NA,1552,2014,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,10,10,2014,TCGA-PRAD
9186,TCGA-HJ-7597,NO,,TCGA-HJ-7597-D32547,91F08499-C9F4-4179-977F-A1A96392F19B,,,,,NA,296,471,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,31,5,2012,TCGA-STAD
9187,TCGA-HJ-7597,NO,,TCGA-HJ-7597-D32549,370C9E04-8F29-4DBD-B78D-2E2E01B3FD0B,,,,,NA,296,471,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,31,5,2012,TCGA-STAD
9188,TCGA-HJ-7597,NO,,TCGA-HJ-7597-D32554,6DDED852-7857-49FD-9A3B-BE565DE984C0,,,,,NA,793,795,Chemotherapy,Methotrexate,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,31,5,2012,TCGA-STAD
3894,TCGA-HL-7533,NO,NA,TCGA-HL-7533-D48759,E2C4D622-6D31-49C1-B697-B920B4734CFD,NA,,NA,,NA,24,87,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,9,2013,TCGA-HNSC
3896,TCGA-HL-7533,NO,NA,TCGA-HL-7533-D48761,A3A1EBF1-F125-413D-9A93-EB84F44577A2,NA,,NA,,NA,24,87,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,20,9,2013,TCGA-HNSC
3895,TCGA-HL-7533,NO,NA,TCGA-HL-7533-D48760,F5D122A1-281B-4BAB-9B1B-0DCDC88619EB,NA,,NA,,NA,24,87,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,20,9,2013,TCGA-HNSC
2834,TCGA-HM-A4S6,NO,NA,TCGA-HM-A4S6-D42760,D3B2B9D8-5887-4271-8C20-F368C42E0097,NA,,NA,,NA,223,243,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,4,2013,TCGA-CESC
8811,TCGA-HR-A2OH,NO,,TCGA-HR-A2OH-D35734,14B225B5-367B-4D68-B6E0-921D5DCF5561,NA,NA,NA,,NA,108,471,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Complete Response,16,10,2012,TCGA-SKCM
8812,TCGA-HR-A2OH,NO,,TCGA-HR-A2OH-D35737,E4A61CA2-56B3-4AC8-BE92-8D8329B14C09,NA,NA,NA,,NA,1729,1753,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,16,10,2012,TCGA-SKCM
8514,TCGA-HS-A5N9,NO,NA,TCGA-HS-A5N9-D49078,756B43EB-8191-484B-92CE-2D8F9A608158,NA,,NA,,NA,49,91,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,25,9,2013,TCGA-SARC
9189,TCGA-HU-8238,NO,,TCGA-HU-8238-D42590,0A1520C0-8375-43B2-B309-C50C377C8746,,,,,NA,18,135,Chemotherapy,Didox,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9191,TCGA-HU-8243,NO,,TCGA-HU-8243-D42415,E3FC6226-824F-41AE-9FD2-B8468E8FF6BC,,,,,NA,36,157,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,26,4,2013,TCGA-STAD
9192,TCGA-HU-8249,NO,,TCGA-HU-8249-D42416,7F56CD5D-86E2-4D92-8925-DDCC98650C78,,,,,NA,27,286,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,26,4,2013,TCGA-STAD
9193,TCGA-HU-8602,NO,,TCGA-HU-8602-D42417,BA8CD6F4-CA91-4C9F-B1F3-E123F5013B46,,,,,NA,30,154,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,26,4,2013,TCGA-STAD
9197,TCGA-HU-A4G3,NO,,TCGA-HU-A4G3-D42583,AC5F6D07-2A0C-4D66-AC41-6CA7629E4A9F,,,,,NA,20,97,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9198,TCGA-HU-A4G3,NO,,TCGA-HU-A4G3-D42584,85535BA0-CB53-4E72-AA93-66DA4FCF2273,,,,,NA,111,184,Chemotherapy,Doxifluridine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9201,TCGA-HU-A4GD,NO,,TCGA-HU-A4GD-D42586,20650429-0759-41B3-BCA9-547FE96DD7FC,,,,,NA,20,76,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9202,TCGA-HU-A4GD,NO,,TCGA-HU-A4GD-D42587,5DF77FF1-7DDB-40D9-A9C6-5F96966B4FE6,,,,,NA,90,397,Chemotherapy,Doxifluridine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9208,TCGA-HU-A4GJ,NO,,TCGA-HU-A4GJ-D42591,A166BF62-DB7E-4884-AFDF-7F3103766133,,,,,NA,39,187,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9207,TCGA-HU-A4GJ,NO,,TCGA-HU-A4GJ-D42655,F6139820-C991-409B-B664-F52203E7A7E9,,,,,NA,39,222,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9206,TCGA-HU-A4GJ,NO,,TCGA-HU-A4GJ-D42656,BE11EE31-1399-4671-A094-92FCC165049F,,,,,NA,564,677,Chemotherapy,TS-1,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9211,TCGA-HU-A4GN,NO,,TCGA-HU-A4GN-D42592,C18BBECB-2DA0-40E6-B8CD-1BEFB5195362,,,,,NA,27,100,Chemotherapy,Mitomycin,DNA synthesis inhibitor,Other,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9212,TCGA-HU-A4GP,NO,,TCGA-HU-A4GP-D42595,99F8A9B1-DC2D-4C3D-8786-9B67216B7F0A,,,,,NA,70,362,Chemotherapy,Didox,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9215,TCGA-HU-A4GT,NO,,TCGA-HU-A4GT-D42597,55D81573-576F-40C3-8F85-070D3733CECF,,,,,NA,43,279,Chemotherapy,Didox,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,26,4,2013,TCGA-STAD
9217,TCGA-HU-A4GX,NO,,TCGA-HU-A4GX-D42599,DA2BC0A9-5B0F-41FB-B4CF-23F58CAE64C2,,,,,NA,48,48,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,26,4,2013,TCGA-STAD
9216,TCGA-HU-A4GX,NO,,TCGA-HU-A4GX-D42598,8AC674A8-6EE9-438E-B986-8153087EDB30,,,,,NA,48,48,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,26,4,2013,TCGA-STAD
9218,TCGA-HU-A4H3,NO,,TCGA-HU-A4H3-D41381,824F83CB-92EE-4A46-B268-5F3AE38BC708,,,,,NA,18,316,Chemotherapy,TS-1,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,25,4,2013,TCGA-STAD
9220,TCGA-HU-A4H3,NO,,TCGA-HU-A4H3-D42582,36BD2379-DDA1-46E1-9ACC-4218A712E883,,,,,NA,466,666,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,26,4,2013,TCGA-STAD
9219,TCGA-HU-A4H3,NO,,TCGA-HU-A4H3-D42338,3182424B-B793-4C4A-AE9D-3417249B826E,,,,,NA,466,NA,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,YES,Clinical Progressive Disease,26,4,2013,TCGA-STAD
9221,TCGA-HU-A4H4,NO,,TCGA-HU-A4H4-D41382,18B88DA0-0F13-4A38-AE5B-883CED6838BE,,,,,NA,13,309,Chemotherapy,TS-1,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,26,4,2013,TCGA-STAD
7871,TCGA-HV-A7OP,NO,NA,TCGA-HV-A7OP-D67213,370AA8D0-2461-45B6-B4C0-DE5A40779D27,NA,NA,NA,NA,NA,39,77,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,3,11,2014,TCGA-PAAD
7875,TCGA-HV-AA8V,NO,NA,TCGA-HV-AA8V-D72241,8323105D-38AA-4E51-84BB-387F82A70B99,NA,NA,NA,NA,NA,37,149,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2015,TCGA-PAAD
7877,TCGA-HV-AA8V,NO,NA,TCGA-HV-AA8V-D72242,06AC957A-3385-44C1-A0CF-F0E9107C9CCF,NA,NA,NA,NA,NA,281,435,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2015,TCGA-PAAD
7876,TCGA-HV-AA8V,NO,NA,TCGA-HV-AA8V-D72243,4F2A89FB-2702-40BC-861F-8FF4DBDD57E1,NA,NA,NA,NA,NA,568,780,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2015,TCGA-PAAD
7878,TCGA-HV-AA8X,NO,NA,TCGA-HV-AA8X-D72249,C83FD968-BEDE-4190-875E-DC65E85123D8,NA,NA,NA,NA,NA,45,253,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2015,TCGA-PAAD
7880,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72664,E2385762-DEE4-45BD-8C0B-3DA126327F68,NA,NA,NA,NA,NA,98,137,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,31,7,2015,TCGA-PAAD
7881,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72665,9E8EAD9F-F9BF-4CF4-8806-2F0AFD879553,NA,NA,NA,NA,NA,553,666,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7883,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72667,A53BCC31-06A9-40A8-980C-20F765053DDB,NA,NA,NA,NA,NA,553,666,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7884,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72668,5388C347-CACE-4321-BFA6-FFFF9F09EF36,NA,NA,NA,NA,NA,553,666,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7882,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72666,7B3514AA-8450-4F5C-A1C6-7614441EAE16,NA,NA,NA,NA,NA,553,666,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7885,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72670,25EBA8D5-CD97-4047-BBDD-A0581EBBCC29,NA,NA,NA,NA,NA,910,960,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7887,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72672,1F781A65-C73D-45BD-A881-B782D63903C2,NA,NA,NA,NA,NA,910,960,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7888,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72673,3D4ABD41-5041-4DA3-AF5C-790CEE5DCC4C,NA,NA,NA,NA,NA,910,960,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7886,TCGA-HZ-7918,NO,NA,TCGA-HZ-7918-D72671,A2826676-98FC-452C-87F2-4E8FFB70B9A5,NA,NA,NA,NA,NA,910,960,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Stable Disease,31,7,2015,TCGA-PAAD
7889,TCGA-HZ-7920,NO,NA,TCGA-HZ-7920-D64071,FC58BD99-3E4F-4C3E-8A7D-6C3CA81CF027,NA,NA,NA,NA,NA,83,118,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,25,8,2014,TCGA-PAAD
7890,TCGA-HZ-7923,NO,NA,TCGA-HZ-7923-D72676,83F7B80F-5EB2-40BF-939C-EA71A0E97AA8,NA,NA,NA,NA,NA,54,194,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,31,7,2015,TCGA-PAAD
7891,TCGA-HZ-7924,NO,NA,TCGA-HZ-7924-D57845,022EC51A-D780-41C1-9D78-DE080E75F4ED,NA,NA,NA,NA,NA,253,522,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,27,3,2014,TCGA-PAAD
7892,TCGA-HZ-8001,NO,NA,TCGA-HZ-8001-D57842,12857F31-99EC-4596-86EC-31F5E78D9280,NA,NA,NA,NA,NA,97,265,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,27,3,2014,TCGA-PAAD
7893,TCGA-HZ-8001,NO,NA,TCGA-HZ-8001-D57843,3D0001CF-08CD-472F-943A-00DF0047F566,NA,NA,NA,NA,NA,97,265,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,27,3,2014,TCGA-PAAD
7894,TCGA-HZ-8317,NO,NA,TCGA-HZ-8317-D60076,75212706-9CCE-4F18-BC1F-3C429D082EB5,NA,NA,NA,NA,NA,137,186,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,5,2014,TCGA-PAAD
7896,TCGA-HZ-8637,NO,NA,TCGA-HZ-8637-D64067,3B49C778-D44B-4D73-8C3B-910910F50C66,NA,NA,NA,NA,NA,76,351,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,25,8,2014,TCGA-PAAD
7897,TCGA-HZ-A49G,NO,NA,TCGA-HZ-A49G-D60086,F497A5B1-D10C-4497-9285-3FC56A92F5CF,NA,NA,NA,NA,NA,81,235,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,5,2014,TCGA-PAAD
7898,TCGA-HZ-A49H,NO,NA,TCGA-HZ-A49H-D57840,68768597-332F-451D-8B10-702DD2B3960B,NA,NA,NA,NA,NA,121,207,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,27,3,2014,TCGA-PAAD
7899,TCGA-HZ-A49I,NO,NA,TCGA-HZ-A49I-D60081,FB71A107-2BC7-4D38-B3D3-499864A3FA74,NA,NA,NA,NA,NA,51,86,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,5,2014,TCGA-PAAD
7901,TCGA-HZ-A77O,NO,NA,TCGA-HZ-A77O-D64069,574A567E-8F03-4CF2-A448-9C4226FD397D,NA,NA,NA,NA,NA,96,120,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,25,8,2014,TCGA-PAAD
7902,TCGA-HZ-A77P,NO,NA,TCGA-HZ-A77P-D65996,4A96715E-5C08-4F9A-93DB-CCD70643F77C,NA,NA,NA,NA,NA,48,146,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,1,10,2014,TCGA-PAAD
7908,TCGA-HZ-A9TJ,NO,NA,TCGA-HZ-A9TJ-D72287,442C68D7-31BB-4A33-8B82-0B04D504F7D1,NA,NA,NA,NA,NA,81,532,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,1,5,2015,TCGA-PAAD
4201,TCGA-IA-A83W,NO,NA,TCGA-IA-A83W-D56323,D3BE17C8-B8E5-4020-8A86-95080E6E2C0D,,,,,NA,496,601,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,3,3,2014,TCGA-KIRP
4198,TCGA-IA-A83W,NO,NA,TCGA-IA-A83W-D56320,B7C47520-760B-411F-9753-7A115AB176EB,,,,,NA,496,601,Chemotherapy,Rituximab,Anti-CD20,Other,NA,,,,NO,Complete Response,3,3,2014,TCGA-KIRP
4199,TCGA-IA-A83W,NO,NA,TCGA-IA-A83W-D56321,5E01E73A-58DE-4BA7-8D65-58499C2097CA,,,,,NA,496,601,Chemotherapy,Vincristine,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,3,3,2014,TCGA-KIRP
4200,TCGA-IA-A83W,NO,NA,TCGA-IA-A83W-D56322,BB498EFE-DC3B-442F-B80C-4C28D72912EC,,,,,NA,496,601,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Complete Response,3,3,2014,TCGA-KIRP
7909,TCGA-IB-7644,NO,NA,TCGA-IB-7644-D42858,4916CEEB-D0B0-4FF8-A182-8BDFF23007DF,NA,NA,NA,NA,NA,74,217,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,2,5,2013,TCGA-PAAD
7910,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D42899,CF6EE2D8-83B1-4E57-8AA1-978F7751E1DC,NA,NA,NA,NA,NA,38,178,Ancillary,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,2,5,2013,TCGA-PAAD
7913,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D44150,7B70B9F7-0FB7-472F-9F9C-8DFDA26EB8D5,NA,NA,NA,NA,NA,38,178,Chemotherapy,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Complete Response,14,6,2013,TCGA-PAAD
7911,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D42900,170F3417-5B57-409A-BBB0-287D4C53F101,NA,NA,NA,NA,NA,811,1230,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,2,5,2013,TCGA-PAAD
7916,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D44153,F0AC5612-4668-4F72-B19C-5A005F87DF81,NA,NA,NA,NA,NA,1224,1230,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7917,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D44154,662AF449-A9E9-4FC3-B8DA-C34CFBAF6CEE,NA,NA,NA,NA,NA,1224,1230,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7912,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D42901,5A729D61-0079-4105-9AE7-045C05258153,NA,NA,NA,NA,NA,1309,1377,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,2,5,2013,TCGA-PAAD
7914,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D44151,BB1A27AB-6136-4F3A-ACE3-6FD08CE7870E,NA,NA,NA,NA,NA,1309,1377,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7915,TCGA-IB-7645,NO,NA,TCGA-IB-7645-D44152,1FFC68F9-3714-445C-815C-32295945EA79,NA,NA,NA,NA,NA,1309,1377,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7918,TCGA-IB-7647,NO,NA,TCGA-IB-7647-D42902,C9594EA0-89E7-4243-A00A-D6A1896CDAC9,NA,NA,NA,NA,NA,141,537,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,2,5,2013,TCGA-PAAD
7919,TCGA-IB-7651,YES,NA,TCGA-IB-7651-D40046,9B0A7C2C-CA89-4061-9917-2C7F15749F9A,NA,NA,NA,NA,NA,124,343,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,11,2,2013,TCGA-PAAD
7920,TCGA-IB-7651,NO,NA,TCGA-IB-7651-D40047,6D399C33-0262-4B9F-8330-E59396E4E1EF,NA,NA,NA,NA,NA,581,581,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,11,2,2013,TCGA-PAAD
7922,TCGA-IB-7651,NO,NA,TCGA-IB-7651-D44160,96D6BB4C-9638-4F6C-8E86-EB16FB647329,NA,NA,NA,NA,NA,581,581,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7921,TCGA-IB-7651,NO,NA,TCGA-IB-7651-D44157,3BCCF868-B1CE-43A1-842B-FF7FA9D83C50,NA,NA,NA,NA,NA,581,581,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Clinical Progressive Disease,14,6,2013,TCGA-PAAD
7923,TCGA-IB-7652,NO,NA,TCGA-IB-7652-D40035,279B8298-D221-4991-A67D-8FF40A046D2E,NA,NA,NA,NA,NA,115,268,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,2,2013,TCGA-PAAD
7924,TCGA-IB-7885,NO,NA,TCGA-IB-7885-D40030,F05C14B6-7552-4E4E-A85D-4669B869B8F6,NA,NA,NA,NA,NA,95,279,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,2,2013,TCGA-PAAD
7925,TCGA-IB-7888,NO,NA,TCGA-IB-7888-D40069,CB5B9C64-2EC8-4338-A27D-FA240F4C4C65,NA,NA,NA,NA,NA,154,329,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,12,2,2013,TCGA-PAAD
7927,TCGA-IB-7888,NO,NA,TCGA-IB-7888-D42985,9A45153C-0BBB-44DB-B71D-B850B3057DB3,NA,NA,NA,NA,NA,154,329,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,7,5,2013,TCGA-PAAD
7926,TCGA-IB-7888,NO,NA,TCGA-IB-7888-D40070,B6EF5CED-D7E6-46D7-8A1C-A461CF9983D2,NA,NA,NA,NA,NA,448,881,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,12,2,2013,TCGA-PAAD
7928,TCGA-IB-7889,NO,NA,TCGA-IB-7889-D40066,A4B3434A-F611-4A48-BD5E-CB14E23CD727,NA,NA,NA,NA,NA,125,202,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,12,2,2013,TCGA-PAAD
7929,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D43048,2E5CEE41-CBA8-4D51-B982-FEEEB16F328C,NA,NA,NA,NA,NA,70,223,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,9,5,2013,TCGA-PAAD
7934,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D46054,8FC87582-4EE8-47F2-BF1C-6CA5CB8155A7,NA,NA,NA,NA,NA,539,539,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,30,7,2013,TCGA-PAAD
7930,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D43049,46B446D6-BAFD-4307-975C-0DE5D2169ADA,NA,NA,NA,NA,NA,539,539,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,9,5,2013,TCGA-PAAD
7932,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D46052,1553F9AB-BF4A-4ACF-88D3-060CA4A2A696,NA,NA,NA,NA,NA,539,539,Chemotherapy,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Stable Disease,30,7,2013,TCGA-PAAD
7933,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D46053,4094693F-A2CF-4EAF-B56F-F6253EE2FA68,NA,NA,NA,NA,NA,539,539,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Stable Disease,30,7,2013,TCGA-PAAD
7935,TCGA-IB-7891,NO,NA,TCGA-IB-7891-D46055,F7A15F0B-8D75-41E4-ABF0-5DE0D51B6734,NA,NA,NA,NA,NA,564,859,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,30,7,2013,TCGA-PAAD
7936,TCGA-IB-8126,NO,NA,TCGA-IB-8126-D68000,AF35AC96-0CDD-401D-A609-AFFB75EE4B33,NA,NA,NA,NA,NA,103,413,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,13,11,2014,TCGA-PAAD
7937,TCGA-IB-8127,NO,NA,TCGA-IB-8127-D40064,416B61B8-1979-4DC2-91A9-E9A4465F1E62,NA,NA,NA,NA,NA,60,194,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,12,2,2013,TCGA-PAAD
7938,TCGA-IB-A5SO,NO,NA,TCGA-IB-A5SO-D42690,54B00A96-AECF-494E-80FC-4B6C29E22184,NA,NA,NA,NA,NA,309,309,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,26,4,2013,TCGA-PAAD
7939,TCGA-IB-A5SP,NO,NA,TCGA-IB-A5SP-D42694,709A2002-9DF0-4574-80ED-A16341327B10,NA,NA,NA,NA,NA,90,169,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,26,4,2013,TCGA-PAAD
7940,TCGA-IB-A5SS,NO,NA,TCGA-IB-A5SS-D42673,27D5DE68-9CE7-464C-80A2-97D09BD28F77,NA,NA,NA,NA,NA,52,259,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,26,4,2013,TCGA-PAAD
7941,TCGA-IB-A6UF,NO,NA,TCGA-IB-A6UF-D61083,4FD47E93-03F7-4448-9377-CAFF9396AFE1,NA,NA,NA,NA,NA,117,271,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,23,6,2014,TCGA-PAAD
7948,TCGA-IB-A7LX,NO,NA,TCGA-IB-A7LX-D56392,47A24FE5-3CCC-44E0-9AE4-B9AF038EA9C9,NA,NA,NA,NA,NA,53,151,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-PAAD
7945,TCGA-IB-A7LX,NO,NA,TCGA-IB-A7LX-D56389,49BD1C12-C61A-4597-893B-CFADB72E8A1B,NA,NA,NA,NA,NA,53,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-PAAD
7946,TCGA-IB-A7LX,NO,NA,TCGA-IB-A7LX-D56390,2B44D38F-905F-4300-9CB5-CCD49A275F3A,NA,NA,NA,NA,NA,53,151,Ancillary,Folinic acid,Rescue agent,Other,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-PAAD
7947,TCGA-IB-A7LX,NO,NA,TCGA-IB-A7LX-D56391,8C588F94-66D7-4CC3-8A04-627383E9E485,NA,NA,NA,NA,NA,53,151,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-PAAD
7949,TCGA-IB-A7LX,NO,NA,TCGA-IB-A7LX-D56393,AE5B9D5C-D218-40BD-83C0-18035DB3D27F,NA,NA,NA,NA,NA,193,230,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-PAAD
7950,TCGA-IB-AAUO,NO,NA,TCGA-IB-AAUO-D60094,5228BF50-9611-4122-8C58-CBE1CC2D606C,NA,NA,NA,NA,NA,91,205,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,5,2014,TCGA-PAAD
7954,TCGA-IB-AAUQ,NO,NA,TCGA-IB-AAUQ-D60163,BFA8B745-20F0-490C-A104-F9C68B1FCE55,NA,NA,NA,NA,NA,135,169,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,30,5,2014,TCGA-PAAD
7952,TCGA-IB-AAUQ,NO,NA,TCGA-IB-AAUQ-D60161,FE6107D6-AE76-4626-93FF-14BCC7D892EF,NA,NA,NA,NA,NA,135,169,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,5,2014,TCGA-PAAD
7953,TCGA-IB-AAUQ,NO,NA,TCGA-IB-AAUQ-D60162,736CE790-7057-4619-BC92-F7EC47DFBBA9,NA,NA,NA,NA,NA,135,169,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Clinical Progressive Disease,30,5,2014,TCGA-PAAD
3537,TCGA-IC-A6RF,NO,NA,TCGA-IC-A6RF-D66427,B234154B-4425-4B73-8D0C-4B6B059EFA23,NA,NA,NA,NA,NA,342,370,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,14,10,2014,TCGA-ESCA
3538,TCGA-IC-A6RF,NO,NA,TCGA-IC-A6RF-D66428,6BEB33CA-F243-4732-96CF-63E8249428F3,NA,NA,NA,NA,NA,342,370,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Complete Response,14,10,2014,TCGA-ESCA
8517,TCGA-IE-A3OV,NO,NA,TCGA-IE-A3OV-D42512,D1F8C9CD-9448-4807-9262-4E14B008910F,NA,,NA,,NA,778,836,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8518,TCGA-IE-A3OV,NO,NA,TCGA-IE-A3OV-D42513,7197956D-15AF-4DF6-9E4C-309575A10959,NA,,NA,,NA,787,836,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8519,TCGA-IE-A3OV,YES,NA,TCGA-IE-A3OV-D42514,29E2D3B7-FCE4-4800-A064-395E7B1CD3B4,NA,,NA,,NA,1411,1594,Chemotherapy,Trabectedin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8520,TCGA-IE-A3OV,YES,NA,TCGA-IE-A3OV-D42515,6FF6DD1F-AC2A-414D-AA89-746B8F5872C7,NA,,NA,,NA,1609,1660,Chemotherapy,Deforolimus,MTOR inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8521,TCGA-IE-A3OV,YES,NA,TCGA-IE-A3OV-D42516,B7432680-8022-4606-9337-709B9E42F436,NA,,NA,,NA,1834,1918,Targeted Molecular therapy,EZN-2968,HIF-1a inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8524,TCGA-IE-A3OV,NO,NA,TCGA-IE-A3OV-D42519,A3AA7DBF-C64A-42F1-ABFC-CFBDFAC513A6,NA,,NA,,NA,2232,2293,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8515,TCGA-IE-A3OV,NO,NA,TCGA-IE-A3OV-D42510,7E52B038-4CA0-4A8A-8A2C-C2771F77E17E,NA,,NA,,NA,102,NA,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8516,TCGA-IE-A3OV,NO,NA,TCGA-IE-A3OV-D42511,92A8EA72-1FDD-4D84-B249-FE68509796E0,NA,,NA,,NA,102,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,23,4,2013,TCGA-SARC
8526,TCGA-IE-A4EH,,NA,TCGA-IE-A4EH-D41004,2AE43EDC-BF5E-44E9-9A34-E51048BEE543,NA,,NA,,NA,326,448,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,4,4,2013,TCGA-SARC
8525,TCGA-IE-A4EH,,NA,TCGA-IE-A4EH-D41932,42163DDA-EA18-4EC7-A948-F04CCB6E19B7,NA,,NA,,NA,326,448,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,4,4,2013,TCGA-SARC
8528,TCGA-IE-A6BZ,,NA,TCGA-IE-A6BZ-D52322,594A5B72-62E0-4BDB-8174-F789A03B36E6,NA,,NA,,NA,112,204,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,2,12,2013,TCGA-SARC
8529,TCGA-IE-A6BZ,,NA,TCGA-IE-A6BZ-D52329,D1351D43-3BBC-4C74-AE1B-B75DF32F8D1E,NA,,NA,,NA,112,204,Ancillary,Mesna,Cytoprotectant,Other,,,NA,,NO,Complete Response,2,12,2013,TCGA-SARC
8527,TCGA-IE-A6BZ,,NA,TCGA-IE-A6BZ-D52320,A3BB1EE7-CCE3-4913-9CC9-3590EBE9A40B,NA,,NA,,NA,112,204,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,2,12,2013,TCGA-SARC
8530,TCGA-IF-A3RQ,NO,NA,TCGA-IF-A3RQ-D41984,FC8C64CF-DFB9-4A7C-AFEB-8F1ACF6CD564,NA,,NA,,NA,441,457,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,8,4,2013,TCGA-SARC
8531,TCGA-IF-A4AJ,NO,NA,TCGA-IF-A4AJ-D41987,9553BA30-65D9-475F-A049-3108069B07A7,NA,,NA,,NA,567,600,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,8,4,2013,TCGA-SARC
3540,TCGA-IG-A3I8,NO,NA,TCGA-IG-A3I8-D37096,E9B6024C-B897-4E62-8722-6273938CDF85,NA,NA,NA,NA,NA,51,53,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,26,11,2012,TCGA-ESCA
3539,TCGA-IG-A3I8,NO,NA,TCGA-IG-A3I8-D37095,9010C4E8-72FB-4D5D-9366-A6E2C221713E,NA,NA,NA,NA,NA,51,53,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,26,11,2012,TCGA-ESCA
3541,TCGA-IG-A3YC,NO,NA,TCGA-IG-A3YC-D53415,C4332799-E655-411F-8981-CC6650C5B631,NA,NA,NA,NA,NA,556,560,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Clinical Progressive Disease,11,12,2013,TCGA-ESCA
3542,TCGA-IG-A7DP,NO,NA,TCGA-IG-A7DP-D62773,A7A42A7C-24A2-4E88-8836-CB6CFAA9BEC4,NA,NA,NA,NA,NA,49,206,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-ESCA
3543,TCGA-IG-A7DP,NO,NA,TCGA-IG-A7DP-D62774,9088A96E-736C-49A3-80CB-7E64190BA076,NA,NA,NA,NA,NA,49,206,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,28,7,2014,TCGA-ESCA
9227,TCGA-IN-7806,NO,,TCGA-IN-7806-D43604,F45B2ED5-5FCE-4530-B895-7D4D6E34A528,,,,,NA,62,116,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,29,5,2013,TCGA-STAD
9228,TCGA-IN-7806,NO,,TCGA-IN-7806-D43605,935A544F-A6D0-41FB-90C0-8468319FE607,,,,,NA,62,116,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,5,2013,TCGA-STAD
9226,TCGA-IN-7806,NO,,TCGA-IN-7806-D43603,60ADFEE7-A33A-46E9-9FB5-1CED530F19A7,,,,,NA,62,116,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,29,5,2013,TCGA-STAD
9230,TCGA-IN-8462,NO,,TCGA-IN-8462-D43598,A2B28491-DEE4-4BE0-AA89-5A33194169A6,,,,,NA,298,319,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,28,5,2013,TCGA-STAD
9231,TCGA-IN-8462,NO,,TCGA-IN-8462-D43599,6D66C746-8C08-4507-9E95-68DAEB38BECD,,,,,NA,298,319,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,28,5,2013,TCGA-STAD
9229,TCGA-IN-8462,NO,,TCGA-IN-8462-D43597,A446E68D-CCAA-4E68-99D0-F77E589DA83D,,,,,NA,298,319,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Clinical Progressive Disease,28,5,2013,TCGA-STAD
9232,TCGA-IN-8462,NO,,TCGA-IN-8462-D43600,84E86AF4-FD87-4366-91A2-3F755E33455A,,,,,NA,427,540,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,28,5,2013,TCGA-STAD
9234,TCGA-IN-A6RO,NO,,TCGA-IN-A6RO-D69485,BEB9ABBE-D8F1-4C12-AB2C-4E3E2BEEF2E0,,,,,NA,83,200,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Complete Response,9,1,2015,TCGA-STAD
9233,TCGA-IN-A6RO,NO,,TCGA-IN-A6RO-D69484,FF3388A1-C715-466B-B5D5-5723C3DA4DD0,,,,,NA,83,200,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Complete Response,9,1,2015,TCGA-STAD
9236,TCGA-IN-A6RP,NO,,TCGA-IN-A6RP-D57382,57DACD9C-C962-4EAF-BD41-E616BA1C8584,,,,,NA,79,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,YES,Clinical Progressive Disease,10,3,2014,TCGA-STAD
9235,TCGA-IN-A6RP,NO,,TCGA-IN-A6RP-D57381,60589C8E-4B78-4EBC-9458-E817FA9CA244,,,,,NA,79,NA,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,YES,Clinical Progressive Disease,10,3,2014,TCGA-STAD
9244,TCGA-IN-A7NU,NO,,TCGA-IN-A7NU-D69491,66407BB0-63A0-4D47-B62F-D1C05D098F9E,,,,,NA,105,169,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,9,1,2015,TCGA-STAD
9243,TCGA-IN-A7NU,NO,,TCGA-IN-A7NU-D69490,73E895E5-F6C4-487C-BF05-61F3FFB8DB30,,,,,NA,105,169,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,NA,,NO,Clinical Progressive Disease,9,1,2015,TCGA-STAD
3897,TCGA-IQ-7630,NO,NA,TCGA-IQ-7630-D38966,62308BC2-5EC2-453B-B7AD-BDBC560EEFA3,NA,,NA,,NA,102,147,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,1,2013,TCGA-HNSC
3898,TCGA-IQ-7630,NO,NA,TCGA-IQ-7630-D38968,02C628D8-7F10-4179-939A-9BE508E45F66,NA,,NA,,NA,102,147,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,7,1,2013,TCGA-HNSC
3899,TCGA-IQ-A61E,NO,NA,TCGA-IQ-A61E-D45794,A1EDB1AA-E75C-4E38-97F4-AEBF97E969C5,NA,,NA,,NA,96,138,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,7,2013,TCGA-HNSC
3900,TCGA-IQ-A61G,NO,NA,TCGA-IQ-A61G-D46116,1AC89840-C432-4BFB-B6FA-8F59B585E207,NA,,NA,,NA,130,168,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,1,8,2013,TCGA-HNSC
3901,TCGA-IQ-A61J,NO,NA,TCGA-IQ-A61J-D45953,EF73E5A4-D9DF-4B59-914F-B55699E32444,NA,,NA,,NA,64,99,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,26,7,2013,TCGA-HNSC
3905,TCGA-IQ-A61O,NO,NA,TCGA-IQ-A61O-D46113,4C230DB3-D647-4B7B-8BA6-D932229055CA,NA,,NA,,NA,69,111,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,8,2013,TCGA-HNSC
2836,TCGA-IR-A3L7,NO,NA,TCGA-IR-A3L7-D38291,99356D52-C28E-407A-A29D-E5A1088525CE,NA,,NA,,NA,67,99,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2837,TCGA-IR-A3LA,NO,NA,TCGA-IR-A3LA-D39484,879222E5-1EFD-4436-A977-13BB90006308,NA,,NA,,NA,81,148,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,1,2013,TCGA-CESC
2838,TCGA-IR-A3LA,NO,NA,TCGA-IR-A3LA-D39485,B61E901D-3B92-401F-AC6A-999C175C46A5,NA,,NA,,NA,81,151,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,24,1,2013,TCGA-CESC
2839,TCGA-IR-A3LB,NO,NA,TCGA-IR-A3LB-D39501,7E1FA50E-B5AD-448C-8001-B6D877993913,NA,,NA,,NA,72,138,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,1,2013,TCGA-CESC
2840,TCGA-IR-A3LB,NO,NA,TCGA-IR-A3LB-D39503,2DAC5EBB-CAE7-49CB-A810-509E31040F63,NA,,NA,,NA,72,141,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,24,1,2013,TCGA-CESC
2841,TCGA-IR-A3LB,NO,NA,TCGA-IR-A3LB-D39505,F04625F9-2C4F-4B6F-944D-C730D8BB68AC,NA,,NA,,NA,363,500,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,24,1,2013,TCGA-CESC
2842,TCGA-IR-A3LB,NO,NA,TCGA-IR-A3LB-D39507,694F1C43-677B-4B42-AB0F-DF306C5C99EA,NA,,NA,,NA,363,500,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,24,1,2013,TCGA-CESC
2843,TCGA-IR-A3LC,NO,NA,TCGA-IR-A3LC-D38296,A95DAC18-6883-4A30-9E1E-27551C9445B7,NA,,NA,,NA,NA,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2844,TCGA-IR-A3LH,NO,NA,TCGA-IR-A3LH-D38301,3D3105F8-BC2E-4485-B58F-96DDF1DB8EE8,NA,,NA,,NA,148,183,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2845,TCGA-IR-A3LI,NO,NA,TCGA-IR-A3LI-D38329,6FD64D29-1926-459E-B5DA-816D3F97CCFE,NA,,NA,,NA,52,73,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2846,TCGA-IR-A3LI,NO,NA,TCGA-IR-A3LI-D38330,F1DBA871-99FD-4D4C-AB21-A146ACDE4608,NA,,NA,,NA,52,73,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2848,TCGA-IR-A3LI,NO,NA,TCGA-IR-A3LI-D38332,2FAF8699-6739-49AC-85ED-333A8BA1E0CF,NA,,NA,,NA,135,211,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2847,TCGA-IR-A3LI,NO,NA,TCGA-IR-A3LI-D38331,01E813AD-1807-4B08-BC61-73BEB8C5C916,NA,,NA,,NA,135,211,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2849,TCGA-IR-A3LK,NO,NA,TCGA-IR-A3LK-D38335,E502C966-183F-4170-A354-B67DE0DE5D91,NA,,NA,,NA,73,101,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
2850,TCGA-IR-A3LK,NO,NA,TCGA-IR-A3LK-D38336,BAB25380-1F3B-440A-95A3-4698D5A3EC9C,NA,,NA,,NA,598,707,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,12,2012,TCGA-CESC
2851,TCGA-IR-A3LK,NO,NA,TCGA-IR-A3LK-D38337,8ADC65C5-06CD-4C1A-8D30-394CAA5648CB,NA,,NA,,NA,598,707,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,14,12,2012,TCGA-CESC
2852,TCGA-IR-A3LL,NO,NA,TCGA-IR-A3LL-D38340,04E0C6F4-594D-4A80-A45A-F15B5D290A01,NA,,NA,,NA,48,80,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,12,2012,TCGA-CESC
8532,TCGA-IS-A3K7,NO,NA,TCGA-IS-A3K7-D38431,155FEE21-5755-4FD7-A972-F506BC2E8FDF,NA,,NA,,NA,126,238,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,14,12,2012,TCGA-SARC
8533,TCGA-IS-A3KA,NO,NA,TCGA-IS-A3KA-D38432,E795A8CB-0FDB-483F-9060-5AF42AA45570,NA,,NA,,NA,101,187,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,NA,,NO,Clinical Progressive Disease,14,12,2012,TCGA-SARC
8534,TCGA-IS-A3KA,NO,NA,TCGA-IS-A3KA-D38433,25FFB536-DE9A-4FA9-AF7A-4BDCA05C740F,NA,,NA,,NA,101,187,Hormone Therapy,Megestrol,Progestin,Other,,,NA,,NO,Clinical Progressive Disease,14,12,2012,TCGA-SARC
8536,TCGA-IW-A3M4,NO,NA,TCGA-IW-A3M4-D33541,D038D104-F4C7-4B09-BB23-BCC122FC0651,NA,,NA,,NA,58,170,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,8,4,2013,TCGA-SARC
8535,TCGA-IW-A3M4,NO,NA,TCGA-IW-A3M4-D33540,CE804F6A-3323-40E7-82AF-6AD406F8E040,NA,,NA,,NA,58,170,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,6,7,2012,TCGA-SARC
5053,TCGA-J1-A4AH,NO,NA,TCGA-J1-A4AH-D38847,F8B27C48-03E3-4AFC-B1D3-73DFD0383A30,NA,,,,NA,68,131,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,27,12,2012,TCGA-LUSC
5054,TCGA-J1-A4AH,NO,NA,TCGA-J1-A4AH-D38850,F96488FF-D720-412E-A208-B10DFB9B7DC6,NA,,,,NA,68,131,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,27,12,2012,TCGA-LUSC
4710,TCGA-J2-8194,NO,,TCGA-J2-8194-D55424,4C297630-A1FD-4811-899D-AA652ACB4F3D,,,,,NA,546,584,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,7,1,2014,TCGA-LUAD
4711,TCGA-J2-8194,NO,,TCGA-J2-8194-D55426,726C1CA1-1718-4EA7-9CAC-8701FA927C14,,,,,NA,546,584,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,7,1,2014,TCGA-LUAD
4712,TCGA-J2-8194,NO,,TCGA-J2-8194-D55427,7AE778AB-433A-4D39-AB87-A4A38B5EF832,,,,,NA,597,640,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,7,1,2014,TCGA-LUAD
8063,TCGA-J9-A52B,NO,NA,TCGA-J9-A52B-D41330,32B2B6C7-AD7A-48FE-A7FD-34F1520F6092,NA,NA,NA,,NA,88,198,Hormone Therapy,Goserelin,LHRH agonist,Other,,,NA,,NO,Partial Response,14,3,2013,TCGA-PRAD
10029,TCGA-JU-AAVI,NO,NA,TCGA-JU-AAVI-D70308,224D054E-7814-473D-94B6-1D2BC4FE3A8F,NA,,,,NA,82,109,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,3,2,2015,TCGA-UCEC
10030,TCGA-JU-AAVI,NO,NA,TCGA-JU-AAVI-D70309,7AB9497C-682E-425B-875B-03613689F3C6,NA,,,,NA,159,229,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,2,2015,TCGA-UCEC
10031,TCGA-JU-AAVI,NO,NA,TCGA-JU-AAVI-D70310,C21C33C8-19B3-4335-907F-69C1D6E90A29,NA,,,,NA,159,229,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,2,2015,TCGA-UCEC
8541,TCGA-JV-A5VE,NO,NA,TCGA-JV-A5VE-D45019,C09645C2-FBC3-451E-82F3-A62018A07C2B,NA,,NA,,NA,38,165,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,2,8,2013,TCGA-SARC
8542,TCGA-JV-A5VE,NO,NA,TCGA-JV-A5VE-D48464,8D4445D0-D8A8-408F-A082-948A36EFB9F4,NA,,NA,,NA,38,165,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,16,10,2013,TCGA-SARC
2854,TCGA-JW-A5VH,NO,NA,TCGA-JW-A5VH-D46358,1A8782DE-A9E9-4CE0-A472-584BE2B1272C,NA,,NA,,NA,27,48,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,6,8,2013,TCGA-CESC
2855,TCGA-JW-A5VH,NO,NA,TCGA-JW-A5VH-D69368,D7A732E4-CD7C-47F1-853A-26C9493EB66C,NA,,NA,,NA,27,48,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,7,1,2015,TCGA-CESC
2856,TCGA-JW-A5VI,NO,NA,TCGA-JW-A5VI-D45006,C5AD3DD1-DB8E-4106-97BE-4CA01A2B0480,NA,,NA,,NA,571,623,Chemotherapy,Topotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,16,10,2013,TCGA-CESC
3545,TCGA-JY-A6FA,NO,NA,TCGA-JY-A6FA-D59866,68C0E85B-FABA-4715-B310-B69F49953D9B,NA,NA,NA,NA,NA,152,271,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,23,5,2014,TCGA-ESCA
3546,TCGA-JY-A6FA,NO,NA,TCGA-JY-A6FA-D59867,D1A15DED-F289-46ED-9F35-2D272C6D1F1C,NA,NA,NA,NA,NA,152,271,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Partial Response,23,5,2014,TCGA-ESCA
3544,TCGA-JY-A6FA,NO,NA,TCGA-JY-A6FA-D53197,D3A65367-ED00-46D2-8210-CFEB2F3FFBD5,NA,NA,NA,NA,NA,152,271,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,16,12,2013,TCGA-ESCA
3547,TCGA-JY-A93D,NO,NA,TCGA-JY-A93D-D61710,5335D65F-37B7-4453-97E9-23EBDD9781BA,NA,NA,NA,NA,NA,150,280,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,3,7,2014,TCGA-ESCA
8545,TCGA-K1-A3PN,NO,NA,TCGA-K1-A3PN-D33661,8035D68F-26CA-4B63-97FA-8169E03503FD,NA,,NA,,NA,121,182,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,12,7,2012,TCGA-SARC
8546,TCGA-K1-A3PN,NO,NA,TCGA-K1-A3PN-D33662,222926A9-0B3F-4478-8692-11B975685510,NA,,NA,,NA,151,182,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,12,7,2012,TCGA-SARC
8547,TCGA-K1-A42X,NO,NA,TCGA-K1-A42X-D49686,4F0F81AF-2208-40CD-98A9-9B723D5D4255,NA,,NA,,NA,2134,2293,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,15,10,2013,TCGA-SARC
8548,TCGA-K1-A42X,NO,NA,TCGA-K1-A42X-D63375,3535D02F-D6F0-4877-8B84-84720DDC0652,NA,,NA,,NA,3256,3417,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,6,8,2014,TCGA-SARC
8550,TCGA-K1-A6RU,NO,NA,TCGA-K1-A6RU-D57316,0060ABD9-1C93-427A-B7FD-9719013B96EF,NA,,NA,,NA,143,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,10,3,2014,TCGA-SARC
224,TCGA-K4-A83P,NO,,TCGA-K4-A83P-D70489,1BE668A8-CB1C-4D9C-A2B8-0993CA43A4D9,NA,,NA,,NA,NA,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,,Clinical Progressive Disease,18,2,2015,TCGA-BLCA
225,TCGA-K4-A83P,NO,,TCGA-K4-A83P-D70495,D954A0C1-B175-485D-837F-4B0E004DB01A,NA,,NA,,NA,NA,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,,Clinical Progressive Disease,18,2,2015,TCGA-BLCA
227,TCGA-K4-AAQO,NO,,TCGA-K4-AAQO-D64607,132A555E-0765-4E61-A452-ACC71978BE5E,NA,,NA,,NA,120,181,,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,5,9,2014,TCGA-BLCA
226,TCGA-K4-AAQO,NO,,TCGA-K4-AAQO-D64606,2ABB2BC6-099E-4E45-9270-AD1FE8B8D172,NA,,NA,,NA,120,181,,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,5,9,2014,TCGA-BLCA
10035,TCGA-K6-A3WQ,NO,NA,TCGA-K6-A3WQ-D59159,7E7328C4-4491-418F-9DB0-4C9AEBECC350,NA,,,,NA,351,NA,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,1,5,2014,TCGA-UCEC
9248,TCGA-KB-A6F7,NO,,TCGA-KB-A6F7-D53982,918103C9-472F-4799-B534-43AE1A9FCBF7,,,,,NA,150,154,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,16,12,2013,TCGA-STAD
9249,TCGA-KB-A93J,NO,,TCGA-KB-A93J-D60968,6DA4D2AD-66A5-4E91-9796-1ABECA4A3CFE,,,,,NA,157,255,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,20,6,2014,TCGA-STAD
8065,TCGA-KC-A4BR,NO,NA,TCGA-KC-A4BR-D69964,853CDD2F-179D-482A-AD0E-62C337B521E8,NA,NA,NA,,NA,1079,NA,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,YES,Complete Response,23,1,2015,TCGA-PRAD
8552,TCGA-KD-A5QS,NO,NA,TCGA-KD-A5QS-D45128,8DCE3E46-2D32-4C91-B76E-D00A7E2D393E,NA,,NA,,NA,30,72,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,8,7,2013,TCGA-SARC
8551,TCGA-KD-A5QS,NO,NA,TCGA-KD-A5QS-D44808,0716E293-6A35-4C13-ADB8-398829AB177F,NA,,NA,,NA,30,72,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,8,7,2013,TCGA-SARC
8554,TCGA-KD-A5QS,NO,NA,TCGA-KD-A5QS-D45130,FA483FDD-A827-4997-8AD6-8DD333FBF76E,NA,,NA,,NA,366,471,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,8,7,2013,TCGA-SARC
8553,TCGA-KD-A5QS,NO,NA,TCGA-KD-A5QS-D45129,0C02F11C-8C6B-4BCE-B900-32DE2E88571A,NA,,NA,,NA,366,876,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,8,7,2013,TCGA-SARC
8555,TCGA-KD-A5QS,NO,NA,TCGA-KD-A5QS-D45131,7CE55EBA-A4B0-4100-8EF7-ADC0BEDF5FBB,NA,,NA,,NA,499,876,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,8,7,2013,TCGA-SARC
8557,TCGA-KD-A5QU,NO,NA,TCGA-KD-A5QU-D45133,D0BBCEA2-A3A1-4BFC-8FCC-BC8234533FEA,NA,,NA,,NA,93,219,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,8,7,2013,TCGA-SARC
8556,TCGA-KD-A5QU,NO,NA,TCGA-KD-A5QU-D45132,8288E9C0-D448-469C-98D1-C4E56EDF508C,NA,,NA,,NA,93,219,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,8,7,2013,TCGA-SARC
8558,TCGA-KF-A41W,NO,NA,TCGA-KF-A41W-D35696,FF0F21F1-F12A-4C8F-824E-956F8BFA921A,NA,,NA,,NA,61,137,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,5,10,2012,TCGA-SARC
8068,TCGA-KK-A59X,YES,NA,TCGA-KK-A59X-D70539,3576D3AF-3981-49FA-9172-1BA765A26C53,NA,NA,NA,,NA,2262,2455,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,23,2,2015,TCGA-PRAD
8067,TCGA-KK-A59X,YES,NA,TCGA-KK-A59X-D70538,63386B22-8EC8-4812-A272-9A67578AE508,NA,NA,NA,,NA,2262,2455,Chemotherapy,Cabazitaxel,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,23,2,2015,TCGA-PRAD
8070,TCGA-KK-A59Y,NO,NA,TCGA-KK-A59Y-D70440,89888F38-A13B-42BE-85BA-51D6FB5845CA,NA,NA,NA,,NA,71,1072,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,16,2,2015,TCGA-PRAD
8073,TCGA-KK-A6E0,NO,NA,TCGA-KK-A6E0-D62512,03FEB539-C786-41E6-9134-3C83D062C466,NA,NA,NA,,NA,424,605,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,18,7,2014,TCGA-PRAD
8074,TCGA-KK-A6E1,NO,NA,TCGA-KK-A6E1-D62513,56A45973-3117-4CC6-A0E8-BCEA71831497,NA,NA,NA,,NA,107,778,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,18,7,2014,TCGA-PRAD
8078,TCGA-KK-A7AU,NO,NA,TCGA-KK-A7AU-D64289,C034043D-9F83-4029-8A75-A798ACA5CC92,NA,NA,NA,,NA,207,564,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Stable Disease,28,8,2014,TCGA-PRAD
8077,TCGA-KK-A7AU,YES,NA,TCGA-KK-A7AU-D64287,D0CAB806-6DC0-455A-8BB5-8BEF31019F7B,NA,NA,NA,,NA,207,676,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Stable Disease,28,8,2014,TCGA-PRAD
8082,TCGA-KK-A7B4,NO,NA,TCGA-KK-A7B4-D68715,1E957A39-9B3B-4817-839E-861028B375AE,NA,NA,NA,,NA,312,439,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Stable Disease,12,12,2014,TCGA-PRAD
8083,TCGA-KK-A8I4,NO,NA,TCGA-KK-A8I4-D63959,DC6BC8AC-818C-433D-8679-DE2BC2E7739C,NA,NA,NA,,NA,1204,1984,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Stable Disease,25,8,2014,TCGA-PRAD
8086,TCGA-KK-A8I7,NO,NA,TCGA-KK-A8I7-D70525,B0CD9665-2A8F-41D5-A214-CA90DB9C3658,NA,NA,NA,,NA,1757,1757,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,27,2,2015,TCGA-PRAD
8087,TCGA-KK-A8I9,NO,NA,TCGA-KK-A8I9-D64033,58E08AE1-0A29-4403-A938-004CBB836036,NA,NA,NA,,NA,151,427,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,25,8,2014,TCGA-PRAD
8091,TCGA-KK-A8ID,NO,NA,TCGA-KK-A8ID-D62209,256DC65D-01FD-403E-BF39-069BA87E52CB,NA,NA,NA,,NA,97,1455,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,25,8,2014,TCGA-PRAD
8095,TCGA-KK-A8II,NO,NA,TCGA-KK-A8II-D62413,3780B9F2-C2CA-4DB2-A58E-6F6FA6A66A55,NA,NA,NA,,NA,2516,2738,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,25,8,2014,TCGA-PRAD
8096,TCGA-KK-A8II,NO,NA,TCGA-KK-A8II-D62416,A00AC439-51F5-40A7-9590-7AF6B71FF39C,NA,NA,NA,,NA,2780,2892,Chemotherapy,Cabazitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,25,8,2014,TCGA-PRAD
8094,TCGA-KK-A8II,NO,NA,TCGA-KK-A8II-D62412,5D53B834-9CE7-4446-8AE5-DF47DEA4BED3,NA,NA,NA,,NA,2431,3467,Hormone Therapy,Degarelix,LHRH antagonist,Other,,,NA,,NO,Clinical Progressive Disease,25,8,2014,TCGA-PRAD
8093,TCGA-KK-A8II,NO,NA,TCGA-KK-A8II-D62410,DE73C80B-5FB5-4350-ADF7-018B3E8BFD2B,NA,NA,NA,,NA,2453,3467,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,25,8,2014,TCGA-PRAD
3983,TCGA-KM-A7Q8,NO,NA,TCGA-KM-A7Q8-D62492,3789FA17-816C-4768-A1FE-E8E49373B5BC,NA,NA,NA,NA,NA,NA,NA,Targeted Molecular therapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,21,7,2014,TCGA-KICH
3986,TCGA-KN-8428,NO,NA,TCGA-KN-8428-D34187,FD53289F-BFB3-419C-A907-26053E04B068,NA,NA,NA,NA,NA,510,638,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,17,8,2012,TCGA-KICH
228,TCGA-KQ-A41P,NO,,TCGA-KQ-A41P-D72534,D447E690-1351-4ED4-9FF8-FFBCDB320B4F,NA,,NA,,NA,189,331,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,13,7,2015,TCGA-BLCA
229,TCGA-KQ-A41P,NO,,TCGA-KQ-A41P-D72535,15643365-9F58-4E83-AF6D-8824F59E4EDD,NA,,NA,,NA,189,331,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,13,7,2015,TCGA-BLCA
9536,TCGA-KS-A4I1,NO,NA,TCGA-KS-A4I1-D40341,07E9DE8F-EBE1-4825-9D60-514BED8E6764,NA,NA,NA,,NA,88,166,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,17,2,2013,TCGA-THCA
9538,TCGA-KS-A4I3,NO,NA,TCGA-KS-A4I3-D40348,E8C4FB17-5A06-4384-BFA6-4BDC8783F5B7,NA,NA,NA,,NA,17,34,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,18,2,2013,TCGA-THCA
9542,TCGA-KS-A4I9,NO,NA,TCGA-KS-A4I9-D40370,4D7C8588-6D1E-43CB-8A23-7B7D3EA12F95,NA,NA,NA,,NA,38,61,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,18,2,2013,TCGA-THCA
9544,TCGA-KS-A4IB,NO,NA,TCGA-KS-A4IB-D40383,1CE45AFA-6925-4270-9137-E395BCD92274,NA,NA,NA,,NA,50,71,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,18,2,2013,TCGA-THCA
9546,TCGA-KS-A4IC,NO,NA,TCGA-KS-A4IC-D40387,2AC59119-83DF-40EF-8C32-88E10516E788,NA,NA,NA,,NA,2,20,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,18,2,2013,TCGA-THCA
9548,TCGA-KS-A4ID,NO,NA,TCGA-KS-A4ID-D40390,B2DC7DB7-36ED-4170-95BC-C813DE3D9E0A,NA,NA,NA,,NA,1,75,Hormone Therapy,Liothyronine,Hormone,Other,NA,,NA,,NO,Complete Response,18,2,2013,TCGA-THCA
3906,TCGA-KU-A6H7,NO,NA,TCGA-KU-A6H7-D49035,11C1650F-C510-4D0F-B3A0-457643D343A3,NA,,NA,,NA,65,100,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,9,2013,TCGA-HNSC
3907,TCGA-KU-A6H8,NO,NA,TCGA-KU-A6H8-D49028,1FF745F6-3C00-419C-A325-A31DC3EC5950,NA,,NA,,NA,122,174,Immunotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,25,9,2013,TCGA-HNSC
7960,TCGA-L1-A7W4,NO,NA,TCGA-L1-A7W4-D56340,5FB9615B-D313-4A53-A138-4B5EF9361BB6,NA,NA,NA,NA,NA,66,116,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,3,2,2014,TCGA-PAAD
7961,TCGA-L1-A7W4,NO,NA,TCGA-L1-A7W4-D69178,C9B519A0-96CE-44C8-B4B6-79502643DCC2,NA,NA,NA,NA,NA,225,225,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,30,12,2014,TCGA-PAAD
5055,TCGA-L3-A524,NO,NA,TCGA-L3-A524-D39419,1E45D553-3C34-4F87-A5A5-8DD5FDEF98C3,NA,,,,NA,197,350,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,1,2013,TCGA-LUSC
5056,TCGA-L3-A524,NO,NA,TCGA-L3-A524-D39421,F9EA6E0A-8493-4756-B589-F804A5CD806F,NA,,,,NA,197,350,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,22,1,2013,TCGA-LUSC
3550,TCGA-L5-A88W,NO,NA,TCGA-L5-A88W-D56122,CA9FC534-0B42-4BEE-9600-2EA5F18738AC,NA,NA,NA,NA,NA,105,138,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-ESCA
3549,TCGA-L5-A88W,NO,NA,TCGA-L5-A88W-D56120,1F0FCD8A-1BE9-45BF-B42C-C071A25479FB,NA,NA,NA,NA,NA,105,225,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-ESCA
3551,TCGA-L5-A88W,NO,NA,TCGA-L5-A88W-D56123,19D9E444-D2FE-491A-A2A3-4DD27F6AD1BB,NA,NA,NA,NA,NA,169,225,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Partial Response,28,1,2014,TCGA-ESCA
3552,TCGA-L7-A56G,NO,NA,TCGA-L7-A56G-D51524,D78F3240-B568-4ADB-A1F3-A64CB8B9F4A6,NA,NA,NA,NA,NA,49,77,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,20,11,2013,TCGA-ESCA
3553,TCGA-L7-A56G,NO,NA,TCGA-L7-A56G-D51525,444BB0FB-489A-480C-8638-08FF3F1A64D3,NA,NA,NA,NA,NA,49,77,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Stable Disease,20,11,2013,TCGA-ESCA
3555,TCGA-L7-A6VZ,NO,NA,TCGA-L7-A6VZ-D52183,1B38AA1C-7053-47C0-99F7-02B5AB9C313A,NA,NA,NA,NA,NA,97,244,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,29,11,2013,TCGA-ESCA
3554,TCGA-L7-A6VZ,NO,NA,TCGA-L7-A6VZ-D52180,3E4B1124-D843-4BAF-8DEC-8B57C91C497D,NA,NA,NA,NA,NA,97,244,Chemotherapy,Folinic acid,Rescue agent,Other,NA,NA,NA,NA,NO,Complete Response,29,11,2013,TCGA-ESCA
3556,TCGA-L7-A6VZ,NO,NA,TCGA-L7-A6VZ-D52184,60EC1500-BC0C-47AD-BBBB-5BF46AFC4CC1,NA,NA,NA,NA,NA,97,245,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,29,11,2013,TCGA-ESCA
4715,TCGA-L9-A743,NO,,TCGA-L9-A743-D58554,BD488F92-7CB9-4C9E-B60D-9F199C561475,,,,,NA,120,193,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,4,2014,TCGA-LUAD
4714,TCGA-L9-A743,NO,,TCGA-L9-A743-D58553,88D31EDF-D154-4FAF-B5A3-0BABE6D20D73,,,,,NA,120,193,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,4,2014,TCGA-LUAD
4716,TCGA-L9-A7SV,NO,,TCGA-L9-A7SV-D55465,01FFB728-9015-4A08-9273-307A5FFCA9C7,,,,,NA,41,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,1,2014,TCGA-LUAD
4717,TCGA-L9-A7SV,NO,,TCGA-L9-A7SV-D55466,AF22DDC1-B76C-49AC-AAC4-32359ACDB718,,,,,NA,41,104,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,7,1,2014,TCGA-LUAD
7966,TCGA-LB-A8F3,NO,NA,TCGA-LB-A8F3-D66972,30C6CCB7-BD97-4B50-8998-DE175D27280B,NA,NA,NA,NA,NA,197,225,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,29,10,2014,TCGA-PAAD
7970,TCGA-LB-A9Q5,NO,NA,TCGA-LB-A9Q5-D67128,97A851F0-3DE0-43B9-8854-F8DA84C0BE80,NA,NA,NA,NA,NA,303,310,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,31,10,2014,TCGA-PAAD
7969,TCGA-LB-A9Q5,NO,NA,TCGA-LB-A9Q5-D67127,38A2C73D-BE03-45BB-A127-EC349F97D9CD,NA,NA,NA,NA,NA,310,310,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,31,10,2014,TCGA-PAAD
2584,TCGA-LD-A74U,NO,,TCGA-LD-A74U-D55160,18D6C097-AA64-4C59-9CA9-C6737668C348,,,,,,52,301,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,30,12,2013,TCGA-BRCA
2585,TCGA-LD-A7W5,NO,,TCGA-LD-A7W5-D56345,71C98143-F9F6-4C6F-A7DD-168C6BC9E034,,,,,,82,145,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,3,2,2014,TCGA-BRCA
8559,TCGA-LI-A67I,NO,NA,TCGA-LI-A67I-D68504,6D039CE7-6C7D-41D0-A704-DBE0AF7F5527,NA,,NA,,NA,595,670,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,21,11,2014,TCGA-SARC
5136,TCGA-LK-A4NW,NO,NA,TCGA-LK-A4NW-D56077,1CE17E8F-BA5E-43EB-B7E8-33392CD27EE3,NA,NA,NA,NA,NA,0,0,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,27,1,2014,TCGA-MESO
5138,TCGA-LK-A4NW,NO,NA,TCGA-LK-A4NW-D56080,73F6EE11-CE3E-4B1C-9833-BAC8325CD588,NA,NA,NA,NA,NA,525,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,27,1,2014,TCGA-MESO
5137,TCGA-LK-A4NW,NO,NA,TCGA-LK-A4NW-D56079,387DEFC7-BCD7-4514-9A51-F3A44247DD61,NA,NA,NA,NA,NA,525,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,27,1,2014,TCGA-MESO
5142,TCGA-LK-A4NZ,NO,NA,TCGA-LK-A4NZ-D56091,BCB7EC0E-A1BE-400B-B4D2-B93E0C72D992,NA,NA,NA,NA,NA,36,36,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,27,1,2014,TCGA-MESO
5143,TCGA-LK-A4O0,NO,NA,TCGA-LK-A4O0-D56093,08F8ED38-F349-443B-AB75-8E891C06267B,NA,NA,NA,NA,NA,53,53,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,27,1,2014,TCGA-MESO
5145,TCGA-LK-A4O5,NO,NA,TCGA-LK-A4O5-D56104,DB87CDFF-37E6-47C8-988E-B1B81FFED6F9,NA,NA,NA,NA,NA,60,60,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
5146,TCGA-LK-A4O5,NO,NA,TCGA-LK-A4O5-D56105,18A4BA5C-E825-478E-AB02-DD1E16B39FF0,NA,NA,NA,NA,NA,118,174,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
5147,TCGA-LK-A4O5,NO,NA,TCGA-LK-A4O5-D56108,417B1999-2455-4910-A6C7-C5655951B84B,NA,NA,NA,NA,NA,118,174,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
5148,TCGA-LK-A4O5,NO,NA,TCGA-LK-A4O5-D56109,DDB77A41-6351-4A7D-A7B8-0C99238C9B95,NA,NA,NA,NA,NA,187,274,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
5149,TCGA-LK-A4O7,NO,NA,TCGA-LK-A4O7-D56110,34DFF33B-3FD8-4FA8-87E1-A5167DF730B5,NA,NA,NA,NA,NA,177,238,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
5150,TCGA-LK-A4O7,NO,NA,TCGA-LK-A4O7-D56111,C0E7154A-02BF-4EBF-84ED-B0FF442F7639,NA,NA,NA,NA,NA,177,238,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,28,1,2014,TCGA-MESO
2591,TCGA-LL-A440,NO,,TCGA-LL-A440-D46389,DDE1F9CF-5FD6-44F3-A2FB-5DA0244330D4,,,,,,60,123,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,8,2013,TCGA-BRCA
2592,TCGA-LL-A440,NO,,TCGA-LL-A440-D46390,33BE396B-855F-4092-A53F-628047C5B25B,,,,,,60,123,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,7,8,2013,TCGA-BRCA
2594,TCGA-LL-A441,NO,,TCGA-LL-A441-D36592,EAC2A2A2-E81E-4A91-A483-5055C21238F3,,,,,,61,133,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,11,2012,TCGA-BRCA
2593,TCGA-LL-A441,NO,,TCGA-LL-A441-D36591,26759221-D07C-4BDA-BBB6-36A76DE3EDA6,,,,,,61,133,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,5,11,2012,TCGA-BRCA
2596,TCGA-LL-A50Y,NO,,TCGA-LL-A50Y-D40968,AAE548CC-C906-4B50-9987-4BEAC371569C,,,,,,54,608,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,8,3,2013,TCGA-BRCA
2608,TCGA-LL-A5YO,YES,,TCGA-LL-A5YO-D43018,9E63512F-49BD-4691-8C4D-920BA81A33D7,,,,,,56,160,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,8,5,2013,TCGA-BRCA
2607,TCGA-LL-A5YO,YES,,TCGA-LL-A5YO-D43017,2796DB97-696B-4A10-94A8-0596D8A2F43E,,,,,,56,160,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,8,5,2013,TCGA-BRCA
2622,TCGA-LL-A73Z,NO,,TCGA-LL-A73Z-D51326,C1E53020-8C36-4C1C-89EB-FFA09DCF92E6,,,,,,18,60,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,15,11,2013,TCGA-BRCA
2621,TCGA-LL-A73Z,NO,,TCGA-LL-A73Z-D51324,7720FC0E-5AB6-4C6A-8EE4-97B0882078E7,,,,,,18,60,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Clinical Progressive Disease,15,11,2013,TCGA-BRCA
2623,TCGA-LL-A73Z,NO,,TCGA-LL-A73Z-D51327,3E79EC05-9045-43FC-94DB-E1CD163B0D88,,,,,,74,109,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,15,11,2013,TCGA-BRCA
2624,TCGA-LL-A73Z,NO,,TCGA-LL-A73Z-D51328,D00B1B78-354F-4C0A-BA7A-27A54ECC394D,,,,,,123,179,Hormone Therapy,Fulvestrant,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,15,11,2013,TCGA-BRCA
2626,TCGA-LL-A740,NO,,TCGA-LL-A740-D51205,53BF41C6-4FAA-40E5-80B2-E3ED637A4E30,,,,,,122,164,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2625,TCGA-LL-A740,NO,,TCGA-LL-A740-D51204,FFDC6873-66C3-41A3-9043-746A13AF38C6,,,,,,122,164,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2627,TCGA-LL-A740,NO,,TCGA-LL-A740-D65062,25DBA480-441A-4F69-9824-94ADC2AACDB4,,,,,,178,255,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,9,2014,TCGA-BRCA
2629,TCGA-LL-A7SZ,YES,,TCGA-LL-A7SZ-D55458,5B4EB4C7-43B4-486D-92BD-4B7E69E4413D,,,,,,62,104,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2628,TCGA-LL-A7SZ,YES,,TCGA-LL-A7SZ-D55457,A3E71F68-6309-4BB8-BF4D-BE485E3E1A0D,,,,,,62,104,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,7,1,2014,TCGA-BRCA
2635,TCGA-LL-A8F5,NO,,TCGA-LL-A8F5-D56705,9B54A11A-0EAE-44E2-BBBF-A52A4FF67166,,,,,,189,259,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,19,2,2014,TCGA-BRCA
2637,TCGA-LL-A9Q3,NO,,TCGA-LL-A9Q3-D59662,637C53B9-68C5-43C6-802C-B9ACAD0B95E6,,,,,,118,531,Immunotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,19,5,2014,TCGA-BRCA
3560,TCGA-LN-A49M,NO,NA,TCGA-LN-A49M-D69770,303D23A3-7833-4E58-8163-EC3A30BB2D5C,NA,NA,NA,NA,NA,95,136,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,19,1,2015,TCGA-ESCA
3561,TCGA-LN-A49O,NO,NA,TCGA-LN-A49O-D69620,0C5C73B3-0BE2-4C92-9240-8E61CFF2D1CB,NA,NA,NA,NA,NA,76,104,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3563,TCGA-LN-A49R,NO,NA,TCGA-LN-A49R-D69774,F418ED67-D0A5-4AFB-86AF-1F718E4E75B7,NA,NA,NA,NA,NA,143,194,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,19,1,2015,TCGA-ESCA
3562,TCGA-LN-A49R,NO,NA,TCGA-LN-A49R-D69773,6F71747B-3A81-40B6-903E-ADB362F6907B,NA,NA,NA,NA,NA,143,194,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,19,1,2015,TCGA-ESCA
3565,TCGA-LN-A49U,NO,NA,TCGA-LN-A49U-D69908,00004F7A-1A2B-4089-B9A8-1129BDE9255F,NA,NA,NA,NA,NA,35,69,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
3564,TCGA-LN-A49U,NO,NA,TCGA-LN-A49U-D69907,D4BB93D8-1AAD-4728-956C-E75DA9940D01,NA,NA,NA,NA,NA,35,69,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
3567,TCGA-LN-A49V,NO,NA,TCGA-LN-A49V-D69626,22EB5B33-D695-463A-9748-17FA0F76CD7C,NA,NA,NA,NA,NA,25,65,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3566,TCGA-LN-A49V,NO,NA,TCGA-LN-A49V-D69625,ADFC1845-2363-4CA5-B17F-2CCFD0FB9953,NA,NA,NA,NA,NA,25,65,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3569,TCGA-LN-A49W,NO,NA,TCGA-LN-A49W-D69630,988835DC-2BCE-4CD5-A94A-2E39F8E384C4,NA,NA,NA,NA,NA,53,82,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3568,TCGA-LN-A49W,NO,NA,TCGA-LN-A49W-D69629,64345F5E-7C7A-428A-A92A-1446630921BF,NA,NA,NA,NA,NA,53,82,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3570,TCGA-LN-A49Y,NO,NA,TCGA-LN-A49Y-D69634,17A7C506-8510-4D03-BE5F-4F287B59F6AF,NA,NA,NA,NA,NA,92,126,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3571,TCGA-LN-A4A1,NO,NA,TCGA-LN-A4A1-D69644,C420323D-84B3-43E2-801D-BBFC4DFBD484,NA,NA,NA,NA,NA,200,236,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3572,TCGA-LN-A4A1,NO,NA,TCGA-LN-A4A1-D69645,AEAF4E45-A9B9-4AA9-AF41-B4FB0212787B,NA,NA,NA,NA,NA,200,236,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3574,TCGA-LN-A4A2,NO,NA,TCGA-LN-A4A2-D69650,3E7431F5-B6A0-4D2D-93C4-1FF18EDF660C,NA,NA,NA,NA,NA,47,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3573,TCGA-LN-A4A2,NO,NA,TCGA-LN-A4A2-D69649,685CADCB-A978-4A6E-845F-30426B0B232A,NA,NA,NA,NA,NA,47,83,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3576,TCGA-LN-A4A3,NO,NA,TCGA-LN-A4A3-D69654,4BE0EDB2-9C2D-4EDA-BB4A-A154DCC7DCC9,NA,NA,NA,NA,NA,39,74,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3575,TCGA-LN-A4A3,NO,NA,TCGA-LN-A4A3-D69653,3ED36C66-2912-495B-84F6-5E38970737BC,NA,NA,NA,NA,NA,39,74,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,15,1,2015,TCGA-ESCA
3577,TCGA-LN-A4A6,NO,NA,TCGA-LN-A4A6-D69903,3F60AB24-CC23-4921-8A81-153C78762330,NA,NA,NA,NA,NA,69,96,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
3581,TCGA-LN-A4A8,NO,NA,TCGA-LN-A4A8-D70200,F40942C3-C5B9-4FE6-B163-5CB4FF67BC24,NA,NA,NA,NA,NA,276,432,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,30,1,2015,TCGA-ESCA
3579,TCGA-LN-A4A8,NO,NA,TCGA-LN-A4A8-D70197,EDC1D146-5DD9-4CE0-BED9-6E523AFDDC1A,NA,NA,NA,NA,NA,276,432,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,30,1,2015,TCGA-ESCA
3580,TCGA-LN-A4A8,NO,NA,TCGA-LN-A4A8-D70199,5DB61336-2915-4F46-B4FA-0FC68E09A694,NA,NA,NA,NA,NA,276,432,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,30,1,2015,TCGA-ESCA
3578,TCGA-LN-A4A8,NO,NA,TCGA-LN-A4A8-D70195,F04BCFD5-B557-4487-BE4B-3B9B15F23FBE,NA,NA,NA,NA,NA,276,432,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Complete Response,30,1,2015,TCGA-ESCA
3583,TCGA-LN-A4MQ,NO,NA,TCGA-LN-A4MQ-D69662,05E7622B-7044-4D47-8969-3164E6E7BECF,NA,NA,NA,NA,NA,102,136,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3582,TCGA-LN-A4MQ,NO,NA,TCGA-LN-A4MQ-D69661,6C1B27CD-13AE-4394-B947-607885AE6F10,NA,NA,NA,NA,NA,102,136,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3585,TCGA-LN-A4MR,NO,NA,TCGA-LN-A4MR-D69666,2AF77EAA-81F8-487E-ABA9-61CADBECFC21,NA,NA,NA,NA,NA,237,270,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3584,TCGA-LN-A4MR,NO,NA,TCGA-LN-A4MR-D69665,28FA5AB8-E14D-407B-BD3D-3A1D5B97AB4C,NA,NA,NA,NA,NA,237,270,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3586,TCGA-LN-A5U6,NO,NA,TCGA-LN-A5U6-D69886,75D95AE8-B5A9-4859-8B2A-FC99AEC995C1,NA,NA,NA,NA,NA,41,92,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
3588,TCGA-LN-A5U7,NO,NA,TCGA-LN-A5U7-D69669,358177BD-A85B-419D-9696-CFCA70B8D9D7,NA,NA,NA,NA,NA,537,693,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3589,TCGA-LN-A5U7,NO,NA,TCGA-LN-A5U7-D69670,F185C559-8658-4847-8150-59A54FCC5126,NA,NA,NA,NA,NA,537,693,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3587,TCGA-LN-A5U7,NO,NA,TCGA-LN-A5U7-D69668,7B6162E8-8C26-4460-89F4-1EC4009B3868,NA,NA,NA,NA,NA,537,693,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3590,TCGA-LN-A7HV,NO,NA,TCGA-LN-A7HV-D69898,059AFB6F-503F-4313-B557-B7B8C0CF56EC,NA,NA,NA,NA,NA,36,71,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
3591,TCGA-LN-A7HX,NO,NA,TCGA-LN-A7HX-D69777,A5C7FCB2-6283-45B0-8211-B655189BA95C,NA,NA,NA,NA,NA,107,142,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,19,1,2015,TCGA-ESCA
3593,TCGA-LN-A7HY,NO,NA,TCGA-LN-A7HY-D69677,1E417D17-8863-4C5D-A04E-E0976A4AC04A,NA,NA,NA,NA,NA,104,159,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3592,TCGA-LN-A7HY,NO,NA,TCGA-LN-A7HY-D69676,8CB481A8-733E-4BB1-B876-C881EA4FF778,NA,NA,NA,NA,NA,104,159,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3595,TCGA-LN-A7HZ,NO,NA,TCGA-LN-A7HZ-D69681,02E0C634-0B68-4051-8A0A-9B08BB96A7FA,NA,NA,NA,NA,NA,112,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3594,TCGA-LN-A7HZ,NO,NA,TCGA-LN-A7HZ-D69680,8C3A2222-9EF7-4A45-B16F-C0D30BED03B1,NA,NA,NA,NA,NA,112,153,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,1,2015,TCGA-ESCA
3597,TCGA-LN-A8HZ,NO,NA,TCGA-LN-A8HZ-D69839,48980E67-A461-476F-9986-0FB914385E5C,NA,NA,NA,NA,NA,42,86,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,1,2015,TCGA-ESCA
3596,TCGA-LN-A8HZ,NO,NA,TCGA-LN-A8HZ-D69838,1944BFE0-C79F-4C05-8639-CACD4A5E2561,NA,NA,NA,NA,NA,42,86,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,21,1,2015,TCGA-ESCA
3598,TCGA-LN-A9FP,NO,NA,TCGA-LN-A9FP-D69783,0A505D7F-02D6-42D9-AD4F-0385A1629A6F,NA,NA,NA,NA,NA,40,60,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,19,1,2015,TCGA-ESCA
3599,TCGA-LN-A9FR,NO,NA,TCGA-LN-A9FR-D69883,C57206BF-9BE4-40E6-889C-85C21131BE8D,NA,NA,NA,NA,NA,23,89,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,22,1,2015,TCGA-ESCA
2857,TCGA-LP-A4AU,NO,NA,TCGA-LP-A4AU-D58086,17273461-E423-4C32-93D2-7A05ABAEDB1C,NA,,NA,,NA,91,307,,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,3,2014,TCGA-CESC
2858,TCGA-LP-A4AU,NO,NA,TCGA-LP-A4AU-D58087,36DCFD67-54B3-451B-BF22-25FE9393781B,NA,,NA,,NA,91,307,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,31,3,2014,TCGA-CESC
231,TCGA-LT-A5Z6,NO,,TCGA-LT-A5Z6-D45446,822C656A-0E82-4336-A8C3-5771FBBDC47D,NA,,NA,,NA,29,166,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,15,7,2013,TCGA-BLCA
230,TCGA-LT-A5Z6,NO,,TCGA-LT-A5Z6-D43759,92EF1CC6-534C-4021-ADF7-5DF2B386E56F,NA,,NA,,NA,29,166,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,3,6,2013,TCGA-BLCA
2859,TCGA-MA-AA3W,NO,NA,TCGA-MA-AA3W-D64865,DE131EAB-9290-4833-8513-3BA191FBDDDC,NA,,NA,,NA,75,110,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,9,2014,TCGA-CESC
2860,TCGA-MA-AA3X,NO,NA,TCGA-MA-AA3X-D64892,10F27E3D-3267-4B36-A08A-A46F8A6D8FD0,NA,,NA,,NA,92,140,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,9,2014,TCGA-CESC
4202,TCGA-MH-A855,NO,NA,TCGA-MH-A855-D59145,AA69EE53-E1A2-4289-9F74-CEE2AE4586EF,,,,,NA,86,205,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,1,5,2014,TCGA-KIRP
4203,TCGA-MH-A855,NO,NA,TCGA-MH-A855-D59147,8CE69491-1200-4D73-A580-CA54DDC7A64D,,,,,NA,86,205,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,1,5,2014,TCGA-KIRP
8562,TCGA-MO-A47P,NO,NA,TCGA-MO-A47P-D58080,B19F3AD3-7DF5-4C25-B2C3-B15239F79B4E,NA,,NA,,NA,33,227,,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Complete Response,31,3,2014,TCGA-SARC
4721,TCGA-MP-A4T9,NO,,TCGA-MP-A4T9-D41351,758F08E1-B373-4964-9966-691B1D562B6C,,,,,NA,34,55,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,15,3,2013,TCGA-LUAD
4720,TCGA-MP-A4T9,NO,,TCGA-MP-A4T9-D41350,C9F75A26-D387-48A4-BA06-A9D5C58CA315,,,,,NA,34,55,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,15,3,2013,TCGA-LUAD
4722,TCGA-MP-A4T9,NO,,TCGA-MP-A4T9-D41352,ECBC2354-5C73-46FD-94A7-D519D192334F,,,,,NA,62,62,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,15,3,2013,TCGA-LUAD
4723,TCGA-MP-A4TC,NO,,TCGA-MP-A4TC-D41397,2D936FD6-139F-4EBD-9EAB-D843254E987A,,,,,NA,25,25,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,3,2013,TCGA-LUAD
4724,TCGA-MP-A4TC,NO,,TCGA-MP-A4TC-D41398,ED1C314A-2C4D-4A19-A6A2-0FB17145C3E5,,,,,NA,25,25,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,3,2013,TCGA-LUAD
4725,TCGA-MP-A4TD,NO,,TCGA-MP-A4TD-D41400,151B0D62-C2EE-442B-8FC7-DDCE9131ABBD,,,,,NA,75,165,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,3,2013,TCGA-LUAD
4726,TCGA-MP-A4TD,NO,,TCGA-MP-A4TD-D41401,429B9434-707A-41B3-A4B6-07DA60A412A3,,,,,NA,75,165,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Complete Response,18,3,2013,TCGA-LUAD
4728,TCGA-MP-A4TF,NO,,TCGA-MP-A4TF-D41410,51556339-4419-45EF-B7B5-597FECF9A3D5,,,,,NA,48,133,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,18,3,2013,TCGA-LUAD
4727,TCGA-MP-A4TF,NO,,TCGA-MP-A4TF-D41409,DB475CAC-B2D9-461C-A714-D5BBD7B9CF48,,,,,NA,48,151,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Partial Response,18,3,2013,TCGA-LUAD
5165,TCGA-MQ-A6BN,NO,NA,TCGA-MQ-A6BN-D46315,8216DD09-498A-439C-987C-3F2722EEFF85,NA,NA,NA,NA,NA,22,519,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,9,8,2013,TCGA-MESO
5164,TCGA-MQ-A6BN,NO,NA,TCGA-MQ-A6BN-D46313,5177E9AC-2F71-4110-AE28-269CBBFE4F39,NA,NA,NA,NA,NA,22,519,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,9,8,2013,TCGA-MESO
5166,TCGA-MQ-A6BN,NO,NA,TCGA-MQ-A6BN-D46317,5B338F35-114B-4BF8-9663-3BCBAACC3ABE,NA,NA,NA,NA,NA,519,672,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,9,8,2013,TCGA-MESO
5167,TCGA-MQ-A6BQ,NO,NA,TCGA-MQ-A6BQ-D46283,7C551E41-3D90-48C5-A4D0-71364E90A751,NA,NA,NA,NA,NA,11,133,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,9,8,2013,TCGA-MESO
5168,TCGA-MQ-A6BQ,NO,NA,TCGA-MQ-A6BQ-D46284,ACA3DCC9-C5CF-47D4-9F9B-0CF61781535A,NA,NA,NA,NA,NA,11,133,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,9,8,2013,TCGA-MESO
5169,TCGA-MQ-A6BR,NO,NA,TCGA-MQ-A6BR-D46303,9879EA05-E178-452A-8A8B-3B9FF4260ADD,NA,NA,NA,NA,NA,NA,117,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,9,8,2013,TCGA-MESO
5170,TCGA-MQ-A6BR,NO,NA,TCGA-MQ-A6BR-D46307,6BFCB11C-3C8F-448E-9F9A-BCC8F5C26005,NA,NA,NA,NA,NA,NA,117,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,9,8,2013,TCGA-MESO
2643,TCGA-MS-A51U,NO,,TCGA-MS-A51U-D64919,4E4467F8-D750-4B3D-9A07-CED8733E6813,,,,,,57,116,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,17,10,2014,TCGA-BRCA
2642,TCGA-MS-A51U,NO,,TCGA-MS-A51U-D64916,E6091FDA-563B-4A0F-A091-666380676D1E,,,,,,57,116,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,17,10,2014,TCGA-BRCA
2641,TCGA-MS-A51U,NO,,TCGA-MS-A51U-D64920,011802B1-AEBD-4C2D-8258-19D929C01583,,,,,,130,178,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,17,10,2014,TCGA-BRCA
9251,TCGA-MX-A666,NO,,TCGA-MX-A666-D61118,5F6546A3-D921-4E6A-85D8-89866B9D9827,,,,,NA,22,22,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,24,6,2014,TCGA-STAD
9252,TCGA-MX-A666,NO,,TCGA-MX-A666-D61119,9433FAAF-66EA-44D6-9D23-E9B5C83C7633,,,,,NA,22,22,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,24,6,2014,TCGA-STAD
9250,TCGA-MX-A666,NO,,TCGA-MX-A666-D61117,F6F569B1-0554-470A-8DDE-0AD8A839EC11,,,,,NA,22,22,Chemotherapy,Epirubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,24,6,2014,TCGA-STAD
9253,TCGA-MX-A666,NO,,TCGA-MX-A666-D61120,8041D0BE-7BC8-4D3B-96A7-A1EA8B8EE0EA,,,,,NA,117,131,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,24,6,2014,TCGA-STAD
9254,TCGA-MX-A666,NO,,TCGA-MX-A666-D61121,CF6DE4EA-0F57-460D-A170-DEB48D99280B,,,,,NA,117,131,Ancillary,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,24,6,2014,TCGA-STAD
2861,TCGA-MY-A5BD,NO,NA,TCGA-MY-A5BD-D67175,6E4581C1-EB5C-493C-8EEC-E6B8ECE74BB5,NA,,NA,,NA,70,119,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2014,TCGA-CESC
2862,TCGA-MY-A5BF,NO,NA,TCGA-MY-A5BF-D67173,F8BD8AE2-4E5B-4FC7-895D-D907C6A45730,NA,,NA,,NA,160,188,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2014,TCGA-CESC
2863,TCGA-MY-A913,NO,NA,TCGA-MY-A913-D59733,6CFF5264-76FD-43DC-87CB-9C01433D42E3,NA,,NA,,NA,30,79,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,5,2014,TCGA-CESC
3911,TCGA-MZ-A5BI,NO,NA,TCGA-MZ-A5BI-D62978,B2A96D32-1EE5-4A57-9353-DA3D56C909D7,NA,,NA,,NA,41,70,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,29,7,2014,TCGA-HNSC
3912,TCGA-MZ-A6I9,NO,NA,TCGA-MZ-A6I9-D59252,009B15C8-A754-424F-A9A6-9E2573853865,NA,,NA,,NA,57,99,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,7,5,2014,TCGA-HNSC
3913,TCGA-MZ-A6I9,YES,NA,TCGA-MZ-A6I9-D59260,6D70EFC4-55DF-4730-8AD2-FBF6389BB96D,NA,,NA,,NA,365,421,Targeted Molecular therapy,Rigosertib,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,7,5,2014,TCGA-HNSC
3914,TCGA-MZ-A6I9,NO,NA,TCGA-MZ-A6I9-D59279,13A3859B-54D8-498C-B246-493D8E7F98BA,NA,,NA,,NA,449,449,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,7,5,2014,TCGA-HNSC
3915,TCGA-MZ-A6I9,NO,NA,TCGA-MZ-A6I9-D59281,EB54E219-0F65-4571-A9D3-4A501BAB7642,NA,,NA,,NA,449,449,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,7,5,2014,TCGA-HNSC
3916,TCGA-MZ-A7D7,NO,NA,TCGA-MZ-A7D7-D56165,46EE99A3-9055-49CB-85CC-5E710923DCC3,NA,,NA,,NA,77,119,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,30,1,2014,TCGA-HNSC
10049,TCGA-N5-A4R8,NO,NA,TCGA-N5-A4R8-D43298,64F48A34-0B0F-4441-B408-98B497A4A1B2,NA,NA,NA,NA,NA,68,159,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10048,TCGA-N5-A4R8,NO,NA,TCGA-N5-A4R8-D43297,8B9C2105-8629-4FD9-8F77-6A4099DDB13C,NA,NA,NA,NA,NA,68,189,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10052,TCGA-N5-A4RF,NO,NA,TCGA-N5-A4RF-D43177,66F92BA8-A2E1-4A59-AE02-DF42313BD04E,NA,NA,NA,NA,NA,69,174,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10053,TCGA-N5-A4RF,NO,NA,TCGA-N5-A4RF-D43338,6565E650-FAEC-4D15-883E-FEC422F2BE80,NA,NA,NA,NA,NA,69,174,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10055,TCGA-N5-A4RJ,NO,NA,TCGA-N5-A4RJ-D43554,A11640AD-57B4-4A80-ADE3-A87B5ED8F24B,NA,NA,NA,NA,NA,85,183,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10054,TCGA-N5-A4RJ,NO,NA,TCGA-N5-A4RJ-D43553,74AF69FF-0137-4BF1-9703-928AFD12138E,NA,NA,NA,NA,NA,85,204,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10056,TCGA-N5-A4RM,NO,NA,TCGA-N5-A4RM-D43525,A44FDC69-9B04-4F9B-9889-3363E3036484,NA,NA,NA,NA,NA,60,123,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,26,5,2013,TCGA-UCS
10057,TCGA-N5-A4RM,NO,NA,TCGA-N5-A4RM-D43526,8482CBDF-DACC-40F3-8A7A-FBFBA3CF3FB3,NA,NA,NA,NA,NA,60,123,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,26,5,2013,TCGA-UCS
10058,TCGA-N5-A4RN,NO,NA,TCGA-N5-A4RN-D43550,73131411-EA83-4C23-BD32-8579A29DF050,NA,NA,NA,NA,NA,65,170,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10059,TCGA-N5-A4RN,NO,NA,TCGA-N5-A4RN-D43551,94642564-65C7-4803-8407-D5E83D527D6D,NA,NA,NA,NA,NA,65,170,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10061,TCGA-N5-A4RO,NO,NA,TCGA-N5-A4RO-D43546,EB2E17C9-3D16-47B4-91DA-9B44792E447A,NA,NA,NA,NA,NA,68,140,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,26,5,2013,TCGA-UCS
10060,TCGA-N5-A4RO,NO,NA,TCGA-N5-A4RO-D43545,DFB37449-BB5F-4DCE-81D5-54F7495557EE,NA,NA,NA,NA,NA,67,141,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,26,5,2013,TCGA-UCS
10062,TCGA-N5-A4RO,NO,NA,TCGA-N5-A4RO-D43547,ECBA332A-596E-4F45-92C6-30DAFA21EE4B,NA,NA,NA,NA,NA,179,300,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,26,5,2013,TCGA-UCS
10064,TCGA-N5-A4RS,NO,NA,TCGA-N5-A4RS-D43334,728C8422-781A-471E-8EF5-44B15212AE7D,NA,NA,NA,NA,NA,NA,135,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10063,TCGA-N5-A4RS,NO,NA,TCGA-N5-A4RS-D43333,90335220-0419-452F-8EC4-6E3F1C98B9CD,NA,NA,NA,NA,NA,NA,135,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10065,TCGA-N5-A4RT,NO,NA,TCGA-N5-A4RT-D43532,D650C1D8-43E3-4BD0-BB94-FA48775BECFF,NA,NA,NA,NA,NA,66,101,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10066,TCGA-N5-A4RT,NO,NA,TCGA-N5-A4RT-D43533,1FA904F7-5F6F-48ED-B139-F53C8E8C32C3,NA,NA,NA,NA,NA,136,206,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10067,TCGA-N5-A4RT,NO,NA,TCGA-N5-A4RT-D43534,AAF23B78-C1E2-454B-BF17-9F4B08D19DA8,NA,NA,NA,NA,NA,136,206,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10069,TCGA-N5-A4RU,NO,NA,TCGA-N5-A4RU-D43529,1B471C64-723B-47E5-BF3F-E38D17555298,NA,NA,NA,NA,NA,48,113,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10068,TCGA-N5-A4RU,NO,NA,TCGA-N5-A4RU-D43528,55ADB583-A187-4920-B3FB-71F66BB766C1,NA,NA,NA,NA,NA,48,113,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10070,TCGA-N5-A4RV,NO,NA,TCGA-N5-A4RV-D43559,89003F69-0CE8-47BC-904B-82C02841D666,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10071,TCGA-N5-A4RV,NO,NA,TCGA-N5-A4RV-D43560,FB28AE34-9DCF-4225-8A38-BD5DA33D8A32,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10073,TCGA-N5-A59E,NO,NA,TCGA-N5-A59E-D43303,974CAA1B-B166-4930-A392-39A98C541ADF,NA,NA,NA,NA,NA,63,63,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10072,TCGA-N5-A59E,NO,NA,TCGA-N5-A59E-D43302,5CDCF00C-2D79-4C67-9B3D-48C4B31784E1,NA,NA,NA,NA,NA,63,224,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10074,TCGA-N5-A59F,NO,NA,TCGA-N5-A59F-D43563,FE06C3DA-79A8-4468-BC4F-EBBB7C2FDF94,NA,NA,NA,NA,NA,70,182,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10075,TCGA-N5-A59F,NO,NA,TCGA-N5-A59F-D43564,A14F7869-8805-451F-ADEA-5F92D1C2BFA7,NA,NA,NA,NA,NA,70,182,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,26,5,2013,TCGA-UCS
10076,TCGA-N6-A4V9,NO,NA,TCGA-N6-A4V9-D56349,62C38EF6-6A8C-4B58-B1F5-F52B8D49E735,NA,NA,NA,NA,NA,33,148,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,3,2,2014,TCGA-UCS
10077,TCGA-N6-A4V9,NO,NA,TCGA-N6-A4V9-D56351,7FD1BA22-C9AD-4198-BD2C-537E50B7B372,NA,NA,NA,NA,NA,33,148,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,3,2,2014,TCGA-UCS
10078,TCGA-N6-A4VC,NO,NA,TCGA-N6-A4VC-D56337,EAA25821-773A-4567-BEAB-41A1617DEFB0,NA,NA,NA,NA,NA,55,160,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,3,2,2014,TCGA-UCS
10079,TCGA-N6-A4VE,NO,NA,TCGA-N6-A4VE-D56380,FAD5240E-662E-4365-A50B-A833407A308A,NA,NA,NA,NA,NA,45,152,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-UCS
10080,TCGA-N6-A4VE,NO,NA,TCGA-N6-A4VE-D56381,769FA40D-F568-46B2-A9D9-F1C5C91F1DE1,NA,NA,NA,NA,NA,45,152,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,4,2,2014,TCGA-UCS
10082,TCGA-N6-A4VF,NO,NA,TCGA-N6-A4VF-D56433,1A5C5EF3-A4DD-4BC5-9554-694CF7647786,NA,NA,NA,NA,NA,77,140,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,6,2,2014,TCGA-UCS
10081,TCGA-N6-A4VF,NO,NA,TCGA-N6-A4VF-D56432,CCDEBE34-EF04-41C1-A674-B189A5D835EB,NA,NA,NA,NA,NA,77,140,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,6,2,2014,TCGA-UCS
10083,TCGA-N6-A4VF,NO,NA,TCGA-N6-A4VF-D56434,41CBC5F9-1EDA-43C1-B8A7-209C01039A2A,NA,NA,NA,NA,NA,77,140,Chemotherapy,Mesna,Cytoprotectant,Other,,NA,NA,NA,NO,Complete Response,6,2,2014,TCGA-UCS
10085,TCGA-N6-A4VG,NO,NA,TCGA-N6-A4VG-D56442,5ABDB8B9-8EDE-43C1-A818-0B8703625628,NA,NA,NA,NA,NA,61,166,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,6,2,2014,TCGA-UCS
10084,TCGA-N6-A4VG,NO,NA,TCGA-N6-A4VG-D56441,CA49A7DA-3F20-4436-82C4-CFC27169170C,NA,NA,NA,NA,NA,62,166,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,6,2,2014,TCGA-UCS
10087,TCGA-N6-A4VG,NO,NA,TCGA-N6-A4VG-D56444,8B18117D-65EE-4E02-9B07-0FF9E46EFFAB,NA,NA,NA,NA,NA,530,649,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,NA,NA,NA,NO,Partial Response,6,2,2014,TCGA-UCS
10086,TCGA-N6-A4VG,NO,NA,TCGA-N6-A4VG-D56443,9F704E4C-1D24-4B0E-AC7F-8D0FC5FB49AA,NA,NA,NA,NA,NA,530,649,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,6,2,2014,TCGA-UCS
10092,TCGA-N7-A4Y0,NO,NA,TCGA-N7-A4Y0-D56713,D96F651E-BE0B-469F-B670-5243CE8497AE,NA,NA,NA,NA,NA,305,324,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,19,2,2014,TCGA-UCS
10088,TCGA-N7-A4Y0,NO,NA,TCGA-N7-A4Y0-D56714,BE711DED-35D0-42E9-B48E-11E2749A030C,NA,NA,NA,NA,NA,305,324,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,19,2,2014,TCGA-UCS
10089,TCGA-N7-A4Y0,NO,NA,TCGA-N7-A4Y0-D56715,D6E62FDF-4CB4-42B5-9603-246A8A0FBFB1,NA,NA,NA,NA,NA,305,324,Ancillary,Mesna,Cytoprotectant,Other,,NA,NA,NA,NO,Stable Disease,19,2,2014,TCGA-UCS
10090,TCGA-N7-A4Y0,NO,NA,TCGA-N7-A4Y0-D56717,E80D425D-4A46-42DB-8D82-B9A5D50A438A,NA,NA,NA,NA,NA,690,690,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,19,2,2014,TCGA-UCS
10091,TCGA-N7-A4Y0,NO,NA,TCGA-N7-A4Y0-D56718,FD3D3C48-3D7D-42A8-A855-0A78C50AE7BD,NA,NA,NA,NA,NA,690,690,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,19,2,2014,TCGA-UCS
10094,TCGA-N7-A4Y8,YES,NA,TCGA-N7-A4Y8-D56723,2E990336-5259-439C-BFBF-2AFD74F66CD3,NA,NA,NA,NA,NA,13,133,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,19,2,2014,TCGA-UCS
10093,TCGA-N7-A4Y8,YES,NA,TCGA-N7-A4Y8-D56722,F1F0425E-6789-4085-8987-43B79DE93AEC,NA,NA,NA,NA,NA,13,133,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Stable Disease,19,2,2014,TCGA-UCS
10095,TCGA-N7-A59B,NO,NA,TCGA-N7-A59B-D56724,D9DFEB55-0EBC-451D-91DF-9D11A8A078E8,NA,NA,NA,NA,NA,72,162,,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,19,2,2014,TCGA-UCS
10096,TCGA-N7-A59B,NO,NA,TCGA-N7-A59B-D56725,B1F26004-8289-4A43-B2AA-C4CCDC26CE84,NA,NA,NA,NA,NA,72,183,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,19,2,2014,TCGA-UCS
10097,TCGA-N7-A59B,NO,NA,TCGA-N7-A59B-D56726,C0479AE5-B6EA-4868-BD60-B9A2C0E4FA34,NA,NA,NA,NA,NA,183,183,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,19,2,2014,TCGA-UCS
10099,TCGA-N8-A4PI,NO,NA,TCGA-N8-A4PI-D40852,8BCEB101-C137-4B78-9DF9-14791DEF569E,NA,NA,NA,NA,NA,57,199,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,4,3,2013,TCGA-UCS
10098,TCGA-N8-A4PI,NO,NA,TCGA-N8-A4PI-D40851,A51235F9-D3B0-4E1D-B403-7917FCD1AE5F,NA,NA,NA,NA,NA,57,199,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,4,3,2013,TCGA-UCS
10101,TCGA-N8-A4PM,NO,NA,TCGA-N8-A4PM-D40855,8901D820-4F2D-40DA-A4FD-8D8E6D1B6F75,NA,NA,NA,NA,NA,98,161,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,4,3,2013,TCGA-UCS
10100,TCGA-N8-A4PM,NO,NA,TCGA-N8-A4PM-D40854,27AFBBB3-03B2-4B81-A2E0-D24AE749998B,NA,NA,NA,NA,NA,98,161,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,4,3,2013,TCGA-UCS
10103,TCGA-N8-A4PN,NO,NA,TCGA-N8-A4PN-D40857,CF4A5104-56B7-4D74-8D6A-7E20A8F88FE0,NA,NA,NA,NA,NA,46,151,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,4,3,2013,TCGA-UCS
10102,TCGA-N8-A4PN,NO,NA,TCGA-N8-A4PN-D40856,C22C189D-94FA-46E3-8F75-1B00A6AA0A8D,NA,NA,NA,NA,NA,46,151,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,4,3,2013,TCGA-UCS
10105,TCGA-N8-A4PO,NO,NA,TCGA-N8-A4PO-D40860,9C15828A-8C53-4B0A-936A-DA31A48145C2,NA,NA,NA,NA,NA,101,144,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,4,3,2013,TCGA-UCS
10104,TCGA-N8-A4PO,NO,NA,TCGA-N8-A4PO-D40859,C92E0028-3884-42A1-BCC4-6788A97A642B,NA,NA,NA,NA,NA,101,144,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,4,3,2013,TCGA-UCS
10106,TCGA-N8-A4PQ,NO,NA,TCGA-N8-A4PQ-D45251,D1B2EE3F-9BD4-4EC7-BD73-D9C5ED00B357,NA,NA,NA,NA,NA,82,194,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,10,7,2013,TCGA-UCS
10107,TCGA-N8-A4PQ,NO,NA,TCGA-N8-A4PQ-D45252,754061CE-9118-49B3-88A7-3ED813050B82,NA,NA,NA,NA,NA,82,194,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,10,7,2013,TCGA-UCS
10108,TCGA-N8-A56S,NO,NA,TCGA-N8-A56S-D45255,25D9642C-EC67-43DC-8ADC-0370847F3DCD,NA,NA,NA,NA,NA,57,183,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,10,7,2013,TCGA-UCS
10109,TCGA-N8-A56S,NO,NA,TCGA-N8-A56S-D45256,ECDE8CC3-8ACD-446E-BAC0-4CEC056C170E,NA,NA,NA,NA,NA,57,183,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Stable Disease,10,7,2013,TCGA-UCS
10110,TCGA-N9-A4PZ,YES,NA,TCGA-N9-A4PZ-D57296,15E091BD-4C8D-427F-A7EF-378C33A9E2BF,NA,NA,NA,NA,NA,88,193,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,Carboplatin,NA,NA,NA,NO,Complete Response,7,3,2014,TCGA-UCS
10111,TCGA-N9-A4PZ,YES,NA,TCGA-N9-A4PZ-D57297,470373D9-9B97-4C32-85C8-A9F80A2FE1C1,NA,NA,NA,NA,NA,88,193,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,Paclitaxel,NA,NA,NA,NO,Complete Response,7,3,2014,TCGA-UCS
10112,TCGA-N9-A4PZ,YES,NA,TCGA-N9-A4PZ-D57298,4FF08648-C18C-4635-84E2-9B9C119427ED,NA,NA,NA,NA,NA,495,538,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,Gemcitabine,NA,NA,NA,NO,Clinical Progressive Disease,7,3,2014,TCGA-UCS
10113,TCGA-N9-A4PZ,YES,NA,TCGA-N9-A4PZ-D57299,EC4FE114-4CC1-4ACA-9CB7-3404AB5F6AF6,NA,NA,NA,NA,NA,495,557,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,Docetaxel,NA,NA,NA,NO,Clinical Progressive Disease,7,3,2014,TCGA-UCS
10114,TCGA-N9-A4PZ,NO,NA,TCGA-N9-A4PZ-D57300,2C1CF146-347C-403C-9747-C4F0ADD48FFB,NA,NA,NA,NA,NA,586,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,7,3,2014,TCGA-UCS
10115,TCGA-N9-A4Q1,YES,NA,TCGA-N9-A4Q1-D57213,74B5E6CA-6C83-4DF0-A35F-EAD5BC084A7B,NA,NA,NA,NA,NA,67,95,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,Cisplatin,NA,NA,NA,NO,Complete Response,7,3,2014,TCGA-UCS
10116,TCGA-N9-A4Q1,NO,NA,TCGA-N9-A4Q1-D57216,C28DAE86-2B25-466B-856C-5F4B2227B227,NA,NA,NA,NA,NA,130,214,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,7,3,2014,TCGA-UCS
10119,TCGA-N9-A4Q1,NO,NA,TCGA-N9-A4Q1-D57294,F1A4D20F-E485-4139-8305-2004A364C4F4,NA,NA,NA,NA,NA,1874,1959,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,7,3,2014,TCGA-UCS
10118,TCGA-N9-A4Q1,NO,NA,TCGA-N9-A4Q1-D57293,BED4B89D-9DA9-4AF9-9EAC-0FE5E97E0160,NA,NA,NA,NA,NA,1874,1959,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,7,3,2014,TCGA-UCS
10121,TCGA-N9-A4Q3,NO,NA,TCGA-N9-A4Q3-D57620,A131B676-513F-4D4A-825E-CE84C70ED57B,NA,NA,NA,NA,NA,771,1128,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,18,3,2014,TCGA-UCS
10120,TCGA-N9-A4Q3,NO,NA,TCGA-N9-A4Q3-D57619,C8744214-83DD-42DC-ADE9-1EB57E9F8480,NA,NA,NA,NA,NA,771,1128,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Partial Response,18,3,2014,TCGA-UCS
10122,TCGA-N9-A4Q3,NO,NA,TCGA-N9-A4Q3-D57629,DE517F7E-8803-4C05-8CBA-9DBB95C4E7F6,NA,NA,NA,NA,NA,1470,1555,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Clinical Progressive Disease,18,3,2014,TCGA-UCS
10124,TCGA-N9-A4Q7,NO,NA,TCGA-N9-A4Q7-D57641,DB7062F1-CB8D-456A-8B55-AC546DC0FBB7,NA,NA,NA,NA,NA,86,161,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,18,3,2014,TCGA-UCS
10123,TCGA-N9-A4Q7,NO,NA,TCGA-N9-A4Q7-D57640,6BDD22EB-1864-441D-9A07-CEFB54B25685,NA,NA,NA,NA,NA,86,205,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,18,3,2014,TCGA-UCS
10125,TCGA-N9-A4Q7,NO,NA,TCGA-N9-A4Q7-D57642,7BC03905-88E3-41C7-A33D-15B4B58CA789,NA,NA,NA,NA,NA,184,205,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,18,3,2014,TCGA-UCS
10127,TCGA-N9-A4Q8,NO,NA,TCGA-N9-A4Q8-D57636,A18D25C9-7A3B-4221-A4C4-C71C9E43983C,NA,NA,NA,NA,NA,252,356,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,18,3,2014,TCGA-UCS
10126,TCGA-N9-A4Q8,NO,NA,TCGA-N9-A4Q8-D57635,1067C5AE-351A-4B1D-87B0-690E3F811A3D,NA,NA,NA,NA,NA,252,356,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,18,3,2014,TCGA-UCS
10128,TCGA-NA-A4QW,NO,NA,TCGA-NA-A4QW-D59447,4EF96420-16DC-4243-A1B9-8DE5E9E16A4F,NA,NA,NA,NA,NA,126,231,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,13,5,2014,TCGA-UCS
5062,TCGA-NC-A5HE,NO,NA,TCGA-NC-A5HE-D42295,FE4B2005-3757-4AA2-9CAF-F1D83E2A4FF4,NA,,,,NA,51,142,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,4,2013,TCGA-LUSC
5063,TCGA-NC-A5HE,NO,NA,TCGA-NC-A5HE-D42296,F1F12BA9-EF24-472C-804D-ED7FE9E3A2CE,NA,,,,NA,51,142,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,16,4,2013,TCGA-LUSC
5064,TCGA-NC-A5HG,NO,NA,TCGA-NC-A5HG-D42334,9A9D8CDF-7F30-4677-9347-DEBA6862878E,NA,,,,NA,37,107,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5065,TCGA-NC-A5HG,NO,NA,TCGA-NC-A5HG-D42335,5EDEA676-B589-44C9-81E5-0FC227AB6C6A,NA,,,,NA,37,107,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5066,TCGA-NC-A5HI,NO,NA,TCGA-NC-A5HI-D42340,F9DA1FB6-F8D4-422E-A1DE-20BDE247F02F,NA,,,,NA,91,169,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5067,TCGA-NC-A5HI,NO,NA,TCGA-NC-A5HI-D42341,1693FBB3-505B-4966-8997-30A246462F61,NA,,,,NA,91,169,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5068,TCGA-NC-A5HJ,NO,NA,TCGA-NC-A5HJ-D42343,5BDAF30B-3C5D-4E1F-9DF5-E790A50F6E7C,NA,,,,NA,411,412,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5069,TCGA-NC-A5HJ,NO,NA,TCGA-NC-A5HJ-D42344,7FD3D7EC-D66F-49AF-B038-2AA48C175B1B,NA,,,,NA,411,412,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5070,TCGA-NC-A5HK,NO,NA,TCGA-NC-A5HK-D42346,7205AE68-7607-4A15-98EF-47A6DFC9A131,NA,,,,NA,37,128,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5071,TCGA-NC-A5HK,NO,NA,TCGA-NC-A5HK-D42347,A75E9E2B-CFE2-486A-ACDF-50C500E65114,NA,,,,NA,37,128,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5072,TCGA-NC-A5HO,NO,NA,TCGA-NC-A5HO-D42352,67C3BB30-C35E-43F2-8429-C101C6339DB4,NA,,,,NA,45,108,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5073,TCGA-NC-A5HO,NO,NA,TCGA-NC-A5HO-D42353,EEBF937A-A339-496C-8041-1F0063771AE9,NA,,,,NA,45,108,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5074,TCGA-NC-A5HP,NO,NA,TCGA-NC-A5HP-D42355,D5D544C4-32F7-4AFA-AB2E-A6BD4BAC381C,NA,,,,NA,52,113,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5075,TCGA-NC-A5HP,YES,NA,TCGA-NC-A5HP-D42356,51755B3E-6D96-4E9C-BA63-A0809B734944,NA,,,,NA,52,113,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5076,TCGA-NC-A5HP,NO,NA,TCGA-NC-A5HP-D42357,CC1C8E74-D6AB-43D0-ADF3-0C827990EE8E,NA,,,,NA,358,448,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5077,TCGA-NC-A5HP,YES,NA,TCGA-NC-A5HP-D42361,DEB9E9EB-C2C6-428A-8F0B-F0855240E59F,NA,,,,NA,540,632,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,17,4,2013,TCGA-LUSC
5079,TCGA-NC-A5HQ,NO,NA,TCGA-NC-A5HQ-D42366,6E87E526-B071-4045-8020-32DF9FB85B37,NA,,,,NA,57,133,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5080,TCGA-NC-A5HQ,NO,NA,TCGA-NC-A5HQ-D42367,31E83691-F98F-4984-BA4E-4E0BEC7C32BD,NA,,,,NA,57,133,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,17,4,2013,TCGA-LUSC
5081,TCGA-NC-A5HR,NO,NA,TCGA-NC-A5HR-D42427,308D6357-E699-46D7-B218-B99D1E748107,NA,,,,NA,49,138,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,19,4,2013,TCGA-LUSC
5082,TCGA-NC-A5HR,NO,NA,TCGA-NC-A5HR-D42428,56ED8DA4-1528-4A84-80B7-B075B1D18949,NA,,,,NA,49,138,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,,,,NO,Complete Response,19,4,2013,TCGA-LUSC
5083,TCGA-NC-A5HT,NO,NA,TCGA-NC-A5HT-D42431,2F85726E-8C4F-4413-B730-57492E8BC231,NA,,,,NA,246,288,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,19,4,2013,TCGA-LUSC
5084,TCGA-NC-A5HT,NO,NA,TCGA-NC-A5HT-D42432,FDA9D83B-436C-4EEE-9983-D7F82CEE7E8B,NA,,,,NA,246,288,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Partial Response,19,4,2013,TCGA-LUSC
5085,TCGA-NC-A5HT,NO,NA,TCGA-NC-A5HT-D55769,47DA8CF7-D95A-4240-B9EA-5CCF9F364C9D,NA,,,,NA,578,677,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,15,1,2014,TCGA-LUSC
5086,TCGA-NC-A5HT,NO,NA,TCGA-NC-A5HT-D55777,4DEF5FBD-F30E-4683-9D09-D5B04A9413B3,NA,,,,NA,578,677,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,15,1,2014,TCGA-LUSC
10130,TCGA-ND-A4WC,NO,NA,TCGA-ND-A4WC-D43002,E26995FE-F611-4484-A2B3-3E8896F55FDD,NA,NA,NA,NA,NA,59,215,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,10,5,2013,TCGA-UCS
10132,TCGA-NF-A4WX,NO,NA,TCGA-NF-A4WX-D43881,E00312BD-467E-4CB9-9D07-35B9B9654D91,NA,NA,NA,NA,NA,46,148,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,5,6,2013,TCGA-UCS
10131,TCGA-NF-A4WX,NO,NA,TCGA-NF-A4WX-D43880,884564F2-E5C1-4CA8-8DF9-FB7145FC5D86,NA,NA,NA,NA,NA,46,148,Targeted Molecular therapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Complete Response,5,6,2013,TCGA-UCS
10135,TCGA-NG-A4VU,NO,NA,TCGA-NG-A4VU-D44640,59CCBC3F-F754-4EF7-BCF5-81BE4449947B,NA,NA,NA,NA,NA,76,258,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,24,6,2013,TCGA-UCS
10134,TCGA-NG-A4VU,NO,NA,TCGA-NG-A4VU-D44639,FFE617C8-7075-4E96-9114-7251D41B3BDC,NA,NA,NA,NA,NA,76,258,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,24,6,2013,TCGA-UCS
10133,TCGA-NG-A4VU,NO,NA,TCGA-NG-A4VU-D44637,20F43490-56F6-4A1F-81D5-7098CB9CC275,NA,NA,NA,NA,NA,76,258,Ancillary,Mesna,Cytoprotectant,Other,,NA,NA,NA,NO,Clinical Progressive Disease,24,6,2013,TCGA-UCS
10139,TCGA-NG-A4VW,NO,NA,TCGA-NG-A4VW-D44625,2129A39E-7366-4464-8D9F-AAD532E89559,NA,NA,NA,NA,NA,57,197,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,24,6,2013,TCGA-UCS
10141,TCGA-NG-A4VW,NO,NA,TCGA-NG-A4VW-D44629,5C345449-04FC-4FAD-8986-363FE24A4939,NA,NA,NA,NA,NA,57,197,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,24,6,2013,TCGA-UCS
10140,TCGA-NG-A4VW,NO,NA,TCGA-NG-A4VW-D44627,6B40810D-49E8-4660-B726-923ED221E96F,NA,NA,NA,NA,NA,57,197,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Complete Response,24,6,2013,TCGA-UCS
3492,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55546,82B8C7FF-E00A-425B-8E6C-831795E65E18,,,,,,98,113,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,8,1,2014,TCGA-COAD
3488,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55541,1E720CC7-E366-4CE8-9105-592433C65063,,,,,,21,189,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,8,1,2014,TCGA-COAD
3487,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55540,7EC61416-55CA-4A5A-8732-EAFED12F5DBC,,,,,,21,189,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Partial Response,8,1,2014,TCGA-COAD
3491,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55545,BAE5FBCF-0997-4137-9D72-74785EBD0A67,,,,,,238,253,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,8,1,2014,TCGA-COAD
3489,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55542,5DC389D6-7100-4C95-9EEA-2FAEC49C30E9,,,,,,21,266,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,8,1,2014,TCGA-COAD
3490,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55544,BC6D54D8-A6D1-46EA-B3C9-6672E953FD2D,,,,,,21,266,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,8,1,2014,TCGA-COAD
3493,TCGA-NH-A50U,NO,,TCGA-NH-A50U-D55547,AE3FD02D-394D-4F6E-8768-2E54B0E05B02,,,,,,280,NA,Chemotherapy,Regorafenib,Hematopoeisis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,8,1,2014,TCGA-COAD
3494,TCGA-NH-A50V,NO,,TCGA-NH-A50V-D40977,86D33EB0-1853-4CA8-9F9A-BF0D9C9B2279,,,,,,22,210,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,8,3,2013,TCGA-COAD
3495,TCGA-NH-A50V,NO,,TCGA-NH-A50V-D40978,1543E54E-1A13-4C79-B149-E1B59A6882F6,,,,,,53,210,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,8,3,2013,TCGA-COAD
3496,TCGA-NH-A50V,NO,,TCGA-NH-A50V-D67775,16E59916-25D8-47FA-BCB8-D292AF311082,,,,,,53,210,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,11,11,2014,TCGA-COAD
3497,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D48254,5EADFF6A-01B3-4724-8D7F-B59A13338091,,,,,,61,135,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,10,9,2013,TCGA-COAD
3504,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D58982,74ED3264-9A64-47E0-8F75-79C3CC3E61DC,,,,,,61,135,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,29,4,2014,TCGA-COAD
3503,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D58981,BB7CA757-40E5-485F-B40D-261FA200138F,,,,,,61,135,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,29,4,2014,TCGA-COAD
3498,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D48255,A41B6E53-6845-4700-8105-90A0A05F439F,,,,,,192,302,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,14,9,2013,TCGA-COAD
3501,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D58979,0544F341-FD79-42FB-9733-CD6D396CC274,,,,,,192,302,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,29,4,2014,TCGA-COAD
3500,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D50202,D27B898F-FB23-4CBA-9769-24BAF44B08C2,,,,,,192,302,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,17,10,2013,TCGA-COAD
3502,TCGA-NH-A6GA,NO,,TCGA-NH-A6GA-D58980,38DFFC3E-A27E-4F6B-BE5E-EBE2884CCC62,,,,,,192,302,Chemotherapy,Irinotecan,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,,,NO,Clinical Progressive Disease,29,4,2014,TCGA-COAD
3505,TCGA-NH-A6GB,NO,,TCGA-NH-A6GB-D47966,203963D4-D536-4882-BA73-DCE96465215E,,,,,,49,212,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,9,2013,TCGA-COAD
3506,TCGA-NH-A6GB,NO,,TCGA-NH-A6GB-D47967,9E5F85B5-470E-4515-8A6D-AE85BC318C71,,,,,,49,212,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Clinical Progressive Disease,3,9,2013,TCGA-COAD
3508,TCGA-NH-A6GB,NO,,TCGA-NH-A6GB-D66875,BEFB19FB-01C4-46FB-AA30-1EC5EAE2D187,,,,,,49,576,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,24,10,2014,TCGA-COAD
3507,TCGA-NH-A6GB,NO,,TCGA-NH-A6GB-D66874,8642643C-31FB-43C3-A3F7-CBDA20E6E9D8,,,,,,49,576,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Clinical Progressive Disease,24,10,2014,TCGA-COAD
3513,TCGA-NH-A8F7,NO,,TCGA-NH-A8F7-D56710,F0209F5E-3A9E-49B9-9A3B-9896B8E2E4C6,,,,,,74,228,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Partial Response,19,2,2014,TCGA-COAD
3512,TCGA-NH-A8F7,NO,,TCGA-NH-A8F7-D56709,F230456E-0328-4F0F-95A1-8D60F7CEA832,,,,,,74,228,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Partial Response,19,2,2014,TCGA-COAD
3514,TCGA-NH-A8F7,NO,,TCGA-NH-A8F7-D56711,28D39D44-463B-4B21-A04E-B6C5ABD0A0DD,,,,,,74,249,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,,,,NO,Partial Response,19,2,2014,TCGA-COAD
3517,TCGA-NH-A8F8,NO,,TCGA-NH-A8F8-D58585,49ED1A3E-5F7C-4833-B8EC-4A3E03CE86FB,,,,,,49,476,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Clinical Progressive Disease,15,4,2014,TCGA-COAD
4729,TCGA-NJ-A7XG,NO,,TCGA-NJ-A7XG-D71392,722B8970-EEDA-4CD9-B2C5-9FE8E763C119,,,,,NA,30,100,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,25,3,2015,TCGA-LUAD
4731,TCGA-NJ-A7XG,NO,,TCGA-NJ-A7XG-D71463,3340775B-1C82-4EB8-9F90-84B465A9C799,,,,,NA,30,128,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,25,3,2015,TCGA-LUAD
4730,TCGA-NJ-A7XG,NO,,TCGA-NJ-A7XG-D71393,4006A0DF-514F-45D2-8CFA-20E163DF66DE,,,,,NA,100,128,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,25,3,2015,TCGA-LUAD
5088,TCGA-NK-A5D1,NO,NA,TCGA-NK-A5D1-D69591,79275F84-FD95-47AF-8015-E48B49ED5194,NA,,,,NA,49,476,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,14,1,2015,TCGA-LUSC
5087,TCGA-NK-A5D1,NO,NA,TCGA-NK-A5D1-D69590,F01A9272-D487-40C9-B709-1A721A0061D7,NA,,,,NA,49,476,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,14,1,2015,TCGA-LUSC
7974,TCGA-OE-A75W,NO,NA,TCGA-OE-A75W-D66437,FD221B8E-9740-47B2-84FB-EFB1BAF89AF7,NA,NA,NA,NA,NA,118,153,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,16,10,2014,TCGA-PAAD
2644,TCGA-OL-A5D7,NO,,TCGA-OL-A5D7-D65248,3B824D33-1415-4513-BD99-B3D2EB3268E0,,,,,,41,104,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2645,TCGA-OL-A5D7,NO,,TCGA-OL-A5D7-D65249,34732C91-371D-4928-9C31-6B8D6A5D76CB,,,,,,41,104,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2646,TCGA-OL-A5RU,NO,,TCGA-OL-A5RU-D65252,69BA6DFE-4BE6-4D86-BA5B-77352DEA913A,,,,,,71,134,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2647,TCGA-OL-A5RU,NO,,TCGA-OL-A5RU-D65253,6A5D8B38-7542-47E7-BC90-14735FEA1214,,,,,,71,134,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2649,TCGA-OL-A5RV,NO,,TCGA-OL-A5RV-D65255,55A6BAAD-D9D1-432E-944D-57781807E2BD,,,,,,63,161,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2650,TCGA-OL-A5RV,NO,,TCGA-OL-A5RV-D65256,D588C324-FD32-4951-B780-BE01F71AA7DD,,,,,,63,161,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2648,TCGA-OL-A5RV,NO,,TCGA-OL-A5RV-D65254,F0F4E472-BC9E-4970-A306-4702DE384D0F,,,,,,63,161,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2652,TCGA-OL-A5RW,NO,,TCGA-OL-A5RW-D65260,47037AD5-7A17-40F3-B7B7-8FA8F3BF1294,,,,,,69,234,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2653,TCGA-OL-A5RW,NO,,TCGA-OL-A5RW-D65261,9A883C83-C334-4ADE-9EC6-DEA81CFB7220,,,,,,69,234,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2651,TCGA-OL-A5RW,NO,,TCGA-OL-A5RW-D65259,B981AF2A-14CD-4F9E-B7F0-E4097AC4A18C,,,,,,69,234,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2655,TCGA-OL-A5RZ,NO,,TCGA-OL-A5RZ-D65263,70A2566A-B315-479A-82BF-250CBCAF6F3B,,,,,,239,331,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2654,TCGA-OL-A5RZ,NO,,TCGA-OL-A5RZ-D65262,20672357-AAF4-4236-A2ED-742216DD61B4,,,,,,239,331,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2656,TCGA-OL-A5S0,NO,,TCGA-OL-A5S0-D65265,8498E674-7702-4F90-9214-66B02D73543D,,,,,,67,228,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2657,TCGA-OL-A5S0,NO,,TCGA-OL-A5S0-D65266,BFE8B8D7-C0CE-4D2E-A587-DDC39BE732B1,,,,,,67,228,Hormone Therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2659,TCGA-OL-A66I,NO,,TCGA-OL-A66I-D65246,43174F1C-A7E8-41DB-91CD-79BF16DDA0CC,,,,,,43,312,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2660,TCGA-OL-A66I,NO,,TCGA-OL-A66I-D65247,BFFBBF56-08F9-40CB-99D1-13CE9A5FB330,,,,,,43,312,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2658,TCGA-OL-A66I,NO,,TCGA-OL-A66I-D64844,F22168A0-48F2-4929-8D24-FC96F98FBDD8,,,,,,43,312,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,12,9,2014,TCGA-BRCA
2661,TCGA-OL-A66O,NO,,TCGA-OL-A66O-D64491,B0AF5BB3-D16F-4702-A5DA-AAA9B59EDEDE,,,,,,129,192,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2662,TCGA-OL-A66O,NO,,TCGA-OL-A66O-D65244,A6C0E34D-00F1-42B6-883B-AE2C88CD9296,,,,,,129,192,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2663,TCGA-OL-A66P,NO,,TCGA-OL-A66P-D64493,1BB36628-3326-4CF1-B898-053AE55A2C10,,,,,,71,162,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2664,TCGA-OL-A66P,NO,,TCGA-OL-A66P-D65245,D827B0B7-5809-4FDC-BA64-92F84625B855,,,,,,71,162,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,24,9,2014,TCGA-BRCA
2666,TCGA-OL-A6VO,NO,,TCGA-OL-A6VO-D65548,AB34EC19-3799-4671-962A-F4C7E3E37EA6,,,,,,71,147,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,10,2014,TCGA-BRCA
2665,TCGA-OL-A6VO,NO,,TCGA-OL-A6VO-D63192,CE66AA70-6EA4-4FAA-84F8-24A41673E3CE,,,,,,71,147,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,8,2014,TCGA-BRCA
1,TCGA-OR-A5JM,NO,NA,TCGA-OR-A5JM-D49539,B4F66718-B197-4EFB-AF9B-380B238BF6B5,NA,NA,NA,NA,NA,378,439,Targeted Molecular therapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,3,10,2013,TCGA-ACC
2,TCGA-OR-A5JM,NO,NA,TCGA-OR-A5JM-D49540,2B5DD32A-1F38-4899-A90F-77C16B1F900E,NA,NA,NA,NA,NA,378,439,Targeted Molecular therapy,Ketoconazole,Antiandrogen|Antiglucocorticoid,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,3,10,2013,TCGA-ACC
10,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D45488,C4F9820C-381E-4EA5-86E2-C6BE026BAF87,NA,NA,NA,NA,NA,55,239,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,16,7,2013,TCGA-ACC
9,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D45487,3511FDB0-AA74-42F8-A96F-22043A6186D2,NA,NA,NA,NA,NA,69,239,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Stable Disease,16,7,2013,TCGA-ACC
8,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D45486,DEC40BA5-E688-457A-92B6-FDCC166D3321,NA,NA,NA,NA,NA,69,239,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Stable Disease,16,7,2013,TCGA-ACC
12,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65713,24E5DD42-A517-41EB-96B5-31B361E509AF,NA,NA,NA,NA,NA,605,694,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
14,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65715,5210E184-AB88-43FB-AA3E-075B069C7641,NA,NA,NA,NA,NA,605,694,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
13,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65714,EDE41FC6-31AC-48CC-90D7-34982230C4E6,NA,NA,NA,NA,NA,605,694,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
15,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65717,C580D8A5-B9BA-408B-B48C-475EC3B9B71D,NA,NA,NA,NA,NA,725,817,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
16,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65718,DB218B3E-4521-4679-B6EC-6007015DDCB0,NA,NA,NA,NA,NA,725,817,Chemotherapy,Streptozocin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
17,TCGA-OU-A5PI,NO,NA,TCGA-OU-A5PI-D65719,63516D8E-6FD0-445D-87C1-A324961E772C,NA,NA,NA,NA,NA,725,878,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,NA,NA,NA,NA,NO,Stable Disease,29,9,2014,TCGA-ACC
7757,TCGA-OY-A56P,NO,NA,TCGA-OY-A56P-D40752,002D674C-302E-4EEE-9324-3C912254F7DC,,,,,NA,26,160,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,27,2,2013,TCGA-OV
7756,TCGA-OY-A56P,NO,NA,TCGA-OY-A56P-D40751,4C69AC4B-5520-421E-ADEF-0F12EB0C0911,,,,,NA,26,160,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,27,2,2013,TCGA-OV
7759,TCGA-OY-A56Q,NO,NA,TCGA-OY-A56Q-D40757,4E265E98-8861-485E-A5C5-21CEDE8B7F99,,,,,NA,23,128,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,27,2,2013,TCGA-OV
7758,TCGA-OY-A56Q,NO,NA,TCGA-OY-A56Q-D40756,E86F10BA-0449-406C-ABBE-AF17416539F6,,,,,NA,23,128,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Complete Response,27,2,2013,TCGA-OV
3919,TCGA-P3-A5Q6,NO,NA,TCGA-P3-A5Q6-D43798,B71ADE8C-6A2D-45B7-B690-2BF5B3F111F5,NA,,NA,,NA,43,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,6,2013,TCGA-HNSC
3920,TCGA-P3-A5Q6,NO,NA,TCGA-P3-A5Q6-D43799,83FE780B-5F32-4B47-ABE0-E710B2CD1AC0,NA,,NA,,NA,43,104,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,4,6,2013,TCGA-HNSC
3922,TCGA-P3-A6SW,NO,NA,TCGA-P3-A6SW-D50087,90C42460-FDE6-4995-AC15-978C9B51A501,NA,,NA,,NA,NA,122,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
3924,TCGA-P3-A6T2,NO,NA,TCGA-P3-A6T2-D50101,B134B856-27DA-4175-8AEF-8BEFC4CE09B8,NA,,NA,,NA,30,91,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
3925,TCGA-P3-A6T3,NO,NA,TCGA-P3-A6T3-D50143,5FBB121D-7484-4EDC-B9D8-531A410C194D,NA,,NA,,NA,61,92,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
3927,TCGA-P3-A6T6,NO,NA,TCGA-P3-A6T6-D50157,ED4A1471-8B9D-40FA-86E0-EF1C08EADB26,NA,,NA,,NA,273,365,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,21,10,2013,TCGA-HNSC
3926,TCGA-P3-A6T6,NO,NA,TCGA-P3-A6T6-D50156,B47DEFB6-7DE6-45BF-88AB-2A193171149F,NA,,NA,,NA,273,365,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,21,10,2013,TCGA-HNSC
3928,TCGA-P3-A6T7,NO,NA,TCGA-P3-A6T7-D50172,17CE025C-47EF-4C35-B1AA-551D7B71D8A6,NA,,NA,,NA,91,122,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
3929,TCGA-P3-A6T8,NO,NA,TCGA-P3-A6T8-D50176,931DA439-B763-4E21-BC67-2AC0E0FFD033,NA,,NA,,NA,92,122,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
2670,TCGA-PE-A5DE,NO,,TCGA-PE-A5DE-D66369,1E2B873D-3AE8-418A-8727-97077CF103B5,,,,,,42,105,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,10,2014,TCGA-BRCA
2669,TCGA-PE-A5DE,NO,,TCGA-PE-A5DE-D42973,F709235A-EEE6-4F2B-BCB5-C273A7BC66D0,,,,,,42,105,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,6,5,2013,TCGA-BRCA
10037,TCGA-PG-A7D5,NO,NA,TCGA-PG-A7D5-D71180,68197989-E32B-4A6C-A219-5BA4C19502DB,NA,,,,NA,60,192,Chemotherapy,Carboplatin|Paclitaxel,Alkylating agent|Antimitotic,Alkylating agent|Antimitotic,,,,,NO,Complete Response,20,3,2015,TCGA-UCEC
18,TCGA-PK-A5HB,YES,NA,TCGA-PK-A5HB-D48538,08ACEB09-01AC-4EF4-843B-3E342FA5AFF7,NA,NA,NA,NA,NA,968,1029,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,16,9,2013,TCGA-ACC
8563,TCGA-PT-A8TR,YES,NA,TCGA-PT-A8TR-D57928,832BE8DF-1543-4DF9-9F32-B2DD61BE1818,NA,,NA,,NA,40,155,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,28,3,2014,TCGA-SARC
8564,TCGA-PT-A8TR,YES,NA,TCGA-PT-A8TR-D57933,1768AC31-22FC-444A-87A4-4605B0B4055A,NA,,NA,,NA,40,155,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,28,3,2014,TCGA-SARC
2865,TCGA-Q1-A5R2,YES,NA,TCGA-Q1-A5R2-D48279,56934D77-B222-4F09-B296-CCA334AAD2D7,NA,,NA,,NA,5,48,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,N/A,,,,NO,Partial Response,11,9,2013,TCGA-CESC
2866,TCGA-Q1-A5R3,YES,NA,TCGA-Q1-A5R3-D48282,C5C29ED4-F72E-4232-ACC3-915430D476E6,NA,,NA,,NA,21,56,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,N/A,,,,NO,Partial Response,11,9,2013,TCGA-CESC
2868,TCGA-Q1-A73O,YES,NA,TCGA-Q1-A73O-D50840,0CBEB31F-1EFD-41EB-8D76-26FF440332EA,NA,,NA,,NA,54,89,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,31,10,2013,TCGA-CESC
7978,TCGA-Q3-A5QY,YES,NA,TCGA-Q3-A5QY-D55666,BE469083-5A1F-42FB-AD19-DF0C2DFE0FDC,NA,NA,NA,NA,NA,35,92,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,13,1,2014,TCGA-PAAD
8814,TCGA-QB-AA9O,NO,,TCGA-QB-AA9O-D60729,CD3E7E8E-E439-4BEC-9C20-21CFAF1A9EE5,NA,NA,NA,,NA,171,234,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,13,6,2014,TCGA-SKCM
10038,TCGA-QF-A5YS,NO,NA,TCGA-QF-A5YS-D44656,F05BDE3B-51A8-49E1-B6B0-13A9A1751181,NA,,,,NA,109,158,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,6,2013,TCGA-UCEC
10039,TCGA-QF-A5YS,NO,NA,TCGA-QF-A5YS-D59671,9DE9F15C-7959-409E-8578-60E6B608576C,NA,,,,NA,109,158,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,19,5,2014,TCGA-UCEC
10040,TCGA-QF-A5YT,NO,NA,TCGA-QF-A5YT-D44676,975570DE-DBC9-4A2B-B9E4-1C2E973DA609,NA,,,,NA,158,200,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,25,6,2013,TCGA-UCEC
3522,TCGA-QG-A5YV,NO,,TCGA-QG-A5YV-D44472,90AC2E57-1CE1-40BD-A06A-24E02797C282,,,,,,72,174,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,20,6,2013,TCGA-COAD
3524,TCGA-QG-A5YW,NO,,TCGA-QG-A5YW-D48503,8B2088DB-6AF0-441E-A2FF-1AD44019549B,,,,,,42,197,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,16,9,2013,TCGA-COAD
3523,TCGA-QG-A5YW,NO,,TCGA-QG-A5YW-D44480,0D4D2171-F422-48BB-B6AF-7B11900BA704,,,,,,42,197,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,20,6,2013,TCGA-COAD
3525,TCGA-QG-A5YX,NO,,TCGA-QG-A5YX-D44483,07AF7F33-432C-43A3-BF5B-12A81384FB74,,,,,,42,527,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,20,6,2013,TCGA-COAD
3930,TCGA-QK-A6IF,NO,NA,TCGA-QK-A6IF-D48967,D07A6E9C-1FC4-4110-A6C8-E48562632703,NA,,NA,,NA,17,63,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,9,2013,TCGA-HNSC
3931,TCGA-QK-A6IF,NO,NA,TCGA-QK-A6IF-D54877,4910BF75-4B3C-44EA-8EC9-1567B5AAA6E7,NA,,NA,,NA,17,63,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,23,12,2013,TCGA-HNSC
3932,TCGA-QK-A6IG,NO,NA,TCGA-QK-A6IG-D48980,15D66913-F58A-49F3-B1C6-26BBEBE16A27,NA,,NA,,NA,51,98,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,9,2013,TCGA-HNSC
3933,TCGA-QK-A6IG,NO,NA,TCGA-QK-A6IG-D54916,D8A6EDE4-2CF3-4796-8B5C-0CBC47C2817C,NA,,NA,,NA,51,98,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,23,12,2013,TCGA-HNSC
3934,TCGA-QK-A6IH,NO,NA,TCGA-QK-A6IH-D48993,34F872C4-F666-475A-8F59-505BAF0D5C35,NA,,NA,,NA,49,84,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,9,2013,TCGA-HNSC
3935,TCGA-QK-A6IH,NO,NA,TCGA-QK-A6IH-D54921,00D9CF82-0A61-40A4-AAE9-A575F284A82A,NA,,NA,,NA,49,84,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,23,12,2013,TCGA-HNSC
3936,TCGA-QK-A6IH,NO,NA,TCGA-QK-A6IH-D66626,3774462C-1318-453E-AC1C-BA0773F7D228,NA,,NA,,NA,NA,396,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,21,10,2014,TCGA-HNSC
3937,TCGA-QK-A6IH,NO,NA,TCGA-QK-A6IH-D66628,184CB90B-679D-49AD-BA58-9D154511A26D,NA,,NA,,NA,NA,396,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Stable Disease,21,10,2014,TCGA-HNSC
3938,TCGA-QK-A6IH,NO,NA,TCGA-QK-A6IH-D66631,A69AB28B-73B3-4939-AEA7-8E28FA2E7BAA,NA,,NA,,NA,NA,396,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Stable Disease,21,10,2014,TCGA-HNSC
3940,TCGA-QK-A6II,NO,NA,TCGA-QK-A6II-D66694,4D656185-33C7-49CB-B9C7-78A4DD88EE23,NA,,NA,,NA,183,183,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,22,10,2014,TCGA-HNSC
3941,TCGA-QK-A6II,NO,NA,TCGA-QK-A6II-D66697,496E7790-5648-4031-8700-B1B8DE9B9A0D,NA,,NA,,NA,183,183,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,22,10,2014,TCGA-HNSC
3942,TCGA-QK-A6II,NO,NA,TCGA-QK-A6II-D66701,BA82D367-59CA-4E0C-A97C-10CEB28623A6,NA,,NA,,NA,183,183,Targeted Molecular therapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,22,10,2014,TCGA-HNSC
3943,TCGA-QK-A8Z7,NO,NA,TCGA-QK-A8Z7-D63234,9ADF32C7-F5CA-4A84-AD80-CB89A18B3ABA,NA,,NA,,NA,105,166,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,4,8,2014,TCGA-HNSC
3944,TCGA-QK-A8Z7,NO,NA,TCGA-QK-A8Z7-D63235,51B88D02-9EEE-49D3-8FB7-DA50B9A64A25,NA,,NA,,NA,105,166,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,4,8,2014,TCGA-HNSC
3948,TCGA-QK-A8Z9,NO,NA,TCGA-QK-A8Z9-D58569,28AACA3B-F335-40D2-8947-6C8AF80A6707,NA,,NA,,NA,50,102,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,14,4,2014,TCGA-HNSC
3949,TCGA-QK-A8Z9,NO,NA,TCGA-QK-A8Z9-D58570,A9932136-BD96-46A5-B4AC-1DA523473034,NA,,NA,,NA,50,102,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,14,4,2014,TCGA-HNSC
8567,TCGA-QQ-A8VD,NO,NA,TCGA-QQ-A8VD-D59593,1150CECC-83B3-43C7-8A26-AC51E065EB89,NA,,NA,,NA,613,1499,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,NA,,NO,Clinical Progressive Disease,15,5,2014,TCGA-SARC
8569,TCGA-QQ-A8VD,NO,NA,TCGA-QQ-A8VD-D59598,0ADD8E6B-4AE9-4543-9160-95F5527F0824,NA,,NA,,NA,2807,2886,Hormone Therapy,Raloxifene,Antiestrogen,Other,,,NA,,NO,Clinical Progressive Disease,15,5,2014,TCGA-SARC
8570,TCGA-QQ-A8VD,NO,NA,TCGA-QQ-A8VD-D59599,4F5C2E4F-8451-4F69-B206-5B11B440F4C0,NA,,NA,,NA,2898,3026,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,15,5,2014,TCGA-SARC
8018,TCGA-QR-A6GT,YES,NA,TCGA-QR-A6GT-D68268,70F6F9B4-61C8-4DFF-80BF-C6E077266E29,NA,NA,NA,NA,NA,2435,3452,Chemotherapy,Cyclophosphamide|Dacarbazine|Vincristine,Alkylating agent|Alkylating agent|Antimitotic,Alkylating agent|Alkylating agent|Antimitotic,,NA,NA,NA,NO,Partial Response,24,11,2014,TCGA-PCPG
8022,TCGA-QR-A70P,YES,NA,TCGA-QR-A70P-D56740,93480EC7-F8E1-41F2-9327-4CE2523084E8,NA,NA,NA,NA,NA,966,NA,Chemotherapy,Cyclophosphamide|Dacarbazine|Vincristine,Alkylating agent|Alkylating agent|Antimitotic,Alkylating agent|Alkylating agent|Antimitotic,CVD,NA,NA,NA,NO,Clinical Progressive Disease,22,10,2014,TCGA-PCPG
10041,TCGA-QS-A5YQ,YES,NA,TCGA-QS-A5YQ-D43117,1CE4A515-1824-497A-89E9-42F23FF07160,NA,,,,NA,65,93,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,5,2013,TCGA-UCEC
10042,TCGA-QS-A5YQ,YES,NA,TCGA-QS-A5YQ-D43752,1DF21841-4223-43CF-8F89-A8669026CC02,NA,,,,NA,128,198,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,6,2013,TCGA-UCEC
10043,TCGA-QS-A5YQ,YES,NA,TCGA-QS-A5YQ-D43753,DB80D6EC-BF5B-46C0-9DA9-B9605C3ECC42,NA,,,,NA,128,198,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,3,6,2013,TCGA-UCEC
10046,TCGA-QS-A8F1,NO,NA,TCGA-QS-A8F1-D56573,9B0EF2CF-5213-4B9B-8272-5A0ACEBD4A63,NA,,,,NA,62,62,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,13,2,2014,TCGA-UCEC
10047,TCGA-QS-A8F1,NO,NA,TCGA-QS-A8F1-D56575,0328D2CB-143C-4018-8CA4-B8DCF60930B7,NA,,,,NA,62,62,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,13,2,2014,TCGA-UCEC
8024,TCGA-QT-A5XJ,NO,NA,TCGA-QT-A5XJ-D43422,AB46A29D-8A98-45BE-AE90-9B67B052BCEA,NA,NA,NA,NA,NA,113,326,Chemotherapy,Temozolomide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,21,5,2013,TCGA-PCPG
8023,TCGA-QT-A5XJ,NO,NA,TCGA-QT-A5XJ-D43421,026BE83A-2C0E-4B6E-AC4F-6C13FBD1B190,NA,NA,NA,NA,NA,113,326,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,21,5,2013,TCGA-PCPG
3600,TCGA-R6-A8W5,NO,NA,TCGA-R6-A8W5-D69253,3FCEBA92-0143-4834-9128-AF65B3EF7EC7,NA,NA,NA,NA,NA,361,385,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,31,12,2014,TCGA-ESCA
3601,TCGA-R6-A8W5,NO,NA,TCGA-R6-A8W5-D70414,E99CB2F1-1A1B-4D61-8FEE-7395CC76907C,NA,NA,NA,NA,NA,361,385,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,12,2,2015,TCGA-ESCA
2872,TCGA-RA-A741,NO,NA,TCGA-RA-A741-D51218,CA996310-983C-4D64-A2A3-1AD4558A97F2,NA,,NA,,NA,118,254,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,13,11,2013,TCGA-CESC
2873,TCGA-RA-A741,NO,NA,TCGA-RA-A741-D51219,27032B2D-9885-4398-B8E1-82EF7C0D1194,NA,,NA,,NA,118,254,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,13,11,2013,TCGA-CESC
2875,TCGA-RA-A741,NO,NA,TCGA-RA-A741-D66182,E0AD8182-60F5-46E5-8B7E-C8623125249C,NA,,NA,,NA,233,254,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,,,NO,Complete Response,3,10,2014,TCGA-CESC
7982,TCGA-RB-AA9M,NO,NA,TCGA-RB-AA9M-D67005,7013F3C2-E108-4502-9B6E-929820A4BD5F,NA,NA,NA,NA,NA,67,218,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,29,10,2014,TCGA-PAAD
8572,TCGA-RN-AAAQ,NO,NA,TCGA-RN-AAAQ-D62295,914CB230-5911-4EFF-8449-46934486E07B,NA,,NA,,NA,40,89,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,15,7,2014,TCGA-SARC
8573,TCGA-RN-AAAQ,NO,NA,TCGA-RN-AAAQ-D71461,3168AEE1-EA48-426F-A025-4514790AEAB2,NA,,NA,,NA,362,392,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,25,3,2015,TCGA-SARC
8575,TCGA-RN-AAAQ,NO,NA,TCGA-RN-AAAQ-D71465,C055BC14-ABF7-41B5-BEA3-9AD5A3AA889E,NA,,NA,,NA,392,453,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,25,3,2015,TCGA-SARC
8574,TCGA-RN-AAAQ,NO,NA,TCGA-RN-AAAQ-D71464,62EAA7D0-1F8D-4B65-B17F-19688BD2CE10,NA,,NA,,NA,392,453,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,25,3,2015,TCGA-SARC
3954,TCGA-RS-A6TO,NO,NA,TCGA-RS-A6TO-D57157,4C52111A-C482-474B-A76A-E10E8346E244,NA,,NA,,NA,41,41,Immunotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Complete Response,10,3,2014,TCGA-HNSC
3530,TCGA-RU-A8FL,NO,,TCGA-RU-A8FL-D68088,6F9A2902-54C7-401D-BEEB-5A1F444AFCCE,,,,,,48,210,Chemotherapy,Oxaliplatin|5-Fluorouracil|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,,,,NO,Clinical Progressive Disease,14,11,2014,TCGA-COAD
3529,TCGA-RU-A8FL,NO,,TCGA-RU-A8FL-D68257,09D26C80-A0A1-453B-901C-347775472D0F,,,,,,270,334,Chemotherapy,5-Fluorouracil|Irinotecan|Folinic acid|Bevacizumab,Antimetabolite|Topoisomerase inhibitor|Rescue agent|Angiogenesis inhibitor,Antimetabolite|Topoisomerase inhibitor|Other,NA,,,,NO,Clinical Progressive Disease,14,11,2014,TCGA-COAD
3528,TCGA-RU-A8FL,NO,,TCGA-RU-A8FL-D68258,35B51064-B60A-468F-A98F-BAC6F14F516D,,,,,,343,677,Chemotherapy,Irinotecan|Cetuximab,Topoisomerase inhibitor|HER1 inhibitor,Topoisomerase inhibitor|Other,NA,,,,NO,Clinical Progressive Disease,14,11,2014,TCGA-COAD
3527,TCGA-RU-A8FL,NO,,TCGA-RU-A8FL-D68261,C47FCF93-73B8-400B-B465-F031923491F1,,,,,,679,756,Chemotherapy,5-Fluorouracil|Irinotecan|Folinic acid|Aflibercept,Antimetabolite|Topoisomerase inhibitor|Rescue agent|Angiogenesis inhibitor,Antimetabolite|Topoisomerase inhibitor|Other,NA,,,,NO,Clinical Progressive Disease,14,11,2014,TCGA-COAD
2676,TCGA-S3-A6ZF,YES,,TCGA-S3-A6ZF-D51086,E2F5E7F8-10E2-4432-A00A-7087B5955C9E,,,,,,65,170,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2673,TCGA-S3-A6ZF,YES,,TCGA-S3-A6ZF-D51061,4503FC44-1AA6-4A16-BE16-63146AF1ECEB,,,,,,65,170,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2675,TCGA-S3-A6ZF,YES,,TCGA-S3-A6ZF-D51087,DA38E0A7-A07F-4D6E-85AD-465748551C97,,,,,,78,170,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2674,TCGA-S3-A6ZF,YES,,TCGA-S3-A6ZF-D51062,2B4A620C-E5B7-45D0-823B-A7D09CD7F72D,,,,,,65,429,Immunotherapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2680,TCGA-S3-A6ZG,NO,,TCGA-S3-A6ZG-D51089,9C1469D0-34BE-4520-A928-C8222B9AA84A,,,,,,52,100,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2683,TCGA-S3-A6ZG,NO,,TCGA-S3-A6ZG-D64188,CE65FD9A-E5F7-42B1-8603-9979F90ABD5F,,,,,,52,100,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,27,8,2014,TCGA-BRCA
2679,TCGA-S3-A6ZG,NO,,TCGA-S3-A6ZG-D51088,4FFDEFCC-4989-4FE3-9F8C-2F66D9CD5EF8,,,,,,52,100,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2681,TCGA-S3-A6ZG,NO,,TCGA-S3-A6ZG-D51090,592DBC73-6BBC-49B6-8C4D-DE2812D431D8,,,,,,116,221,Hormone Therapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2685,TCGA-S3-A6ZH,YES,,TCGA-S3-A6ZH-D51095,9A50CE8C-5949-4FBC-9D18-2BF7A3C8FFC6,,,,,,141,185,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2686,TCGA-S3-A6ZH,YES,,TCGA-S3-A6ZH-D51097,1AF804F2-0DDD-4DC3-9977-DA151A2F69AE,,,,,,141,185,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2684,TCGA-S3-A6ZH,YES,,TCGA-S3-A6ZH-D51093,4FF7C7C8-9204-4234-8E32-E4E647B7A669,,,,,,141,185,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,12,11,2013,TCGA-BRCA
2691,TCGA-S3-AA0Z,NO,,TCGA-S3-AA0Z-D58343,B9B5E318-2BBB-4B47-82CC-96C736833EFC,,,,,,84,84,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2689,TCGA-S3-AA0Z,NO,,TCGA-S3-AA0Z-D58353,3637BA55-6C9D-4F13-A47E-32FD9792653B,,,,,,84,84,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2690,TCGA-S3-AA0Z,NO,,TCGA-S3-AA0Z-D58342,52E9F222-05FA-42AB-A37A-8494A24CC569,,,,,,84,84,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2693,TCGA-S3-AA10,NO,,TCGA-S3-AA10-D58351,765A1845-816A-48C0-B600-D8D63C2E7DE9,,,,,,75,199,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2694,TCGA-S3-AA10,NO,,TCGA-S3-AA10-D58352,A162E470-A31A-43EF-B7CC-48C25D10E121,,,,,,75,199,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2695,TCGA-S3-AA10,NO,,TCGA-S3-AA10-D58354,DFEAFB3D-F85C-4E98-96CE-3BB8DAE7C12E,,,,,,75,199,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2697,TCGA-S3-AA11,NO,,TCGA-S3-AA11-D58358,0469F246-0A00-46F4-ACA0-0B25A14C6D08,,,,,,53,169,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2698,TCGA-S3-AA11,NO,,TCGA-S3-AA11-D58359,88D345D0-A5BB-4598-983F-ABA5E9ADE52E,,,,,,169,309,Hormone Therapy,Exemestane,Aromatase inhibitor,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2699,TCGA-S3-AA11,NO,,TCGA-S3-AA11-D67566,FF58F7AA-3F5B-42A3-B786-9CD8F5B3998B,,,,,,309,NA,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,YES,Complete Response,7,11,2014,TCGA-BRCA
2702,TCGA-S3-AA14,NO,,TCGA-S3-AA14-D58561,19C8BDA0-73FA-4112-A3E0-04738D2582BE,,,,,,62,104,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2703,TCGA-S3-AA14,NO,,TCGA-S3-AA14-D58562,6E4C1CA4-4878-438D-BA03-D9E0A56288F4,,,,,,62,104,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2701,TCGA-S3-AA14,NO,,TCGA-S3-AA14-D58559,83B53265-EDFD-4A74-ACCA-B6D079983317,,,,,,62,104,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2707,TCGA-S3-AA15,NO,,TCGA-S3-AA15-D58381,CD0DBE0D-1FF4-4A8C-A3EF-5397C30A382A,,,,,,82,125,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2708,TCGA-S3-AA15,NO,,TCGA-S3-AA15-D58382,4ACE7463-6DB8-42D6-93B0-327859CD747E,,,,,,82,125,Ancillary,Pegfilgrastim,CSF,Other,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2706,TCGA-S3-AA15,NO,,TCGA-S3-AA15-D58380,0B7D016E-CC28-4274-BF66-92AC08BD4CCD,,,,,,82,125,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
2709,TCGA-S3-AA15,NO,,TCGA-S3-AA15-D58383,B4C53B22-0A11-4216-A8A3-EE51B419C715,,,,,,138,236,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,18,4,2014,TCGA-BRCA
7983,TCGA-S4-A8RM,NO,NA,TCGA-S4-A8RM-D58777,FB088F9A-7617-42A1-9420-1F376215F167,NA,NA,NA,NA,NA,103,264,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,23,4,2014,TCGA-PAAD
9457,TCGA-S6-A8JY,NO,NA,TCGA-S6-A8JY-D56238,D91547A5-479A-4B48-9D79-A0D5223FC809,NA,NA,NA,NA,NA,11,81,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,30,1,2014,TCGA-TGCT
9456,TCGA-S6-A8JY,NO,NA,TCGA-S6-A8JY-D56237,A20B5A1F-CCBD-4A76-937D-5B98025631CF,NA,NA,NA,NA,NA,11,81,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,30,1,2014,TCGA-TGCT
3602,TCGA-S8-A6BV,NO,NA,TCGA-S8-A6BV-D62066,C6AE99D4-691F-4EFF-AC73-48517141A4B6,NA,NA,NA,NA,NA,276,290,Chemotherapy,Oxaliplatin|5-Fluorouracil|Folinic acid,Alkylating agent|Antimetabolite|Rescue agent,Alkylating agent|Antimetabolite|Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,11,7,2014,TCGA-ESCA
5176,TCGA-SC-A6LM,YES,NA,TCGA-SC-A6LM-D49070,E5090969-23A9-4E8D-90BE-8AF2B9EF28F9,NA,NA,NA,NA,NA,391,543,Chemotherapy,Everolimus,MTOR inhibitor,Other,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5178,TCGA-SC-A6LM,NO,NA,TCGA-SC-A6LM-D49075,ABDBEF67-CBED-4B4D-ABED-8B589E7758AB,NA,NA,NA,NA,NA,571,634,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5177,TCGA-SC-A6LM,NO,NA,TCGA-SC-A6LM-D49071,7338A86C-B2E4-4614-AE7D-61DC38DEE370,NA,NA,NA,NA,NA,564,711,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5179,TCGA-SC-A6LM,NO,NA,TCGA-SC-A6LM-D49076,5BABFACF-C446-4759-A245-852BFA171478,NA,NA,NA,NA,NA,739,760,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5180,TCGA-SC-A6LM,NO,NA,TCGA-SC-A6LM-D49077,8165B981-D8B6-4CCA-80AA-652FCC9ED909,NA,NA,NA,NA,NA,790,816,Chemotherapy,Vinorelbine,Antimitotic,Antimitotic,,NA,NA,NA,NO,Stable Disease,23,10,2013,TCGA-MESO
5183,TCGA-SC-A6LP,YES,NA,TCGA-SC-A6LP-D50418,84026AE9-2766-4170-84A6-4B3F1373EACD,NA,NA,NA,NA,NA,12,12,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5184,TCGA-SC-A6LP,YES,NA,TCGA-SC-A6LP-D50419,C552BBD7-60A4-4CDC-951B-8EBFC2BC1F79,NA,NA,NA,NA,NA,12,12,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,23,10,2013,TCGA-MESO
5186,TCGA-SC-A6LQ,NO,NA,TCGA-SC-A6LQ-D50421,1E1C04C8-A6E2-468F-ADFF-C2F0DAA98E39,NA,NA,NA,NA,NA,74,137,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,23,10,2013,TCGA-MESO
5185,TCGA-SC-A6LQ,NO,NA,TCGA-SC-A6LQ-D50420,10CE3290-E6D4-47DC-B198-18B11A885B8A,NA,NA,NA,NA,NA,74,137,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,23,10,2013,TCGA-MESO
5188,TCGA-SC-A6LR,YES,NA,TCGA-SC-A6LR-D50424,8F257798-0780-463A-8595-7675C72B1541,NA,NA,NA,NA,NA,83,146,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,23,10,2013,TCGA-MESO
5187,TCGA-SC-A6LR,YES,NA,TCGA-SC-A6LR-D50423,A5547AE3-9E3C-4D6C-8B10-E29EE3535673,NA,NA,NA,NA,NA,83,146,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,23,10,2013,TCGA-MESO
5190,TCGA-SC-AA5Z,YES,NA,TCGA-SC-AA5Z-D71148,02A887E2-48B1-46B8-82D9-2C21C707075B,NA,NA,NA,NA,NA,34,34,Vaccine,GL-ONC1,Oncolytic virus,Other,,NA,NA,NA,NO,Clinical Progressive Disease,19,3,2015,TCGA-MESO
5192,TCGA-SC-AA5Z,NO,NA,TCGA-SC-AA5Z-D71146,F52392E4-A909-4516-9663-407CC952668A,NA,NA,NA,NA,NA,106,170,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,19,3,2015,TCGA-MESO
5191,TCGA-SC-AA5Z,NO,NA,TCGA-SC-AA5Z-D71147,52FE421A-E454-4BE9-A672-B038DB28044C,NA,NA,NA,NA,NA,106,170,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,19,3,2015,TCGA-MESO
5193,TCGA-SH-A7BC,NO,NA,TCGA-SH-A7BC-D50308,81069D8F-3D68-46B8-AE66-5C265A70C59D,NA,NA,NA,NA,NA,165,278,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5194,TCGA-SH-A7BC,NO,NA,TCGA-SH-A7BC-D52235,24F871C3-1FE7-464A-A2ED-CF12EBE8E931,NA,NA,NA,NA,NA,165,278,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5195,TCGA-SH-A7BC,NO,NA,TCGA-SH-A7BC-D52236,FFB25A77-140A-47D5-91B5-7EACFA43368F,NA,NA,NA,NA,NA,573,649,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5196,TCGA-SH-A7BC,NO,NA,TCGA-SH-A7BC-D52238,E76948B5-CFE3-4093-9F27-379262C877D8,NA,NA,NA,NA,NA,573,649,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5198,TCGA-SH-A7BD,NO,NA,TCGA-SH-A7BD-D51534,4ED4CC48-6B53-42EB-8360-E4BF90D84039,NA,NA,NA,NA,NA,58,163,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,20,11,2013,TCGA-MESO
5197,TCGA-SH-A7BD,NO,NA,TCGA-SH-A7BD-D50933,1B0C0DEC-22F8-4F16-AD52-214A5DB8EAFF,NA,NA,NA,NA,NA,58,163,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,20,11,2013,TCGA-MESO
5200,TCGA-SH-A7BD,NO,NA,TCGA-SH-A7BD-D52243,85584AD6-B2B1-43EC-92C5-8305865F8CAC,NA,NA,NA,NA,NA,388,429,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5199,TCGA-SH-A7BD,NO,NA,TCGA-SH-A7BD-D52242,3EB3FDBB-5D2F-488A-917F-4BF0C8234AD5,NA,NA,NA,NA,NA,388,429,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,2,12,2013,TCGA-MESO
5201,TCGA-SH-A7BH,NO,NA,TCGA-SH-A7BH-D50998,DBF51D93-E608-443C-9896-03F1FD26AA16,NA,NA,NA,NA,NA,153,195,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,2,12,2013,TCGA-MESO
5202,TCGA-SH-A7BH,NO,NA,TCGA-SH-A7BH-D51946,0573561F-4D29-49F2-A20B-720F3D624D9F,NA,NA,NA,NA,NA,153,195,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,10,12,2013,TCGA-MESO
5203,TCGA-SH-A9CT,NO,NA,TCGA-SH-A9CT-D57896,9CA244FC-06AD-46BE-8259-654D3F1587DA,NA,NA,NA,NA,NA,46,155,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-MESO
5204,TCGA-SH-A9CT,NO,NA,TCGA-SH-A9CT-D57897,1DAFC172-88F7-42A8-827C-5347B2BDFA95,NA,NA,NA,NA,NA,46,155,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-MESO
5207,TCGA-SH-A9CU,NO,NA,TCGA-SH-A9CU-D58131,DEDB8A45-6BE9-4D3A-90F4-4191E571DA47,NA,NA,NA,NA,NA,56,178,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-MESO
5206,TCGA-SH-A9CU,NO,NA,TCGA-SH-A9CU-D58132,AD0A4412-3D74-46DE-A900-1CFD84BEF100,NA,NA,NA,NA,NA,56,178,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-MESO
8577,TCGA-SI-A71O,YES,NA,TCGA-SI-A71O-D65180,B8894426-5180-4B83-892A-E743E8C40261,NA,,NA,,NA,350,462,Immunotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,22,10,2014,TCGA-SARC
8578,TCGA-SI-A71O,YES,NA,TCGA-SI-A71O-D66702,5C7B5E08-DD51-43A2-92FF-07A13956CA5F,NA,,NA,,NA,350,462,Chemotherapy,Everolimus,MTOR inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,22,10,2014,TCGA-SARC
8579,TCGA-SI-A71O,YES,NA,TCGA-SI-A71O-D66704,CFD8BEFB-D4A7-47E1-9471-2E41CC24FFE8,NA,,NA,,NA,489,545,Chemotherapy,Tivozanib,Angiogenesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,22,10,2014,TCGA-SARC
8580,TCGA-SI-A71P,NO,NA,TCGA-SI-A71P-D71509,231E3C90-0B94-455D-A491-E214B07C45BD,NA,,NA,,NA,174,269,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,26,3,2015,TCGA-SARC
3531,TCGA-SS-A7HO,NO,,TCGA-SS-A7HO-D71978,55A13292-9E26-4AFA-8FCF-9772EE2C47E2,,,,,,37,93,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Complete Response,31,3,2015,TCGA-COAD
3532,TCGA-SS-A7HO,NO,,TCGA-SS-A7HO-D71979,6E855AC1-15F0-41DD-995C-21AA794684C2,,,,,,37,93,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,,,NO,Complete Response,31,3,2015,TCGA-COAD
3533,TCGA-SS-A7HO,NO,,TCGA-SS-A7HO-D71980,056AC44F-3B85-41FF-9157-7475F0735646,,,,,,37,93,Ancillary,Folinic acid,Rescue agent,Other,NA,,,,NO,Complete Response,31,3,2015,TCGA-COAD
9276,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56026,103EB591-19F6-4513-9C8B-827AFB26479C,,,,,NA,28,35,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9274,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56024,9537E9B4-12CC-4C88-958D-BDD3EA6D731B,,,,,NA,28,35,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9275,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56025,E144DD9C-E3F1-4829-913B-50D8BC142A35,,,,,NA,28,35,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9279,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56029,9AB7E907-6432-4B21-BD00-A9B54C75D9B2,,,,,NA,64,70,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9277,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56027,DD4BCA11-AB99-4B38-AEE3-4D1663F1D9FB,,,,,NA,64,70,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9278,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56028,A7CD5CC5-D770-4116-A896-AC30DB749220,,,,,NA,64,70,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9282,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56032,5AB31E67-4DC4-4DD8-A7C3-0773F438D310,,,,,NA,101,106,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9280,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56030,C9F32FDA-F421-4527-902A-4ABB77F4ACDD,,,,,NA,101,106,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9281,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56031,9C70D3A7-938A-48BA-A737-C21F70D4284E,,,,,NA,101,106,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9285,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56035,DAE012FB-2F68-4F22-AC83-0C1BEEBAA327,,,,,NA,136,141,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9283,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56033,8BE1D762-19E4-4265-8DE6-427F23A9BCD6,,,,,NA,136,141,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
9284,TCGA-SW-A7EB,NO,,TCGA-SW-A7EB-D56034,9B3B6E87-EB4B-4AC5-AAEF-F8062393C748,,,,,NA,136,141,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,,NA,,NO,Stable Disease,25,1,2014,TCGA-STAD
4204,TCGA-SX-A7SM,NO,NA,TCGA-SX-A7SM-D59368,0A8BD6FE-31D6-480D-906A-CDFD599310A5,,,,,NA,66,362,Targeted Molecular therapy,Pazopanib,Angiogenesis inhibitor|Antiproliferative,Other,NA,,,,NO,Partial Response,10,5,2014,TCGA-KIRP
233,TCGA-SY-A9G5,NO,,TCGA-SY-A9G5-D66297,5099B55A-B4B4-4D54-B510-43CBC090970D,NA,,NA,,NA,83,145,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,8,10,2014,TCGA-BLCA
232,TCGA-SY-A9G5,NO,,TCGA-SY-A9G5-D66296,B16969E0-B6D0-45A5-BBE2-2BED7B62C63B,NA,,NA,,NA,83,145,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,8,10,2014,TCGA-BLCA
3955,TCGA-T2-A6WX,NO,NA,TCGA-T2-A6WX-D50752,B9E77C04-E6CA-4FEF-B4F4-2188EEE920DD,NA,,NA,,NA,71,92,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,30,10,2013,TCGA-HNSC
3956,TCGA-T2-A6WX,NO,NA,TCGA-T2-A6WX-D50753,DD3FD6F9-5E1B-492B-9188-E3787EF58B65,NA,,NA,,NA,71,92,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,30,10,2013,TCGA-HNSC
3957,TCGA-T2-A6WX,NO,NA,TCGA-T2-A6WX-D50754,8466B93A-61FF-4DA0-8E3E-79BF58ED4414,NA,,NA,,NA,71,92,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,30,10,2013,TCGA-HNSC
3960,TCGA-T2-A6WZ,NO,NA,TCGA-T2-A6WZ-D50327,03FF8C25-E9D2-48DB-B0B7-91EB1EDDB840,NA,,NA,,NA,128,163,Chemotherapy,Cetuximab,HER1 inhibitor,Other,,,,,NO,Clinical Progressive Disease,22,10,2013,TCGA-HNSC
3959,TCGA-T2-A6WZ,YES,NA,TCGA-T2-A6WZ-D50299,1338CC83-0121-4F93-A0D2-2C4D9D09A8BE,NA,,NA,,NA,247,303,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,21,10,2013,TCGA-HNSC
3961,TCGA-T2-A6X0,NO,NA,TCGA-T2-A6X0-D49735,FC96B3A3-F5E0-44D7-B386-042B36E43162,NA,,NA,,NA,60,95,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,21,10,2013,TCGA-HNSC
3962,TCGA-TN-A7HJ,NO,NA,TCGA-TN-A7HJ-D65225,A1722FCD-DE8D-4C67-AAD0-56F66AC25A07,NA,,NA,,NA,31,92,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,9,2014,TCGA-HNSC
3963,TCGA-TN-A7HL,NO,NA,TCGA-TN-A7HL-D65230,B3AB0570-937F-45FD-9E04-FD0041693492,NA,,NA,,NA,35,62,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,23,9,2014,TCGA-HNSC
4261,TCGA-UB-A7MA,NO,NA,TCGA-UB-A7MA-D63552,4E50B011-3187-4D5E-A047-470F592F99F1,NA,,NA,,NA,60,207,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,12,8,2014,TCGA-LIHC
4260,TCGA-UB-A7MA,NO,NA,TCGA-UB-A7MA-D63551,AA478972-0FC7-49A8-991F-F69895F7266A,NA,,NA,,NA,60,207,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,12,8,2014,TCGA-LIHC
4264,TCGA-UB-A7MB,NO,NA,TCGA-UB-A7MB-D63686,B5DB5B04-A285-4B4F-9677-5EF63DC2CC7A,NA,,NA,,NA,123,168,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,15,8,2014,TCGA-LIHC
4267,TCGA-UB-A7MB,NO,NA,TCGA-UB-A7MB-D63689,008CFE07-942D-4EAD-B4F7-D21BA4F9BF5D,NA,,NA,,NA,480,510,Chemotherapy,Oxaliplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,15,8,2014,TCGA-LIHC
4266,TCGA-UB-A7MB,NO,NA,TCGA-UB-A7MB-D63688,E1751217-035E-4A98-9E0D-0A4B84DF6C7A,NA,,NA,,NA,480,510,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,15,8,2014,TCGA-LIHC
2876,TCGA-UC-A7PG,NO,NA,TCGA-UC-A7PG-D61868,DB97B514-17D5-4D9A-9C22-0896A63486ED,NA,,NA,,NA,58,90,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-CESC
5226,TCGA-UD-AAC1,NO,NA,TCGA-UD-AAC1-D59773,B2106F76-1A95-4086-99FB-A035DDCDAF6D,NA,NA,NA,NA,NA,94,183,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,6,6,2014,TCGA-MESO
5225,TCGA-UD-AAC1,NO,NA,TCGA-UD-AAC1-D59771,51ADEBB1-D47A-4019-ACD8-439201C8993B,NA,NA,NA,NA,NA,148,183,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,6,6,2014,TCGA-MESO
5227,TCGA-UD-AAC4,NO,NA,TCGA-UD-AAC4-D59343,7956CC31-98D0-4E28-8BB5-04D8270B6AD6,NA,NA,NA,NA,NA,308,462,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,6,6,2014,TCGA-MESO
5230,TCGA-UD-AAC4,NO,NA,TCGA-UD-AAC4-D59344,DD597ABA-31DC-4929-9296-B6E9917D1563,NA,NA,NA,NA,NA,308,462,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,6,6,2014,TCGA-MESO
5229,TCGA-UD-AAC4,YES,NA,TCGA-UD-AAC4-D59345,AA623C1D-8F85-4574-8D31-C7D858A958BC,NA,NA,NA,NA,NA,608,651,Chemotherapy,Sunitinib,Angiogenesis inhibitor|Antiproliferative,Other,,NA,NA,NA,NO,Clinical Progressive Disease,6,6,2014,TCGA-MESO
5228,TCGA-UD-AAC4,NO,NA,TCGA-UD-AAC4-D59346,742244E0-AA6F-40C6-9EB5-42C29C6AF31F,NA,NA,NA,NA,NA,693,693,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,6,6,2014,TCGA-MESO
5233,TCGA-UD-AAC6,NO,NA,TCGA-UD-AAC6-D53081,A9E9D4DB-B522-4880-8D0B-C32E338BA8FC,NA,NA,NA,NA,NA,138,256,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,9,6,2014,TCGA-MESO
5234,TCGA-UD-AAC6,NO,NA,TCGA-UD-AAC6-D60385,3D86C940-5FD3-401D-A0B7-37A4CECAB654,NA,NA,NA,NA,NA,138,256,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,9,6,2014,TCGA-MESO
3964,TCGA-UF-A7JC,NO,NA,TCGA-UF-A7JC-D60396,ACA937EB-EA78-4861-9C8F-A59D61AFACFA,NA,,NA,,NA,131,173,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,6,2014,TCGA-HNSC
3965,TCGA-UF-A7JF,NO,NA,TCGA-UF-A7JF-D61376,CECD3B5E-EFBB-4887-BD87-698128E8CA5D,NA,,NA,,NA,71,86,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,6,2014,TCGA-HNSC
3966,TCGA-UF-A7JJ,NO,NA,TCGA-UF-A7JJ-D61379,563F9629-9C8D-427B-A688-8E030C041F9C,NA,,NA,,NA,60,102,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,6,2014,TCGA-HNSC
3967,TCGA-UF-A7JK,NO,NA,TCGA-UF-A7JK-D61371,76455436-956B-48B1-8EC1-A59BF38E804C,NA,,NA,,NA,132,174,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,6,2014,TCGA-HNSC
3968,TCGA-UF-A7JT,NO,NA,TCGA-UF-A7JT-D61384,2D947D8B-A1DA-44E7-8952-C35E22BA5F20,NA,,NA,,NA,173,229,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,28,6,2014,TCGA-HNSC
7998,TCGA-US-A774,NO,NA,TCGA-US-A774-D54084,84B4EDC7-65BE-4731-850B-DD2DD98E8E6E,NA,NA,NA,NA,NA,116,250,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,16,12,2013,TCGA-PAAD
5238,TCGA-UT-A88C,NO,NA,TCGA-UT-A88C-D68699,148F1A79-F6C9-4E84-9A59-28584FF8B9C0,NA,NA,NA,NA,NA,24,66,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,16,12,2014,TCGA-MESO
5239,TCGA-UT-A88C,NO,NA,TCGA-UT-A88C-D68801,34849F39-EB2D-4A3B-B5BF-B371E6372720,NA,NA,NA,NA,NA,24,66,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,16,12,2014,TCGA-MESO
5241,TCGA-UT-A88D,NO,NA,TCGA-UT-A88D-D68802,829E7989-55C8-4511-A257-5C860B7DCBFE,NA,NA,NA,NA,NA,24,66,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Stable Disease,16,12,2014,TCGA-MESO
5240,TCGA-UT-A88D,NO,NA,TCGA-UT-A88D-D68803,5B15B1A6-FCE2-4D99-9EA4-DDEF63660A96,NA,NA,NA,NA,NA,24,66,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Stable Disease,16,12,2014,TCGA-MESO
3989,TCGA-UW-A7GR,YES,NA,TCGA-UW-A7GR-D54191,3237FFE4-790D-4C54-8F2B-F5B75B60D901,NA,NA,NA,NA,NA,22,288,Chemotherapy,Sorafenib,Antiproliferative,Other,NA,NA,NA,NA,NO,Partial Response,17,12,2013,TCGA-KICH
3988,TCGA-UW-A7GR,YES,NA,TCGA-UW-A7GR-D54190,5B20A89E-1F30-4D80-B29F-F57E09B5BA9E,NA,NA,NA,NA,NA,22,288,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,NA,NA,NA,NA,NO,Partial Response,17,12,2013,TCGA-KICH
235,TCGA-UY-A78L,YES,,TCGA-UY-A78L-D69856,0E39EA87-108E-4729-AE4A-09934E78A61C,NA,,NA,,NA,152,232,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,21,1,2015,TCGA-BLCA
234,TCGA-UY-A78L,YES,,TCGA-UY-A78L-D68687,233EC6CE-DA51-400F-8878-827ECA237236,NA,,NA,,NA,152,232,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,10,12,2014,TCGA-BLCA
237,TCGA-UY-A8OB,NO,,TCGA-UY-A8OB-D71221,75DB2664-316D-409E-BF69-FB0D747D9638,NA,,NA,,NA,NA,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,23,3,2015,TCGA-BLCA
236,TCGA-UY-A8OB,NO,,TCGA-UY-A8OB-D70404,69B088FE-1097-4781-BCC0-EF0EA698B9DC,NA,,NA,,NA,NA,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,11,2,2015,TCGA-BLCA
8101,TCGA-V1-A8WV,NO,NA,TCGA-V1-A8WV-D70124,CDCD5F39-D1E3-4320-9114-8495C372B93F,NA,NA,NA,,NA,250,615,Hormone Therapy,LHRH agonist,LHRH agonist,Other,,,NA,,NO,Complete Response,27,1,2015,TCGA-PRAD
8102,TCGA-V1-A8WW,NO,NA,TCGA-V1-A8WW-D70125,609DB5A7-FA2E-47F6-8F2C-206604C55158,NA,NA,NA,,NA,112,NA,Hormone Therapy,LHRH agonist,LHRH agonist,Other,,,NA,,YES,Clinical Progressive Disease,27,1,2015,TCGA-PRAD
3604,TCGA-V5-A7RC,NO,NA,TCGA-V5-A7RC-D59062,B33CAC32-0CC7-4C57-952C-45F78579C747,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2014,TCGA-ESCA
3605,TCGA-V5-A7RC,NO,NA,TCGA-V5-A7RC-D59064,904870D3-D3FF-432C-9ED6-A7FD9BA53A9A,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Clinical Progressive Disease,30,4,2014,TCGA-ESCA
3606,TCGA-V5-A7RE,NO,NA,TCGA-V5-A7RE-D68618,74DE4935-DB6A-4E5C-890F-C00C5E266DAF,NA,NA,NA,NA,NA,36,67,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,4,12,2014,TCGA-ESCA
3607,TCGA-V5-A7RE,NO,NA,TCGA-V5-A7RE-D68619,4C6E7E82-714D-4486-9D30-708DAAC39811,NA,NA,NA,NA,NA,36,67,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Partial Response,4,12,2014,TCGA-ESCA
3608,TCGA-V5-A7RE,NO,NA,TCGA-V5-A7RE-D68620,60CD4F4C-C89D-4C38-9AB9-182278AEF585,NA,NA,NA,NA,NA,304,380,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,4,12,2014,TCGA-ESCA
3609,TCGA-V5-AASV,NO,NA,TCGA-V5-AASV-D59071,6D30A8B2-264A-4E6C-8869-8F0FBC017FFD,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-ESCA
3610,TCGA-V5-AASV,NO,NA,TCGA-V5-AASV-D59074,16B387A7-F3D8-4B34-A3F7-3B869CFF6B50,NA,NA,NA,NA,NA,NA,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Partial Response,30,4,2014,TCGA-ESCA
2712,TCGA-V7-A7HQ,NO,,TCGA-V7-A7HQ-D71971,AAF9A475-0FCA-4018-A727-0BCEFFE5281D,,,,,,129,1869,Hormone Therapy,Letrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,31,3,2015,TCGA-BRCA
9463,TCGA-VF-A8AD,NO,NA,TCGA-VF-A8AD-D64954,F2D736FC-6D29-4E8B-A561-ED0A7DADBCCE,NA,NA,NA,NA,NA,218,340,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,16,9,2014,TCGA-TGCT
9461,TCGA-VF-A8AD,NO,NA,TCGA-VF-A8AD-D56935,7BB94AF0-AB2F-405C-8DC3-3450B4DF092B,NA,NA,NA,NA,NA,218,340,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,27,2,2014,TCGA-TGCT
9462,TCGA-VF-A8AD,NO,NA,TCGA-VF-A8AD-D64953,9DCDFBAD-1FE3-42E4-9CFB-C4332ADC08E9,NA,NA,NA,NA,NA,218,340,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,16,9,2014,TCGA-TGCT
8106,TCGA-VN-A88R,NO,NA,TCGA-VN-A88R-D69093,E461CF9E-FEC2-453C-BE1B-5B22D15FA441,NA,NA,NA,,NA,652,666,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Partial Response,29,12,2014,TCGA-PRAD
8108,TCGA-VP-A878,NO,NA,TCGA-VP-A878-D64443,3F20F81C-E5F0-4D71-A4AA-32D7B7A7FE20,NA,NA,NA,,NA,115,784,Hormone Therapy,Goserelin,LHRH agonist,Other,,,NA,,NO,Complete Response,2,9,2014,TCGA-PRAD
8110,TCGA-VP-A87D,NO,NA,TCGA-VP-A87D-D61664,A144D529-8C3F-4EA1-93CE-939B46873189,NA,NA,NA,,NA,248,370,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,2,7,2014,TCGA-PRAD
8112,TCGA-VP-A87D,NO,NA,TCGA-VP-A87D-D61667,CB1EE873-6DC0-40B2-85BC-20DF5C5F2AA2,NA,NA,NA,,NA,248,837,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,2,7,2014,TCGA-PRAD
8111,TCGA-VP-A87D,NO,NA,TCGA-VP-A87D-D61668,C472A1E0-34A1-4606-954F-D8A4145268DE,NA,NA,NA,,NA,370,837,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,2,7,2014,TCGA-PRAD
9286,TCGA-VQ-A8DT,NO,,TCGA-VQ-A8DT-D64317,4E65A83C-270A-4A8C-98AF-560BE8C8534C,,,,,NA,94,222,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,28,8,2014,TCGA-STAD
9287,TCGA-VQ-A8DU,NO,,TCGA-VQ-A8DU-D64319,E2E1E597-3757-4066-8D2F-AEB723369B31,,,,,NA,130,130,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,28,8,2014,TCGA-STAD
9288,TCGA-VQ-A8DZ,NO,,TCGA-VQ-A8DZ-D64321,81F636F1-DE6B-45C1-87C8-9011394A5341,,,,,NA,201,341,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,28,8,2014,TCGA-STAD
9289,TCGA-VQ-A8E0,NO,,TCGA-VQ-A8E0-D64680,5F7FF237-739E-4B57-84A3-046625B24DA0,,,,,NA,NA,NA,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9290,TCGA-VQ-A8E2,NO,,TCGA-VQ-A8E2-D64324,A5F2A67A-C50A-4FA4-AF85-EE0426650DE7,,,,,NA,145,277,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,28,8,2014,TCGA-STAD
9292,TCGA-VQ-A8P3,NO,,TCGA-VQ-A8P3-D64335,C18D0623-C8DB-4FCD-A983-6DAFF2074744,,,,,NA,124,254,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,28,8,2014,TCGA-STAD
9294,TCGA-VQ-A8PB,NO,,TCGA-VQ-A8PB-D64339,D5460FEE-2114-400B-A562-20B3220DCE89,,,,,NA,63,273,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,28,8,2014,TCGA-STAD
9295,TCGA-VQ-A8PD,NO,,TCGA-VQ-A8PD-D64343,1F2B1403-26D0-485E-8B91-D5B2A3BBE0DD,,,,,NA,117,121,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,29,8,2014,TCGA-STAD
9296,TCGA-VQ-A8PP,NO,,TCGA-VQ-A8PP-D64347,F22052EF-BC6D-43DA-8C42-4EFA26744DF3,,,,,NA,165,333,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,29,8,2014,TCGA-STAD
9297,TCGA-VQ-A8PT,NO,,TCGA-VQ-A8PT-D64353,098B323A-0B39-48E9-96A2-EAE6950695C1,,,,,NA,193,197,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9298,TCGA-VQ-A8PT,NO,,TCGA-VQ-A8PT-D64354,3EE08022-2343-48AC-928A-CE9768F8A27E,,,,,NA,221,263,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9299,TCGA-VQ-A8PU,NO,,TCGA-VQ-A8PU-D64696,C426D913-C9BD-4C61-AB68-1878AFB6B6F1,,,,,NA,139,288,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,9,2014,TCGA-STAD
9300,TCGA-VQ-A8PY,NO,,TCGA-VQ-A8PY-D64358,E2D0DF33-C876-4C1C-BEB5-5AFE512111CB,,,,,NA,54,192,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9301,TCGA-VQ-A8PZ,NO,,TCGA-VQ-A8PZ-D64363,6367C026-7AF2-4BFE-91CE-A39993B8FDD5,,,,,NA,121,234,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9302,TCGA-VQ-A91D,NO,,TCGA-VQ-A91D-D64677,11C87F76-33D3-4962-800E-13276D39684F,,,,,NA,147,242,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9303,TCGA-VQ-A91E,NO,,TCGA-VQ-A91E-D64374,8DC05F0E-3518-41BC-916D-6AE3A1CAE36C,,,,,NA,59,59,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9304,TCGA-VQ-A91K,NO,,TCGA-VQ-A91K-D64377,B474ED84-E71A-4546-B8C4-4DF74D7D0352,,,,,NA,89,234,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9305,TCGA-VQ-A91N,NO,,TCGA-VQ-A91N-D66745,159F25A1-0142-455B-A134-A89B2C4BC995,,,,,NA,98,219,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,23,10,2014,TCGA-STAD
9306,TCGA-VQ-A91Q,NO,,TCGA-VQ-A91Q-D64382,91421FCF-D5D9-4AF6-B476-31DE5F8DCCF1,,,,,NA,158,311,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9307,TCGA-VQ-A91S,NO,,TCGA-VQ-A91S-D65299,81AAF0DA-6506-45FB-8B3C-84257778CBD3,,,,,NA,122,238,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,21,9,2014,TCGA-STAD
9308,TCGA-VQ-A91V,NO,,TCGA-VQ-A91V-D64685,51E9B0EE-C954-42A8-9405-A956314733F2,,,,,NA,77,228,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9309,TCGA-VQ-A91V,NO,,TCGA-VQ-A91V-D64686,D10959BE-23EE-4949-9566-C88A298F0369,,,,,NA,77,228,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9310,TCGA-VQ-A91W,NO,,TCGA-VQ-A91W-D64384,482DA894-9EEF-4A33-9B3B-5A9D9FAF50A1,,,,,NA,87,217,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,29,8,2014,TCGA-STAD
9311,TCGA-VQ-A91Y,NO,,TCGA-VQ-A91Y-D64390,3B7E868F-35CF-4044-AB80-ABFD27FF0316,,,,,NA,84,237,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,29,8,2014,TCGA-STAD
9312,TCGA-VQ-A91Z,NO,,TCGA-VQ-A91Z-D67233,9B48A985-B662-403D-A6CD-9FB498AB278F,,,,,NA,97,322,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,3,11,2014,TCGA-STAD
9313,TCGA-VQ-A91Z,NO,,TCGA-VQ-A91Z-D67234,78598CD3-2552-407A-A6D7-5D6D29F0F92E,,,,,NA,97,322,Chemotherapy,Folinic acid,Rescue agent,Other,NA,,NA,,NO,Complete Response,3,11,2014,TCGA-STAD
9314,TCGA-VQ-A922,NO,,TCGA-VQ-A922-D64400,6A9F4DBF-C49F-4FE0-9C09-19EC8CC2F732,,,,,NA,83,85,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,29,8,2014,TCGA-STAD
9315,TCGA-VQ-A928,NO,,TCGA-VQ-A928-D64403,0ED28588-E3E5-4F96-8A42-5252CB038C0B,,,,,NA,98,138,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,29,8,2014,TCGA-STAD
9316,TCGA-VQ-A94O,NO,,TCGA-VQ-A94O-D64672,524E53E4-6434-4F21-9C5E-9D701A56E6F3,,,,,NA,200,392,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9317,TCGA-VQ-A94R,NO,,TCGA-VQ-A94R-D64670,75810C15-1476-4192-9D27-164BDB5FF842,,,,,NA,591,645,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9318,TCGA-VQ-AA64,NO,,TCGA-VQ-AA64-D64673,B6EE592E-F365-4CB9-9AB4-A2BC1D21D202,,,,,NA,73,192,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,9,2014,TCGA-STAD
9319,TCGA-VQ-AA68,NO,,TCGA-VQ-AA68-D64702,F3DDCC61-8947-4F46-94EF-40384F945D2E,,,,,NA,152,324,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,9,2014,TCGA-STAD
9320,TCGA-VQ-AA6B,NO,,TCGA-VQ-AA6B-D64669,71291602-C996-44B8-9751-2F16D0F9FCF9,,,,,NA,131,262,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,9,2014,TCGA-STAD
9321,TCGA-VQ-AA6D,NO,,TCGA-VQ-AA6D-D64666,ACF2E282-F57B-4B12-AB29-082AE46A2AA2,,,,,NA,77,114,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Complete Response,9,9,2014,TCGA-STAD
9322,TCGA-VQ-AA6F,NO,,TCGA-VQ-AA6F-D64682,B2EBE675-9B97-4D60-8383-A8ABD5F954F8,,,,,NA,119,249,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9323,TCGA-VQ-AA6G,NO,,TCGA-VQ-AA6G-D64691,2A41B04D-9375-48C1-8043-9F44FD0E8B08,,,,,NA,171,297,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9324,TCGA-VQ-AA6I,NO,,TCGA-VQ-AA6I-D64658,FACF827A-A698-4023-936B-84131CD34022,,,,,NA,133,349,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
9325,TCGA-VQ-AA6K,NO,,TCGA-VQ-AA6K-D64660,29547B3E-086E-46B1-9D0B-A81674996103,,,,,NA,136,280,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,,NA,,NO,Clinical Progressive Disease,9,9,2014,TCGA-STAD
3611,TCGA-VR-A8EQ,NO,NA,TCGA-VR-A8EQ-D68739,8F7AE69B-1E26-4DE5-9F9C-DF6518F85D4E,NA,NA,NA,NA,NA,115,236,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,15,12,2014,TCGA-ESCA
3613,TCGA-VR-A8ER,NO,NA,TCGA-VR-A8ER-D66906,1AE75182-0440-4E07-9F08-C6E05724B5E0,NA,NA,NA,NA,NA,103,268,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,27,10,2014,TCGA-ESCA
3612,TCGA-VR-A8ER,NO,NA,TCGA-VR-A8ER-D66905,E6659E32-6364-40DC-8F77-1777C6CF55D9,NA,NA,NA,NA,NA,103,268,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,27,10,2014,TCGA-ESCA
3614,TCGA-VR-AA4D,NO,NA,TCGA-VR-AA4D-D66898,5536C83A-0850-4745-B899-77926D90B939,NA,NA,NA,NA,NA,166,288,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,27,10,2014,TCGA-ESCA
3615,TCGA-VR-AA4D,NO,NA,TCGA-VR-AA4D-D66899,8B93B0B1-E373-43D6-AEE3-F4D28E72F2FF,NA,NA,NA,NA,NA,166,288,Ancillary,Folinic acid,Rescue agent,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,27,10,2014,TCGA-ESCA
2877,TCGA-VS-A8EC,NO,NA,TCGA-VS-A8EC-D61977,E92C9CD5-FA20-429C-9D02-ED80C876D1CB,NA,,NA,,NA,430,617,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,7,2014,TCGA-CESC
2878,TCGA-VS-A8EC,NO,NA,TCGA-VS-A8EC-D62009,922C203B-1B73-4D57-906F-518241AC938B,NA,,NA,,NA,430,617,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,10,7,2014,TCGA-CESC
2879,TCGA-VS-A8EH,NO,NA,TCGA-VS-A8EH-D62772,6AA03F28-F6A9-444D-86FF-1E86AA069F1A,NA,,NA,,NA,67,88,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,7,2014,TCGA-CESC
2880,TCGA-VS-A8EI,NO,NA,TCGA-VS-A8EI-D64588,9081E806-69F2-43F6-8E10-E6D99C3BACD3,NA,,NA,,NA,16,47,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,9,2014,TCGA-CESC
2881,TCGA-VS-A8EJ,NO,NA,TCGA-VS-A8EJ-D62775,D2AD658E-3F2A-48BD-82EE-431A683B66BE,NA,,NA,,NA,136,155,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,7,2014,TCGA-CESC
2882,TCGA-VS-A8EJ,NO,NA,TCGA-VS-A8EJ-D62776,908D2796-3195-4448-8BD1-72E85523306F,NA,,NA,,NA,169,322,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,7,2014,TCGA-CESC
2883,TCGA-VS-A8EJ,NO,NA,TCGA-VS-A8EJ-D62777,D2D50CB6-E465-45B9-A255-2178CEC9FE12,NA,,NA,,NA,169,322,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,24,7,2014,TCGA-CESC
2884,TCGA-VS-A8EK,NO,NA,TCGA-VS-A8EK-D62778,4608A3B1-2585-4E69-8194-33D9CA824C35,NA,,NA,,NA,58,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,24,7,2014,TCGA-CESC
2885,TCGA-VS-A8EL,NO,NA,TCGA-VS-A8EL-D64589,B38CCD33-80D7-4EDA-B3C7-28F024DC880D,NA,,NA,,NA,46,81,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,5,9,2014,TCGA-CESC
2886,TCGA-VS-A8QC,NO,NA,TCGA-VS-A8QC-D61994,31286449-EDE9-4BC3-ADA7-30943A71494A,NA,,NA,,NA,35,175,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-CESC
2887,TCGA-VS-A8QF,NO,NA,TCGA-VS-A8QF-D62000,E09A597F-8072-47C3-BAA2-520E63D22AAA,NA,,NA,,NA,92,118,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,10,7,2014,TCGA-CESC
2888,TCGA-VS-A8QH,NO,NA,TCGA-VS-A8QH-D62005,BBB1806B-37D4-4DAD-BA0D-870901A18049,NA,,NA,,NA,62,98,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Partial Response,10,7,2014,TCGA-CESC
2891,TCGA-VS-A8QM,NO,NA,TCGA-VS-A8QM-D65296,1C0DBDC1-83FA-4B53-A402-A48ABA89A4B4,NA,,NA,,NA,49,81,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,21,9,2014,TCGA-CESC
2890,TCGA-VS-A8QM,NO,NA,TCGA-VS-A8QM-D61947,5079FF1A-2F4B-4088-8168-7A3A3042489A,NA,,NA,,NA,49,136,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,10,7,2014,TCGA-CESC
2892,TCGA-VS-A94W,NO,NA,TCGA-VS-A94W-D70275,D1241E75-98C5-4EE9-AC69-D282F12CAE1D,NA,,NA,,NA,75,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,3,2,2015,TCGA-CESC
2893,TCGA-VS-A94X,NO,NA,TCGA-VS-A94X-D62787,85118345-207B-43EC-A69C-E16BD65A1EA5,NA,,NA,,NA,64,92,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,24,7,2014,TCGA-CESC
2894,TCGA-VS-A94Y,NO,NA,TCGA-VS-A94Y-D62789,6D107EBB-1755-4A7C-9A3A-21A49777DDFB,NA,,NA,,NA,95,104,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,24,7,2014,TCGA-CESC
2895,TCGA-VS-A94Z,NO,NA,TCGA-VS-A94Z-D62793,138D8801-6CD9-43F9-B8D3-1FB6FB9BF29A,NA,,NA,,NA,52,80,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,7,2014,TCGA-CESC
2896,TCGA-VS-A954,NO,NA,TCGA-VS-A954-D62797,31C84693-FA3B-435F-8746-78CEA4D4B89F,NA,,NA,,NA,94,122,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,7,2014,TCGA-CESC
2897,TCGA-VS-A957,NO,NA,TCGA-VS-A957-D62800,FE43C9DF-DCCC-4A9A-B4E6-05BD6260167D,NA,,NA,,NA,119,140,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,7,2014,TCGA-CESC
2898,TCGA-VS-A958,NO,NA,TCGA-VS-A958-D62804,4B8E9E37-3369-4E1F-9D37-45B1B326F4A0,NA,,NA,,NA,69,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,24,7,2014,TCGA-CESC
2899,TCGA-VS-A9U5,NO,NA,TCGA-VS-A9U5-D63439,EF658883-3A46-4E6C-8256-6A45287BD55E,NA,,NA,,NA,36,71,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2900,TCGA-VS-A9U6,NO,NA,TCGA-VS-A9U6-D63446,BDE69B17-53CF-4220-96CA-A9006A4A466E,NA,,NA,,NA,74,105,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,11,8,2014,TCGA-CESC
2901,TCGA-VS-A9U7,NO,NA,TCGA-VS-A9U7-D63460,188BFB3C-D196-47B2-9C99-4FACCD06ADE7,NA,,NA,,NA,192,220,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2902,TCGA-VS-A9UA,NO,NA,TCGA-VS-A9UA-D63477,B1D0877D-E150-40BF-AD5F-ACB4BBEAC36D,NA,,NA,,NA,118,162,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2903,TCGA-VS-A9UB,NO,NA,TCGA-VS-A9UB-D65878,107F4992-511B-4946-8096-D16382E92606,NA,,NA,,NA,65,100,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-CESC
2904,TCGA-VS-A9UC,NO,NA,TCGA-VS-A9UC-D63478,C0D9120A-6CA4-4746-997B-0B828C421848,NA,,NA,,NA,146,203,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,11,8,2014,TCGA-CESC
2905,TCGA-VS-A9UD,NO,NA,TCGA-VS-A9UD-D63434,535F5BEE-B950-4EE1-89A0-C45F7565B1B7,NA,,NA,,NA,55,89,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2906,TCGA-VS-A9UH,NO,NA,TCGA-VS-A9UH-D63870,5ECDA20A-D998-4660-A6B2-F178C7B054EE,NA,,NA,,NA,90,133,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,20,8,2014,TCGA-CESC
2908,TCGA-VS-A9UM,NO,NA,TCGA-VS-A9UM-D64654,3B0630CF-E2D6-4CFE-B50C-B5938FFA47C7,NA,,NA,,NA,41,210,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,9,2014,TCGA-CESC
2909,TCGA-VS-A9UM,NO,NA,TCGA-VS-A9UM-D64655,4F2F9A4B-B3AF-4690-B6AB-F0E62933E730,NA,,NA,,NA,41,210,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,9,2014,TCGA-CESC
2907,TCGA-VS-A9UM,NO,NA,TCGA-VS-A9UM-D64650,5E4A789E-39EA-4751-A2C1-1CE33311769B,NA,,NA,,NA,423,459,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,9,2014,TCGA-CESC
2910,TCGA-VS-A9UO,NO,NA,TCGA-VS-A9UO-D63484,7DF378B9-E2A9-41C7-BCF8-FFE5A356565D,NA,,NA,,NA,52,69,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2911,TCGA-VS-A9UP,NO,NA,TCGA-VS-A9UP-D63458,82CD6A7E-AD39-4A38-A53F-0AD1EABE3268,NA,,NA,,NA,92,119,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2912,TCGA-VS-A9UR,NO,NA,TCGA-VS-A9UR-D63470,5160FB3B-17E6-47A9-B589-32D895E197B2,NA,,NA,,NA,45,90,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2913,TCGA-VS-A9UU,NO,NA,TCGA-VS-A9UU-D65893,96F43D49-0111-4847-BC76-553F3DD390C3,NA,,NA,,NA,43,57,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-CESC
2914,TCGA-VS-A9UY,NO,NA,TCGA-VS-A9UY-D64585,47D7D03D-BCC9-4123-AE5B-71157465604C,NA,,NA,,NA,6,34,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,9,2014,TCGA-CESC
2915,TCGA-VS-A9V0,NO,NA,TCGA-VS-A9V0-D65886,F3AA1D6F-478C-4EAB-A251-42884E286649,NA,,NA,,NA,144,166,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,1,10,2014,TCGA-CESC
2916,TCGA-VS-A9V1,NO,NA,TCGA-VS-A9V1-D64593,70591F56-179A-43E5-BC9C-587884B78384,NA,,NA,,NA,21,49,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,5,9,2014,TCGA-CESC
2917,TCGA-VS-A9V3,NO,NA,TCGA-VS-A9V3-D63454,BA99CD4B-A6DE-4981-A47C-FB8A203105F1,NA,,NA,,NA,68,96,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,8,2014,TCGA-CESC
2919,TCGA-VS-A9V5,NO,NA,TCGA-VS-A9V5-D65882,502961DD-9C7F-4032-BED4-F6E20D29702F,NA,,NA,,NA,89,124,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,1,10,2014,TCGA-CESC
2920,TCGA-VS-AA62,NO,NA,TCGA-VS-AA62-D68117,98AE48EA-B27C-4014-8A6C-E1759052C4A4,NA,,NA,,NA,34,64,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,13,11,2014,TCGA-CESC
8816,TCGA-W3-A825,NO,,TCGA-W3-A825-D57947,3493FCF2-8598-4291-972C-E0184ECA691A,NA,NA,NA,,NA,1644,1767,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,31,3,2014,TCGA-SKCM
8818,TCGA-W3-A825,NO,,TCGA-W3-A825-D59256,E2963A06-F227-4313-8A57-804FCDFB892A,NA,NA,NA,,NA,1644,1767,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Partial Response,6,5,2014,TCGA-SKCM
8819,TCGA-W3-A825,NO,,TCGA-W3-A825-D59257,629BC50C-21B1-4874-B541-81D0A4F1AAB6,NA,NA,NA,,NA,1644,1767,Chemotherapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Partial Response,6,5,2014,TCGA-SKCM
8817,TCGA-W3-A825,NO,,TCGA-W3-A825-D59255,B8BEA87F-2415-4525-A51B-1A3E320FBFED,NA,NA,NA,,NA,1644,1767,Chemotherapy,Vinblastine,Antimitotic,Antimitotic,,,,,NO,Partial Response,6,5,2014,TCGA-SKCM
8821,TCGA-W3-A825,NO,,TCGA-W3-A825-D59259,A0F6E18A-B10B-4902-89AA-BF9808530488,NA,NA,NA,,NA,1644,1767,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Partial Response,6,5,2014,TCGA-SKCM
8823,TCGA-W3-AA1O,NO,,TCGA-W3-AA1O-D61896,D5AA006A-D5B5-427A-84DF-EAF25033C4BD,NA,NA,NA,,NA,61,92,Chemotherapy,Carmustine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,7,2014,TCGA-SKCM
8825,TCGA-W3-AA1O,NO,,TCGA-W3-AA1O-D61898,AF74B106-14D2-4701-97C2-F83ABE6480E7,NA,NA,NA,,NA,61,92,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,7,2014,TCGA-SKCM
8826,TCGA-W3-AA1O,NO,,TCGA-W3-AA1O-D61899,C2D8F52F-1FE8-4192-A751-446D06312B6D,NA,NA,NA,,NA,61,92,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,9,7,2014,TCGA-SKCM
8824,TCGA-W3-AA1O,NO,,TCGA-W3-AA1O-D61897,ED899617-E068-4510-BBA9-961A458E5461,NA,NA,NA,,NA,61,92,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,9,7,2014,TCGA-SKCM
8829,TCGA-W3-AA1Q,NO,,TCGA-W3-AA1Q-D62003,87B9AEA1-BB2A-4A7E-B450-19716583263C,NA,NA,NA,,NA,1492,NA,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8827,TCGA-W3-AA1Q,YES,,TCGA-W3-AA1Q-D62013,A7A2B5D3-CD67-4ACB-B405-9F403544CE8A,NA,NA,NA,,NA,1735,NA,Hormone Therapy,Tamoxifen,Antiestrogen,Other,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8831,TCGA-W3-AA1Q,YES,,TCGA-W3-AA1Q-D62010,47A8FABB-17DD-4089-AA7B-C16923DA985A,NA,NA,NA,,NA,1735,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8828,TCGA-W3-AA1Q,YES,,TCGA-W3-AA1Q-D62011,0AB73F01-3AA9-423C-AA65-5ED7AD1866D8,NA,NA,NA,,NA,1735,NA,Targeted Molecular therapy,Trastuzumab,HER2 inhibitor,Other,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8838,TCGA-W3-AA1W,NO,,TCGA-W3-AA1W-D62342,5C9B4049-50B4-42FC-B5E4-E3840532F7E0,NA,NA,NA,,NA,335,761,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8841,TCGA-W3-AA21,NO,,TCGA-W3-AA21-D62455,3171F663-933C-4459-AB16-F6F3DC6A1C7B,NA,NA,NA,,NA,3075,NA,Chemotherapy,Temozolomide,Alkylating agent,Alkylating agent,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
8840,TCGA-W3-AA21,NO,,TCGA-W3-AA21-D62454,87E7F2A0-DFEE-43A5-A83B-9AAC109954F7,NA,NA,NA,,NA,3075,NA,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Clinical Progressive Disease,17,7,2014,TCGA-SKCM
2930,TCGA-W5-AA2H,NO,NA,TCGA-W5-AA2H-D66540,81CA8572-5288-4103-975B-F4EB32778652,NA,NA,NA,NA,NA,59,271,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,20,10,2014,TCGA-CHOL
2931,TCGA-W5-AA2T,NO,NA,TCGA-W5-AA2T-D59942,240B497B-AD30-49EC-959C-FB016B32EE77,NA,NA,NA,NA,NA,56,205,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Complete Response,24,5,2014,TCGA-CHOL
2932,TCGA-W5-AA2Z,NO,NA,TCGA-W5-AA2Z-D66543,CDDAAF81-D81D-4D0A-9DDD-98DC9F980058,NA,NA,NA,NA,NA,63,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,YES,Clinical Progressive Disease,20,10,2014,TCGA-CHOL
2933,TCGA-W5-AA2Z,NO,NA,TCGA-W5-AA2Z-D66544,AB9BF75B-1B5E-41F4-8927-5CEEBBB41ADA,NA,NA,NA,NA,NA,63,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,YES,Clinical Progressive Disease,20,10,2014,TCGA-CHOL
2935,TCGA-W5-AA36,NO,NA,TCGA-W5-AA36-D66587,13B1D563-8D8D-499C-B749-C67DE30D4DE3,NA,NA,NA,NA,NA,41,76,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Stable Disease,21,10,2014,TCGA-CHOL
2934,TCGA-W5-AA36,NO,NA,TCGA-W5-AA36-D66586,142FCDBF-2454-419D-8C30-0163EF88F077,NA,NA,NA,NA,NA,41,76,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Stable Disease,21,10,2014,TCGA-CHOL
8028,TCGA-WB-A81Q,NO,NA,TCGA-WB-A81Q-D61219,5CD70E48-B19F-4AAF-A773-600513BA7EC3,NA,NA,NA,NA,NA,620,704,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,15,7,2014,TCGA-PCPG
8026,TCGA-WB-A81Q,NO,NA,TCGA-WB-A81Q-D61216,B6282500-2BB2-40D8-B7C1-A4CA2A497893,NA,NA,NA,NA,NA,620,704,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Clinical Progressive Disease,15,7,2014,TCGA-PCPG
8025,TCGA-WB-A81Q,NO,NA,TCGA-WB-A81Q-D61215,49ED470B-6516-4F8D-A653-B7B4F99ED4CB,NA,NA,NA,NA,NA,620,704,Chemotherapy,Vincristine,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,15,7,2014,TCGA-PCPG
8027,TCGA-WB-A81Q,NO,NA,TCGA-WB-A81Q-D61218,D9AB3EEE-1F63-4F38-874D-A0782BA8DAD6,NA,NA,NA,NA,NA,707,749,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,15,7,2014,TCGA-PCPG
8843,TCGA-WE-A8K5,NO,,TCGA-WE-A8K5-D67279,4F22B8A1-36C5-44EA-AEB9-3738C17AE1C4,NA,NA,NA,,NA,1823,1860,Chemotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,3,11,2014,TCGA-SKCM
8846,TCGA-WE-A8ZN,YES,,TCGA-WE-A8ZN-D64452,3991EC25-0547-4967-9567-7EF9A6338B9D,NA,NA,NA,,NA,1533,1618,Chemotherapy,Nivolumab,Anti-PD1,Other,,,,,NO,Clinical Progressive Disease,8,9,2014,TCGA-SKCM
8849,TCGA-WE-A8ZR,NO,,TCGA-WE-A8ZR-D67324,B445763E-9415-4BEA-9CA8-7DD8DD3BEDE0,NA,NA,NA,,NA,137,261,Chemotherapy,Vemurafenib,Proapoptotic,Other,,,,,NO,Clinical Progressive Disease,4,11,2014,TCGA-SKCM
8850,TCGA-WE-AAA0,NO,,TCGA-WE-AAA0-D67375,ABFA30DE-189E-4F48-9E24-6B8B25ACF046,NA,NA,NA,,NA,856,917,Immunotherapy,Ipilimumab,Anti-CTLA4,Other,,,,,NO,Clinical Progressive Disease,4,11,2014,TCGA-SKCM
8852,TCGA-WE-AAA4,NO,,TCGA-WE-AAA4-D63852,8E1A8681-1E06-43ED-9331-24D2371A9E83,NA,NA,NA,,NA,360,360,Chemotherapy,Melphalan,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,22,9,2014,TCGA-SKCM
7762,TCGA-WR-A838,NO,NA,TCGA-WR-A838-D57160,392FF296-622C-4E06-8938-686004A62D8D,,,,,NA,30,92,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,,,,NO,Clinical Progressive Disease,3,10,2014,TCGA-OV
7763,TCGA-WR-A838,NO,NA,TCGA-WR-A838-D66186,CCE11CBD-98D9-43FB-99E6-8770D1782337,,,,,NA,30,92,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,,,,NO,Clinical Progressive Disease,3,10,2014,TCGA-OV
2717,TCGA-WT-AB41,NO,,TCGA-WT-AB41-D62425,1D21BF3A-67F1-4026-A0E6-739FCA50B55A,,,,,,89,150,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,16,7,2014,TCGA-BRCA
2716,TCGA-WT-AB41,NO,,TCGA-WT-AB41-D62424,D3833BF8-80A4-48E5-B86D-8F75692C7472,,,,,,89,150,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,16,7,2014,TCGA-BRCA
2714,TCGA-WT-AB41,NO,,TCGA-WT-AB41-D62422,F3CB280B-1BAF-4C0D-AC67-5A602FB8F3BF,,,,,,181,273,Hormone Therapy,Anastrozole,Aromatase inhibitor,Other,,,,,NO,Complete Response,16,7,2014,TCGA-BRCA
4269,TCGA-WX-AA44,NO,NA,TCGA-WX-AA44-D70641,CF571D27-7579-40DA-8545-E2A600A0CDA1,NA,,NA,,NA,306,375,Targeted Molecular therapy,Sorafenib,Antiproliferative,Other,,,,,NO,Partial Response,27,2,2015,TCGA-LIHC
4270,TCGA-WX-AA47,NO,NA,TCGA-WX-AA47-D60468,922F00F2-DA7A-4866-B953-CE6B32C5B780,NA,,NA,,NA,331,493,Chemotherapy,Sorafenib,Antiproliferative,Other,,,,,NO,Clinical Progressive Disease,10,6,2014,TCGA-LIHC
9464,TCGA-WZ-A7V4,NO,NA,TCGA-WZ-A7V4-D72691,3D6FA302-29F9-4F2C-95EC-A883A04AE829,NA,NA,NA,NA,NA,28,28,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,31,7,2015,TCGA-TGCT
8582,TCGA-X2-A95T,NO,NA,TCGA-X2-A95T-D57459,3AAB17FE-A8DA-4582-97C2-1082FD0E40B1,NA,,NA,,NA,10,132,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,11,3,2014,TCGA-SARC
8581,TCGA-X2-A95T,NO,NA,TCGA-X2-A95T-D57454,A829DFD3-C239-4447-B661-D28674EEA0F0,NA,,NA,,NA,10,132,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,11,3,2014,TCGA-SARC
8583,TCGA-X6-A7WC,NO,NA,TCGA-X6-A7WC-D67909,8F565E3C-59F7-4AE8-8D04-4C36B8F207C7,NA,,NA,,NA,819,854,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Stable Disease,12,11,2014,TCGA-SARC
8588,TCGA-X6-A8C4,YES,NA,TCGA-X6-A8C4-D69807,BCD131BB-444E-4374-BB31-968326E5E535,NA,,NA,,NA,327,504,Chemotherapy,Bevacizumab,Angiogenesis inhibitor,Other,,,NA,,NO,Clinical Progressive Disease,20,1,2015,TCGA-SARC
8589,TCGA-X6-A8C4,YES,NA,TCGA-X6-A8C4-D69808,A184FF52-868D-43A6-A904-04D9471314A9,NA,,NA,,NA,327,504,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,20,1,2015,TCGA-SARC
8586,TCGA-X6-A8C4,YES,NA,TCGA-X6-A8C4-D68090,65783E91-8B22-4BF2-BF45-02B7875476AB,NA,,NA,,NA,327,504,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,13,11,2014,TCGA-SARC
8591,TCGA-X6-A8C6,NO,NA,TCGA-X6-A8C6-D68289,3A13E060-572E-4755-9847-C96363D98453,NA,,NA,,NA,785,840,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,14,11,2014,TCGA-SARC
8592,TCGA-X6-A8C6,NO,NA,TCGA-X6-A8C6-D68303,177312FD-E011-4F3B-87B6-BE59C40B8E29,NA,,NA,,NA,911,966,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,14,11,2014,TCGA-SARC
9563,TCGA-X7-A8M6,,NA,TCGA-X7-A8M6-D66991,39473049-A17F-447E-8FA8-9BA1CAE7BE13,NA,NA,NA,NA,NA,NA,2000,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,29,10,2014,TCGA-THYM
9565,TCGA-X7-A8M6,,NA,TCGA-X7-A8M6-D66993,58085D58-C71C-4C7F-9A49-645D82C04D33,NA,NA,NA,NA,NA,NA,2000,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,29,10,2014,TCGA-THYM
9564,TCGA-X7-A8M6,,NA,TCGA-X7-A8M6-D66992,28923673-503B-4238-B601-0FC4AC61B761,NA,NA,NA,NA,NA,NA,2000,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Clinical Progressive Disease,29,10,2014,TCGA-THYM
9562,TCGA-X7-A8M6,,NA,TCGA-X7-A8M6-D59244,25C12E8A-D1B2-4E60-9388-2ECA6E44B2D1,NA,NA,NA,NA,NA,4100,4213,Chemotherapy,Pemetrexed,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Clinical Progressive Disease,6,5,2014,TCGA-THYM
8594,TCGA-X9-A971,NO,NA,TCGA-X9-A971-D66942,F5B6039C-1A83-44CA-ACB5-89C6DC008EA9,NA,,NA,,NA,413,434,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,19,12,2014,TCGA-SARC
8593,TCGA-X9-A971,NO,NA,TCGA-X9-A971-D66941,17B6D62D-9809-4C58-8F5D-0ABA8A45A7AA,NA,,NA,,NA,413,434,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,29,10,2014,TCGA-SARC
8596,TCGA-X9-A973,NO,NA,TCGA-X9-A973-D64513,90E19734-F9E8-4DAA-B97E-1CE1FA545BF7,NA,,NA,,NA,323,392,Chemotherapy,Dacarbazine,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,4,9,2014,TCGA-SARC
8597,TCGA-X9-A973,NO,NA,TCGA-X9-A973-D64512,730B3E9A-D6B7-4BDD-8F7C-D307DB145B56,NA,,NA,,NA,323,392,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Stable Disease,4,9,2014,TCGA-SARC
8595,TCGA-X9-A973,NO,NA,TCGA-X9-A973-D64503,D6BA0EBE-0350-4C63-8E68-ECDED06A45BC,NA,,NA,,NA,323,392,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Stable Disease,4,9,2014,TCGA-SARC
7999,TCGA-XD-AAUG,NO,NA,TCGA-XD-AAUG-D63175,B29BB9E2-68DB-4044-9713-DC961C593392,NA,NA,NA,NA,NA,13,109,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,1,8,2014,TCGA-PAAD
8000,TCGA-XD-AAUG,NO,NA,TCGA-XD-AAUG-D63177,85F2A4E6-842C-4178-93A5-1436B669947B,NA,NA,NA,NA,NA,13,109,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,NA,NA,NA,NO,Clinical Progressive Disease,1,8,2014,TCGA-PAAD
8006,TCGA-XD-AAUI,NO,NA,TCGA-XD-AAUI-D63169,3180DB50-116F-47A4-8191-9C5F13DFC5E9,NA,NA,NA,NA,NA,62,181,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Clinical Progressive Disease,1,8,2014,TCGA-PAAD
9467,TCGA-XE-A8H1,NO,NA,TCGA-XE-A8H1-D61308,5226B93D-9ADA-4273-BB8B-F3086F03D38E,NA,NA,NA,NA,NA,24,84,Chemotherapy,Platinum,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,27,6,2014,TCGA-TGCT
9465,TCGA-XE-A8H1,NO,NA,TCGA-XE-A8H1-D57168,5CF50B3F-A08C-4952-A057-798A972EAAE6,NA,NA,NA,NA,NA,24,84,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,4,3,2014,TCGA-TGCT
9466,TCGA-XE-A8H1,NO,NA,TCGA-XE-A8H1-D61307,C1497948-B61F-4400-98D0-9D2DE8732E1F,NA,NA,NA,NA,NA,24,84,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,27,6,2014,TCGA-TGCT
9470,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62814,62FDFE46-847C-4CD0-BD6A-228DF64108DF,NA,NA,NA,NA,NA,18,61,Chemotherapy,Platinum,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Clinical Progressive Disease,25,7,2014,TCGA-TGCT
9468,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62812,5EBA66D6-8F86-4439-A73B-F72AEA9D9EC4,NA,NA,NA,NA,NA,18,61,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Clinical Progressive Disease,25,7,2014,TCGA-TGCT
9469,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62813,0D76D6E7-525B-473E-B3AA-B60E3C343338,NA,NA,NA,NA,NA,18,61,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Clinical Progressive Disease,25,7,2014,TCGA-TGCT
9471,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62815,6B3E0774-411B-48CF-9CCB-DDE143AADCC3,NA,NA,NA,NA,NA,349,413,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,25,7,2014,TCGA-TGCT
9473,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62817,E231730F-3149-4D98-A36B-83D4F9CCB31F,NA,NA,NA,NA,NA,349,413,Chemotherapy,Platinum,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,25,7,2014,TCGA-TGCT
9472,TCGA-XE-AANJ,NO,NA,TCGA-XE-AANJ-D62816,B7CD6A5D-3660-4120-8658-44E2D0A8F431,NA,NA,NA,NA,NA,349,413,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,NA,NA,NA,NA,NO,Complete Response,25,7,2014,TCGA-TGCT
9476,TCGA-XE-AANV,NO,NA,TCGA-XE-AANV-D62602,E93320ED-1CDE-4BE6-88F1-A8CC33AA9715,NA,NA,NA,NA,NA,1455,1512,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,22,7,2014,TCGA-TGCT
9474,TCGA-XE-AANV,NO,NA,TCGA-XE-AANV-D62600,BF98BFF8-0F0F-43CE-AF29-13BF6F7A0A98,NA,NA,NA,NA,NA,1455,1512,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,22,7,2014,TCGA-TGCT
9475,TCGA-XE-AANV,NO,NA,TCGA-XE-AANV-D62601,31CC0A0A-77AA-43E9-A6BA-F8E72CE506A1,NA,NA,NA,NA,NA,1455,1512,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,22,7,2014,TCGA-TGCT
9479,TCGA-XE-AAOD,NO,NA,TCGA-XE-AAOD-D63374,F9F92A27-ACBA-4445-8254-94D2D3DA14E6,NA,NA,NA,NA,NA,77,82,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,6,8,2014,TCGA-TGCT
9477,TCGA-XE-AAOD,NO,NA,TCGA-XE-AAOD-D63372,05BEB1FE-605C-4123-B876-17471EDF845D,NA,NA,NA,NA,NA,77,82,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,6,8,2014,TCGA-TGCT
9478,TCGA-XE-AAOD,NO,NA,TCGA-XE-AAOD-D63373,A17F2684-1369-4FC6-9B91-42254F9581AB,NA,NA,NA,NA,NA,77,82,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,6,8,2014,TCGA-TGCT
9482,TCGA-XE-AAOJ,NO,NA,TCGA-XE-AAOJ-D63259,F5C9B97F-A258-46F3-97AA-53F95CEA9462,NA,NA,NA,NA,NA,63,153,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,5,8,2014,TCGA-TGCT
9480,TCGA-XE-AAOJ,NO,NA,TCGA-XE-AAOJ-D63257,B2198555-D763-491F-A02C-2AD807F02EDE,NA,NA,NA,NA,NA,63,153,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Partial Response,5,8,2014,TCGA-TGCT
9481,TCGA-XE-AAOJ,NO,NA,TCGA-XE-AAOJ-D63258,26E0224E-0589-4EEF-A833-6157B6F00B3F,NA,NA,NA,NA,NA,63,153,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Partial Response,5,8,2014,TCGA-TGCT
239,TCGA-XF-A9SH,YES,,TCGA-XF-A9SH-D60614,7C8A6B39-2A32-46E1-AADF-5A6241BDE19F,NA,,NA,,NA,625,996,Chemotherapy,Halichondrin B,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,16,6,2014,TCGA-BLCA
240,TCGA-XF-A9SH,YES,,TCGA-XF-A9SH-D60615,5E4B3CA0-F30A-4AB4-92B0-21CE18C5F673,NA,,NA,,NA,1633,1680,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
241,TCGA-XF-A9SH,NO,,TCGA-XF-A9SH-D60616,E6E517CD-69CD-47B1-A37C-3E391358760C,NA,,NA,,NA,1759,1782,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
243,TCGA-XF-A9SH,NO,,TCGA-XF-A9SH-D60618,DF017D1D-16C0-43F6-94AB-B00A20C21B55,NA,,NA,,NA,1759,1782,Ancillary,Mesna,Cytoprotectant,Other,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
242,TCGA-XF-A9SH,NO,,TCGA-XF-A9SH-D60617,69B4DD39-6085-4AD4-AF71-2BAD0CC5C38C,NA,,NA,,NA,1759,1782,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
244,TCGA-XF-A9SK,NO,,TCGA-XF-A9SK-D56757,CA01F02D-27E1-4691-84DB-C85358D13EDE,NA,,NA,,NA,NA,-368,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Partial Response,24,2,2014,TCGA-BLCA
246,TCGA-XF-A9SK,NO,,TCGA-XF-A9SK-D59548,C5CAB0B3-D160-40EC-B953-DC062772B140,NA,,NA,,NA,142,304,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,25,8,2014,TCGA-BLCA
245,TCGA-XF-A9SK,NO,,TCGA-XF-A9SK-D59547,AFD80131-BB45-4B48-8FDA-D8DD17DB58E5,NA,,NA,,NA,142,304,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,25,8,2014,TCGA-BLCA
248,TCGA-XF-A9SU,NO,,TCGA-XF-A9SU-D59905,D6E029D5-9B39-43B5-A982-1DBEA353A1EE,NA,,NA,,NA,137,137,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
247,TCGA-XF-A9SU,NO,,TCGA-XF-A9SU-D59904,BFE57565-B6DD-447B-81D7-F7D6FA898FCE,NA,,NA,,NA,137,137,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,16,6,2014,TCGA-BLCA
249,TCGA-XF-A9SV,NO,,TCGA-XF-A9SV-D56790,596F516C-004B-4C0B-B076-4D3E4BAB175D,NA,,NA,,NA,0,0,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Clinical Progressive Disease,20,2,2014,TCGA-BLCA
251,TCGA-XF-A9SV,NO,,TCGA-XF-A9SV-D60793,20BA299F-7C25-4BC2-BB4F-565932294B6A,NA,,NA,,NA,174,208,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
250,TCGA-XF-A9SV,NO,,TCGA-XF-A9SV-D60792,DD1352CC-3227-4F0F-A511-88FD346D3CEF,NA,,NA,,NA,174,208,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
254,TCGA-XF-A9SX,NO,,TCGA-XF-A9SX-D61325,2B62B01D-0739-459F-A8CF-09AB969D0727,NA,,NA,,NA,136,348,Chemotherapy,Platinum,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
253,TCGA-XF-A9SX,NO,,TCGA-XF-A9SX-D61323,33DFE922-C183-4518-A06C-6CB9DD506E92,NA,,NA,,NA,136,348,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
255,TCGA-XF-A9SY,NO,,TCGA-XF-A9SY-D61329,9B51FD68-FAD7-4443-99BA-9C30ABC2158A,NA,,NA,,NA,199,256,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
256,TCGA-XF-A9SY,NO,,TCGA-XF-A9SY-D61330,FF865837-071F-4A5F-A0FE-293C5CD41B14,NA,,NA,,NA,199,256,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,5,7,2014,TCGA-BLCA
258,TCGA-XF-A9SZ,NO,,TCGA-XF-A9SZ-D61363,4AF3BF48-56AA-4F54-B844-FEE9CA96906F,NA,,NA,,NA,97,169,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,27,6,2014,TCGA-BLCA
257,TCGA-XF-A9SZ,NO,,TCGA-XF-A9SZ-D61362,B5C1A628-866C-470D-BA8A-0F7C97FCC91D,NA,,NA,,NA,97,169,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,27,6,2014,TCGA-BLCA
259,TCGA-XF-A9T4,NO,,TCGA-XF-A9T4-D61598,8569E177-53CE-4F0A-A13B-A91033FBCA52,NA,,NA,,NA,158,281,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,1,7,2014,TCGA-BLCA
260,TCGA-XF-A9T4,NO,,TCGA-XF-A9T4-D61599,37732A8A-3221-43E0-9005-D6DD476681B4,NA,,NA,,NA,158,281,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,1,7,2014,TCGA-BLCA
263,TCGA-XF-A9T4,NO,,TCGA-XF-A9T4-D61602,566FD975-165D-48C5-B55E-F799C2467205,NA,,NA,,NA,402,436,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,1,7,2014,TCGA-BLCA
261,TCGA-XF-A9T4,NO,,TCGA-XF-A9T4-D61600,C7B176F7-AE11-4554-9D9E-BE4ACD7E4D05,NA,,NA,,NA,402,436,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,1,7,2014,TCGA-BLCA
262,TCGA-XF-A9T4,NO,,TCGA-XF-A9T4-D61601,4202EF5B-25B9-4985-A80C-D178F51C37CE,NA,,NA,,NA,402,436,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Clinical Progressive Disease,1,7,2014,TCGA-BLCA
265,TCGA-XF-A9T5,NO,,TCGA-XF-A9T5-D61661,4CD8075E-9FC3-4BC0-854E-7E1757A94428,NA,,NA,,NA,687,757,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,2,7,2014,TCGA-BLCA
264,TCGA-XF-A9T5,NO,,TCGA-XF-A9T5-D61658,5A0BF7D9-C1D3-40C8-A743-08C9DC439BFD,NA,,NA,,NA,687,757,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,2,7,2014,TCGA-BLCA
268,TCGA-XF-AAME,NO,,TCGA-XF-AAME-D62019,74172342-04F3-4F20-A105-7C8E9E7332EF,NA,,NA,,NA,2500,2543,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,11,7,2014,TCGA-BLCA
267,TCGA-XF-AAME,NO,,TCGA-XF-AAME-D62018,5C2FA8E7-E9CB-4A48-96B8-95A7693E491C,NA,,NA,,NA,2500,2543,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,11,7,2014,TCGA-BLCA
266,TCGA-XF-AAME,NO,,TCGA-XF-AAME-D62017,F30604A8-2DC5-41A4-94B1-ECCF7B8E8D50,NA,,NA,,NA,2569,2569,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,11,7,2014,TCGA-BLCA
270,TCGA-XF-AAMF,NO,,TCGA-XF-AAMF-D62165,B24DCE72-D14C-46B8-BDA3-F31C0BFC76E0,NA,,NA,,NA,161,274,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,12,7,2014,TCGA-BLCA
269,TCGA-XF-AAMF,NO,,TCGA-XF-AAMF-D62164,34818ACA-D38D-4BCB-AEB2-E0EE140B02F9,NA,,NA,,NA,161,274,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,12,7,2014,TCGA-BLCA
271,TCGA-XF-AAMG,NO,,TCGA-XF-AAMG-D61740,0EFF6E6D-4AC0-42E3-BBAC-B0E7F4EA0976,NA,,NA,,NA,74,151,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,21,7,2014,TCGA-BLCA
272,TCGA-XF-AAMG,NO,,TCGA-XF-AAMG-D61739,8B357F3E-0BE3-4DFF-86E8-14A7AB8F41DA,NA,,NA,,NA,74,151,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,21,7,2014,TCGA-BLCA
274,TCGA-XF-AAMJ,NO,,TCGA-XF-AAMJ-D62172,CDEADBEB-7461-4531-8F71-3CADA30D810F,NA,,NA,,NA,82,143,Chemotherapy,Platinum,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,12,7,2014,TCGA-BLCA
273,TCGA-XF-AAMJ,NO,,TCGA-XF-AAMJ-D62171,D68B731D-FAF0-437A-957F-045178B96A76,NA,,NA,,NA,82,143,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,12,7,2014,TCGA-BLCA
275,TCGA-XF-AAMR,NO,,TCGA-XF-AAMR-D62176,DC0734AB-1A00-4F51-B45A-79BBC93ECFD4,NA,,NA,,NA,119,192,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,13,7,2014,TCGA-BLCA
276,TCGA-XF-AAMR,NO,,TCGA-XF-AAMR-D62177,9D981374-EAE9-42D6-A165-E82DAB559C5C,NA,,NA,,NA,119,192,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,13,7,2014,TCGA-BLCA
277,TCGA-XF-AAMY,NO,,TCGA-XF-AAMY-D62220,A1380301-5B3D-4542-A8FE-04A142DA42A0,NA,,NA,,NA,669,853,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,15,7,2014,TCGA-BLCA
278,TCGA-XF-AAMY,NO,,TCGA-XF-AAMY-D62221,A03EFBED-7200-459C-BD63-8118F79AA905,NA,,NA,,NA,671,853,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,15,7,2014,TCGA-BLCA
279,TCGA-XF-AAMZ,NO,,TCGA-XF-AAMZ-D62345,FEC38DE9-1E37-4277-B128-DE87B74E792C,NA,,NA,,NA,0,0,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Clinical Progressive Disease,15,7,2014,TCGA-BLCA
282,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62517,93A46A11-39E8-4593-AE3F-4AB50B3E623D,NA,,NA,,NA,53,175,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,19,7,2014,TCGA-BLCA
281,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62516,00007185-662F-4AF9-B90F-B73DEDEAE8A7,NA,,NA,,NA,53,175,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Complete Response,19,7,2014,TCGA-BLCA
283,TCGA-XF-AAN0,YES,,TCGA-XF-AAN0-D62518,6C3388FA-B1D4-4315-BE94-CC4E39FAB53E,NA,,NA,,NA,614,866,Chemotherapy,Halichondrin B,Antimitotic,Antimitotic,Anti-tubulin agent,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
286,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62521,60FD150C-836A-4098-905F-CB879F56DF75,NA,,NA,,NA,898,1052,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
284,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62519,B7F6E64F-1BB2-4388-AABF-F62AB860C455,NA,,NA,,NA,898,1052,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
285,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62520,535127D6-B422-4608-A7D1-1B0ED7D63611,NA,,NA,,NA,898,1052,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
288,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62523,BB3FECDF-1F45-42B9-BC18-242AB337CFE0,NA,,NA,,NA,1094,1136,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
287,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62522,BA0FAC90-B83B-4B17-9C03-35C0198A3273,NA,,NA,,NA,1094,1136,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
290,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62525,2A7E98EA-34FF-45BB-BB07-D816EF52D85B,NA,,NA,,NA,1265,1318,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
289,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62524,F0FF819C-FA2C-4E7B-A1CA-8CD498BD3371,NA,,NA,,NA,1265,1318,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
291,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62526,D1BB434A-F94E-4706-A788-71D092772679,NA,,NA,,NA,1423,1486,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
292,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62527,4E2AD69A-535F-4040-B362-1FE4451470F1,NA,,NA,,NA,1465,1486,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Partial Response,19,7,2014,TCGA-BLCA
293,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62528,BF52CAD0-17AF-465D-B6B0-3E4368D6A4FD,NA,,NA,,NA,1598,1598,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,19,7,2014,TCGA-BLCA
294,TCGA-XF-AAN0,NO,,TCGA-XF-AAN0-D62529,226B95EA-5675-4BA5-A592-3FD8A86E53C5,NA,,NA,,NA,1598,1598,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,NA,,NO,Clinical Progressive Disease,19,7,2014,TCGA-BLCA
298,TCGA-XF-AAN1,NO,,TCGA-XF-AAN1-D62348,31A09893-A09C-4BE3-A64A-11D2D283BACC,NA,,NA,,NA,0,0,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Clinical Progressive Disease,16,7,2014,TCGA-BLCA
297,TCGA-XF-AAN1,NO,,TCGA-XF-AAN1-D62347,A9E44A74-1D24-42CF-B7E4-45E5EE58D785,NA,,NA,,NA,0,0,Immunotherapy,BCG vaccine,Proinflammatory immunomodulator,Other,,,NA,,NO,Partial Response,16,7,2014,TCGA-BLCA
299,TCGA-XF-AAN3,NO,,TCGA-XF-AAN3-D62344,D4FB8933-FBBE-4CAB-A174-BC166465ECC7,NA,,NA,,NA,121,142,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,20,7,2014,TCGA-BLCA
300,TCGA-XF-AAN3,NO,,TCGA-XF-AAN3-D62538,DEB2649C-47A3-4709-A79E-3DBDCEEF801D,NA,,NA,,NA,121,142,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,20,7,2014,TCGA-BLCA
301,TCGA-XF-AAN5,NO,,TCGA-XF-AAN5-D62542,DD5FBE8B-3A35-44F8-8014-02334A3FACCA,NA,,NA,,NA,127,211,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,20,7,2014,TCGA-BLCA
302,TCGA-XF-AAN5,NO,,TCGA-XF-AAN5-D62543,9A823C6E-A86F-4A1C-A542-03795247A7A9,NA,,NA,,NA,127,211,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,20,7,2014,TCGA-BLCA
307,TCGA-XF-AAN7,NO,,TCGA-XF-AAN7-D62548,CF060018-E3F7-45BA-8407-8CF590D28DD6,NA,,NA,,NA,0,9,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,21,7,2014,TCGA-BLCA
306,TCGA-XF-AAN7,NO,,TCGA-XF-AAN7-D62547,76A9D3F2-9A8E-4A07-8BA5-45DAC66F7D5A,NA,,NA,,NA,0,9,Chemotherapy,Paclitaxel,Antimitotic,Antimitotic,,,NA,,NO,Stable Disease,21,7,2014,TCGA-BLCA
303,TCGA-XF-AAN7,NO,,TCGA-XF-AAN7-D62544,85C213D0-980A-474E-872A-1C13921AF1F4,NA,,NA,,NA,162,200,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Partial Response,21,7,2014,TCGA-BLCA
304,TCGA-XF-AAN7,NO,,TCGA-XF-AAN7-D62545,9182B031-3872-486A-B137-38E2A151FF89,NA,,NA,,NA,162,200,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Partial Response,21,7,2014,TCGA-BLCA
305,TCGA-XF-AAN7,NO,,TCGA-XF-AAN7-D62546,F3AB0FF8-2D1F-47EB-83FA-09CF13D375EF,NA,,NA,,NA,351,374,Chemotherapy,Ifosfamide,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,21,7,2014,TCGA-BLCA
308,TCGA-XF-AAN7,YES,,TCGA-XF-AAN7-D62549,0DBB730F-938A-4675-A8DE-8575ACA21C6A,NA,,NA,,NA,399,442,Chemotherapy,Docetaxel|Vandetanib,Topoisomerase inhibitor|HER1 inhibitor|Angiogenesis inhibitor,Topoisomerase inhibitor|Other,Blinded: Zactima or Placebo. Zactima is a kinase inhibitor,,NA,,NO,Clinical Progressive Disease,21,7,2014,TCGA-BLCA
8116,TCGA-XJ-A9DI,NO,NA,TCGA-XJ-A9DI-D59827,1572B2F1-99F4-4B83-B2E3-67C95C87A27E,NA,NA,NA,,NA,913,1339,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Partial Response,21,5,2014,TCGA-PRAD
8115,TCGA-XJ-A9DI,NO,NA,TCGA-XJ-A9DI-D59826,DD5BF1E7-BA7F-4E34-B04A-A202A1E8F538,NA,NA,NA,,NA,1339,1461,Hormone Therapy,Nilutamide,Antiandrogen,Other,,,NA,,NO,Partial Response,21,5,2014,TCGA-PRAD
8120,TCGA-XK-AAIV,NO,NA,TCGA-XK-AAIV-D67002,CE546E39-233A-4D3C-9B8B-8CD19D791C6C,NA,NA,NA,,NA,97,126,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,29,10,2014,TCGA-PRAD
9566,TCGA-XM-AAZ1,NO,NA,TCGA-XM-AAZ1-D64574,B68B86FE-EC6A-4E28-A62E-CC2ADB4D717D,NA,NA,NA,NA,NA,13,55,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Stable Disease,4,9,2014,TCGA-THYM
2719,TCGA-XX-A899,NO,,TCGA-XX-A899-D67388,E8DE13D8-49EB-4C42-AE4A-FCBA49BD0CC1,,,,,,96,201,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,11,11,2014,TCGA-BRCA
2720,TCGA-XX-A899,NO,,TCGA-XX-A899-D67518,A746793A-ADCD-4ED7-A7C7-A3BD3B1403C8,,,,,,96,201,Chemotherapy,Docetaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,11,11,2014,TCGA-BRCA
8011,TCGA-YB-A89D,NO,NA,TCGA-YB-A89D-D67759,B27A4A44-DE9B-414A-8CD6-C7B0D4105968,NA,NA,NA,NA,NA,87,123,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,11,2014,TCGA-PAAD
8010,TCGA-YB-A89D,NO,NA,TCGA-YB-A89D-D67758,2AD5E07E-6E63-4F61-8E02-B0991D0FDA77,NA,NA,NA,NA,NA,7,210,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,11,11,2014,TCGA-PAAD
309,TCGA-YC-A89H,NO,,TCGA-YC-A89H-D66948,9F434C9E-E3D8-4C44-85B2-098F5CAB7AC7,NA,,NA,,NA,35,83,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,11,11,2014,TCGA-BLCA
310,TCGA-YC-A89H,NO,,TCGA-YC-A89H-D66947,8485E45C-7B44-420A-892F-E94F0B86A2A5,NA,,NA,,NA,35,83,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,11,11,2014,TCGA-BLCA
8859,TCGA-YG-AA3O,NO,,TCGA-YG-AA3O-D59918,0C714B72-9B80-4436-B8E8-4236A49D60BB,NA,NA,NA,,NA,977,1006,Immunotherapy,Interferon,Proinflammatory immunomodulator,Other,,,,,NO,Partial Response,23,5,2014,TCGA-SKCM
8121,TCGA-YL-A8HJ,NO,NA,TCGA-YL-A8HJ-D56596,76F32FE0-FEB6-4E85-8E91-384D6F3C5986,NA,NA,NA,,NA,209,306,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8122,TCGA-YL-A8HJ,NO,NA,TCGA-YL-A8HJ-D56597,5A16D516-B0FC-46E3-B2B9-EB9459872149,NA,NA,NA,,NA,209,1036,Hormone Therapy,Goserelin,LHRH agonist,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8123,TCGA-YL-A8HK,NO,NA,TCGA-YL-A8HK-D57499,63BCA1CC-443D-46BA-871B-698BE1EB1FE6,NA,NA,NA,,NA,179,208,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8125,TCGA-YL-A8HL,NO,NA,TCGA-YL-A8HL-D57505,C9047040-F593-4900-AB18-8F84A7E3AB27,NA,NA,NA,,NA,132,162,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8126,TCGA-YL-A8HL,NO,NA,TCGA-YL-A8HL-D57506,13E4A7E5-1C0B-4702-95A8-801835DA59E4,NA,NA,NA,,NA,132,1228,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8127,TCGA-YL-A8HM,NO,NA,TCGA-YL-A8HM-D57509,3DD9A683-6AA5-4EE5-A273-F242110B7386,NA,NA,NA,,NA,216,251,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8128,TCGA-YL-A8HM,NO,NA,TCGA-YL-A8HM-D57510,87372656-6CA8-49B7-B522-A98A53DB14ED,NA,NA,NA,,NA,216,752,Hormone Therapy,Goserelin,LHRH agonist,Other,,,NA,,NO,Complete Response,13,3,2014,TCGA-PRAD
8129,TCGA-YL-A8SB,NO,NA,TCGA-YL-A8SB-D58881,B4751861-3FE1-4BFE-9586-3B84AB33EA35,NA,NA,NA,,NA,270,299,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,25,4,2014,TCGA-PRAD
8130,TCGA-YL-A8SB,NO,NA,TCGA-YL-A8SB-D58883,1D8F3346-59B8-480C-845C-7434F35F6070,NA,NA,NA,,NA,280,998,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,25,4,2014,TCGA-PRAD
8133,TCGA-YL-A8SC,NO,NA,TCGA-YL-A8SC-D58907,B386BFEF-969E-4B19-BF5A-1EF30509ABCF,NA,NA,NA,,NA,166,195,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Partial Response,27,4,2014,TCGA-PRAD
8137,TCGA-YL-A8SL,NO,NA,TCGA-YL-A8SL-D58895,2B3267EB-DC47-4793-97D4-FFBB33CE99FD,NA,NA,NA,,NA,266,296,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,25,4,2014,TCGA-PRAD
8139,TCGA-YL-A8SO,NO,NA,TCGA-YL-A8SO-D58910,20F48B38-F689-4EB1-B880-87C97A84107F,NA,NA,NA,,NA,1387,1862,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,27,4,2014,TCGA-PRAD
8142,TCGA-YL-A8SP,NO,NA,TCGA-YL-A8SP-D59004,869F8115-76EA-4E73-873C-97A68E412372,NA,NA,NA,,NA,359,749,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,30,4,2014,TCGA-PRAD
8141,TCGA-YL-A8SP,NO,NA,TCGA-YL-A8SP-D59003,9E726B6D-22E0-47A1-9FA4-B54FCDDFA43F,NA,NA,NA,,NA,359,749,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,30,4,2014,TCGA-PRAD
8143,TCGA-YL-A8SP,NO,NA,TCGA-YL-A8SP-D59007,057173BD-C7F4-4750-882A-B9B51145C98A,NA,NA,NA,,NA,1183,2170,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Partial Response,30,4,2014,TCGA-PRAD
8144,TCGA-YL-A8SP,NO,NA,TCGA-YL-A8SP-D59011,17D96CC4-B3A0-46C2-AF8A-5454AD7E54AF,NA,NA,NA,,NA,1814,2170,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Partial Response,30,4,2014,TCGA-PRAD
8147,TCGA-YL-A9WH,NO,NA,TCGA-YL-A9WH-D58468,B6EAC208-CC5C-4B45-B620-6B72C066898B,NA,NA,NA,,NA,203,232,Hormone Therapy,Bicalutamid,Antiandrogen,Other,,,NA,,NO,Complete Response,10,4,2014,TCGA-PRAD
8149,TCGA-YL-A9WK,NO,NA,TCGA-YL-A9WK-D58525,F8E9D4D1-6D56-45DE-ADB1-2EA475E6BAF7,NA,NA,NA,,NA,360,834,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,13,4,2014,TCGA-PRAD
8150,TCGA-YL-A9WK,NO,NA,TCGA-YL-A9WK-D58526,9543A0FE-AD9C-4CCA-80E7-970743C86032,NA,NA,NA,,NA,1163,1527,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,13,4,2014,TCGA-PRAD
8153,TCGA-YL-A9WL,NO,NA,TCGA-YL-A9WL-D58513,29A62183-65A9-48E8-A74D-F04980EC5C9E,NA,NA,NA,,NA,271,349,Hormone Therapy,Leuprolide,Aromatase inhibitor,Other,,,NA,,NO,Complete Response,12,4,2014,TCGA-PRAD
9483,TCGA-YU-A90Q,NO,NA,TCGA-YU-A90Q-D65286,DD493DB2-3671-43C2-9156-7B83020FB26C,NA,NA,NA,NA,NA,219,252,Chemotherapy,Carboplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,21,9,2014,TCGA-TGCT
9484,TCGA-YU-A912,NO,NA,TCGA-YU-A912-D65290,190BA546-7D6F-4128-B5F5-738650ED7A85,NA,NA,NA,NA,NA,26,111,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,21,9,2014,TCGA-TGCT
9485,TCGA-YU-A94D,NO,NA,TCGA-YU-A94D-D65291,3E5D9E6C-26BB-4721-8481-1F9629CBC8AD,NA,NA,NA,NA,NA,69,151,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,21,9,2014,TCGA-TGCT
9486,TCGA-YU-AA4L,NO,NA,TCGA-YU-AA4L-D65292,C566721F-1484-4BCF-ABB4-9DFBAB6F69DE,NA,NA,NA,NA,NA,2,83,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Stable Disease,21,9,2014,TCGA-TGCT
9489,TCGA-YU-AA4L,NO,NA,TCGA-YU-AA4L-D65295,A3C35ED5-97A8-4BE3-85FE-A8B8E741C676,NA,NA,NA,NA,NA,250,358,Chemotherapy,Oxaliplatin|Gemcitabine,Alkylating agent|Antimetabolite,Alkylating agent|Antimetabolite,NA,NA,NA,NA,NO,Complete Response,21,9,2014,TCGA-TGCT
9490,TCGA-YU-AA61,NO,NA,TCGA-YU-AA61-D66895,F0EF0252-E1D0-4C6D-A736-44F61655705D,NA,NA,NA,NA,NA,49,106,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,27,10,2014,TCGA-TGCT
8013,TCGA-YY-A8LH,NO,NA,TCGA-YY-A8LH-D58237,ACCAF7FF-00A3-4118-BB1C-6B4217B643CD,NA,NA,NA,NA,NA,43,71,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Partial Response,3,4,2014,TCGA-PAAD
8014,TCGA-YY-A8LH,NO,NA,TCGA-YY-A8LH-D58238,A233DBFC-6847-4425-B307-4C4FB73A6F30,NA,NA,NA,NA,NA,85,135,Chemotherapy,Capecitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,3,4,2014,TCGA-PAAD
8012,TCGA-YY-A8LH,NO,NA,TCGA-YY-A8LH-D58241,3E280610-EBD3-4767-9ED7-3D83B9F047FC,NA,NA,NA,NA,NA,176,218,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,3,4,2014,TCGA-PAAD
8015,TCGA-Z5-AAPL,NO,NA,TCGA-Z5-AAPL-D68156,16523B71-9232-4675-9846-B0EF85F0DD5B,NA,NA,NA,NA,NA,5,21,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,NA,NA,NA,NO,Complete Response,13,11,2014,TCGA-PAAD
8017,TCGA-Z5-AAPL,NO,NA,TCGA-Z5-AAPL-D69056,5277FB1E-A345-47B3-B3C8-FD85D9D5297D,NA,NA,NA,NA,NA,5,21,Chemotherapy,5-Fluorouracil,Antimetabolite,Antimetabolite,,NA,NA,NA,NO,Complete Response,24,12,2014,TCGA-PAAD
8016,TCGA-Z5-AAPL,NO,NA,TCGA-Z5-AAPL-D69055,6173B8CB-3B7E-42D2-BBC2-D23124482BC2,NA,NA,NA,NA,NA,5,21,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,NA,NA,NA,NO,Complete Response,24,12,2014,TCGA-PAAD
2723,TCGA-Z7-A8R5,NO,,TCGA-Z7-A8R5-D58761,3B9407D6-8ECF-44E6-A3C8-821C5FF3B17A,,,,,,61,181,Chemotherapy,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Stable Disease,9,7,2014,TCGA-BRCA
2724,TCGA-Z7-A8R5,NO,,TCGA-Z7-A8R5-D58762,975E7C8D-AADD-4A83-8053-CDE2D86B1A5A,,,,,,61,181,,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Stable Disease,9,7,2014,TCGA-BRCA
2722,TCGA-Z7-A8R5,NO,,TCGA-Z7-A8R5-D58759,08450109-B43A-47C4-8D73-9711DF983444,,,,,,61,181,Chemotherapy,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Stable Disease,9,7,2014,TCGA-BRCA
2726,TCGA-Z7-A8R6,NO,,TCGA-Z7-A8R6-D58750,644F7063-1BA4-4B84-99E4-012DB9AE1486,,,,,,31,153,,Cyclophosphamide,Alkylating agent,Alkylating agent,,,,,NO,Complete Response,9,7,2014,TCGA-BRCA
2727,TCGA-Z7-A8R6,NO,,TCGA-Z7-A8R6-D58751,21D2B8CE-9A15-4401-936E-688113BD6678,,,,,,31,153,,Paclitaxel,Antimitotic,Antimitotic,,,,,NO,Complete Response,9,7,2014,TCGA-BRCA
2725,TCGA-Z7-A8R6,NO,,TCGA-Z7-A8R6-D58749,A2A69EA3-72CF-46C2-B6D6-DF0A093887A5,,,,,,31,153,,Doxorubicin,Topoisomerase inhibitor,Topoisomerase inhibitor,,,,,NO,Complete Response,9,7,2014,TCGA-BRCA
313,TCGA-ZF-AA4V,NO,,TCGA-ZF-AA4V-D72083,ED9CC992-A9F2-41F2-9711-1747A3A1F37E,NA,,NA,,NA,202,265,Chemotherapy,Cisplatin|Gemcitabine,Alkylating agent|Antimetabolite,Alkylating agent|Antimetabolite,,,NA,,NO,Complete Response,10,4,2015,TCGA-BLCA
315,TCGA-ZF-AA51,NO,,TCGA-ZF-AA51-D72092,097FAF51-5B92-4A4C-940C-73BE0DA86F74,NA,,NA,,NA,69,148,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,10,4,2015,TCGA-BLCA
314,TCGA-ZF-AA51,NO,,TCGA-ZF-AA51-D72091,785199D4-90BF-40CE-AEAB-A5EA5953AAA3,NA,,NA,,NA,69,148,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,10,4,2015,TCGA-BLCA
317,TCGA-ZF-AA53,NO,,TCGA-ZF-AA53-D72089,348A86EE-A088-45D5-BF2B-ABE4D6526C42,NA,,NA,,NA,68,166,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,10,4,2015,TCGA-BLCA
316,TCGA-ZF-AA53,NO,,TCGA-ZF-AA53-D72088,C1E16CF1-0677-4402-B05C-6A1FC943E0D5,NA,,NA,,NA,68,166,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,10,4,2015,TCGA-BLCA
319,TCGA-ZF-AA58,NO,,TCGA-ZF-AA58-D72103,907B197A-9F12-421F-986E-019634FFD53B,NA,,NA,,NA,166,NA,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Complete Response,13,4,2015,TCGA-BLCA
318,TCGA-ZF-AA58,NO,,TCGA-ZF-AA58-D72102,0DAABAAD-5EF1-47DF-9196-94BAEB18E3D5,NA,,NA,,NA,166,NA,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Complete Response,13,4,2015,TCGA-BLCA
321,TCGA-ZF-AA5H,NO,,TCGA-ZF-AA5H-D72106,CAB786E1-619B-4568-A424-698490997C7B,NA,,NA,,NA,135,177,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,,,NA,,NO,Clinical Progressive Disease,13,4,2015,TCGA-BLCA
320,TCGA-ZF-AA5H,NO,,TCGA-ZF-AA5H-D72105,9182BB2E-2590-4004-A0E1-0F826DC256B8,NA,,NA,,NA,135,177,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,,,NA,,NO,Clinical Progressive Disease,13,4,2015,TCGA-BLCA
2938,TCGA-ZH-A8Y4,NO,NA,TCGA-ZH-A8Y4-D57457,0C3D3AAA-8392-4A62-BD01-C0EA99C146CF,NA,NA,NA,NA,NA,70,162,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Partial Response,11,3,2014,TCGA-CHOL
2940,TCGA-ZH-A8Y5,NO,NA,TCGA-ZH-A8Y5-D57467,BDEA6737-0E80-4FE9-AA9C-4B0D215895A0,NA,NA,NA,NA,NA,132,231,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Partial Response,11,3,2014,TCGA-CHOL
2939,TCGA-ZH-A8Y5,NO,NA,TCGA-ZH-A8Y5-D57466,4F0CFB1E-6B24-47EE-A71F-5A949E02D46E,NA,NA,NA,NA,NA,132,246,Chemotherapy,Gemcitabine,Antimetabolite,Antimetabolite,NA,NA,NA,NA,NO,Partial Response,11,3,2014,TCGA-CHOL
9493,TCGA-ZM-AA05,NO,NA,TCGA-ZM-AA05-D61141,EAF6AF84-35CB-4F67-9CB9-E0B223BA2577,NA,NA,NA,NA,NA,20,77,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9491,TCGA-ZM-AA05,NO,NA,TCGA-ZM-AA05-D61139,F9DE8D9F-3146-4D38-866E-EF0647837B1B,NA,NA,NA,NA,NA,20,87,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9492,TCGA-ZM-AA05,NO,NA,TCGA-ZM-AA05-D61140,2F0D3432-47A0-4E00-91CF-1C8BE0740614,NA,NA,NA,NA,NA,20,87,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9496,TCGA-ZM-AA06,NO,NA,TCGA-ZM-AA06-D61138,4E773173-03FA-4906-AEBF-0E1EEF02C0A8,NA,NA,NA,NA,NA,48,48,Chemotherapy,Bleomycin,DNA synthesis inhibitor|RNA synthesis inhibitor,Other,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9495,TCGA-ZM-AA06,NO,NA,TCGA-ZM-AA06-D61137,B794C2CD-CA2A-42CD-825A-ACA5E7B27FE7,NA,NA,NA,NA,NA,47,50,Chemotherapy,Etoposide,Topoisomerase inhibitor,Topoisomerase inhibitor,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT
9494,TCGA-ZM-AA06,NO,NA,TCGA-ZM-AA06-D61136,BFA1FBE7-EEF6-454B-8162-938BBC106EB5,NA,NA,NA,NA,NA,47,51,Chemotherapy,Cisplatin,Alkylating agent,Alkylating agent,NA,NA,NA,NA,NO,Complete Response,25,6,2014,TCGA-TGCT